תשע"א/י"ב
8/2011
א' באלול התשע"א
August 31,2011
יומן הפטנטים והמדגמים
PATENTS AND DESIGNS JOURNAL
Page/עמוד
Patents
Applications filed
Applications accepted
Patents granted
Patents renewed
Patents renewed for 20 years
Changes in particulars entered in
register
Corrections
Country codes
Indices of applications accepted
Designs
Designs registered
Designs canceled
1
4
78
295
295
297
310
311
335
324
310
323
פטנטים
בקשות שהוגשו
בקשות שקובלו
פטנטים שניתנו
פטנטים שחודשו
פטנטים שחודשו לעשרים שנה
שינויים בפרטים רשומים בפנקס
תיקונים
קודים למדינות
מפתחות לבקשות שהתקבלו
מדגמים
מדגמים שנרשמו
מדגמים שבוטלו
August 31,2011 -א' באלול התשע"א
ידיעות כלליות
: וכו' בענייני פטנטים ומדגמים יש לשלוח אל, מסמכים,מכתבים
. ירושלים, מלחה5 בנין, גנים טכנולוגיים ירושלים,רשם הפטנטים והמדגמים
'אגרות ללשכת הפטנטים מתקבלות אך ורק על ידי תשלום לחשבון הרשות בבנק הדואר מס
יש להציג קבלת בנק הדואר ללשכה יחד עם הבקשה לפעולה שעבורה האגרה.0-24145-2
.שולמה
GENERAL INFORMATION
Letters, documents, etc. concerning Patents and Designs should be addressed to:
The Patent Authority, Jerusalem Technology Park, Building5, Malcha., Jerusalem.
Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of the
Authority, No. 0-24145-2. The receipt of the Postal Bank must be presented to the office
together with the application for the action for which the fee has been paid.
Copyright by the State of Israel. No
Extracts may be published except with the
permission of the Patent Office.
2
זכות היוצרים בתקצירים אלה שמורה למדינת
אין להעתיק מתקצירים אלה אלא,ישראל
.ברשות לשכת הפטנטים
August 31,2011 -א' באלול התשע"א
PATENTS
NOTICE UNDER SECTION 16 OF THE
PATENTS LAW, 5727-1967
In the following there are listed new
applications complying with the provisions
of rule 32(a) of the Patent Regulations, 57281968:
Particulars of the applications are given in
the following order:
Number and date of application and the first
four symbols of the International
Classification.
Title of invention (as proposed by applicant)
Applicant
Priority right:
Convention countryNumber and date of
Foreign application
International Application Number
International Publication Number
3
פטנטים
- תשכ"ז, לחוק הפטנטים16 הודעה לפי סעיף
1967
להלן רשימת בקשות חדשות הממלאות אחר
)א( לתקנות32 הדרישות שנקבעו בתקנה
:1968- תשכ"ח,הפטנטים
:פרטי הבקשות מובאים לפי סדר זה
מספר הבקשה – ותאריך הגשתה וארבעה
הסמנים הראשונים של הסיווג הבינלאומי
(שם האמצאה )כפי שהוצע ע"י המבקש
המבקש
– מדינת האיגוד
:דין קדימה
תאריך ומספר
בקשת החוץ
מספר בקשה בינלאומית
מספר פרסום בינלאומי
August 31,2011 -א' באלול התשע"א
13/07/2008
192779
A METHOD AND A SYSTEM FOR
DETERMINING THE SPATIAL
LOCATION OF NODES IN A
WIRELESS NETWORK
MICHAEL ROTHSCHILD
US
60/949567
13/07/2007
60/988284
15/11/2007
US
30/12/2010
שיטה ומערכת לקביעת מיקום מרחבי של
תחנות ברת אלחוטית
210370
4
F41A (2010.01)
התעשיה האוירית לישראל בע"מ
212692
ANTI-THEFT APPARATUS FOR
SOLAR PANELS
SOLARIS ENERGY SYSTEMS LTD
US
61/360613
01/07/2010
61/423755
16/12/2010
US
PCT/IL/2011/000278
03/01/2011
מיכאל רוטשילד
טיל
PROJECTILE
ISRAEL AEROSPACE INDUSTRIES
LTD.
27/03/2011
H04W (2010.01)
212760
E05B (2010.01)
התקן נגד גניבות לפנלים סולאריים
סולאריס אנרג'י מערכות בע"מ
A61B (2010.01)
August 31,2011 -א' באלול התשע"א
INTERNAL AND EXTERNAL DISC
SHUNTS ALLEVIATE BACK PAIN
TERESA T. YEUNG OF
02/01/2010
US
61/335140
61/399088
06/07/2010
US
PCT/US/2011/000007
WO/2011/082390
29/05/2011
הסטות דיסקוס פנימיות וחיצוניות להקלה
בכאבי גב
213199
מערכת הדמיה רב פונקציונלית
MULTI-FINCTION IMAGING SYSTEM
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
23/12/2009
G01S (2010.01)
רפאל מערכות לחימה מתקדמות בע"מ
213227
METHOD AND DATA PROCESSING
SYSTEM FOR SIMULATING AN
EMBEDDED SYSTEM
INCHRON GMBH
G01S (2010.01)
שיטה ומערכת עיבוד להדמיית מערכת
משובצת
PCT/EP/2009/067871
06/06/2011
213427
METHOD AND SYSTEM FOR
PROPAGATION TIME
MEASUREMENT AND CALIBRATION
USING MUTUAL COUPLING IN A
RADIO FREQUENCY
TRANSMIT/RECEIVE SYSTEM
RAYTHEON COMPANY
28/06/2010
US
12/825193
5
G01V (2010.01)
שיטה ומערכת למדידה וכיול של זמן
התפשטות המשתמשות בהצמדה הדדית
קליטה גל רדיו/במערכת שידור
August 31,2011 -א' באלול התשע"א
09/06/2011
213462
STAND ALONE WIMAX SYSTEM
AND METHOD
RUGGEDOM INC
CA
2732181
18/02/2011
12/06/2011
213497
LIGHT PUBLIC KEY
CRYPTOGRAPHY
NDS LIMITED
30/06/2011
213864
213902
SYSTEM AND METHOD FOR THE
MONITORING OF LIQUID PUANTITY,
DEFICIT AND CONSUMPTION
ITSHAK YESHAAYAHU BEN YESHA
6
ושיטה,מערכת ווימקס כיחידה בודדת
G06F (2010.01)
הצפנת מפתח פומבי יעילה
METHOD FOR REMOVING A LYTIC
ENZYME FROM A HETEROGENEOUS
MIXTURE
OMRIX BIOPHARMACEUTICALS
LTD.
03/07/2011
G06F (2010.01)
C12N (2010.01)
שיטה לסילוק אנזים ליטי מתמיסה
הטרוגנית
אומריקס ביופארמאצבטיקה בע"מ
A61M (2010.01)
גרעון,מערכת ושיטה לניטור כמות
וצריכת נוזלים
יצחק ישעיהו בן ישע
August 31,2011 -א' באלול התשע"א
03/07/2011
213903
HYBRID ELECTRICITY GENERATION
DEVICE
YAIR DANEL
03/07/2011
213914
IMPROVED DATA ENTRY SYSTEMS
BENJAMIN FIROOZ GHASSABIAN
05/07/2011
213939
SPRINKLER BASE
NAANDAN JAIN IRRIGATION C.S.
LTD.
US
12/836328
14/07/2010
13/01/2010
213946
SYSTEM AND METHOD FOR
INSPECTING A WAFER
SEMICONDUCTOR TECHNOLOGIES
& INSTRUMENTS PTE LTD (SG)
200900229SG
13/01/2009
6
7
B60W (2010.01)
מתקן היברידי ליצור חשמל
יאיר דנאל
G06F (2010.01)
שיטות משופרות להכנסת נתונים
בנימין פירוז גסביאן
B05B (2010.01)
בסיס לממטרה
אגודה שיתופית- דן ג'יין השקייה-נען
חקלאית בע"מ
H01L (2010.01)
מערכת ושיטה לבחינת פרוסות
August 31,2011 -א' באלול התשע"א
200901110-7
SG
PCT/SG/2010/000006
WO/2010/082902
16/02/2009
06/07/2011
213947
A METHOD AND AMUSEMENT
DEVICE THAT DETECTS THE
GARBAGE VOLUME INSIDE
GARBAGE CANS
RAZ BERMAN
26/01/2010
שיטה ומכשיר למטרות בידור אשר מזהה
את נפח האשפה בתוך פחי האשפה
רז ברמן
213948
CUTTING TOOL HAVING
ADJUSTMENT MECHANISM
ISCAR LTD.
24/02/2009
IL
197205
PCT/IL/2010/000061
WO/2010/097789
08/01/2010
8
B23B (2010.01)
כלי חיתוך בעל מנגנון כוונון
ישקר בע"מ
213950
C12N (2010.01)
פוליפפטידים של טרנסאמינאז
TRANSAMINASE POLYPEPTIDES
CODEXIS, INC
US
61/143401
08/01/2009
PCT/US/2010/020563
WO/2010/081053
11/01/2010
B30B (2010.01)
213951
A23L (2010.01)
August 31,2011 -א' באלול התשע"א
PROCESSED CITRUS FRUIT RAW JUICE
OR THE CONCENTRATE THEREOF,
THEIR PREPARATION METHOD AND
PRODUCTS COMPRISING THE SAME
YANG SHENG TANG COMPANY
LIMITED
CN
200910000665.1 13/01/2009
PCT/CN/2010/000039
WO/2010/081385
02/02/2010
,מיץ הדרים מעובד גולמי או רכז
הכנתם ושיטה ותוצרים המכילים אותם
C07D (2010.01)
213953
פירימידינים דחוסים
FUSED PYRIMIDINES
BAYER SCHERING PHARMA
AKTIENGESELLSCHAFT
EP
09075072.0 13/02/2009
09152914.9
16/02/2009
EP
PCT/EP/2010/000620
WO/2010/091808
15/01/2010
COMMUNICATION DEVICE,
COMMUNICATION METHOD, AND
INTEGRATED CIRCUIT
PANASONIC CORPORATION
2009JP
16/01/2009
007906
2009-007907 16/01/2009
JP
PCT/JP/2010/050752
WO/2010/082691
08/01/2010
התקן ושיטה לתקשורת ומעגל משולב
213955
METHOD FOR IMPROVED
BIOACTIVATION OF MEDICATIONS
DRITTE PATENTPORTFOLIO
BETEILIGUNGSGESELLSCHAFT MBH &
CO. KG
DE
102009004204.0 09/01/2009
9
H04L (2010.01)
213954
A61K (2010.01)
שיטה עבור פעילות ביולוגית משופרת
של תרופות
August 31,2011 -א' באלול התשע"א
PCT/DE/2010/000009
WO/2010/078867
12/01/2010
213956
DEVICE AND METHOD OF MARKING
A SET OF PRODUCTS
COMMISSARIAT A L'ENERGIE
ATOMIQUE ET AUX ENERGIES
ALTERNATIVES
FR
0950183
14/01/2009
PCT/FR/2010/050041
WO/2010/081986
15/01/2010
התקן ושיטה לסימון סדרת תוצרים
213957
METHOD FOR CONTROLLING AN
ELEVATOR SYSTEM
INVENTIO AG
EP
09150771.5 16/01/2009
PCT/EP/2010/000196
WO/2010/081709
28/12/2009
10
B66B (2010.01)
שיטה לבקרה של מערכת מעלית
213958
METHOD, APPARATUS AND
COMPUTER PROGRAM PRODUCT
FOR PROVIDING CIPHERING
PROBLEM RECOVERY FOR
UNACKNOWLEDGED MODE RADIO
BEARER
NOKIA CORPORATION
US
12/363001
30/01/2009
PCT/FI/2009/051039
WO/2010/086490
G03H (2010.01)
H04W (2010.01)
התקן ותוכנית מחשב למתן שחזור,שיטה
בעיית צופן לנושא אות רדיו בלתי מזוהה
August 31,2011 -א' באלול התשע"א
03/02/2010
USE OF A GLUCOCORTICOID
COMPOSITION FOR THE
TREATMENT OF SEVERE AND
UNCONTROLLED ASTHMA
ACTIVAERO GMBH RESEARCH &
DEVELOPMENT
US
12/365754
04/02/2009
PCT/EP/2010/051321
WO/2010/089330
19/12/2002
A61K (2010.01)
213959
שימוש בתכשיר גלוקוקורטיקואיד לטיפול
באסטמה חריפה ושאינה ניתנת לשליטה
C07C (2010.01)
213960
–הידרוקסיל אתיל2–(–)פניל מותמר2
קרבמאטים
2-(SUBSTITUTED PHENYL)-2HYDROXYL -ETHYL CARBAMATES
ORTHO-MCNEIL PHARMACEUTICAL,
INC.
EP
01205097.7 21/12/2001
60/418084
11/10/2002
US
PCT/EP/2002/014843
WO/2003/053916
06/07/2011
A01C (2010.01)
213961
מכשיר לפיזור חומר גרגרי
שלמה שטרן
GRANULAR MATERIAL SPREADER
ZAMIR KAYE
12/02/2010
213962
TEXTILE ARTICLE FOR PATIENTS
AFFECTED BY A SKIN DISEASE
LENZI EGISTO S.P.A
IT
MI2009A000196 13/02/2009
PCT/IB/2010/000267
WO/2010/092462
11
A41B (2010.01)
פריט אריג למטופלים שסובלים ממחל
עור
August 31,2011 -א' באלול התשע"א
13/01/2010
213963
LEAD EXTRACTION METHODS AND
APPARATUS
LEADEX CARDIAC LTD
US
61/144176
13/01/2009
PCT/IB/2010/000206
WO/2010/082139
11/01/2010
שיטות והתקנים למיצוי עופרת
213964
PHOSPHORAMIDATE DERIVATIVES
OF GUANOSINE NUCLEOSIDE
COMPOUNDS FOR TREATMENT OF
VIRAL INFECTIONS
UNIVERSITY COLLEGE OF CARDIFF
CONSULTANTS LIMITED
US
61/143527
09/01/2009
61/185426
09/06/2009
US
PCT/US/2010/020632
WO/2010/081082
07/07/2011
INTERACTIVE ADVERTISING
PROJECTION SYSTEM ON
BUILDINGS
OMER AGIV
26/04/2004
12
A61B (2010.01)
C07H (2010.01)
נגזרי פוספוראמידט של תרכובות
נוקליאוזידי גונוסין לטיפול בדלקות
ויראליות
213965
G09F (2010.01)
מערכת אינטראקטיבית להקרנה ופרסום
על בניינים
עומר עגיב
213966
B29C (2010.01)
August 31,2011 -א' באלול התשע"א
AN ORIENTED FILM FROM
ALLOYED THERMOPLASTIC
POLYMERS, AND A METHOD FOR
SUCH MANUFACTURE
OLE-BENDT RASMUSSEN
GB
0309315.0
24/04/2003
PCT/EP/2004/004687
WO/2004/094129
04/02/2010
קרום מכוון העשוי סגסוגת מפולימרים
תרמופלסטיים ושיטה לייצורו
B65D (2010.01)
213967
CONTAINER FOR MEDICAL
PRODUCTS
DAIKYO SEIKO, LTD.
2009JP
04/02/2009
023578
PCT/JP/2010/051569
WO/2010/090244
03/02/2010
מיכל עובר מוצרים רפואיים
213968
METHOD FOR THE PRODUCTION OF A
STACK OF MEDICAMENT POUCHES
USED FOR STORING AND SUPPLYING
MEDICAMENT WAFERS, MEDICAMENT
POUCH TEMPLATE FOR PRODUCING
SAID STACK, AND USE OF THE
MEDICAMENT FOR PRODUCING SAID
STACK, AND USE OF THE
MEDICAMENT POUCH TEMPLATE
BAYER SCHERING PHARMA
AKTIENGESELLSCHAFT
DE
102009008026.0 06/02/2009
102009008028.7
06/02/2009
DE
PCT/EP/2010/000647
WO/2010/089091
10/06/2009
13
213969
A61J (2010.01)
שיטה ליצור מערום פאוצים תרופתיים
המשמשים לאחסון וניפוק תרופות
תבנית פאוץ תרופתי ליצור,דקות
מערום זה ושימוש של תבנית הפאוץ
התרופתי
A61K (2010.01)
August 31,2011 -א' באלול התשע"א
COMBINATION THERAPIES FOR
NEOPLASTIC DISORDERS
CYLENE PHARMACEUTICALS, INC.
US
61/143282
08/01/2009
PCT/US/2009/046948
WO/2010/080170
08/01/2010
PROCESSING BIOMASS
XYLECO, INC.
US
61/147377
PCT/US/2010/020449
WO/2010/085380
רפואה משולבת לאי סדרים שאתיים
עיבוד ביומאסה
26/01/2009
213971
12/01/2010
213973
SALT OF
TETRAHYDROTRIAZOLOPYRIDINE
DERIVATIVE AND CRYSTAL
THEREOF
EISAI R&D MANAGEMENT CO., LTD.
2009JP
26/02/2009
043268
61/155613
26/02/2009
US
PCT/JP/2010/053372
WO/2010/098490
14
C07K (2010.01)
אתרים קושרי דנא מודולריים ושיטות
לשימוש בהם
MODULAR DNA-BINDING DOMAINS
AND METHODS OF USE
ULLA BONAS
DE
102009004659.3 12/01/2009
09165328
13/07/2009
EP
13/07/2009
61/225043
US
PCT/IB/2010/000154
WO/2010/079430
24/02/2010
C12P (2010.01)
213970
C07D (2010.01)
מלח של תולדת
טטראהידרוטריאזולופירידין וקריסטל שלו
August 31,2011 -א' באלול התשע"א
16/02/2010
213974
ISOXAZOLE-ISOXAZOLE AND
ISOXAZOLE-ISOTHIAZOLE
DERIVATIVES
F. HOFFMANN-LA ROCHE AG
EP
09153162.4 19/02/2009
PCT/EP/2010/051890
WO/2010/094669
26/03/2010
08/01/2010
15
A61K (2010.01)
–קינאז עם3 מעכבים של פוספואינוזיטיד
קבוצה קושרת אבץ
213977
STABILIZED AGROCHEMICAL
COMPOSITION
SYNGENTA PARTICIPATIONS AG
US
61/143494
09/01/2009
A61K (2010.01)
IGG EGFR1 טיפול בסרטן עם נוגדן אנטי
שעבר הומניזציה ואירינוטקאן
213976
PHOSPHOINOSITIDE 3-KINASE
INHIBITORS WITH A ZINC BINDING
MOIETY
CURIS, INC.
US
61/143271
08/01/2009
61/172580
24/04/2009
US
PCT/US/2010/020495
WO/2010/080996
07/01/2010
תולדות איזוקסאזול–איזוקסאזול
ואיזוקסאזול–איזותיאזול
213975
TREATMENT OF CANCER WITH A
HUMANIZED ANTI-EGFR IGG1
ANTIBODY AND INRIOTECAN
ROCHE GLYCART AG
EP
09156844.4 31/03/2009
PCT/EP/2010/053973
WO/2010/112413
C07D (2010.01)
A01N (2010.01)
תכשיר אגרוכימיקלי יציב
August 31,2011 -א' באלול התשע"א
PCT/US/2010/020344
WO/2010/080891
213978
15/01/2010
EQUALIZER WITH A VARIABLE
TRANSFER CURVE
ELETTRONICA S.P.A.
IT
RM2009A000022 23/01/2009
PCT/IT/2010/000008
WO/2010/084519
18/02/2010
אקולייזר עם עקומת העברה משתנה
213979
5-(2-{[6-(2,2-DIFLUORO-2PHENYLETHOXY)HEXYL]AMINO}-1HYDROXYETHYL)-8HYDROXYQUINOLIN-2 (1H)-ONE
FOR THE TREATMENT OF LUNG
FUNCTION
ALMIRALL, S.A.
EP
09382020.7 18/02/2009
PCT/EP/2010/001026
WO/2010/094483
18/02/2010
16
A61K (2010.01)
–2––דיפלואורו2,2)–6]}–2)–5
–1–{פנילאתוקסי(הקסיל[אמינו
––הידרוקסיקווינולינ8–(הידרוקסיאתיל
(–ון לטיפול בתפקוד ריאהH1)2
213980
5-(2-{[6-(2,2-DIFLUORO-2PHENYLETHOXY)HEXYL]AMINO}-LHYDROXYETHYL)-8HYDROXYQUINOLIN-2 (1H)-ONE
AND ITS USE IN THE TREATMENT
OF PULMONARY DISEASES
ALMIRALL, S.A.
EP
09382021.5 18/02/2009
PCT/EP/2010/001027
WO/2010/094484
H01P (2010.01)
C07D (2010.01)
–2––דיפלואורו2,2)–6]}–2)–5
–L–{פנילאתוקסי(הקסיל[אמינו
–2––הידרוקסיקווינולינ8–(הידרוקסיאתיל
(–ון ושימוש שלו בטיפול במחלות שלH1)
הריאות
August 31,2011 -א' באלול התשע"א
23/02/2010
213981
ISOXAZOLE/O-PYRIDINE
DERIVATIVES WITH ETHYL AND
ETHENYL LINKER
F. HOFFMANN-LA ROCHE AG
EP
09153575.7 25/02/2009
PCT/EP/2010/052224
WO/2010/097368
16/03/2010
–פירידין עם חיבורO/תולדות איזוקסאזול
אתיל ואתניל
213982
PIPERIDINE DERIVATIVES AS NK3
RECEPTOR ANTAGONISTS
F. HOFFMANN-LA ROCHE AG
EP
09155585.4 19/03/2009
PCT/EP/2010/053417
WO/2010/106081
19/02/2010
213983
HETEROARYL SUBSTITUTED
PYRIDAZINONE DERIVATIVES
F. HOFFMANN-LA ROCHE AG
EP
09153391.9 23/02/2009
PCT/EP/2010/052116
WO/2010/094762
04/06/2003
213984
SPIROINDOLINEPIPERIDINE
DERIVATIVES
SYNGENTA LIMITED
GB
0213715.6
20/01/2002
PCT/GB/2003/002424
WO/2003/106457
17
C07D (2010.01)
C07D (2010.01)
נגזרות של פיפרידין כאנטגוניסטים של
NK3 רצפטור
C07D (2010.01)
נגזרות של פירידאזינון המותמרות
בהטרואריל
C07D (2010.01)
נגזרות של ספירואינדולינפיפרידין
August 31,2011 -א' באלול התשע"א
213986
07/01/2010
QUICK DRYING POLYMERIC
COATING
SPECIALTY FERTILIZER PRODUCTS,
LLC
US
12/351589
09/01/2009
12/651356
31/12/2009
US
PCT/US/2010/020350
WO/2010/080896
213988
08/01/2010
A LIQUID DISPENSER
JUICELOOP (PTY) LTD
ZA
2008/7174
PCT/ZA/2010/000001
WO/2010/081175
B67D (2010.01)
09/01/2009
213989
CONTAINER FOR COSMETIC
POWDER
IL MAKIAGE LTD
B65D (2010.01)
מיכל עבור אבקה קוסמטית
איל מקיאג' בע"מ
213990
COMPOSITIONS FOR
DECONTAMINATION
ISRAEL INSTITUTE FOR
BIOLOGICAL RESEARCH
IL
196375
07/01/2009
PCT/IL/2010/000018
WO/2010/079487
18
ציפוי פולימרי מהיר ייבוש
מנפק לנוזלים
07/07/2011
07/01/2010
C08L (2010.01)
C11D (2010.01)
תכשירים לטיהור חומרים מסוכנים
המכון למחקר ביולוגי בישראל
August 31,2011 -א' באלול התשע"א
11/01/2010
213992
PRO-NEUROGENIC COMPOUNDS
BOARD OF REGENTS OF THE
UNIVERSITY OF TEXAS SYSTEM
US
61/143755
09/01/2009
PCT/US/2010/020681
WO/2010/081115
21/01/2010
213993
POLY (ADP-RIBOSE) POLYMERASE
(PARP) INHIBITORS
TAKEDA PHARMACEUTICAL
COMPANY LIMITED
23/01/2009
US
61/146740
61/228879
27/07/2009
US
PCT/US/2010/021669
WO/2010/085570
07/01/2010
213994
TRANSPARENT ARMOR SYSTEM
SCHOTT DIAMONDVIEW ARMOR
PRODUCTS, LLC
07/01/2009
US
12/349832
PCT/US/2010/000033
WO/2010/080699
12/01/2010
213995
TISSUE REGENERATION
MEMBRANE
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM LTD.
19
A61K (2010.01)
תרכובות פרו–ניורוגניות
C07D (2010.01)
–ריבוז(פולימראזADP) מעכבי פולי
(PARP)
F41H (2010.01)
מערכת שריון שקופה
A61L (2010.01)
ממברנה להתחדשות רקמות
יישום חברה לפיתוח המחקר של
האוניברסיטה העברית בירושלים בע"מ
August 31,2011 -א' באלול התשע"א
US
61/193947
PCT/IL/2010/000028
WO/2010/079496
12/01/2009
29/01/2010
213996
SULFAMOYL-PHENYL-UREIDOBENZAMIDINE DERIVATIVES,
COMPOSITIONS COMPRISING THE
SAME AND USES THEREOF
4SC AG
US
61/148617
30/01/2009
PCT/EP/2010/000546
WO/2010/086177
12/01/2010
213997
HETEROATOM- CONTAINING
CYCLIC COMPOUNDS,
COMPOSITIONS COMPRISING THE
SAME AND USES THEREOF
DAIICHI SANKYO COMPANY,
LIMITED
200919/01/2009
JP
008635
PCT/JP/2010/050221
WO/2010/082563
10/07/2011
DRINKING WATER VENDING
DISPENSER FACILITATED TO
COLLECT AND PURIFY DRAINAGE
WATER
WOOSH WATER SYSTEMS LTD
20
213998
C07D (2010.01)
–תולדות סולפאמויל–פניל–אוראידו
תכשירים המכילים אותם,בנזאמיד
ושימושים בהם
C07D (2010.01)
תרכובות ציקליות המכילות הטרואטום
תכשירים המכילים אותן ושימושים בהן
G07B (2010.01)
מכונה לטיהור ומכירת מי שתייה
רונן ברמן
August 31,2011 -א' באלול התשע"א
213999
10/07/2011
DRINKING CENTRAL DATA AND
CONTROL SYSTEM OR ARTIFICIAL
INTELLIGENCE DRIVER ASSISTANT
ASSISTANT DEVICE
ELIAHU ARAD
US
61147495
27/01/2009
US
PCT/IL2010/000065 27/01/2010
מערכת שליטה ונתונים מרכזית
לנהג או התקן עזר לנהג עם בינה
מלאכותית
214000
H04B (2010.01)
15/02/2010
EFFICIENT SAMPLING AND
RECONSTRUCTION OF SPARSE
MULTI-BAND SIGNALS
TECHNION RESEARCH &
DEVELOPMENT FOUNDATION LTD.
US
61/153438
18/02/2009
61/247030
30/09/2009
US
61/265365
01/12/2009
US
PCT/IB/2010/050661
WO/2010/095083
10/07/2011
10/07/2011
אליהו ארד
–דגימה ושחזור יעילים של אותות מרובי
פס דלילים
214001
LEADFRAME FOR SEMICONDUCTOR
DEVICES, INTEGRAL CIRCUITS AND
STACK OF DICE
EDLIN SOLOMON
US
12/931490
03/02/2011
21
B60L (2010.01)
214002
H01L (2010.01)
לידפרמה בישביל התקנים מוליכים
תוכניות ינטגרלית וחבילת,למחצה
גבישית
אדלין סולומון
H04W (2010.01)
August 31,2011 -א' באלול התשע"א
METHOD AND SYSTEM FOR
MANAGING A WIRELESS NETWORK
COMPRISING A DISTRIBUTED
ANTENNA SYSTEM (DAS)
ALVARION LTD.
10/07/2011
שיטה ומערכת לניהול רשת אלחוטית
(DAS) הכוללת מערכת אנטנות מבוזרת
214003
BRACELET AUTOMATIC DETECTION
CORRECTION OF DISEASE IN THE
BODY "HOMEOSTASIS ARTIFICIAL"
MOSHE BINYAMIN
10/07/2011
214004
214005
22
צמיד לזיהוי ותיקון אוטומטי של מחלות
" בגוף – "הומיאוסזיס מלאכותי
משה בנימין
F16L (2010.01)
F16L (2010.01)
נווטון
יצחק ברזוזה
PILOT
ISAAC BARZUZA
12/01/2010
A61K (2010.01)
סעפת
יצחק ברזוזה
MANIFOLD
ISAAC BARZUZA
10/07/2011
אלווריון בע"מ
214006
G06Q (2010.01)
August 31,2011 -א' באלול התשע"א
SYSTEM AND METHOD FOR
MANAGING ACCOUNT LINKAGES
BETTER ATM SERVICES, INC.
US
61/204855
12/01/2009
12/686096
12/01/2010
US
PCT/US/2010/020765
WO/2010/081147
28/01/2010
מערכת ושיטה לניהול קישורי חשבון
FURLABLE SHAPE-MEMORY
SPACECRAFT REFLECTOR WITH
OFFSET FEED AND A METHOD FOR
PACKAGING AND MANAGING THE
DEPLOYMENT OF SAME
COMPOSITE TECHNOLOGY
DEVELOPMENT, INC.
29/01/2009
US
12/361700
PCT/US/2010/022372
WO/2010/088362
05/11/2009
מחיר אור זיכרון–צורה מתקפל עם הזנה
ושיטה לאריזתו וניהול,מקוזזת לחללית
התפרסותו
214008
METHOD AND DEVICE FOR
SEPARATING CARBON DIOXIDE FROM
AN EXHAUST GAS OF A FOSSIL FIRED
POWER PLANT
SIEMENS AKTIENGESELLSCHAFT
DE
102009006314.5 28/01/2008
PCT/EP/2009/064699
WO/2010/086039
11/02/2009
DECOY MATERIAL PACKAGE, A
DISPENSER AND A METHOD FOR
DISPENSING DECOY MATERIAL
SAAB AB
H01Q (2010.01)
214007
214009
B01D (2010.01)
שיטות ומכשיר להפרדת פחמן דו
חמצני מגז פליטה של תחנת כוח
מופעלת ע"י שריפת מאובנים
B64D (2010.01)
מנפק ושיטה לניפוק,מארז לחומר פתיון
חומר פתיון
PCT/SE/2009/050144
23
August 31,2011 -א' באלול התשע"א
WO/2010/093292
08/01/2010
214010
ניידות זרימת נתונים
DATA FLOW MOBILITY
INTERDIGITAL PATENT HOLDINGS,
INC.
US
61/143524
09/01/2009
61/164181
27/03/2009
US
PCT/US/2010/020452
WO/2010/080966
08/01/2010
214011
ELECTRO-ACTIVE SPECTACLES AND
ASSOCIATED ELECTRONICS
PIXELOPTICS, INC.
US
61/143459
09/01/2009
61/152140
12/02/2009
US
61/157579
05/03/2009
US
61/157580
05/03/2009
US
61/170222
17/04/2009
US
61/242406
15/09/2009
US
61/252770
19/10/2009
US
PCT/US/2010/020498
WO/2010/080999
11/01/2010
24
G02C (2010.01)
משקפיים פעילות–חשמלית ואלקטרוניקה
מתאימה
214012
ENERGETIC NUTRITIONAL
COMPOSITION COMPRISING A
LAXATIVE, ELECTROLYTES AND
CARBOHYDRATES
UNIVERSITE LIBRE DE BRUXELLES
EP
09150475.3 13/01/2009
12/633405
08/12/2009
US
PCT/EP/2010/050210
WO/2010/081781
H04W (2010.01)
A61K (2010.01)
תכשיר תזונה אנרגטי המכיל חומר
אלקטרוליטים ופחמימות,משלשל
August 31,2011 -א' באלול התשע"א
19/01/2010
214013
APPARATUS FOR DISPENSING
MADE-TO-ORDER FROZEN
BEVERAGE
NICEVEND LTD
US
61/145660
19/01/2009
61/164488
30/03/2009
US
PCT/IB/2010/050234
WO/2010/082185
10/07/2011
–מכשיר לחלוקת משקה קפוא המוכן על
פי הזמנה
NICEVEND LTD
214014
214015
DEVICE FOR TREATING EYE
CONDITIONS
BIOLASE TECHNOLOGY, INC.
US
60/675162
26/04/2005
60/687991
06/06/2005
US
60/703084
27/07/2005
US
60/709737
19/08/2005
US
60/776023
22/02/2006
US
PCT/US/2006/016066
WO/2006/116621
11/07/2011
FLODED BABY BATH
SHARON WEIN
25
B65D (2010.01)
מיכל לשפתון
איל מקיאג' בע"מ
LIPSTICK TUBE
IL MAKIAGE LTD
26/04/2006
A23G (2010.01)
A61B (2010.01)
מכשיר לטיפול במצבים הקשורים לעיניים
214016
A47G (2010.01)
אמבטיה מתקפלת לתינוק
שרון ויין
August 31,2011 -א' באלול התשע"א
11/07/2011
F42C (2010.01)
214017
METHOD AND SYSTEM FOR
DERIVING A SEPARATION
DISTANCE
SHAY LITANI
11/01/2010
מערכת ושיטה להפקת מרחק הפרדה
שי ליטני
F16M (2010.01)
214018
MOVABLE ASSEMBLY AND
APPLICATION TO MOVABLE
DEVICES
EFFRAYIM DRORI
11/01/2009
IL
196421
PCT/IL/2010/000024
WO/2010/079493
19/01/2010
מכלול מתנייד ויישום למכשירים
מתניידים
אפרים דרורי
214019
דיציאנופירידינים מותמרים
באלקילאמינו ומטרימי תרופות אסטר
של חומצה אמינית שלהם
ALKYLAMINO-SUBSTITUTED
DICYANOPYRIDINES AND THEIR
AMINO ACID ESTER PRODRUGS
BAYER PHARMA AG
DE
102009006602.0 29/01/2009
PCT/EP/2010/000262
WO/2010/086101
15/01/2010
HIGH QUANTUM EFFICIENCY
OPTICAL DETECTORS
26
C07D (2010.01)
214020
H01L (2010.01)
גלאים אופטיים עם נצילות קוונטית גבוהה
August 31,2011 -א' באלול התשע"א
RAYTHEON COMPANY
US
61/145041
12/611388
US
PCT/US/2010/021136
WO/2010/083372
07/01/2010
15/01/2009
03/11/2009
214021
מערכת ושיטה להדמאה וחישה תוך
שימוש במוספט
IMAGE SENSING SYSTEM AND
METHOD UTILIZING A MOSFET
RAYTHEON COMPANY
US
12/354467
15/01/2009
PCT/US/2010/020288
WO/2010/083078
19/01/2009
H01L (2010.01)
214022
C07K (2010.01)
אנאלוגים של מלאנוקורטין עם פעילות
אנטימיקרוביאלית
MELANOCORTIN ANALOGS WITH
ANTIMICROBIAL ACIVITY
FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO
PCT/EP/2009/000290
WO/2010/081492
28/01/2010
214023
CRYSTALLINE N-{(1-S)-2-AMINO-1[(3FLUOROPHENYL)METHYL]ETHYL}5-CHLORO-4-(4-CHLORO-1-METHYL1H-PYRAZOL-5-YL)-2THIOPHENECARBOXAMIDE
HYDROCHLORIDE
GLAXOSMITHKLINE LLC
US
61/148490
30/01/2009
PCT/US/2010/022323
WO/2010/088331
27
A61K (2010.01)
–3)]–1––אמינוN–((1–S)–2
–4)–4––כלורו5–{פלואורופניל(מתיל[אתיל
–2–(–יל5––פיראזולH1––מתיל1–כלורו
תיאופנהקרבוקסיאמיד הידרוכלוריד
גבישי
August 31,2011 -א' באלול התשע"א
22/12/2009
214024
ENERGY EFFICIENT LASER
DETECTION AND RANGING SYSTEM
RAYTHEON COMPANY
US
12/357122
21/01/2009
PCT/US/2009/069210
WO/2010/123532
28/09/2007
מערכת לייזר לגילוי טווח ונצילות אנרגיה
214025
DELIVERY TOOL FOR
PERCUTANEOUS DELIVERY OF A
PROSTHESIS
HEART LEAFLET TECHNOLOGIES,
INC.
28/09/2006
US
60/827373
PCT/US/2007/079978
WO/2008/040014
11/07/2011
214026
28
B01D (2010.01)
מכלול סינון נוזלים המתנקה מעצמו
דורון בע"מ.ה.ג
214027
N-ACYL ANTHRANILIC ACID
DERIVATIVE OR SALT THEREOF
TOYAMA CHEMICAL CO., LTD.
2009JP
30/01/2009
020274
2009-020424 30/01/2009
JP
A61F (2010.01)
מכשיר העברה להעברת תותבת דרך
העור
SELF-CLEANING FLUID FILTER
ASSEMBLY
G.H. DORON LTD
14/07/2010
US
61/364028
29/01/2010
G01S (2010.01)
C07C (2010.01)
–אסיל אנת'ראניליתN נגזרת של חומצת
או מלח שלה
August 31,2011 -א' באלול התשע"א
2009-020462
JP
2009-239188
JP
PCT/JP/2010/051209
WO/2010/087430
30/01/2009
16/10/2009
02/02/2010
214028
A NOVEL CYANOPYRIMIDINE
DERIVATIVE
OTSUKA PHARMACEUTICAL CO.,
LTD.
200903/02/2009
JP
022339
PCT/JP/2010/051738
WO/2010/090299
12/07/2011
214030
214031
A SYSTEM AND METHOD FOR
PURCHASING IN A NON-VIRTUAL
STORE
YITZHAK FRENKEL
05/03/2010
29
נגזרת חדשה של קיאנופירימידין
G10H (2010.01)
תזמורת של אדם אחד
גיטרס בע"מ.בי.אם.או
ONE MAN BAND
O.M.B GUITARS LTD
12/07/2011
A61P (2010.01)
G07B (2010.01)
מערכת ושיטה לרכישה בחנות ממשית
מלכה לסרי
214033
C07D (2010.01)
August 31,2011 -א' באלול התשע"א
3H-IMIDAZO[4,5-C]PYRIDINE-6CABOXAMIDES AS ANTIINFLAMMATORY AGENTS
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
09154414.8 05/03/2009
09179618.5
17/12/2009
EP
PCT/EP/2010/052799
WO/2010/100249
13/01/2010
–6–[פירידיןC–5,4]–אימידאזוH3
קרבוקסאמידים כגורמים נוגדי דלקת
214034
SINGLE -CELL NUCLEIC ACID
ANALYSIS
FLUIDIGM CORPORATION
US
61/144416
13/01/2009
61/146583
22/01/2009
US
61/284309
15/12/2009
US
PCT/US/2010/020942
WO/2010/083250
14/01/2010
18/02/2010
G06F (2010.01)
מערכת לגילוי רמת תמיכה של מאפיינים
אופציונלים במאגר מידע
214036
PHARMACEUTICAL COMPOSITION
FOR INHALATION
SANOFI AG
EP
09153082.4 18/02/2009
PCT/EP/2010/052026
WO/2010/094731
30
אנליזה של חומצת גרעין עם תא בודד
214035
SYSTEM FOR DISCOVERING LEVEL
OF SUPPORT OF OPTIONAL
FEATURES IN A DATABASE
RESEARCH IN MOTION LIMITED
US
12/353778
14/01/2009
PCT/CA/2010/000045
WO/2010/081224
C12Q (2010.01)
A61K (2010.01)
תכשיר רוקחות לשאיפה
August 31,2011 -א' באלול התשע"א
01/02/2010
214037
METHOD FOR PRODUCING 2HALOGENOMETHYLPHENYL
ACETIC ACID DERIVATIVES
BASF SE
EP
08172487.4 05/02/2009
PCT/EP/2010/051144
WO/2010/089267
09/02/2010
12/07/2011
–הלוגנומתילפניל2 שיטה לייצור תולדות
חומצה אצטית
214038
TIME-TEMPERATURE INDICATOR
BASED ON THIOALKYL AND
THIOARYL SUBSTITUTED
SPIROAROMATICS
FRESHPOINT HOLDINGS SA
EP
09152675.6 12/02/2009
PCT/EP/2010/051528
WO/2010/092030
CARBON FILTER DEVICE AND AIR
FILTER APPARATUS
YAROK BAIR PROTECTION
INDUSTRIES LTD
31
C09K (2010.01)
מחוון זמן–טמפרטורה המבוסס על חומרים
ספירוארומטים מותמרים בתיאואלקיל
ותיאואריל
214039
INTEGRATED WATER FILTER AND
COOLER
KENNEDY ELECTRICAL & ASSETS
LTD.
12/07/2011
C07C (2010.01)
A47J (2010.01)
מסנן מים והתקן קירור משולב
קנדי חשמל ונכסים בע"מ
214041
B01D (2010.01)
התקן מסנן פחם ומתקן לסינון אויר
ירוק בעיר תעשיות מיגון בע"מ
August 31,2011 -א' באלול התשע"א
13/01/2010
B01D (2010.01)
214042
SOLVENT AND ACID STABLE
MEMBRANES, METHODS OF
MANUFACTURE THEREOF AND
METHODS OF USE THEREOF INTER
ALIA FOR SEPARATING METAL IONS
FROM LIQUID PROCESS STREAMS
B.P.T. BIO PURE TECHNOLOGIES
LTD
US
61/193962
13/01/2009
61/144459
14/01/2009
US
PCT/IL/2010/000032
WO/2010/082194
,ממברנות עמידות בממסים וחומצות
שיטות לייצורן ושיטות לשימוש בהן בין
היתר להפרדת יוני מתכת מזרמי תהליך
נוזליים
ביופיור טכנולוגיה בע"מ.טי.פי.בי
214043
24/03/2010
IMPLANTS, TOOLS, AND METHODS FOR
SINUS LIFT AND LATERAL RIDGE
AUGMENTATION
MAXILLENT LTD
US
12/485199
16/06/2009
IL
PCT/IL2009/000931 29/09/2009
PCT/IL/2010/000252
WO/2010/146573
19/02/2010
214044
PRODUCTION OF IRON
ORTHOPHOSPHATE
CHEMISCHE FABRIK BUDENHEIM KG
DE
102009001204.4 26/02/2009
PCT/EP/2010/052108
WO/2010/097341
32
A61C (2010.01)
ושיטות להרמת, כבלים,שתלים
הסינוסים ושיפור הרכס הצדדי
מקסילנט בע"מ
C01B (2010.01)
ייצור ברזל אורתופוספאט
August 31,2011 -א' באלול התשע"א
21/12/2009
214045
A MESHWORK MADE OF RIBBONS
LANDERTSHAMER, FRIEDRICH
16/01/2009
AT
A61/2009
PCT/AT/2009/000492
WO/2010/081179
13/01/2010
214046
RATIO BASED BIOMARKERS AND
METHODS OF USE THEREOF
THE GOVERNMENT OF THE UNITED
STATES OF AMERICA AS
REPRESENTED BY THE SECRETARY
OF THE DEPARTMENT OF HEALTH
AND HUMAN SERVICES
14/01/2009
US
61/144501
PCT/US/2010/020944
WO/2010/083252
12/01/2010
214047
METHODS FOR TREATING
VASCULAR LEAK SYNDROME
AKEBIA THERAPEUTICS INC.
US
61/144022
12/01/2009
61/184986
08/06/2009
US
PCT/US/2010/020817
WO/2010/081172
12/01/2010
214048
COMPOUNDS, COMPOSITIONS, AND
METHODS FOR PREVENTING
METASTASIS OF CANCER CELLS
AKEBIA THERAPEUTICS INC.
33
B29D (2010.01)
רשת עשויה מרצועות
G01N (2010.01)
ביומרקרים המבוססים על יחס ושיטות
לשימושם
A01N (2010.01)
תכשירים לטיפול בזליגת כלי דם
A01N (2010.01)
תכשירים למניעת גרורות של תאים
סרטניים
August 31,2011 -א' באלול התשע"א
US
61/223260
PCT/US/2010/020822
WO/2011/005330
10/02/2010
06/07/2009
214049
AGONISTS AND ANTAGONISTS OF
THE S1P5 RECEPTOR, AND
METHODS OF USES THEREOF
ABBOTT LABORATORIES
US
61/207301
10/02/2009
PCT/US/2010/023768
WO/2010/093704
30/03/2005
15/01/2010
C07D (2010.01)
תהליך להכנת אוקסיקודון הידרוכלוריד
– 14 חלקים למיליון25–המכיל פחות מ
הידרוקסיקודאינון
214051
NEW STABLE FORMULATIONS OF
RECOMBINANT HUMAN ALBUMINHUMAN GRANULOCYTE COLONY
STIMULATING FACTOR FUSION
PROTEIN
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
61/145436
16/01/2009
61/145440
16/01/2009
US
34
P1S5 אגונסטים ואנטגוניסטים לקולטן
ושיטות ושימושים שלהם
214050
PROCESS FOR PREPARING
OXYCODONE HYDROCHLORIDE
HAVING LESS THAN 25 PPM 14HYDROXYCODEINONE
EURO-CELTIQUE S.A.
US
60/557492
30/03/2004
60/601534
13/08/2004
US
18/10/2004
60/620072
US
60/648625
31/01/2005
US
60/651778
10/02/2005
US
PCT/US/2005/010666
WO/2005/097801
A01N (2010.01)
A61K (2010.01)
תרכובת רוקחית יציבה חדשה לחלבון
איחוי רקומביננטי של אלבומין אנושי
לפקטור מעורר מושבות של גרנולוציטים
טבע תעשיות פרמצבטיות בע"מ
August 31,2011 -א' באלול התשע"א
PCT/US/2010/021235
WO/2010/083434
15/01/2010
214052
NEW STABLE FORMULATIONS OF
RECOMBINANT HUMAN ALBUMINHUMAN GRANULOCYTE COLONY
STIMULATING FACTOR FUSION
PROTEIN
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
61/145436
16/01/2009
61/145440
16/01/2009
US
PCT/US/2010/021241
WO/2010/083439
09/02/2010
תרכובת רוקחית יציבה חדשה לחלבון
איחוי רקומביננטי של אלבומין אנושי
CSF–) לפקטור מושבות של גרנולוציטים
(G
214053
STENT
EVYSIO MEDICAL DEVICES ULC
US
61/202239
09/02/2009
PCT/CA/2010/000170
WO/2010/088776
13/01/2010
214054
TETOMILAST POLYMORPHS
LRM INDUSTRIES INTERNATIONAL,
INC.
US
61/144256
13/01/2009
PCT/US/2010/000068
WO/2010/083029
22/01/2010
35
A61K (2010.01)
214056
טבע תעשיות פרמצבטיות בע"מ
A61F (2010.01)
צנתר
F24J (2010.01)
פולימורפים של טטומילאסט
A47C (2010.01)
August 31,2011 -א' באלול התשע"א
METHOD AND APPARATUS FOR
DYNAMICALLY CORRECTING
POSTURE
BACKJOY ORTHOTICS, LLC
US
61/147053
23/01/2009
PCT/US/2010/021881
WO/2010/085707
26/02/2010
214057
CONTENT RENDERING ON A
COMPUTER
MICROSOFT CORPORATION
US
12/397351
04/03/2009
PCT/US/2010/025678
WO/2010/101790
14/01/2010
EJECTION DEVICE
PRIMEQUAL SA
FR
0900199
PCT/EP/2010/050411
WO/2010/081854
06/01/2010
214058
36
G06Q (2010.01)
תוכן עיבוד במחשב
A61M (2010.01)
התקן פליטה
16/01/2009
214059
SYSTEM AND METHOD FOR
DETECTION OF EAS MARKER
SHIELDING
SENSORMATIC ELECTRONICS, LLC
US
12/352645
13/01/2009
PCT/US/2010/000023
WO/2010/083020
14/01/2010
שיטה והתקן לתיקון דינמי של עמידה
יציבה
214060
G08B (2010.01)
EAS מערכת ושיטה לגילוי מיגון סמן
H05B (2010.01)
August 31,2011 -א' באלול התשע"א
MULTI-MODE PORTABLE LIGHTING
DEVICE
MAG INSTRUMENT, INC.
US
12/353396
14/01/2009
PCT/US/2010/000083
WO/2010/083037
14/01/2010
214061
PROCESSES FOR PREPARING JAK
INHIBITORS AND RELATED
INTERMEDIATE COMPOUNDS
INCYTE CORPORATION
US
61/144991
15/01/2009
PCT/US/2010/021003
WO/2010/083283
07/04/2010
214064
AIR DUCT AND TONER CARTRIDGE
USING SAME
LEXMARK INTERNATIONAL INC.
US
12/421725
10/04/2009
PCT/US/2010/030171
WO/2010/118085
15/01/2010
214065
RPG LAUNCHER DETERRENT
BEYOND TODAY SOLUTIONS &
TECHNOLOGY LLC
US
61/205077
15/01/2009
61/215036
01/05/2009
US
12/455472
02/06/2009
US
PCT/US/2010/021108
WO/2010/090804
37
מכשיר תאורה נייד רב–מצבים
C07D (2010.01)
ותרכובותJAK תהליכים להכנת מעכבי
ביניים קשורות
G03G (2010.01)
צינור אויר ומחסנית דיו המשתמשת בו
F41G (2010.01)
מרתיעRPG משגר
August 31,2011 -א' באלול התשע"א
02/02/2010
214066
UPLINK OPEN-LOOP SPATIAL
MULTIPLEXING IN WIRELESS
COMMUNICATIONS
QUALCOMM INCORPORATED
US
61/149209
02/02/2009
12/697619
01/02/2010
US
PCT/US/2010/022882
WO/2010/088665
15/01/2010
ריבוב מרחבי לולאה–פתוחה של קישור
למעלה בתקשורת אלחוטית
214067
METHODS OF DETERMINING
PATIENT RESPONSE BY
MEASUREMENT OF HER-2
EXPRESSION
LABORATORY CORPORATION OF
AMERICA HOLDINGS
15/01/2009
US
61/145029
PCT/US/2010/021272
WO/2010/083463
30/06/2010
15/01/2010
38
B21K (2010.01)
מהדקים בעלי תוכן חומר מופחת ושיטות
ומערכות לייצורם
214070
ELECTRICAL CONNECTOR FOR A
HELMET-MOUNTED NIGHT VISION
SYSTEM
G01N (2010.01)
שיטות לקביעת מטופל על ידי מדידת
HER–2 ביטוי
214069
REDUCED MATERIAL CONTENT
FASTENERS AND SYSTEMS AND
METHODS FOR MANUFACTURING
THE SAME
OHIO ROD PRODUCTS
US
12/648658
29/12/2009
PCT/US/2010/040536
WO/2011/081676
H04B (2010.01)
H01R (2010.01)
מחבר חשמלי למערכת ראיית לילה
מוצבת על קסדה
August 31,2011 -א' באלול התשע"א
ITT MANUFACTURING
ENTERPRISES, INC.
US
12/363055
PCT/US/2010/021133
WO/2010/088065
30/01/2009
15/01/2010
214071
OPTIMIZED IMAGING SYSTEM FOR
COLLECTION OF HIGH RESOOLUION
IMAGERY
RAYTHEON COMPANY
US
12/367480
06/02/2009
PCT/US/2010/021182
WO/2010/090805
15/01/2010
13/07/2011
FOOD PRODUCT AND METHOD OF
PRESERVING SAME
YONA ZOREF
39
מערכת הדמיה מיועלת לאיסוף דימויים
בעלי רזולוציה גבוהה
214072
METHODS OF DETERMINING
PATIENT RESPONSE BY
MEASUREMENT OF HER-3
LABORATORY CORPORATION OF
AMERICA HOLDINGS
15/01/2009
US
61/145029
61/176630
08/05/2009
US
61/187962
17/06/2009
US
PCT/US/2010/021281
WO/2010/083470
H04N (2010.01)
G01N (2010.01)
–3 שיטות לקביעת מטופל על ידי מדידת
HER
214073
A23L (2010.01)
מוצר מזון ושיטה לשימורו
יונה צורף
August 31,2011 -א' באלול התשע"א
13/07/2011
214074
EFFICIENT PROCESS TO DISTRIBUTE
A WEBSITE TO ISRAELI ONLINE
DIRECTORIES
ELAD COHEN
11/02/2010
214075
USE OF PC FOR TREATMENT
FOLLOW UP
SYNERON MEDICAL LTD
US
12/388051
18/02/2009
PCT/IL/2010/000121
WO/2010/095126
03/03/2010
214076
AN RF ELECTRODE FOR AESTHETIC
AND BODY SHAPING DEVICES AND
METHOD OF USING SAME
SYNERON MEDICAL LTD
US
12/402936
12/03/2009
PCT/IL/2010/000173
WO/2010/103507
18/03/2010
214077
A METHOD AND APPARATUS FOR
LIPOSUCTION
SYNERON MEDICAL LTD
01/04/2009
US
61/165529
PCT/IL/2010/000222
WO/2010/113147
40
G06F (2010.01)
תהליך יעיל להפצת אתר אינטרנט
לאינדקסים ישראליים
אלעד כהן
A63B (2010.01)
שימוש במחשב למעקב אחר טיפול
סינרון מדיקל בע"מ
A61F (2010.01)
אלקטרודה להעברת תדר רדיו לטיפול
אסתטי ואופן השימוש בו
סינרון מדיקל בע"מ
A61B (2010.01)
שיטה ומכשיר לשאיבת שומן
סינרון מדיקל בע"מ
August 31,2011 -א' באלול התשע"א
14/01/2010
214078
תוכנה שולחנית משולבת לניהול נתוני
וירוסים
INTEGRATED DESKTOP SOFTWARE
FOR MANAGEMENT OF VIRUS DATA
GATACA, LLC
US
61/205033
14/01/2009
PCT/US/2010/021071
WO/2010/083331
15/01/2010
214080
REQUESTING OFFLINE PROFILE
DATA FOR ONLINE USE IN A
PRIVACY-SENSITIVE MANNER
ALMONDNET, INC.
US
61/144969
15/01/2009
PCT/US/2010/021256
WO/2010/083450
29/05/2007
214082
214083
IMMUNOGLOBULIN VARIANTS AND
USES THEREOF
GENENTECH, INC.
US
60/434115
16/12/2002
60/526163
01/12/2003
US
PCT/US/2003/040426
41
G06F (2010.01)
בקשת נתונים של פרופיל לא מקוון באופן
חשאי–רגיש
FLUID PURGE IN A MEDICAL
INJECTION SYSTEM
ACIST MEDICAL SYSTEMS, INC.
US
60/804682
14/06/2006
PCT/US/2007/069834
WO/2007/146586
16/12/2003
G06T (2010.01)
A61M (2010.01)
ניקוי נוזלים במערכת הזרקה רפואית
C12N (2010.01)
וריאנטים של אימונוגלובולין והשימוש
בהם
August 31,2011 -א' באלול התשע"א
WO/2004/056312
10/12/1998
A61K (2010.01)
214084
TREATMENT WITH ANTI ErbB2
ANTIBODIES
GENENTECH, INC.
US
60/069346
12/12/1997
PCT/US/1998/026266
WO/1999/031140
ErbB2–טיפול עם נוגדי אנטי
214085
03/02/2010
התקן ושימוש לאחסון ואספקת תרופות
בצורת לוחות דקיקים
DEVICE AND USE FOR STORAGE AND
PROVISION OF MEDICAMENT WAFERS
BAYER PHARMA AG
DE
102009008027.9 06/02/2009
PCT/EP/2010/000646
WO/2010/089090
15/01/2010
214086
MALATE SALT OF N-(4-{[6,7BIS(METHYLOXY)QUINOLIN-4YL]OXY}PHENYL)-N-(4FLUOROPHENYL)CYCLOPROPANE1,1-DICARBOXAMIDE, AND
CRYSTALLINE FORMS THEREOF
FOR THE TREATMENT OF CANCER
EXELIXIS, INC.
US
61/145421
16/01/2009
PCT/US/2010/021194
WO/2010/083414
19/01/2010
42
A61J (2010.01)
C07D (2010.01)
–N–{4–{[7,6 מלח מלאט של
–4–ביס)מתילאוקסי(קווינולין
–N–(4–(יל[אוקסי{פניל
–1,1–פלואורופניל(ציקלופרופאן
וצורות גבישיות לטיפול,דיקרבוקסאמיד
בסרטן
214087
A01N (2010.01)
August 31,2011 -א' באלול התשע"א
USE OF SUCCINATE
DEHYDROGENASE INHIBITORS FOR
CONTROLLING POWDERY MILDEW
PRIMARY INFECTIONS
BAYER CROPSCIENCE AG
EP
09356006.8 30/01/2009
PCT/EP/2010/000265
WO/2010/086103
19/01/2010
214088
PESTICIDAL CONTROL DEVICE
WITH HIGH LOAD OF ACTIVE
INGREDIENT
BAYER ANIMAL HEALTH GMBH
US
61/148233
29/01/2009
PCT/EP/2010/000264
WO/2010/086102
27/01/2010
214090
OPHTHALMIC LENS PRECURSOR
JOHNSON & JOHNSON VISION CARE,
INC.
30/01/2009
US
12/363138
PCT/US/2010/022222
WO/2010/088266
27/01/2010
214091
LONG SHELF LIFE MILK-RELATED
PRODUCTS, AND A PROCESS AND
MILK PROCESSING PLANT FOR
THEIR MANUFACTURE
ARLA FOODS AMBA
27/01/2009
US
61/147614
PCT/DK/2010/050019
WO/2010/085957
43
שימוש במעכבי סוקינאט דהידרוגנאז
לשליטה בזיהומי טחב אבקתי
A01N (2010.01)
התקן בקרה להדברת חרקים עם כמות
גבוהה של מרכיב פעיל
B29D (2010.01)
מקדם עדשות עיניות
A23C (2010.01)
חלב בעל חיי מדף ארוכים ומוצרי חלב
ותהליך ומפעל לעיבוד חלב,קשורים
לייצורם
August 31,2011 -א' באלול התשע"א
14/07/2011
A METHOD AND SYSTEM FOR
DETERMINING A DRIVING
PERFORMANCE VARIABLE
GREENROAD DRIVING
TECHNOLOGIES LTD.
24/01/2010
G09B (2010.01)
214092
שיטה ומערכת לקביעת משתנה עבור
ביצועי נהיגה
גרינרואד טכנולוגיות נהיגה בע"מ
214093
מתקן ניטור מרחוק לשמרטפות
REMOTE BABYSITTING MONITOR
ASER RICH LIMITED
US
61/146664
23/01/2009
PCT/IL/2010/000057
WO/2010/084495
20/01/2010
214094
TETHER FOR TROPOSPHERIC AEOLIAN
GENERATOR
SEQUOIA AUTOMATION S.R.L
IT
TO2009U000008 23/01/2009
PCT/IT/2010/000015
WO/2010/084520
02/02/2010
44
D07B (2010.01)
חבל לגנרטור טרופוספרי אהלוהי
214097
SIMIAN ADENNOVIRUS NUCLEIC ACIDAND AMINO ACID-SEQUENCES, VECTORS
CONTAINING SAME, AND USES THEREOF
OKAIROS AG
EP
PCT/EP2009/000672
61/172624
US
H04B (2010.01)
C07K (2010.01)
רצפים של חומצות גרעין וחומצות
,אמינו של נגיף אדנו סימיאן
וקטורים המכילים אותם
ושימשושיהם
02/02/2009
24/04/2009
August 31,2011 -א' באלול התשע"א
61/174852
US
61/266342
US
PCT/EP/2010/000616
WO/2010/086189
09/02/2010
01/05/2009
03/12/2009
214098
C מעכבי וירוס הפטיטיס
HEPATITIS C VIRUS INHIBITORS
BRISTOL-MYERS SQUIBB COMPANY
US
61/153186
17/02/2009
12/701919
08/02/2010
US
PCT/US/2010/023582
WO/2010/096302
27/01/2010
214099
CONJUGATE BASED SYSTEMS FOR
CONTROLLED DRUG DELIVERY
SMARTCELLS, INC.
US
61/147878
28/01/2009
61/159643
12/03/2009
US
61/162107
20/03/2009
US
61/163084
25/03/2009
US
61/219897
24/06/2009
US
07/07/2009
61/223572
US
19/10/2009
61/252857
US
PCT/US/2010/022268
WO/2010/088294
19/01/2009
ANIMAL SCENT DETECTION
APPARATUS AND SYSTEM
REESE, DAVID
C07D (2010.01)
A01N (2010.01)
מערכות מבוססות הצמדה למתן תרופה
מבוקר
214100
A01K (2010.01)
מכשיר ומערכת לאיתור ריח ע"י חיה
PCT/US/2009/000332
WO/2010/082915
45
August 31,2011 -א' באלול התשע"א
06/08/2009
214101
COMMUNICATING DISTINCT DATA
USING POLARIZED DATA SIGNALS
MACRAE, NIGEL, IAIN, STUART
US
12/499084
07/07/2009
PCT/US/2009/052904
WO/2011/005269
17/01/2010
18/01/2010
קישור של מידע ברור תוך שימוש באותות
מידע קוטביים
214103
A COMPOSITE MATERIAL AND
METHOD OF PREPARING THE SAME
FROM SUBSTANTIALLY UNSORTED
WASTE
NOVA-ARENA LTD
US
61/193985
15/01/2009
PCT/IL/2010/000042
WO/2010/082202
214105
214106
NOVEL INTRA UTERINE DEVICE
OCON MEDIXAL LTD
18/01/2009
US
61/145558
PCT/IL/2010/000035
46
B09B (2010.01)
חומר מרוכב ושיטה להכנתו מפסולת לא
ממוינת
COMPOSITE MATERIAL BONE
IMPLANT
N.M.B. MEDICAL APPLICATIONS
LTD.
US
61/205160
16/01/2009
61/213991
06/08/2009
US
PCT/IB/2010/050225
WO/2010/082183
14/01/2010
H04B (2010.01)
A61B (2010.01)
שתל עצם מחומרים מרוכבים
מדיקל אפליקיישנס בע"מ.ב.מ.נ
A61F (2010.01)
התקן תוך רחמי
אוקון מדיקל בע"מ
August 31,2011 -א' באלול התשע"א
WO/2010/082197
17/01/2010
214107
COMPOSITIONS AND METHODS FOR
BLOCKING ETHYLENE RESPONSE
FIELD CROPS USING 3(CYCLOPROPYL-1-ENYL)PROPANOIC SODIUM SALT
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM LTD
US
61/144758
15/01/2009
PCT/IL/2010/000043
WO/2010/082203
23/03/2010
שיטה ותרכובת לעיכוב תגובה לאתילן
בגידולי–שדה
יישום חברה לפיתוח המחקר של
האוניברסיטה העברית בירושלים בע"מ
214110
214111
HYDROXY-METHYL ISOXAZOLE
DERIVATIVES AS GABA A
MODULATORS
F. HOFFMANN-LA ROCHE AG
EP
09157200.8 02/04/2009
PCT/EP/2010/054141
WO/2010/112475
47
C07D (2010.01)
–2––טריפלואורו1,1,1 תרכובות
–3,2 הידרוקסיפרופיל מותמרות על ידי
דיאריל או הטרואריל
2,3-DIARYL-OR HETEROARYLSUBSTITUTED 1,1,1-TRIFLUORO-2HYDROXYPROPYL COMPOUNDS
F. HOFFMANN-LA ROCHE AG
EP
09156267.8 26/03/2009
PCT/EP/2010/053737
WO/2010/108903
30/03/2010
A01N (2010.01)
C07D (2010.01)
תולדות של הידרוקסי–מתיל איזוקסאזול
GABAA כמאפננים של
August 31,2011 -א' באלול התשע"א
08/02/2010
214112
TERIAZOLO [4,3-B]PYRIDAZINE
DERIVATIVES AND THEIR USES FOR
PROSATATE CANCER
ASTRAZENECA AB
US
61/151221
10/02/2009
61/187766
17/06/2009
US
PCT/GB/2010/050191
WO/2010/092371
23/03/2004
214115
C07D (2010.01)
[ פיריאזיןB–3,4] תולדות של טריאזולו
ושימושיהם עבור סרטן הערמונית
G06F (2010.01)
מערכת אישית להעברת הודעות
מולטימדיה
PERSONALIZED MULTIMEDIA
MESSAGING SYSTEM
NDS LIMITED
PCT/IL/2004/000261
WO/2005/091537
23/03/2004
214116
G06F (2010.01)
מערכת אישית להעברת הודעות
מולטימדיה
PERSONALIZED MULTIMEDIA
MESSAGING SYSTEM
NDS LIMITED
PCT/IL/2004/000261
WO/2005/091537
15/01/2010
214117
IMIDAZOTHIAZOLE DERIVATIVES
DAIICHI SANKYO COMPANY,
LIMITED
2009JP
16/01/2009
007536
PCT/JP/2010/050372
WO/2010/082612
48
C07D (2010.01)
תולדות אימידאטיאזול
August 31,2011 -א' באלול התשע"א
23/01/2004
214118
TOPICAL COMPOSITION
COMPRISING CLINDAMYCIN
STIEFEL RESEARCH AUSTRALIA
PTY LTD.
US
60/442280
24/01/2003
60/454832
13/03/2003
US
PCT/AU/2004/000088
WO/2004/064833
20/01/2010
27/01/2010
CRYSTALLINE INSULINCONJUGATES
SMARTCELLS, INC.
US
61/159643
61/162107
US
61/163084
US
61/147878
US
61/219896
US
61/219897
US
61/223572
US
61/252857
US
PCT/US/2010/022277
WO/2010/088300
49
תכשיר מקומי המכיל קלינדמיסין
214119
STRUCTURE WITH A REUSABLE
ABSORBENT LAYER AND
ASSOCIATED SLEEVE
GENERATION PLUME
FR
0900240
20/01/2009
PCT/FR/2010/050087
WO/2010/084285
A61K (2010.01)
A61F (2010.01)
מבנה עם שכבת סופג הניתן לשימוש חוזר
ושרוול הקשור אליו
214126
C07K (2010.01)
תצמיד–אינסולין גבישי
12/03/2009
20/03/2009
25/03/2009
28/03/2009
24/06/2009
24/06/2009
07/07/2009
19/10/2009
August 31,2011 -א' באלול התשע"א
18/01/2010
214127
תכשירים לחיסון
VACCINE COMPOSITIONS
AGIRX LIMITED
EP
09000610.7 16/01/2009
PCT/EP/2010/000253
WO/2010/081738
19/01/2010
214128
SOLAR COMBINED CYCLE POWER
SYSTEMS
YEDA RESEARCH AND
DEVELOPMENT CO. LTD.
19/01/2009
US
61/145583
PCT/IL/2010/000048
WO/2010/082206
23/02/2010
15/03/2010
50
ידע חברה למחקר ופיתוח בע"מ
C07D (2010.01)
B1 תרכובות כאנטגוניסטים של ברדיקינין
214130
NEIL3 PEPTIDES AND VACCINES
INCLUDING THE SAME
ONCOTHERAPY SCIENCE, INC.
US
61/210512
18/03/2009
PCT/JP/2010/001808
WO/2010/106770
H01L (2010.01)
מערכות כח מחזוריות משולבות שמש
214129
COMPOUNDS AS BRADYKININ B1
ANTAGONISTS
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
09153778.7 26/02/2009
PCT/EP/2010/052232
WO/2010/097372
A61K (2010.01)
C12N (2010.01)
וחיסונים המכילים אותםNEIL3 פפטידי
August 31,2011 -א' באלול התשע"א
26/02/2010
214131
HYPER IgE ANIMAL MODEL WITH
ENHANCED IMMUNOGLOBULIN
HEAVY CHAIN CLASS SWITCHING
TO Ce
GENENTECH, INC.
US
61/156299
27/02/2009
PCT/US/2010/025507
WO/2010/099384
11/03/2010
214132
COMBINATIONS OF
PHOSPHOINOSITIDE 3-KINASE
INHIBITOR COMPOUNDS AND
CHEMOTHERAPEUTIC AGENTS FOR
THE TREATMENT OF
HEMATOPOIETIC MALIGNANCIES
GENENTECH, INC.
12/03/2009
US
61/159622
PCT/US/2010/026903
WO/2010/105008
12/02/2010
214133
SKIN TREATMENT
PEPLIN RESEARCH PTY LIMITED
US
61/152599
13/02/2009
PCT/AU/2010/000152
WO/2010/091472
22/01/2009
214134
NEW COMBINATION OF ACTIVE
INGREDIENTS CONTAINING A NON
STEROIDAL ANTI INFLAMMATORY
DRUG AND A COLCHICOSIDE
DERIVATIVE
SANOFI
51
C12N (2010.01)
עם החלפהIgE מודל בעל–חיים היפר
מוגברת של שרשרת אימונוגלובולינית
Ce כבדה עם
A61K (2010.01)
צירופים של תרכובות של מעכב
–קינאז וגורמים3 פוספואינוסיטיד
כימותרפיים לטיפול בממאירויות
המאטופויטיאות
A61K (2010.01)
טיפול בעור
A61K (2010.01)
תערובת חדשה של רכיבים פעילים
הכוללת תרופה לא–סטרואידית נוגדת
דלקת ונגזרת קולכיקוסיד
August 31,2011 -א' באלול התשע"א
PCT/IN/2009/000071
WO/2010/084500
15/08/2005
214135
TEMPORAL ENVELOPE SHAPING
FOR SPATIAL AUDIO CODING USING
FREQUENCY DOMAIN WIENER
FILTERING
DOLBY LABORATORIES LICENSING
CORPORATION
US
60/604836
25/08/2004
PCT/US/2005/029157
WO/2006/026161
214136
21/01/2010
CHRONOTHERAPEUTIC
PHARMACEUTICAL COMPOSITION
ABBOTT HEALTHCARE PRIVATE
LIMITED
IN
140/MUM/2009 22/01/2009
PCT/IN/2010/000035
WO/2010/089772
04/02/2010
214137
PYRIDAZINONE COMPOUNDS
TAKEDA PHARMACEUTICAL
COMPANY LIMITED
US
61/202207
05/02/2009
61/213,927
30/07/2009
US
PCT/US/2010/000307
WO/2010/090737
04/02/2010
52
214139
G10L (2010.01)
גיבוש מעטפת זמנית עבוק קידוד קול
WIENER מרחבי באמצעות סינון
DOMAIN FREQUENCY
A61K (2010.01)
תכשיר רוקחי כרונופואי
A01N (2010.01)
תרכובות פירידזינון
G06F (2010.01)
August 31,2011 -א' באלול התשע"א
DATA ENTRY SYSTEM
KEYLESS SYSTEMS LTD
IL
196898
196933
IL
196969
IL
197861
IL
198068
IL
199258
IL
199466
IL
199947
IL
200428
IL
200513
IL
201089
IL
202245
IL
PCT/IL/2010/000098
WO/2010/089740
28/01/2010
מערכת להכנסת נתונים
קילס סיסטמס בע"מ
04/02/2009
05/02/2009
09/02/2009
26/03/2009
07/04/2009
09/06/2009
21/06/2009
19/07/2009
16/08/2009
20/08/2009
21/09/2009
19/11/2009
214140
A METHOD FOR MODIFYING
COMPOSITE MEMBRANES FOR
LIQUID SEPARATIONS
BEN GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
29/01/2009
US
61/202122
PCT/IL/2010/000071
WO/2010/086852
22/01/2010
214143
POST-OPERATIVE ADJUSTMENT
TOOL, MINIMALLY INVASIVE
ATTACHMENT APPARATUS, AND
ADJUSTABLE TRICUSPID RING
ST. JUDE MEDICAL, CARDIOLOGY
DIVISION, INC.
US
61/146560
22/01/2009
61/157649
05/03/2009
US
PCT/US/2010/021810
WO/2010/085649
53
B01D (2010.01)
שיטה לשיפור מבני ממברנות להפרדת
נוזלים
הרשות,גוריון בנגב-אוניברסיטת בן
למחקר ופיתוח
A61B (2010.01)
חיבור בעל,מכשיר כיוונון לאחר ניתוח
פולשנות מינימלית וטבעת תלת–צניפית
ניתנת לכיוונון
August 31,2011 -א' באלול התשע"א
22/01/2010
214144
MAGNETIC DOCKING SYSTEM AND
METHOD FOR THE LONG TERM
ADJUSTMENT OF AN IMPLANTABLE
DEVICE
ST. JUDE MEDICAL, CARDIOLOGY
DIVISION, INC.
US
61/146569
22/01/2009
PCT/US/2010/021822
WO/2010/085659
28/12/2009
214145
SOLID PHARMACEUTICAL
COMPOSITION COMPRISING
AMLODIPINE AND LOSARTAN
HANMI HOLDINGS CO., LTD.
10-200923/01/2009
KR
0005840
10-200924/09/2009
KR
0090540
PCT/KR/2009/007829
WO/2010/085047
05/06/2009
214146
SOLID PHARMACEUTICAL
COMPOSITION COMPRISING
AMLODIPINE AND LOSARTAN WITH
IMPROVED STABILITY
HANMI HOLDINGS CO., LTD.
10-2009KR
23/01/2009
0005840
10-200924/04/2009
KR
0036011
PCT/KR/2009/003028
WO/2010/085027
54
A61F (2010.01)
מערכת עגינה מגנטית ושיטה לכיוונון
ארוך טווח של מכשיר מושתל
A61K (2010.01)
תכשיר רוקחי מוצק המכיל אמלודיפין
ולוסארטאן
A61K (2010.01)
תכשיר רוקחי מוצק המכיל אמלודיפין
ולוסארטאן בעל יציבות משופרת
August 31,2011 -א' באלול התשע"א
13/02/2009
214147
SOLID-OPERATIVE ADJUSTMENT
TOOL, MINIMALLY INVASIVE
ATTACHMENT APPARATUS, AND
ADJUSTABLE TRICUSPID RING
HANMI HOLDINGS CO., LTD.
10-2009KR
23/01/2009
0005840
PCT/KR/2009/000704
WO/2010/085014
26/01/2010
214148
SACCHAROMYCES CEREVISIAE
STRAINS WITH PHYTOSANITARY
CAPABILITIES
LESAFFRE ET COMPAGNIE
FR
09/00339
27/01/2009
PCT/IB/2010/050336
WO/2010/086790
01/01/2007
214149
MULTI- SCREENED COMPUTER
MONITOR UNIT
U-SEE 2 LIMITED
18/02/2010
תכשיר רוקחי מוצק המכיל אמלודיפין
ולוסארטאן ותהליך לייצורו
C12N (2010.01)
זנים של סכארומיצס סרוויסיא בעלי
יכולות של הגנה על צמח מפני מחלות
G09F (2010.01)
יחידת צג רב–מסכי למחשב
סיט סחר בע"מ.די
214152
A FAN ASSEMBLY
DYSON TECHNOLOGY LIMITED
GB
0903679.9
04/03/2009
PCT/GB/2010/050269
55
A61K (2010.01)
F24F (2010.01)
הרכבה של מאוורר
August 31,2011 -א' באלול התשע"א
WO/2010/100451
214153
20/01/2010
משחה חדשה לטיפול בעור עשוי תוך
בחומרים נגד,שימוש בנתרן פיוזידייט
פטריות ובסטרואידים
A NOVEL DERMACEUTICAL CREAM
MADE USING SODIUM FUSIDATE,
ANTIFUNGALS AND STEROIDS
VANANGAMUDI, SULUR,
SUBRAMANIAM
IN
133/MUM/2009 21/01/2009
PCT/IB/2010/050243
WO/2010/084458
19/01/2010
214154
METHODS EMPLOYING NONCODING RNA EXPRESSION ASSAYS
SISTEMIC SCOTLAND LIMITED
GB
0900809.5
19/01/2009
0917708.0
09/10/2009
GB
PCT/GB/2010/000076
WO/2010/082039
15/01/2010
56
C12Q (2010.01)
RNA שיטות המשתמשות באבחוני ביטוי
אי–מקודד
214156
MEDICAMENT IDENTIFICATION
SYSTEM FOR MULTI-DOSE
INJECTION DEVICES
SANOFI-AVENTIS DEUTSCHLAND
GMBH
US
61/146768
23/01/2009
09002398.7
20/02/2009
EP
PCT/EP/2010/050443
WO/2010/084084
22/01/2010
A61K (2010.01)
214157
A61M (2010.01)
מערכת לזיהוי תרופה להתקנים רבי
מינונים
A61M (2010.01)
August 31,2011 -א' באלול התשע"א
מנגנון לכיוון המינון בהתקן להעברת
תרופה
DRUG DELIVERY DEVICE DOSE
SETTING MECHANISM
SANOFI-AVENTIS DEUTSCHLAND
GMBH
EP
09000895.4 22/01/2009
12/357899
22/01/2009
US
PCT/EP/2010/050709
WO/2010/084164
02/12/2009
B62D (2010.01)
214158
ריצוף מיכל
CONTAINER FLOORING
CONFORCE INTERNATIONAL, INC.
US
61/145832
20/01/2009
PCT/CA/2009/001736
WO/2010/083583
15/01/2010
214160
COMPOSITIONS COMPRISING A
LIPOPHILIC EXTRACT OF ZINGIBER
OFFICINALE AND AN EXTRACT OF
CYNARA SCOLYMUS, WHICH ARE
USEFUL FOR THE PREVENTION AND
TREATMENT OF OESOPHAGEAL
REFLUX AND IRRITABLE BOWEL
SYNDROME
INDENA S.P.A.
IT
MI2009A000051 20/01/2009
IT
MI2009A001358 29/07/2009
PCT/EP/2010/000205
WO/2010/083968
15/01/2010
57
A61K (2010.01)
תכשירים המכילים מיצוי ליפופילי של
ומיצוי שלOFFICINALE ZINGIBER
אשר הינםSCOLYMUS CYNARA
יעילים למניעה וטיפול החזר ושטי
ותסמונת המעי הרגיז
214161
A61K (2010.01)
August 31,2011 -א' באלול התשע"א
COMPOSITIONS COMPRISING
LIPOPHILIC EXTRACTS OF ZINGIBER
OFFICINALE AND ECHINACEA
ANGUSTIFOLIA FOR THE
PREVENTION AND TREATMENT OF
GASTRO-OESOPHAGEAL REFLUX
AND CHEMOTHERAPY-INDUCED
EMESIS
INDENA S.P.A.
IT
MI2009000049 20/01/2009
PCT/EP/2010/000204
WO/2010/083967
27/01/2010
214162
WOUND DRESSINGS, METHODS AND
APPARATUS FOR MAKING SAME
AND STORAGE AND USE THEREOF
IGAL KUSHNIR
27/01/2009
US
61/147513
PCT/IL/2010/000066
WO/2010/086848
20/01/2010
214163
COMPOSITIONS AND METHODS FOR
INDUCTION OF ANTIGEN-SPECIFIC
TOLERANCE
NORTHWESTERN UNIVERSITY
US
61/145941
20/01/2009
PCT/US/2010/021547
WO/2010/085509
02/07/2002
58
214164
תכשירים המכילים מיצויים ליפופיליים
– וOFFICINALE ZINGIBER של
ANGUSTIFOLIA ECHINACEA
למניעה וטיפול של החזר ושטי והקאות
מושרות כמותרפיה
A61L (2010.01)
, שיטות והתקנים להכנתן,תחבושות
אחסונן והשימוש בהן
קושניר יגאל
A61K (2010.01)
תכשירים ושיטות להשראת טולרנטיות
ספציפית לאנטיגן
C12P (2010.01)
August 31,2011 -א' באלול התשע"א
PROCESS FOR THE PREPARATION
OF INTERMEDIATES USEFUL IN THE
SYNTHESIS OF STATIN
DERIVATIVES ESPECIALLY 7AMINO 3,5-DIHYDROXY HEPTANOIC
ACID DERIVATIVES, AND
INTERMEDIATES THEREOF
CIBA SPECIALTY CHEMICALS
HOLDING INC.
EP
01810670.8 06/07/2001
PCT/EP/2002/007307
WO/2003/004450
02/07/2002
תהליך להכנת חומרי ביניים שימושיים
בהכנת נגזרות סטאטין במיוחד נגזרות של
חומצה,–דיהדרוקסין5,3––אמינו7
הפטאנואית וחומרי ביניים שלה
INTERMEDIATES USEFUL IN THE
SYNTHESIS OF STATIN
DERIVATIVES
CIBA SPECIALTY CHEMICALS
HOLDING INC.
EP
01810670.8 06/07/2001
PCT/EP/2002/007307
WO/2003/004450
29/01/2010
חומרי ביניים שימושיים בהכנת נגזרות
סטאטין
214166
METHOD FOR THE PRODUCTION OF A
CERAMIC ABSORBER MEMBER FOR
SOLAR RADIATION, AND ABSORBER
MEMBER
SAINT-GOBAIN INDUSTRIEKERAMIK
RODENTAL GMBH
DE
102009006953.4 30/01/2009
PCT/EP/2010/051134
WO/2010/086430
25/01/2010
NEW ADENOSINE RECEPTOR
LIGANDS AND USES THEREOF
59
C12P (2010.01)
214165
214167
B28B (2010.01)
שיטה לייצור איבר קירמי סופג עבור
ואיבר סופג,קרינה סולרית
C07D (2010.01)
ליגנדים חדשים לקולטן אדנוסין
ושימושים בהם
August 31,2011 -א' באלול התשע"א
DOMAIN THERAPEUTICS
EP
09360007.0 26/01/2009
PCT/IB/2010/000416
WO/2010/084425
18/01/2010
214168
IMPROVED COMPACT VACUUM
MATERIAL HANDLER
VACULIFT, INC. (DBA VACUWORX
INTERNATIONAL)
US
12/355843
19/01/2009
PCT/US/2010/021326
WO/2010/083490
26/01/2010
214169
FLAVOR ENCAPSULATION AND
METHOD THEREOF
FRITO-LAY NORTH AMERICA, INC.
27/01/2009
US
12/360387
PCT/US/2010/022102
WO/2010/088211
03/02/2010
214170
COMMUNICATIONS DEVICE
INCLUDING A FILTER FOR
NOTCHING WIDEBAND RECEIVE
SIGNALS AND ASSOCIATED
METHODS
HARRIS CORPORATION
US
12/364631
03/02/2009
PCT/US/2010/022956
WO/2010/091034
60
F01P (2010.01)
מכשיר קומפטקי משופר לטיפול בחומר
בואקום
A23D (2010.01)
תרמול של חומרי טעם ושיטה לכך
H04B (2010.01)
התקן תקשורת הכולל מסנן לברירת
אותות מתקבלים רחבי פס ושיטות
הקשורות לכך
August 31,2011 -א' באלול התשע"א
26/09/2005
214173
METHODS AND SYSTEMS FOR
CRYOGENIC COOLING
CRYODYNAMICS, LLC
US
10/952531
27/09/2004
PCT/US/2005/034532
WO/2006/137887
26/09/2005
שיטות ומערכות לקירור קריוגני
214174
METHODS AND SYSTEMS FOR
CRYOGENIC COOLING
CRYODYNAMICS, LLC
27/09/2004
US
10/952531
PCT/US/2005/034532
WO/2006/137887
16/02/2010
09/02/2010
61
C07C (2010.01)
הרכבים רוקחיים,נגזרות של אמינוטטרלין
ושימוש שלהן בטיפול,המכילים אותן
214176
METHODS OF USING AND
COMPOSITIONS COMPRISING PDE4
MODULATORS FOR TREATMENT,
PREVENTION AND MANAGEMENT
OF TUBERCULOSIS
CELGENE CORPORATION
US
61/151467
10/02/2009
PCT/US/2010/023533
WO/2010/093588
A61F (2010.01)
שיטות ומערכות לקירור קריוגני
214175
AMINOTETRALINE DERIVATIVES,
PHARMACEUTICAL COMPOSITIONS
CONTAINING THEM, AND THEIR USE
IN THERAPY
ABBOTT LABORATORIES
16/02/2009
US
61/152825
PCT/EP/2010/051903
WO/2010/092180
A61F (2010.01)
A61K (2010.01)
שיטות לשימוש והרכבים המכילים
מניעה, לטיפולPDE4 מודולטורים של
וניהול של שחפת
August 31,2011 -א' באלול התשע"א
19/01/2010
214177
DECELERATOR COMPRISING
DECELERATION TANK AND
EXTRACTION CONVEYOR
PICKER TECHNOLOGIES LLC
US
61/145899
20/01/2009
61/146468
22/01/2009
US
PCT/US/2010/021412
WO/2010/085450
16/02/2010
214178
PURIFICATION OF 1-[2-(2,4DIMETHYLPHENYLSULFANYL)
PHENYL]PIPERAZINE
H. LUNDBECK A/S
DK
PA200900223 17/02/2009
PCT/DK/2010/050039
WO/2010/094285
22/01/2010
214179
ACTUATED FEEDFORWARD
CONTROLLED SOLAR TRACKING
SYSTEM
INSPIRED SURGICAL
TECHNOLOGIES, INC.
US
61/146508
22/01/2009
61/171263
21/04/2009
US
61/254963
26/10/2009
US
PCT/US/2010/021708
WO/2010/085592
21/06/2007
62
214180
A01D (2010.01)
מאיט המכיל מיכל האטה ומסוע מיצוי
C07D (2010.01)
–(–דימתילפנילסולפניל2,4)–2 ]–1 ניקוי
פניל[פיפרזין
F24J (2010.01)
מערכת מעקב סולארית מבוקרת
המופעלת בהיזון קדימה
C07H (2010.01)
August 31,2011 -א' באלול התשע"א
CRYSTALLINE SOLVATES AND
COMPLEXES OF (1S)-1,5-ANHYDRO1-C-(3-((PHENYL)METHYL)PHENYL)D-GLUCITOL DERIVATIVES WITH
AMINO ACIDS AS SGLT2 INHIBITORS
FOR THE TREATMENT OF DIABETES
BRISTOL-MYERS SQUIBB COMPANY
US
60/817118
28/06/2006
11/765481
20/06/2007
US
PCT/US/2007/071749
WO/2008/002824
21/06/2007
214181
CRYSTALLINE SOLVATES AND
COMPLEXES OF (1S)-1,5-ANHYDRO1-C-(3-((PHENYL)METHYL)PHENYL)D-GLUCITOL DERIVATIVES WITH
AMINO ACIDS AS SGLT2 INHIBITORS
FOR THE TREATMENT OF DIABETES
BRISTOL-MYERS SQUIBB COMPANY
US
60/817118
28/06/2006
11/765481
20/06/2007
US
PCT/US/2007/071749
WO/2008/002824
21/06/2007
C07H (2010.01)
סולבטים גבישיים וקומפלקסים של נגזרות
–C–1–(3––אנהידרוS)–1,51)
–גלוציטול עםD–())פניל(מתיל(פניל
חומצות אמינו המשמשים כמעכבי
עבור הטיפול בסוכרתSGLT2
214182
CRYSTALLINE SOLVATES AND
COMPLEXES OF (1S)-1,5-ANHYDRO1-C-(3-((PHENYL)METHYL)PHENYL)D-GLUCITOL DERIVATIVES WITH
AMINO ACIDS AS SGLT2 INHIBITORS
FOR THE TREATMENT OF DIABETES
BRISTOL-MYERS SQUIBB COMPANY
US
60/817118
28/06/2006
11/765481
20/06/2007
US
PCT/US/2007/071749
WO/2008/002824
63
סולבטים גבישיים וקומפלקסים של נגזרות
–C–1–(3––אנהידרוS)–51,1)
–גלוציטול עםD–())פניל(מתיל(פניל
חומצות אמינו המשמשים כמעכבי
עבור הטיפול בסוכרתSGLT2
C07H (2010.01)
סולבטים גבישיים וקומפלקסים של נגזרות
–C–1–(3––אנהידרוS)–1,51)
–גלוציטול עםD–())פניל(מתיל(פניל
חומצות אמינו המשמשים כמעכבי
עבור הטיפול בסוכרתSGLT2
August 31,2011 -א' באלול התשע"א
28/04/2006
214183
מערכת פארמה–אינפורמטיקה
PHARMA-INFORMATICS SYSTEM
PROTEUS BIOMEDICAL, INC
28/04/2005
US
60/676145
60/694078
24/06/2005
US
01/09/2005
60/713680
US
60/790335
07/04/2006
US
PCT/US/2006/016370
WO/2006/116718
03/03/2010
214184
214185
A SYSTEM FOR COLLECTING
CONDENSED DEW WATER AND A
METHOD OF USING THE SAME
KATZIR HAIM
US
61/146009
21/01/2009
PCT/IL/2010/000053
WO/2009/027975
23/01/2010
64
E03B (2010.01)
מערכת לאיסוף מי טל מרוכזים ושיטה
לשימוש
חיים קציר
214186
POULTRY CARRIERS AND METHODS
RESTRAINING POULTRY
NOVA-TECH ENGINEERING, INC.
US
61/146732
23/01/2009
PCT/US/2010/021900
WO/2010/085718
C07D (2010.01)
קוטלי פטריות פיראזולים
FUNGICIDAL PYRAZOLES
E.I. DU PONT DE NEMOURS AND
COMPANY
US
61/157046
03/03/2009
61/304053
12/02/2010
US
PCT/US/2010/026003
WO/2010/101973
21/01/2010
A61J (2010.01)
A61D (2010.01)
מנשאים לבעלי כנף ושיטות לריסון בעלי
כנף
August 31,2011 -א' באלול התשע"א
23/01/2010
214187
FOURTH TOE PROCESSING
SYSTEMS AND METHODS
NOVA-TECH ENGINEERING, INC.
US
61/146737
23/01/2009
61/146732
23/01/2009
US
PCT/US/2010/021901
WO/2010/085719
05/01/2010
מערכות ושיטות לטיפול בבוהן הרביעית
214188
214192
PLANT VOLATILES BASED ON RCURCUMENE
KEYGENE N.V.
WO
PCT/EP/2010/001599 04/03/2010
PCT/EP/2010/001599
WO/2010/099985
19/01/2009
DOSEG DISPENSING DEVICE
RESCUE DOSE LTD
WO
PCT/IL2009/000074
PCT/IL/2009/000074
WO/2009/095904
65
F16L (2010.01)
טבעת אחיזת צינור
קראוס תעשיות מתכת בע"מ
PIPE GRIP RING
KRAUSZ METAL INDUSTRIES LTD.
US
12/352174
12/01/2009
PCT/US/2010/020069
WO/2010/080743
04/03/2010
A61D (2010.01)
214193
A01N (2010.01)
–R נדיפי צמחים מבוססים על
קורקומין
B65B (2010.01)
מתקן למינון תרופות
רסקיו דוז בע"מ
19/01/2009
August 31,2011 -א' באלול התשע"א
19/07/2011
214194
TRAINING AND THERAPY
APPARATUS
YAEL CASPI BLATCH
21/01/2010
התקן לאימון ולטיפול
ענת צחור
214195
214196
METHOD AND SYSTEM FOR IMAGE
CORRECTION ACROSS MULTIPLE
SPECTRAL REGIMES
FLIR SYSTEMS, INC.
US
60/696299
01/07/2005
11/207536
19/08/2005
US
PCT/US/2006/025504
WO/2007/005567
30/11/2006
66
G06K (2010.01)
שיטה ומערכת לתיקון דמויות דרך תחומי
קרינה רבים
214198
COMPOSITIONS AND METHODS FOR
THE TREATMENT OF DISEASES AND
DISORDERS ASSOCIATED WITH
CYTOKINE SIGNALING
GENENTECH, INC.
C12Q (2010.01)
שיטות להכפלת חומצות גרעיניות של
C הנגיף הפטיטוס
METHODS FOR AMPLIFYING
HEPATITIS C VIRUS NUCLEIC ACIDS
VERTEX PHARMACEUTICALS
INCORPORATED
US
61/146083
21/01/2009
PCT/US/2010/021589
WO/2010/090857
29/06/2006
A63B (2010.01)
C07K (2010.01)
תכשירים ושיטות לטיפול במחלות ואי
סדרים הקשורים לאיתות ציטוקיני
August 31,2011 -א' באלול התשע"א
US
60/741640
60/822597
US
PCT/US/2006/061418
WO/2007/126439
22/01/2010
02/12/2005
16/08/2006
מתן של גורם אחד או יותר עם שחרור
מושהה
SUSTAINED RELEASED DELIVERY
OF ONE OR MORE AGENTS
QLT INC.
US
61/146860
23/01/2009
61/152909
16/02/2009
US
27/07/2009
61/228894
US
61/277000
18/09/2009
US
PCT/US/2010/021868
WO/2010/085696
21/01/2010
A61M (2010.01)
214199
C04B (2010.01)
214200
TAILORED GEOPOLYMER
COMPOSITE BINDERS FOR CEMENT
AND CONCRETE APPLICATIONS
THE CATHOLIC UNIVERSITY OF
AMERICA
22/01/2009
US
61/146494
PCT/US/2010/021605
WO/2010/085537
01/02/2010
כורכנים מותאמים מחומר מרוכב
גיאופולימרי ליישומי מלט ובטון
214201
SOLAR ABSORBER MODULE AND
SOLAR ABSORBER ARRANGEMENT
SAINT-GOBAIN INDUSTRIEKERAMIK
RODENTAL GMBH
DE
102009006952.6 30/01/2009
PCT/EP/2010/051181
WO/2010/086443
67
F24J (2010.01)
מודול קולט סולרי וסידור לקולט סולרי
August 31,2011 -א' באלול התשע"א
15/02/2010
214202
A METHOD FOR PRODUCING METAL
POWDERS
METALYSIS LIMITED
GB
0902486.0
13/02/2009
PCT/GB/2010/000266
WO/2010/092358
28/01/2010
03/08/2006
שיטה לייצור אבקות מתכת
214203
CARBOXAMIDE COMPOUNDS AND
METHODS FOR USING THE SAME
RIGEL PHARMACEUTICALS, INC.
US
61/147982
28/01/2009
PCT/US/2010/022411
WO/2010/088392
214204
214205
POOL CLEANING ROBOT
MAYTRONICS LTD.
US
11/196737
04/08/2005
PCT/IL/2006/000901
WO/2007/015251
68
C07D (2010.01)
תרכובות קרבוקסאמיד ושיטות לשימוש
בהן
POOL CLEANING ROBOT
MAYTRONICS LTD.
US
11/196737
04/08/2005
PCT/IL/2006/000901
WO/2007/015251
03/08/2006
B22F (2010.01)
E04H (2010.01)
רובוט לניקוי בריכות מים
מיטרוניקס בע"מ
E04H (2010.01)
רובוט לניקוי בריכות מים
מיטרוניקס בע"מ
August 31,2011 -א' באלול התשע"א
06/02/2010
OIL-BASED AGROCHEMICAL
COMPOSITIONS WITH INCREASED
VISCOSITY
COGNIS IP MANAGEMENT GMBH
EP
09002181.7 17/02/2009
PCT/EP/2010/000752
WO/2010/094408
04/02/2010
A01N (2010.01)
214206
תכשירים חקלאיים מבוססים על שמן עם
צמיגות מוגברת
A01N (2010.01)
214207
תכשירים חקלאיים
AGRICULTURAL COMPOSITIONS
COGNIS IP MANAGEMENT GMBH
EP
09002015.7 13/02/2009
PCT/EP/2010/000670
WO/2010/091817
22/01/2010
COMPOSITIONS AND METHODS FOR
INHIBITION OF THE JAK PATHWAY
RIGEL PHARMACEUTICALS, INC.
US
61/147059
23/01/2009
61/241630
11/09/2009
US
PCT/US/2010/021856
WO/2010/085684
17/05/2005
JAK תכשירים ושיטות לעיכוב מסלול
214210
ANTIBODIES THAT BIND PSCA PROTEINS
FOR DIAGNOSIS OF CANCER
AGENSYS, INC.
US
10/857484
28/05/2004
US
PCT/US2004/17231 28/05/2004
60/616381
05/10/2004
US
60/617881
12/10/2004
US
60/621310
21/10/2004
US
60/633077
02/12/2004
US
69
C07D (2010.01)
214208
C07K (2010.01)
PSCA נוגדנים הנקשרים לחלבוני
לאבחון סרטן
August 31,2011 -א' באלול התשע"א
60/672000
US
PCT/US/2005/017412
WO/2005/118864
14/04/2005
22/01/2009
214211
STABLE VACCINE COMPOSITIONS
AND METHODS FOR PREPARING
THE SAME
PHARMATHENE INC.
A61K (2010.01)
תכשירי חיסון יציבים ושיטות להכנתם
PCT/GB/2009/050051
WO/2010/084298
27/01/2010
214212
METHOD AND SYSTEM FOR
IMPLANT DELIVERY
SILENSEED LTD
27/01/2009
US
61/147548
PCT/IL/2010/000067
WO/2010/086849
20/07/2011
214213
TRANSMISSION SCHEME FOR
MULTIPLE-INPUT COMMUNICATION
COPPERGATE COMMUNICATIONS
LTD.
US
61/365898
20/07/2010
21/01/2010
70
214214
A61M (2010.01)
שיטה ומערכת להצבת שתל
סיילנסיד בע"מ
H04L (2010.01)
תכנית שידור לתקשורת מרובת כניסות
קופרגייט תקשורת בע"מ
H01S (2010.01)
August 31,2011 -א' באלול התשע"א
APPARATUS AND METHOD FOR
MODE CONTROL IN SEMI-GUIDING
AMPLIFIER MEDIUM
RAYTHEON COMPANY
US
12/358983
23/01/2009
PCT/US/2010/021637
WO/2010/085554
21/01/2010
התקן ושיטה לבקרת מצב במדיית מגביר
מנחה–למחצה
214215
RADIO FREQUENCY PARTICLES
RAYTHEON COMPANY
US
61/146609
22/01/2009
PCT/US/2010/021683
WO/2010/123597
20/07/2011
214216
SEWAGE FLOW METERING METHOD
ROBERTO ZIMMERMAN
20/07/2010
GB
1012161.4
04/02/2010
214218
SYSTEMS AND METHODS FOR BIOELECRICITY PRODUCTION
BEN GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
US
61/149707
04/02/2009
PCT/IL/2010/000099
WO/2010/089741
22/01/2010
71
214219
H01Q (2010.01)
חלקיקי תדר רדיו
B03B (2010.01)
שיטה לניטור שפכים
רוברטו צימרמן
H01M (2010.01)
מערכות ושיטות לייצור בין–חשמלי
הרשות,גוריון בנגב-אוניברסיטת בן
למחקר ופיתוח
C07C (2010.01)
August 31,2011 -א' באלול התשע"א
PROCESS FOR ISOLATING
TIGECYCLINE AND TIGECYCLINE
MADE THEREFROM
HOVIONE INTER LTD.
PT
104350
23/01/2009
PCT/GB/2010/000104
WO/2010/084325
21/01/2010
214220
DELAYED RELEASE RASAGILINE
FORMULATION
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
23/01/2009
US
61/205833
12/456029
09/06/2009
US
12/456001
09/06/2009
US
12/456031
09/06/2009
US
12/455976
09/06/2009
US
12/689044
18/01/2010
US
PCT/US/2010/000174
WO/2010/085354
26/01/2010
תהליך לבידוד טיגציקלין וטיגאיקלין
המוכן באמצעותו
תרכובות רוקחיות בעלות שחרור מושהה
המכילות רסאג'ילין
214221
PROCESSES FOR COATING A
CARRIER WITH MICROPARTICLES
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
61/147287
26/01/2009
PCT/US/2010/022045
WO/2010/085780
09/02/2010
214224
A SPRING COMPACTOR MACHINE
TAYLOR, CECIL RAY
US
61/150938
09/02/2009
12/702816
09/02/2010
US
72
A01N (2010.01)
טבע תעשיות פרמצבטיות בע"מ
A61K (2010.01)
תהליך לציפוי נשא בחלקיקים מיקרונים
טבע תעשיות פרמצבטיות בע"מ
B30B (2010.01)
מכונה לצמצום קפיצים
August 31,2011 -א' באלול התשע"א
PCT/US/2010/023657
WO/2010/110949
12/02/2004
214230
העברה רכה לרשתות שונות הנעזרים
שונות הנעזרים על ידי קצה–עד קצה
פרוטוקול יישום
SOFT HANDOFF ACROSS DIFFERENT
NETWORKS ASSISTED BY AN ENDTO-END APPLICATION
QUALCOMM INCORPORATED
US
10/366454
12/02/2003
PCT/US/2004/004600
WO/2004/073282
27/03/2006
214245
PROCESS FOR PRODUCTION OF 1-(3(2-(1-BENZOTHIOPHEN-5YL)ETHOXY)PROPYL)AZETIDIN-3OL OR SALTS THEREOF
TOYAMA CHEMICAL CO., LTD.
200528/03/2005
JP
090831
2005-174738 15/06/2005
JP
2005-206808 15/07/2005
JP
2005-230666 09/08/2005
JP
PCT/JP/2006/306127
WO/2006/104088
15/03/2007
73
C07D (2010.01)
–)–2)–3)–1 הליך עבור ייצור של
–3––איל(פרופיל(אזאטידין5–בנזות'יאופן
אול או מלחים מזה
214252
TETOMILAST POLYMORPHS
OTSUKA PHARMACEUTICAL CO.,
LTD.
2006JP
17/03/2006
075307
PCT/JP/2007/055931
WO/2007/119496
H04L (2010.01)
A61K (2010.01)
פולימורפים של טטומילאסט
August 31,2011 -א' באלול התשע"א
15/03/2007
214253
פולימורפים של טטומילאסט
TETOMILAST POLYMORPHS
OTSUKA PHARMACEUTICAL CO.,
LTD.
2006JP
17/03/2006
075307
PCT/JP/2007/055931
WO/2007/119496
15/03/2007
214254
214262
THERAPEUTIC HUMAN ANTI-IL-1R1
MONOCLONAL ANTIBODY
MEDAREX INC.
US
60/408719
06/09/2002
PCT/US/2003/027978
WO/2004/022718
05/09/2003
74
A61K (2010.01)
אנושיR1–IL1 נוגדן חד–שבטי רפואי נגד
214263
THERAPEUTIC HUMAN ANTI-IL-1R1
MONOCLONAL ANTIBODY
MEDAREX INC.
US
60/408719
06/09/2002
PCT/US/2003/027978
WO/2004/022718
A61K (2010.01)
פולימורפים של טטומילאסט
TETOMILAST POLYMORPHS
OTSUKA PHARMACEUTICAL CO.,
LTD.
2006JP
17/03/2006
075307
PCT/JP/2007/055931
WO/2007/119496
05/09/2003
A61K (2010.01)
A61K (2010.01)
אנושיR1–IL1 נוגדן חד–שבטי רפואי נגד
August 31,2011 -א' באלול התשע"א
23/10/2001
214267
IN VITRO GENETICALLY MODIFIED
MICRO-ORGANS EXPRESSING A
FACTOR VIII AND USES RELATED
THERETO
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM LTD.
C12N (2010.01)
מיקרו–איברים מהונדסים גנטית במבחנה
VIII (המבטאים פקטורVITRO–IN)
ושימושים הקשורים בהם
יישום חברה לפיתוח המחקר של
האוניברסיטה העברית בירושלים בע"מ
PCT/IL/2001/000976
WO/2003/035851
23/10/2001
214268
IN VITRO GENETICALLY MODIFIED
MICRO-ORGANS EXPRESSING A
ERYTHROPOIETIN AND USES
RELATED THERETO
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM LTD.
C12N (2010.01)
מיקרו–איברים מהונדסים גנטית במבחנה
( המבטאים אריתרופויטיןVITRO–IN)
ושימושים הקשורים בהם
יישום חברה לפיתוח המחקר של
האוניברסיטה העברית בירושלים בע"מ
PCT/IL/2001/000976
WO/2003/035851
15/07/2004
214280
HUMAN ANTI-NGF NEUTRALIZING
ANTIBODIES AS SELECTIVE NGF
PATHWAY INHIBITORS
MEDAREX INC.
US
60/487431
15/07/2003
PCT/US/2004/022876
WO/2005/019266
75
C07K (2010.01)
( )גורם גידול עצביNGF נוגדים נגד
NGF כמעכבי מסלול,המנטרל פעילות
ספציפיים
August 31,2011 -א' באלול התשע"א
15/07/2004
214281
HUMAN ANTI-NGF NEUTRALIZING
ANTIBODIES AS SELECTIVE NGF
PATHWAY INHIBITORS
MEDAREX INC.
US
60/487431
15/07/2003
PCT/US/2004/022876
WO/2005/019266
76
C07K (2010.01)
( )גורם גידול עצביNGF מוגדים נגד
NGF כמעכבי מסלול,המנטרל פעילות
ספציפיים
August 31,2011 -א' באלול התשע"א
NOTICE UNDER SECTION 26 OF THE
PATENTS LAW, 5727-1967
The applications, particulars of which are set
out below, have been accepted pursuant to
Section 17 of the Patents Law. Any person
wishing to oppose the grant of a patent on any
of the applications published here, may,
within three months from the date of this
journal, give to the Commissioner of Patents
notice under Section 30 of the Patents Law, in
the manner prescribed in regulations 57 et seq
of the Patents Regulations, 5728-1968
77
- לחוק הפטנטים תשכ"ז26 הודעה לפי סעיף
1976
הבקשות שפרטיהן מתפרסמים להלן קובלו
כל המעונין. לחוק הפטנטים17 לפי סעיף
להתנגד למתן פטנט על פי בקשה מהבקשות
תוך שלושה חדשים,המתפרסמות רשאי
להגיש לרשם הפטנטים,מתאריך יומן זה
לחוק הפטנטים30 הודעת התנגדות לפי סעיף
ואילך לתקנות57 בדרך הקבועה בתקנה
.1968 – תשכ"ח,הפטנטים
Particulars of the applications, where
applicable, are given in the following order:
[11] [21] Number of application
[54] Title of invention
[22] Application date
[31] [32] [33] Number and date of foreign
application – convention country.
*[51] Int.Cl.
[61] Application for patent of addition
[62] Divisional application
[71] Applicant
[72] Inventor
[87] International Publication Number
[74] Address for service
[57] Abridgement of invention (in the
language in which the specification is drawn
up)
פרטי הבקשות במידה ויישימים מובאים לפי
:סדר זה
מספר הבקשה
שם האמצאה
תאריך הבקשה
מספר ותאריך של בקשות החוץ – מדינת
האגוד
*סיווג בינלאומי
בקשה לפטנט מוסף
בקשת חלוקה
המבקש
הממציא
מס' פרסום של בקשה הבינלאומית
מען למסירת מסמכים
(תקציר האמצאה )בשפה בה ערוך הפירוט
*Note:, patent applications published in this
journal were classified according to the
International Classification version that was
in force when this journal was prepared.
בקשות הפטנטים שפורסמו ביומן:**הערה
זה סווגו בהתאם לגרסת הסיווג הבינלאומי
.שהייתה בתוקף בעת הכנת הבקשות לפרסום
August 31,2011 -א' באלול התשע"א
[11][21]
113909
,התקן רפואי הכולל מגנט מונע הניתן להשתלה
מגנט מניע חיצוני מצומד אליו והתקן הניתן
להשתלה שמופעל על ידי סיבוב המגנט המונע
[54]
MEDICAL APPARATUS
COMPRISING AN
IMPLANTABLE DRIVEN
MAGNET, AN EXTERNAL DRIVE
MAGNET COUPLED THERETO
AND AN IMPLANTABLE DEVICE
OPERATED BY ROTATION OF
SAID DRIVEN MAGNET
[22]
[51]
[71]
29.05.1995
Int. Cl.(2010.01) A61B 05//0436, A61M 01//00
AMS RESEARCH CORPORATION,
U.S.A.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
[57]
,' קולב ושות.סנפורד ט
מרמורק,4 שער הגיא
רחובות2273 .ד. ת,
A medical apparatus comprising: a drive magnet, externally located with respect to a
subject body, having a first axis and mounted for rotation about said first axis; a driven
magnet having a second axis and configured and dimensioned to be implantable in the
subject's body and mounted for rotation about said second axis by sequential magnetic
pole coupling with said drive magnet when said magnet is implanted in the subject's
body and the drive magnet is rotated sufficiently close to the driven magnet to be
magnetically coupled thereto; and an implant device implantable in the subject body
coupled to said driven magnet to be operated by rotation of said driven magnet.
__________________
[11][21]
78
134527
ממשק ביומטרי
[54]
BIOMETRICS INTERFACE
[22]
[51]
[71]
14.02.2000
Int. Cl.(2010.01) G06F 21//00, H04K 01//00, H04L 09//00, 09//32
BIOGUARD COMPONENTS AND
ראש,ביוגארד רכיבים וטכנולוגיות בע"מ
TECHNOLOGY LTD.
העין
August 31,2011 -א' באלול התשע"א
[74]
[57]
,אגמון-סורוקר
14 רחוב שנקר,בית נולטון
הרצליה פיתוח
SOROKER-AGMON,
14 SHENKAR ST.,
HERZLIYA PITUAH 46725
A personal identifier including a biometric sensor providing at least one biometric
output and a sensor identification output, and an encryption functionality for
encrypting the at least one biometric intput and the sensor identification output to
provide an encrypted identification output. A personal identification method is also
disclosed.; A personal identifier including a biometric sensor providing at least one
biometric output and a sensor identification output, and an encryption functionality for
encrypting the at least one biometric intput and the sensor identification output to
provide an encrypted identification output. A personal identification method is also
disclosed.
__________________
[11][21]
136201
בהכנת תרופהErbB2 שימוש בנוגדן אנטי
לטיפול בסרטן השד
[54]
USE OF AN ANTI ERBB2
ANTIBODY IN THE
PREPARATION OF A
MEDICAMENT FOR TREATMENT
OF MALIGNANT BREAST
CANCER
[22]
[31]
[51]
[71]
[87]
[74]
10.12.1998
60/069346
[32] 12.12.1997
[33]
Int. Cl.(2010.01) A61K 39//395, C07K 16//32
GENENTECH, INC., U.S.A.
WO/1999/031140
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57]
The present invention concerns the treatment of disorders characterized by the
overexpression of ErbB2. More specifically, the invention concerns the treatment of
human patients susceptible to or diagnosed with cancer overexpressing ErbB2 with a
combination of an anti-ErbB2 antibody and a chemotherapeutic agent other than an
anthracycline, e.g. doxorubicin or epirubicin.
The applications for division
79
,214084
US
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
בקשות חלוקה מבקשה זו
August 31,2011 -א' באלול התשע"א
.שטרם פורסמו
from this application have
not yet been published
__________________
[11][21]
143394
תהליך,תרכובות הטרוציקליות ארומטיות
להכנתן והשימוש בהן להכנת תרופות לטיפול
במחלות דלקתיות
[54]
AROMATIC HETEROCYCLIC
COMPOUNDS, PROCESS FOR
THEIR PREPARATION AND
THEIR USE FOR PREPARATION
OF MEDICAMENTS FOR
TREATING INFLAMMATORY
DISEASES
[22]
[31]
[51]
09.12.1999
60/116400
[32] 19.01.1999
[33] US
Int. Cl.(2008.04) A61K 313/96, A61P 29/00, C07D 207/10, 207/34, 231/38, 233/88,
263/48, 277/38, 307/66, 333/36, 401/12, 401/14, 403/12, 405/12, 409/12, 413/12,
417/12, 471/02, 498/02
BOEHRINGER INGELHEIM
PHARMACEUTICALS, INC., U.S.A.
WO/2000/043384
REINHOLD COHN AND PARTNERS,
,ריינהולד כהן ושותפיו
26A HABARZEL ST.,
'א26 רחוב הברזל
RAMAT HACHAYAL 69710
רמת החייל
[71]
[87]
[74]
[57]
Disclosed are novel aromatic heterocyclic compounds of formula (I) wherein Ar1,
Ar2, L, Q and X are described herein. The compounds are useful in pharmaceutic
compositions for treating diseases or pathological conditions involving inflammation
such as chronic inflammatory diseases. Also disclosed are processes of making such
compounds.
__________________
[11][21]
[54]
80
NASAL DELIVERY DEVICE
144988
התקן המעביר חומר לאף
August 31,2011 -א' באלול התשע"א
[22]
[31]
[51]
[71]
[87]
[74]
[57]
03.03.2000
9904906.6
[32] 03.03.1999
9911686.5
19.05.1999
Int. Cl.(2010.01) A61M 15//00, 15//08
OPTINOSE AS, NORWAY
WO/2000/051672
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[33]
GB
GB
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
A delivery device (20, 22) for and a method of delivering a substance to the nasal
airway (1) of a subject, in particular the posterior region of the nasal airway, the
delivery device comprising: a closure unit for causing the closure of the oropharyngeal
velum of the subject; and a delivery unit for delivering a gas flow entraining a
substance to one of the nostrils of the subject at such a driving pressure as to flow
around the posterior margin of the nasal septum and out of the other nostril of the
subject, wherein the delivery unit comprises a nosepiece (30, 40, 58, 82, 102, 132)
which includes an outlet through which the gas flow is in use delivered to the one
nostril and a sealing member for sealing the one nostril to the outlet such as in use to
prevent the escape of the gas flow through the one nostril.
__________________
[11][21]
[54]
ORAL-NASAL CANNULA
[22]
[51]
[71]
[74]
07.10.2001
Int. Cl.(2010.01) A61M 16//06, 25//00
ORIDION MEDICAL 1987 LTD.
WEBB & CO.,
2 PEKERIS ST., P.O.B. 2189,
REHOVOT 76121
[57]
81
145821
קנולה פומית\אפית
ירושלים, בע"מ1987 אורידיון מדיקל
,'ד"ר וב ושות
2 רח' פקריס
רחובות2189 .ד. ת,
An oral/nasal cannula for collection of exhaled gases from a subject comprising: two
August 31,2011 -א' באלול התשע"א
nasal prongs for insertion into the nostrils of the subject;
an oral prong for placement near the oral cavity of the subject; and a collection tube
for the collection of the exhaled gases from the subject,
said nasal prongs, said oral prong and said collection tube being connected at a single
junction configurated to be located substantially near the nostrils of the subject;
wherein said oral prong features a distal end having a cross section substatially larger
then the cross section of said oral prong at its proximal end.
__________________
[11][21]
[54]
PROTECTIVE ARMOR MODULE
[22]
[51]
[71]
29.01.2002
Int. Cl.(2010.01) F41H 05//04
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
[57]
82
147881
מודול מיגון משוריין
,רפאל מערכות לחימה מתקדמות בע"מ
חיפה
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
An armor module (20) comprising a rigid casing having a front face (26), a top face
defining a top of the casing and a bottom face defining a bottom of the casing, and a
plurality of multi-layer planar discrete cassettes (30-38) fixedly mounted within the
casing; each cassette having a general structure comprising a top base plate and a
bottom base plate, made from suitable material and sandwiching between them at least
a one layer of one of an energetic material; wherein the cassettes are mounted within
the casing in such a manner that the top face comprises said top base plate of the
uppermost cassette, and the bottom face comprises said bottom base plate of the
lowermost cassette and wherein at least said uppermost cassette and said lowermost
cassette comprise the same general structure.
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
147979
התקנים נטולי מגע
[54]
CONTACTLESS PORTABLE
OBJECT
[22]
[31]
[51]
[71]
[87]
[74]
26.06.2001
00/08438
[32] 29.06.2000
Int. Cl.(2010.01) G06K 01//00
ASK S.A., FRANCE
WO/2002/001496
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57]
The invention concerns a display peripheral device for contact-free portable object
such as a smart card (10) for displaying data concerning the use of said portable object.
Said peripheral device comprises a chip, display means (16) and power and data
receiving means (18), not connected by ohmic contact to the portable object. Said
reception means is a planar winding serving as secondary of a transformer whereof the
primary consists of an antenna (14) of the portable object, when the latter receives
power and data, coming from a reader of the portable object, by electromagnetic
coupling.
[33]
FR
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
__________________
[11][21]
83
[54]
BUTT-WELDING SYSTEM
[22]
11.06.2002
150148
מערכת להלחמת צינורות פלסטיק
August 31,2011 -א' באלול התשע"א
[51]
[71]
[74]
[57]
Int. Cl.(2009.01) F16L 47/02
YONATAN LEVIN
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
נהריה,יהונתן לוין
עורכי דין ועורכי,קבוצת איתן מהולל
,פטנטים
10 שדרות אבא אבן
הרצליה2081 .ד. ת,
A system for plastic-pipe butt-welding comprising: (a) a base made of at least three
sliding-shafts installed between two end plates; (b) two sets of clamps each set
contain at least one clamp, wherein each of said clamps adapted to receive an end of a
length of a plastic pipe, said clamps being supported from first and second slidingshafts of said base to be in opposed relation to each other whereby the length of
plastic-pipe supported thereby are substantially coaxial, said sets of clamps being
capable of relative movement along said sliding-shafts toward and away from each
other, said clamps having an axial dimension to be able to clamp a portion of the
length of the respective length of pipe adjacent the end; and (c) a heating element
pivotally joined to the third sliding-shaft of said base, wherein said heating element is
capable of sliding along said third sliding-shaft and being movable from a first
position between said sets of clamps and second position spaced laterally from said
first position and wherein said heating element has opposed planer faces which when
said heating element is in said first position each are in opposed relation to said clamps
and are transverse to the central axis of the length of pipe.
__________________
84
August 31,2011 -א' באלול התשע"א
[11][21]
154589
פפטידים חודרי ממברנות והשמושים בהם
[54]
MEMBRANE PENETRATING
PEPTIDES AND USES THEREOF
[22]
[31]
23.08.2001
60/227647
[32] 25.08.2000
[33] US
0103110.3
07.02.2001
GB
Int. Cl.(2010.01) C07K 19//00, C12N 15//62
AVENTISUB II INC., U.S.A.
WO/2002/018572
PEARL COHEN ZEDEK LATZER,
,פרל כהן צדק לצר
5 SHENKAR ST.,
5 רח' שנקר,1 ים-מרכז גב
P.O.B. 12704,
הרצליה12704 .ד. ת,
HERZLIYA 46733
The present invention is directed to membrane penetrating peptides useful as in vivo,
ex vivo and in vitro intracellular delivery devices for compound of interest. More
particularly, the invention involves identification of membrane penetrating peptides
which may be used as protein carriers for delivery of acompound of interest to cells, to
methods of delivering a compound of interest attached to membrane penetrating
peptides to cells.
[51]
[71]
[87]
[74]
[57]
__________________
[11][21]
[54]
COMPOSITIONS CONTAINING
PLAQUE ASSOCIATED
MOLECULES AND USES
THEREOF FOR PREPARING
MEDICAMENTS FOR
PREVENTION AND TREATMENT
OF ATHEROSCLEROSIS
[22]
[31]
03.01.2002
60/259512
85
[32]
04.01.2001
156770
תכשירים המכילים מולקולות הנגזרות מפלאק
ושימוש בהם להכנת תכשירים למניעת טרשת
עורקים ולטיפול בה
[33]
US
August 31,2011 -א' באלול התשע"א
[51]
[71]
[72]
[87]
[74]
[57]
Int. Cl.(2010.01) A61K 38//17
VASCULAR BIOGENICS LTD.
אור יהודה,וסקולר ביוג'ניק בע"מ
DROR HARATS, JACOB GEORGE
' יעקב ג'ורג,דרור חרץ
WO/2002/053092
G.E. EHRLICH (1995) LTD.,
,( בע"מ1995) ארליך.אי.ג'י
AYALON TOWER, 15TH FLOOR,
11 רחוב מנחם בגין, 15 קומה,מגדל איילון
11 MENACHEM BEGIN ST.,
רמת גן
RAMAT GAN 52521
Methods and compositions employing plaque associated molecules effective in
inducing mucosal tolerance and inhibiting inflammatory processes contributing to
atheromatous vascular disease and sequalae are provided.
__________________
[11][21]
157374
גלולה
[54]
CAPSULE
[22]
[31]
[51]
[71]
[87]
[74]
12.02.2002
09/785512
[32] 16.02.2001
[33] US
Int. Cl.(2010.01) H04B 01//66
VISIONSENSE LTD.
פתח תקוה,ויז'נסנס בע"מ
WO/2002/067593
BOROCHOV, KORAKH & CO.,
,'בורוכוב קורח ושות
15TH FLOOR, ATIDIM TOWER,
מגדל כלל עתידים
KIRYAT ATIDIM,
אביב-תל58100 .ד. ת,
P.O.B. 58100,
TEL AVIV 61580
System for producing a stereoscopic image of an object, and displaying the
stereoscopic image, the system including a capsule and a control unit, the capsule
including a sensor assembly (202), a processor (208) coupled with the sensor
assembly, a capsule transceiver coupled with the processor, a light source (206), and a
power supply for supplying electrical power to the capsule transceiver, the processor,
the light source (206) and to the sensor assembly (202), the control unit including a
control unit transceiver, and an image processing system connected to the control unit
transceiver, wherein, the sensor assembly detects the stereoscopic image, the processor
(208) captures the stereoscopic image, the capsule transceiver transmits the
stereoscopic image to the control unit transceiver and the image processing system
processes the stereoscopic image.
[57]
86
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
157922
תכשיר המכיל וריאנט של פפטיד נטריאורטי
לטיפול בדיספלזיות בשלד
[54]
COMPOSITION COMPRISING
NATRIURETIC PEPTIDE
VARIANT FOR TREATMENT OF
SKELETAL DYSPLASIAS
[22]
[31]
20.03.2002
142118
[32] 20.03.2001
[33] IL
60/276939
20.03.2001
US
Int. Cl.(2010.01) A61K 38//22, A61P 19//00, C07K 14//58
HEPACORE LTD.
ציונה- נס,הפאקור בע"מ
WO/2002/074234
WEBB & CO.,
,'ד"ר וב ושות
2 PEKERIS ST., P.O.B. 2189,
2 רח' פקריס
REHOVOT 76121
רחובות2189 .ד. ת,
The present invention discloses pharmaceutical compositions for the treatment of
skeletal dysplasias, comprising as an active ingredient at least one natriuretic peptide.
Unexpectedly, it has been shown that the natriuretic factors may be effective for bone
elongation in situations of abnormal bone growth especially for Achondroplasia. The
effects of the natriuretic peptide may be further enhanced by prolonging its residence
time or action at the target site.
[51]
[71]
[87]
[74]
[57]
The applications for division
from this application have
not yet been published
,213845
בקשות חלוקה מבקשה זו
.שטרם פורסמו
__________________
87
August 31,2011 -א' באלול התשע"א
[11][21]
160182
יחידת קצה לשלב תריס
[54]
SHUTTER SLAT END PIECE
[22]
[51]
[71]
[74]
02.02.2004
Int. Cl.(2010.01) E06B 09//11, 09//15
KLIL INDUSTRIES LTD.
כרמיאל,קליל תעשיות בע"מ
EITAN, PEARL, LATZER AND
, לצר וכהן צדק, פרל,איתן
COHEN ZEDEK,
7 רחוב שנקר
P.O.B. 12688,
הרצליה12688 .ד. ת,
HERZLIYA 46733
A shutter slat end piece for a roll-up hollow shutter slat, said end piece comprising an
internal and an external component, said internal component being dimensioned to fit
into the hollow portion of said slat at either extremity thereof and being provided with
a recess allowing insertion of a fastener therein, said end piece further comprising an
external component dimensioned to slidingly engage the shutter rail, said external
component being arranged on both opposite faces to house a head of said fastener,
insertion of said fastener through said external component and into said recess of said
internal component rigidly joining said two components and expanding said internal
component to lock against walls of said hollow portion of said shutter slat.
[57]
__________________
[11][21]
[54]
HINGE FOR MOBILE ELEMENTS
OR FURNITURE WINGS WITH
MECHANISM TO ADJUST HEIGHT
[22]
[31]
[51]
[71]
[74]
26.02.2004
UD2003A000046 [32] 28.02.2003
Int. Cl.(2010.01) E05D 07//00, 07//04
OTLAV SPA, ITALY
EITAN, PEARL, LATZER AND COHEN
ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
[57]
88
160598
ציר לאלמנטים ניידים או כנפי רהיטים עם
מנגנון להתאמת גובה
[33]
IT
, לצר וכהן צדק, פרל,איתן
7 רחוב שנקר
הרצליה12688 .ד. ת,
Hinge (10) for articulating a mobile structure (11) with respect to a fixed frame (22)
comprises two hinge elements (12, 15) to be fixed together to the mobile structure, or
to the fixed frame and a central hinge element (13) disposed between the two hinge
elements (12, 15) and to be fixed to the fixed frame or, respectively, to the mobile
August 31,2011 -א' באלול התשע"א
structure. A pivot (16) is axially inserted in the three hinge elements (12, 13, 15) and
an intermediate threaded bushing (17) is axially disposed between the central hinge
element (13) and one of the two hinge elements (12, 15). The threaded bushing is
provided with first coupling means (35a) coupled, without reciprocal rotation, with
second coupling means (31) provided on the pivot, so that the rotation of the latter
commands the axial movement of the two hinge elements (12, 15) with respect to the
central hinge element (13).
__________________
[11][21]
[54]
BALLISTIC ARMOR WITH
PARTICULARLY A LAYER OF
HARD BODIES
[22]
[51]
[71]
[72]
11.03.2004
Int. Cl.(2010.01) F41H 05//04
PLASAN -KIBBUTZ SASA
MOSHE RAVID, YOAV
HIRSCHBERG
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
[57]
89
160843
שיריון בליסטי הכולל במיוחד שכבת גופים קשים
קבוץ סאסא- פלסאן
יואב הירשברג,משה רביד
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
An armor (10) designed for ballistic protection against armor piercing projectiles (P)
including a first projectile having a first diameter and a second projectile having a
second diameter greater than the first diameter, the armor being configured for
mounting on a surface to be protected and comprising a main armor plate (14) being
August 31,2011 -א' באלול התשע"א
configured to stop alone, or together with said surface to be protected, at least the first
projectile, and being incapable of stopping alone, or together with said surface to be
protected, the second projectile, and including a layer which is distinct from said
surface and at least partially made of a material capable of ballistic performance, said
armor further comprising an auxiliary armor plate (16) located in front of the main
armor plate and spaced therefrom by an area, which is at least partially free of any
additional layers, said auxiliary plate being made of material capable of ballistic
performance and having through holes (19) spaced from each other, free of material
capable of ballistic performance, said holes being designed in accordance with
parameters of the first and second projectiles, such that the holes are larger in crosssection than the first projectile and smaller in their cross-section then the second
projectile.
__________________
[11][21]
in–) מיקרו–איברים מהונדסים גנטית במבחנה
( המבטאים פקטור קרישת דם ושימושיםvitro
הקשורים בהם
[54]
IN VITRO GENETICALLY
MODIFIED MICRO-ORGANS
EXPRESSING A BLOOD
CLOTTING FACTOR AND USES
RELATED THERETO
[22]
[51]
[71]
23.10.2001
Int. Cl.(2010.01) A61K 35//00, 48//00, C12N 01//00, 15//87
YISSUM RESEARCH
יישום חברה לפיתוח המחקר של
DEVELOPMENT COMPANY OF
,האוניברסיטה העברית בירושלים בע"מ
THE HEBREW UNIVERSITY OF
ירושלים
JERUSALEM LTD.
EDUARDO N. MITRANI
מטרני.אדוארדו נ
WO/2003/035851
PEARL COHEN ZEDEK LATZER,
,פרל כהן צדק לצר
5 SHENKAR ST.,
5 רח' שנקר,1 ים-מרכז גב
P.O.B. 12704,
הרצליה12704 .ד. ת,
HERZLIYA 46733
Micro-organ cultures which include isolated populations of cells having specific
characteristics are described. Salient features of the subject micro-organ cultures
include the ability to be maintained in culture for relatively long periods of time, as
well as the preservation of an organ microarchitecture which facilitates, for example,
cell-cell and cell-matrix interactions analogous to those occurring in the source organ.
The micro-organ cultures of the invention can be used in methods for delivering gene
products to recipient subjects, for identifying cell proliferative and cell differentiating
agents, and identification and isolation of progenitor and stem cells. In addition, the
micro-organ cultures of the present invention can be used in methods for identifying
August 31,2011 -א' באלול התשע"א
[72]
[87]
[74]
[57]
90
161472
inhibitors of cell proliferation, cell differentiation and viral infectivity. In other
embodiments, the micro-organ cultures can be used for transplantation.
The applications for
division from this
application have not yet
been published
,214268,214267
בקשות חלוקה מבקשה זו
.שטרם פורסמו
__________________
[11][21]
161721
מנהל פעולות גומלין של זיכרון
[54]
TRANSACTIONAL MEMORY
MANAGER
[22]
[31]
01.11.2002
60/330842
[32] 01.11.2001
[33] US
60/365169
19.03.2002
US
Int. Cl.(2010.01) G06F 17//30
VERISIGN, INC., U.S.A.
WO/2003/038683
WOLFF, BREGMAN AND GOLLER,
, ברגמן וגולר,וולף
P.O.B. 1352,
ירושלים1352 .ד. ת,
JERUSALEM 91013
Embodiments of the present invention provide a method and system for high-speed
database searching with concurrent, transaction-based updating for large database
systems. Specifically, a plurality of search queries may be received over a network
(910), the database may be searched (930), and a plurality of search replies (940) may
be sent over the network (950). While searching the database (930), new information
may be received over the network (960), a plurality of new database elements may be
created based on the new information (970), a dirty bit may be set within each new
database element (975), a pointer to each new database element may be written to the
database using a single uninterruptible operation (980), and the dirty bit within each
new database element may be cleared (985).
[51]
[71]
[87]
[74]
[57]
91
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
161735
אימות כפול של משתמש שרת אי מייל ושרת
אימות
[54]
DUAL AUTHENTICATION OF A
REQUESTOR USING A MAIL
SERVER AND AN
AUTHENTICATION SERVER
[22]
[31]
29.10.2002
60/350097
[32] 02.11.2001
[33] US
10/060525
29.01.2002
US
10/060792
29.01.2002
US
Int. Cl.(2010.01) G06F 21//00, 21//20, H04L 29//06
JUNIPER NETWORKS, INC., U.S.A.
WO/2003/041360
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[51]
[71]
[87]
[74]
[57]
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
Improved approaches for providing secure access to resources maintained on private
networks are disclosed. In one embodiment, the resources being accessed can be email
resources. The secure access can be provided through a public network using a
standard network browser. Multiple remote users are able to gain restricted and
controlled access to at least portions of a private network through a common access
point. The solution provided by the improved approaches is not only easily set up and
managed, but also able to support many remote users in a cost-effective manner. In the
case of email resources, the solution provided by the improved approaches allows not
only native access to email resources but also robust authentication approaches.
__________________
92
August 31,2011 -א' באלול התשע"א
[11][21]
161843
– פירידילמתיל–תיאזולין4––אמינו2 נגזרות של
להכנת תרופות המשמשות כמעכבות ניטריק
אוקסיד – סינטאז בר–השראה
[54]
DERIVATIVES OF 2-AMINO-4PYRIDYLMETHYL-THIAZOLINE
FOR THE PREPARATION OF
MEDICAMENTS FOR USE AS
INHIBITORS OF INDUCIBLE NOSYNTHASE
[22]
[31]
07.11.2002
01/14508
[32] 09.11.2001
[33] FR
60/352978
30.01.2002
US
Int. Cl.(2010.01) A61K 31//4402, A61P 01//00, 01//04, 03//10, 09//10, 11//06, 13//12,
17//00, 19//02, 21//00, 25//00, 29//00, 31//04, 35//00, C07D 21/3/40, 41/7/00, C07F
07//18
AVENTIS PHARMA S.A., FRANCE
WO/2003/039446
EITAN, PEARL, LATZER AND
, לצר וכהן צדק, פרל,איתן
COHEN ZEDEK,
7 רחוב שנקר
P.O.B. 12688,
הרצליה12688 .ד. ת,
HERZLIYA 46733
The invention concerns the use of 2-amino-4-pyridylmethyl-thiazoline derivatives of
formula (I), wherein: either R1 = R2 = Cl, or C1-C4 alkyl, or hydroxy; or C1-C4
alkoxy or at least one of the two R1 and R2 is hydrogen and the other a C1-C4 alkyl
radical, a hydroxy, a C1-C4 alkoxy or a chlorine or their pharmaceutically acceptable
salts as inhibitors of inducible NO-synthase.
[51]
[71]
[87]
[74]
[57]
__________________
[11][21]
162214
תולדות פירידין ותכשירי רוקחות המכילים אותן
[54]
PYRIDINE DERIVATIVES AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME
[22]
[31]
[51]
06.12.2002
0129260.6
[32] 06.12.2001
[33] GB
Int. Cl.(2010.01) A61K 31//136, 31//44, A61P 13//00, 21//00, 25//00, 43//00, C07D
21/3/64, 40/1/04, 40/1/12, 40/1/14, 40/5/04, 40/5/14, 40/9/04, 40/9/14, 41/3/04,
41/3/10, 41/3/14, 41/7/04, 41/7/14, 47/1/06
August 31,2011 -א' באלול התשע"א
93
[71]
[87]
[74]
[57]
EISAI RESEARCH AND
DEVELOPMENT MANAGEMENT
CO., LTD., JAPAN
WO/2003/047577
WOLFF, BREGMAN AND GOLLER,
, ברגמן וגולר,וולף
P.O.B. 1352,
ירושלים1352 .ד. ת,
JERUSALEM 91013
The present invention relates to compositions comprising 1, 2-dihydropyridin-2-one
compounds and an immunoregulatory or anti-inflammatory agent. The compositions
are useful for the prevention or the treatment of neurodegenerative diseases, for
example demyelinating disorders.
__________________
[11][21]
162405
–2– (– )פניל מותמר2 תהליך להכנתן
הידרוקסיאתיל קרבאמאטים וחומרי ביניים
שלהם
[54]
PROCESS FOR PREPARING 2(SUBSTITUTED PHENYL)-2HYDROXYETHYL CARBAMATES
AND INTERMEDIATES THEREOF
[22]
[31]
19.12.2002
01205097.7
[32] 21.12.2001
[33] EP
60/418084
11.10.2002
US
Int. Cl.(2010.01) C07C 26/9/04, 27/1/10, 43//178, 69//734
ORTHO-MCNEIL
PHARMACEUTICAL, INC., U.S.A.
WO/2003/053916
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[51]
[71]
[87]
[74]
[57]
The invention concerns a new process for preparing (S)-(+)-2-(substituted phenyl)-2hydroxy-ethyl carbamates and to novel intermediates used in this process. It further
relates to polymorphic forms of said carbamates and to processes for preparing said
polymorphic forms.
The applications for division
from this application have
not yet been published
94
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
,213960,207485
בקשות חלוקה מבקשה זו
.שטרם פורסמו
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
מזרק הרכבה
[54]
SYRINGE ASSEMBLY
[22]
[51]
[71]
[74]
04.07.2004
Int. Cl.(2010.01) A61M 05//00, 05//315
IGAL SHARON
DAVID BLUM,
53 HASHALOM,
GIVATAYIM 53454
[57]
162854
קיסריה,יגאל שרון
,עו"ד דויד בלום
53 דרך השלום
גבעתיים
A syringe assembly (2) comprising: a dispensing unit (10) including a substantially
cylindrical dispensing unit body having top and bottom sealable open ends; a separate,
independent plunger unit (30) including a substantially cylindrical plunger unit body
having a top open sealable end defining a joining sleeve (34), a bottom sealable open
end, and an inner sidewall diameter that is larger then the diameter of said joining
sleeve; said joining sleeve having an inner sidewall diameter which is substantially the
same as an inner sidewall diameter of said dispensing unit body; a plunger (44)
disposed in the bottom open end of said plunger unit body, the plunger having a shaft
and a plunger head (64); said plunger head having an outer diameter which is
substantially the same as the inner sidewall diameter of said joining sleeve; wherein
said bottom open end of said dispensing unit is adapted and configurated for coaxial
locking engagement with said top open opening of said plunger unit to form a multiunit syringe assembly; and wherein said plunger head seals said plunger unit when it
sealingly engages the joining sleeve, and allows two-way flow communication
between said dispensing unit and said plunger unit when said plunger head is retracted
into the plunger unit body and disengages said joining sleeve.
__________________
95
August 31,2011 -א' באלול התשע"א
[11][21]
163066
zcytor17 ליגנדים של הרצפטור
[54]
LIGANDS FOR THE ZCYTOR17
RECEPTOR
[22]
[31]
21.01.2003
60/350325
[32] 18.01.2002
[33] US
60/375323
25.04.2002
US
60/435315
19.12.2002
US
Int. Cl.(2010.01) A61K 38//19, 39//00, C07K 07//08, 14//52, 16//24, 19//00, C12N
15//19
ZYMOGENETICS INC., U.S.A.
WO/2003/060090
REINHOLD COHN AND PARTNERS,
,ריינהולד כהן ושותפיו
26A HABARZEL ST.,
'א26 רחוב הברזל
RAMAT HACHAYAL 69710
רמת החייל
[51]
[71]
[87]
[74]
[57]
The present invention relates to zcytor171ig polynucleotide, polypeptide and antizcytor17 antibody molecules. The zcytor171ig is a novel cytokine. The polypeptides
may be used within methods for stimulating the immune system, and proliferation
and/or development of hematopoietic cells in vitro and in vivo. The present invention
also includes methods for producing the protein, uses therefor and antibodies thereto.
The applications for division
from this application have
not yet been published
,210455,210454
בקשות חלוקה מבקשה זו
.שטרם פורסמו
__________________
[11][21]
[54]
PEPTIDES, ANTIBODIES
DIRECTED THEREAGAINST AND
METHODS USING SAME FOR
DIAGNOSING AND TREATING
AMYLOID-ASSOCIATED
DISEASES
[22]
[31]
30.01.2003
60/352578
60/392266
10/235852
96
[32]
31.01.2002
01.07.2002
06.09.2002
163285
נוגדנים המכוונים נגדם ושיטות,פפטידים
לשימוש בהם לאבחון ולטיפול במחלות
הקשורות לאמילואידים
[33]
US
US
US
August 31,2011 -א' באלול התשע"א
[51]
[71]
[72]
[87]
[74]
[57]
60/436453
27.12.2002
US
60/514974
29.10.2003
US
Int. Cl.(2010.01) A61K 38//04, 38//06, 38//07, 38//17, 38//23, A61P 25//28, C07K
05//00
TEL AVIV UNIVERSITY FUTURE
אביב פיתוח טכנולוגיות-אוניברסיטת תל
TECHNOLOGY DEVELOPMENT
.יו.אי.עתידיות )שותפות מוגבלת(אצל טי
L.P.
- תל,ניהול טכנולוגיות עתידיות בע"מ
אביב
EHUD GAZIT
אהוד גזית
WO/2003/063760
G.E. EHRLICH (1995) LTD.,
,( בע"מ1995) ארליך.אי.ג'י
AYALON TOWER, 15TH FLOOR,
11 רחוב מנחם בגין, 15 קומה,מגדל איילון
11 MENACHEM BEGIN ST.,
רמת גן
RAMAT GAN 52521
A peptide comprising at least 3 amino acid residues and less than 15 amino acid
residues, the peptide including an amino acid sequence as set forth in SEQ ID NO: 7 as
well as pharmaceutical compositions and kits including same, and methods using same
for diagnosing and treating amyloid associated diseases.
__________________
[11][21]
[54]
WATERMELON PLANT
HOMOZYGOUS FOR THE E
GENE, SAID GENE CONFERRING
THE PHYSICAL TRAIT OF A
BRITTLE RIND ON THE FRUIT
OF SAID PLANT, METHOD FOR
PRODUCING SAID PLANT AND
POLLEN, OVULE, FRUITS AND
SEEDS OF SAID PLANT
[22]
[31]
25.02.2003
10/091154
[32] 05.03.2002
10/349509
22.01.2003
Int. Cl.(2010.01) A01H 01//00, 05//00
SYNGENTA PARTICIPATIONS AG,
SWITZERLAND
WO/2003/075641
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
[51]
[71]
[87]
[74]
97
163770
שמעניק לפרי של,E צמח אבטיח הומוזיגוטי לגן
הצמח את התכונה הפיזיקאלית של קליפה
, ביציות, שיטה להכנתו ואבקנים,שברירית
פירות וזרעים שלו
[33]
US
US
,לוצאטו את לוצאטו
עומר,גן תעשייה
August 31,2011 -א' באלול התשע"א
[57]
P.O.B. 5352,
באר שבע5352 .ד. ת,
BEER-SHEVA 84152
An enhanced, diploid pollenizer watermelon plant and method used to maximize the
yield of triploid seedless watermelons per area. The enhanced pollenizer watermelon
plant of the invention is either a hybrid variety, an open-pollinated variety or a
synthetic variety, that exhibits the characteristics of small leaves and fruit with a brittle
rind that splits when the fruit is overripe or breaks when relatively small physical
forces are applied. The watermelon plant of the invention is also preferably
characterized by extended flowering duration, thereby increasing the number of
triploid watermelon flowers that are pollinated and set fruit. The method for producing
a seedless watermelon fruit, includes the steps of providing a pollenizer diploid
watermelon plant, extending the duration of flowering of the pollenizer plant while
reducing the number of such plants needed to pollenize the same number of triploid
watermelon plants, and maximizing dispersal of the pollenizer watermelon plant
throughout the field of triploid watermelon plants.
The applications for division
from this application have
not yet been published
,193676
בקשות חלוקה מבקשה זו
.שטרם פורסמו
__________________
[11][21]
163843
תרסיס רוקחי של פורמוטרול ומיכל מתאים
להובלתו
[54]
PHARMACUTICAL AEROSOL
FORMULATION OF
FORMOTEROL AND CANISTER
SUITABLE FOR ITS DELIVERY
[22]
[31]
26.02.2003
02004786.6
[32] 01.03.2002
[33] EP
02023589.1
23.10.2002
EP
Int. Cl.(2010.01) A61K 09//00, 09//12, 09//72, 47//06, 47//10, A61P 11//06, 11//08
CHIESI FARMACEUTICI S.P.A.,
ITALY
WO/2003/074024
REINHOLD COHN AND PARTNERS,
,ריינהולד כהן ושותפיו
26A HABARZEL ST.,
'א26 רחוב הברזל
RAMAT HACHAYAL 69710
רמת החייל
[51]
[71]
[87]
[74]
[57]
98
The present invention relates to a pharmaceutical formulation for use in the
administration of a long-acting ß2-agonist by inhalation. In particular this invention
relates to a chemically stable highly efficient formoterol HFA solution formulation to
be administered by pressurised metered dose inhalers (pMDIs) characterized by a deep
August 31,2011 -א' באלול התשע"א
lung penetration. The invention also relates to methods for the preparation of said
formulation and to its use in respiratory diseases such as asthma and chronic
obstructive pulmonary disease (COPD).
__________________
[11][21]
164773
תולדות אסטר של חומצה דקהידרואיזוקווינולין
–קרבוקסילית ושימושן בהכנת תרופות3–
[54]
ESTER DERIVATIVES OF A
DECAHYDROISOQUINOLINE-3CARBOXYLIC ACID AND USE
THEREOF IN THE PREPARATION
OF MEDICAMENTS
[22]
[31]
[51]
[71]
[87]
[74]
14.04.2003
60/376,120
[32] 26.04.2002
[33] US
Int. Cl.(2010.01) A61K 31//4725, A61P 25//04, 25//06, C07D 40/1/06
ELI LILLY AND COMPANY, U.S.A.
WO/2003/091243
LUZZATTO & LUZZATTO,
,לוצאטו את לוצאטו
INDUSTRIAL PARK, OMER,
עומר,גן תעשייה
P.O.B. 5352,
באר שבע5352 .ד. ת,
BEER-SHEVA 84152
The present invention provides compounds of formula (I) The present invention further
provides the use of a compound of formula (I) for the manufacture of a medicament for
the treatment of a neurological disorder. The present invention further provides the use
of a compound of formula (I) for the manufacture of a medicament for the treatment of
pain or migraine.
[57]
__________________
[11][21]
[54]
99
USE OF EPOTHILONE
DERIVATIVES FOR THE
PREPARATION OF
MEDICAMENTS FOR TREATING
164783
שימוש בנגזרת של אפותילון להכנת תרופות
לטיפול במחלות סרטן
August 31,2011 -א' באלול התשע"א
CANCER DISEASES
[22]
[31]
[51]
[71]
[87]
[74]
[57]
30.04.2003
60/377,063
[32] 01.05.2002
[33] US
Int. Cl.(2010.01) A61K 31//41, 31//426, 45//06, C07D 41/7/00
NOVARTIS AG, SWITZERLAND
WO/2003/092683
LUZZATTO & LUZZATTO,
,לוצאטו את לוצאטו
INDUSTRIAL PARK, OMER,
עומר,גן תעשייה
P.O.B. 5352,
באר שבע5352 .ד. ת,
BEER-SHEVA 84152
The present invention relates to a method of treating a warm-blooded animal,
especially a human, having a cancer disease selected from hepatoma; primary fallopian
tube cancer; primary peritoneal cancer; breast cancer progressing after treatment with
hormonal agents or radiotherapy; renal cell carcinoma progressing after treatment with
a cytokine, radiotherapy and/or nephrectomy,; melanoma progressing after
radiotherapy; prostate cancer progressing after orchiectomy, ovarian cancer
progressing after treatment with a platinum compound or radiotherapy; and colorectal
cancer progressing after radiotherapy and/or treatment with oxaliplatin or irinotecan;
and metastasis thereof comprising administering to said animal a therapeutically
effective amount of an epothilone derivative of formula (I).
__________________
[11][21]
[54]
2-(ALPHAHYDROXYPENTYL)BENZOATE,
ITS PREPARATION,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
IT AND THEIR USE IN THE
PREPARATION OF
MEDICAMENTS
[22]
09.05.2002
100
164845
, הכנתה,– )אלפא–הידרוקסיפניל(בנזואט2
תכשירי רוקחות המכילים אותה והשימוש בהם
להכנת תרופות
August 31,2011 -א' באלול התשע"א
[51]
[71]
[87]
[74]
[57]
Int. Cl.(2010.01) A61K 31//19, C07C 51//00, 65//00, 65//03
INSTITUTE OF MATERIA
MEDICA, CHINESE ACADEMY OF
MEDICAL SCIENCES, CHINA
WO/2003/095412
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
The present invention relates to a new compound of 2-(alpha-hydroxypentyl)
benzoate, its preparation and the pharmaceutical composition in which the compound
is used as active ingredient; the invention also relates to the use of the compound for
preventing and treating cardioischemia, cerbroischemia and cardiac or cerebral arterial
embolism, etc.
__________________
[11][21]
165002
שיטה ומערכת לחלוקת מסמכים
[54]
METHOD AND SYSTEM FOR
DISTRIBUTING DOCUMENTS
[22]
[31]
24.05.2000
PQ0559
[32] 25.05.1999
[33] AU
PQ1313
30.06.1999
AU
Int. Cl.(2010.01) B41J 02//175, G06F 03//12, G06Q 10//00
DIVISION FROM 146647
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2000/072137
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[51]
[62]
[71]
[87]
[74]
[57]
101
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
A method of distributing documents, via a communications network, to a plurality of
receiving stations associated with a plurality of users. At least one document layout is
pointcast to each receiving station, the document layout being associated with a
predetermined user and defining one or more data objects such as text, images and
graphics. Collections of shared data objects are then multicast, via the communications
network, to the receiving stations on the basis of the respective users' document
layouts. Each collection is only transmitted to those receiving stations whose users'
August 31,2011 -א' באלול התשע"א
document layouts include data objects in that collection.
__________________
[11][21]
[54]
FORMULATIONS CONTAINING
AMIODARONE AND
SULFOALKYL ETHER
CYCLODEXTRIN
[22]
[31]
[51]
[71]
29.04.2003
10/139620
[32] 04.05.2002
Int. Cl.(2010.01) C08B 37//00
CYDEX PHARMACEUTICALS, INC.,
U.S.A.
WO/2003/092590
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[87]
[74]
[57]
102
165022
–הרכבים המכילים אמיאודארון וסולפואלקיל
אתר ציקלודקסטרין
[33]
US
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
The present invention provides aqueous parenteral formulations containing an
antiarrhythmic agent, such as amiodarone, and a sulfoalkyl ether cyclodextrin. The
liquid formulations are clear, sterilizable, and chemically and physically stable. The
liquid formulations do not require a surfactant and do not precipitate upon dilution
with distilled water or other pharmaceutically acceptable liquid carrier. The sulfoalkyl
ether cyclodextrin-containing formulation provides significant advantages over other
cyclodextrin-containing formulations of amiodarone. The formulation can be prepared
in acidic, neutral and slightly basic medium while providing acceptable concentrations
of amiodarone suitable for parental administration. An SAE-CD-containing
formulation of amiodarone can be provided in liquid form or as a reconstitutable
powder. Moreover, highly concentrated solutions exceeding 200 mg of amiodarone per
mL can be prepared. Solutions can be made either dilutable or non-dilutable with water
at room temperature or under conditions typically encountered in the clinic.
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
165226
נגזרות של ספירואינדולינפיפרידין
[54]
SPIROINDOLINEPIPERIDINE
DERIVATIVES
[22]
[31]
[51]
[71]
04.06.2003
0213715.6
[32] 20.01.2002
[33] GB
Int. Cl.(2010.01) A01N 43//90, C07D 21/1/70, 21/1/76, 47/1/10, 49/1/10
SYNGENTA PARTICIPATIONS AG,
SWITZERLAND
WO/2003/106457
LUZZATTO & LUZZATTO,
,לוצאטו את לוצאטו
INDUSTRIAL PARK, OMER,
עומר,גן תעשייה
P.O.B. 5352,
באר שבע5352 .ד. ת,
BEER-SHEVA 84152
Insecticidal, acaricidal, nematicidal or molluscicidal compounds of formula (I) wherein
Y is a single bond, C=O, C=S or C=(O)q where q is 0, 1 or 2; and R1, R2, R3, R4, R8, R9
and R10 are as defined in the claims or salts or N-oxides thereof, processes for
preparing them and compositions containing them.
[87]
[74]
[57]
The applications for division
from this application have
not yet been published
,213984
בקשות חלוקה מבקשה זו
.שטרם פורסמו
__________________
[11][21]
[54]
103
METHOD FOR THE
PRODUCTION OF 1,2,4TRIAZOLYLMETHYL-OXIRANES
AND SOME INTERMEDIATES
THEREOF
165248
– טריאזולילמתיל4 ,2 ,1 שיטה ליצור
אוקסירנים ומספר חומרי ביניים שלהם
August 31,2011 -א' באלול התשע"א
[22]
[31]
[51]
[71]
[87]
[74]
[57]
06.06.2003
10228196.3
[32] 24.06.2002
Int. Cl.(2010.01) C07D 40/5/00
BASF AKTIENGESELLSCHAFT,
GERMANY
WO/2004/000835
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[33]
DE
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
The invention relates to a method for the production of 1,2,4-triazol-1-yl-methyloxiranes of formula (I) wherein A and B are the same or different and independently
represent C1-C4-alkyl, phenyl-C1-C2-alkyl,. C3 --C6-cycloalkyl, C3-C6-cycloalkenyl,
tetrahydropyranyl, tetrahydrofuranyl, dioxanyl or phenyl. The phenyl radical can
contain 1-3 substituents selected form the group: halogen, nitro, C1-C4-alkyl, C1-C4alkyloxy, phenoxy, amino, C1-C2-halogenalkyl or phenylsulfonyl, characterised in that
a) an oxirane of formula (II) wherein A and B have the above mentioned meaning and
L represents a nucleophilically substitutable leaving group which is reacted with 4amino-1,2,4-triazol of formula (III), IV to form 4-amino-1,2,4-triazolium salts of
formula (IV). The invention also relates to a method for the production of l,2,4triazolylmethyl-oxiranes.
__________________
[11][21]
165304
––איל1––פנילפיפרזיןN שימוש בנגזרות של
אצטמיד להכנת תכשירים רוקחיים לטיפול
במצבים הקשורים לסכרת
[54]
USE OF DERIVATIVES OF NPHENYLPIPERAZIN-1-YLACETAMIDE FOR PREPARATION
OF PHARMACEUTICAL
COMPOSITIONS FOR
TREATMENT OF DIABETES
RELATED CONDITIONS
[22]
[31]
21.05.2003
60/382781
[32] 21.05.2002
[33] US
60/459332
31.03.2003
US
Int. Cl.(2010.01) A61K 31//495, A61P 03//10, C07D 29/5/14, 29/5/15, 40/5/12
GILEAD PALO ALTO, INC., U.S.A.
WO/2003/099281
REINHOLD COHN AND PARTNERS,
,ריינהולד כהן ושותפיו
26A HABARZEL ST.,
'א26 רחוב הברזל
August 31,2011 -א' באלול התשע"א
[51]
[71]
[87]
[74]
104
רמת החייל
RAMAT HACHAYAL 69710
[57]
Methods comprising the administration of a partial fatty acid oxidation inhibitor such
as ranolazine are provided for treating diabetes, lowering plasma level of HbAlc,
gluclose plasma levels, total cholesterol levels and delaying onset of diabetic
retinopathy in a diabetic, pre-diabetic, or a non-diabetic mammal while minimizing
undesirable side effects.
The applications for division
from this application have
not yet been published
,213809,213806
בקשות חלוקה מבקשה זו
.שטרם פורסמו
__________________
[11][21]
166085
שיטה והתקן לשימוש באובייקטי נתונים זהים
המייצגים משתמש ברשת נתונים מבוזרת
[54]
METHOD AND APPARATUS FOR
USE OF IDENTICAL DATA
OBJECTS REPRESENTING A
USER IN A DISTRIBUTED
COMMUNICATIONS NETWORK
[22]
[51]
[71]
[72]
30.12.2004
Int. Cl.(2010.01) G08B 03//00, H04L 12//66, 29//06, 29//08
TADIRAN TELECOM LTD.
פתח תקוה,תדיראן טלקום בע"מ
SHIMON YANAI, NIR DWECK, GIL
גיל זיידמן, ניר דואק,שמעון ינאי
ZAIDMAN
ALEF GIMEL - INTELLECTUAL
, ייעוץ לקניין רוחני בע"מ- .ג.א
PROPERTY CONSULTING LTD.,
רחובות2079 .ד. ת,
P.O.B. 2079,
REHOVOT 76120
[74]
[57]
105
A method and device are provided for conducting a media communication session
with at least one user presented by at least one data object, where the data object
resides at a plurality of platforms associated with a distributed IP communication
network. The media communication session is established following the initiation of a
August 31,2011 -א' באלול התשע"א
request to establish that session, where the request identifies the at least one data
object but does not specify any communication device through which that media
communication session will be established.
__________________
[11][21]
[54]
ROUTING METHOD AND SYSTEM
[22]
19.01.2005
[51]
[71]
[74]
Int. Cl.(2010.01) H04J 01//16, H04L 12//56
TEJAS ISRAEL LTD.
BLUM, GADOR & CO.,
53 HASHALOM RD.,
GIVATAYIM 53454
166390
שיטה ומערכת לניתוב
,' גדור ושות,בלום
מגדל23 קומה,53 דרך השלום
הורד
גבעתיים
A method for routing data over a telecommunications carrier network including at
least two switching devices defining at least one physical link, the method including
defining in advance a plurality of traffic flows, each associated with specific routing
through at least one of the physical links in the network; configuring a routing
system according to the traffic flows; collecting data of traffic transmitted over at
least some of the traffic flows, calculating traffic statistics, from the collected data,
106
August 31,2011 -א' באלול התשע"א
for each of the flows in the network; and re-calculating the routing system
configuration utilizing the calculated traffic statistics.
__________________
[11][21]
166433
L 2 תכשירי חיסון המכילים ליפואולגוסכרידים
ניסריהLGTB ובודדו מחיידקL 3 או
מניגיטידיס ותהליך להכנתם
[54]
VACCINE COMPOSITIONS
COMPRISING L2 OR L3
IMMUNOTYPE
LIPOOLIGOSACCHARIDES
FROM LGTB NEISSERIA
MENIGITIDIS AND PROCESS FOR
THEIR PREPARATION
[22]
[31]
31.07.2003
0218037.0
[32] 02.08.2002
[33] GB
0218036.2
02.08.2002
GB
0218035.4
02.08.2002
GB
0218051.1
02.08.2002
GB
0220197.8
30.08.2002
GB
0220199.4
30.08.2002
GB
0225524.8
01.11.2002
GB
0225531.3
01.11.2002
GB
0230164.6
24.12.2002
GB
0230168.7
24.12.2002
GB
0230170.3
24.12.2002
GB
0305028.3
05.03.2003
GB
Int. Cl.(2010.01) A61K 39//095, 39//102, A61P 37//04, C07K 14//22, C12N 01//21
GLAXOSMITHKLINE
BIOLOGICALS S.A., BELGIUM
[51]
[71]
107
August 31,2011 -א' באלול התשע"א
[87]
[74]
WO/2004/014417
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57]
The present invention relates to the field of neisserial vaccine compositions, their
manufacture, and the use of such compositions in medicine. More particularly it relates
to processes of making novel engineered meningococcal strains which are more
suitable for the production of neisserial, in particular meningococcal, outer-membrane
vesicle (or bleb) vaccines. Advantageous processes and vaccine products are also
described based on the use of novel LOS subunit or meningococcal outer-membrane
vesicle (or bleb) vaccines which have been rendered safer and/or more effective for use
in human subjects. In particular combinations of gene downregulations are described
such as PorA & OpA, PorA and OpC, OpA and OpC, and PorA and OpA and OpC.
Alternatively, or in addition, lgtB- is shown to be an optimal mutation for effectively
and safely using L3 and/or L2 LOS in Neisseria vaccine compositions. Bleb vaccines
derived from lgtB- and capsular polysaccharide deficient meningococcal mutants are
further described; as are advantageous methods of making bleb preparations where
LOS is to be retained as an important antigen.
The applications for division
from this application have
not yet been published
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
,213264
בקשות חלוקה מבקשה זו
.שטרם פורסמו
__________________
[11][21]
166501
שיטה ומערכת לתקשר תוכן במערכת תקשורת
לשירותי שידור
[54]
METHOD AND SYSTEM FOR
COMMUNICATING CONTENT ON
A BROADCAST SERVICES
COMMUNICATION SYSTEM
[22]
[31]
15.08.2003
10/226058
[32] 21.08.2002
[33]
10/226059
21.08.2002
Int. Cl.(2010.01) H04B 07//26, H04L 01//00
QUALCOMM INCORPORATED,
U.S.A.
WO/2004/019635
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[51]
[71]
[87]
[74]
[57]
108
US
US
,' קולב ושות.סנפורד ט
מרמורק,4 שער הגיא
רחובות2273 .ד. ת,
An outer decoder and an inner decoder encode a block of information to be
transmitted, to improve protection by adding redundancy. The redundancy permits
August 31,2011 -א' באלול התשע"א
decoding of the information from less than a complete encoded block of information.
Time re-alignment of two transmissions of the same content from two base stations
can mitigate the problem of duplicated frames. The user of the subscriber station can
experience seamless service without repetition of content, even when handing over to a
new cell while receiving a buffer of broadcast content.
__________________
[11][21]
166755
מכניס צנתר בעל מחט נסיגה
[54]
IV CATHETER INTRODUCER
WITH RETRACTABLE NEEDLE
[22]
[51]
[71]
08.02.2005
Int. Cl.(2010.01) A61M 25//01
RETRACTABLE TECHNOLOGIES,
INC., U.S.A.
WO/2004/050138
WOLFF, BREGMAN AND GOLLER,
, ברגמן וגולר,וולף
P.O.B. 1352,
ירושלים1352 .ד. ת,
JERUSALEM 91013
An IV catheter introducer having a retractable needle holder and a tubular plunger that
are held by a detent structure in a preferred positional relationship prior to and during
insertion of the catheter. Following insertion, the plunger is pushed past the detent
structure, permitting a compressed spring to force the needle holder upwardly into the
plunger. A vented end cap in the plunger permits rapid venting of air displaced during
retraction of the needle holder. The needle holder includes a flash chamber that is
easily viewable through a clear plastic housing. Wings are provided on the housing to
facilitate one-handed operation of the device. A method for assembling the subject
catheter introducer is also disclosed.
[87]
[74]
[57]
109
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
166830
תכשירים נוגדי חיידקים
[54]
ANTIMICROBIAL
COMPOSITIONS
[22]
[31]
12.08.2003
60/403169
[32] 12.08.2002
[33] US
60/403004
12.08.2002
US
Int. Cl.(2010.01) A61K 08//00, 08//30, 36//00
LONZA INC., U.S.A.
WO/2004/014416
LUZZATTO & LUZZATTO,
,לוצאטו את לוצאטו
INDUSTRIAL PARK, OMER,
עומר,גן תעשייה
P.O.B. 5352,
באר שבע5352 .ד. ת,
BEER-SHEVA 84152
The present invention provides an antimicrobial composition comprising an
antimicrobial effective amount (such as a preservative, bactericidal, and/or fungicidal
effective amount) of a mixture comprising at least two of: (a) lemon grass oil; (b)
cinnamaldehyde, cinnamon oil, cinnamomum cassia, cinnamon extract, cassia leaf oil,
3,4-dihydroxycinnamic acid or salt thereof, or a mixture thereof; (c) sorbic acid, or a
salt thereof; (d) erythorbic acid, or a salt thereof; (e) benzoic acid, or a salt thereof; (f)
arabinogalactan, galactoarabinan, or a mixture thereof; (g) a hexahydro-iso-alpha-acid,
tetrahydro-iso-alpha-acid, or a mixture thereof; (h) Achillea fragrantissima oils,
Santolina fragrantissima oils, Forssk oils, Lavender cotton oils; and (i) Glucono Delta
Lactone. The present invention also provides a product (preferably a product other
than a foodstuff, pharmaceutical, or cosmetic) comprising a preservative effective
amount of cinnamaldehyde or a mixture of cinnamaldehyde and one or more alkanoldialkyl hydantoins.
[51]
[71]
[87]
[74]
[57]
The applications for division
from this application have
110
,197073
בקשות חלוקה מבקשה זו
.שטרם פורסמו
August 31,2011 -א' באלול התשע"א
not yet been published
__________________
[11][21]
167013
גביש אלפא של,תהליך להכנת איוואבראדין
תכשירים רוקחיים, איוואבראדין הידרוכלוריד
המכילים אותו ושימוש בהם
[54]
PROCESS FOR SYNTHESIS OF
IVABRADINE, ALPHACRYSTALLINE FORM OF
IVABRADINE HYDROCHLORIDE,
PHARMACEUTICAL
COMPOSITIONS COMPRISING IT
AND USES THEREOF
[22]
[31]
[51]
[71]
21.02.2005
04.03830
[32] 13.04.2004
[33]
Int. Cl.(2010.01) A61K 31//55, C07D 22/3/16
LES LABORATOIRES SERVIER,
FRANCE
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
[57]
FR
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
Process for the synthesis of formula (I): additional salts thereof with a pharmaceutical
acceptable acid and hydrates thereof.
Alpha-crystalline form of ivabradine hydrochloride.
Medicinal products containing alpha-crystalline form of ivabradine hydrochloride,
which are useful as bradycardics.
__________________
[11][21]
[54]
PROCESS FOR PRODUCTION OF
A 2-(HYDROXYMETHYL)
CYCLOPROPANECARBOXYLIC
COMPOUND
[22]
[31]
05.09.2003
2002-263700
111
[32]
10.09.2002
167058
(–)הידרוקסימתיל2 תהליך לייצור תרכובת של
ציקלופרופאנקרבוקסילית
[33]
JP
August 31,2011 -א' באלול התשע"א
[51]
[71]
[87]
[74]
[57]
Int. Cl.(2010.01) C07C 51//377, 67//317, 69//00
SUMITOMO CHEMICAL COMPANY,
LIMITED., JAPAN
WO/2004/024667
DR. YITZHAK HESS & PARTNERS,
,ד"ר יצחק הס ושותפיו
279 HAYARKON ST.,
279 רחוב הירקון
P.O.B. 6451,
תל אביב6451 .ד. ת,
TEL AVIV 61063
A process for production of 2-(hydroxymethyl)cyclo- propanecarboxylic acids
represented by the general formula (2): (2) [wherein R1 is hydrogen, linear, branched,
or cyclic alkyl, or substituted or unsubstituted aryl; and R2 and R3 are each
independently hydrogen or methyl], characterized by reacting a compound represented
by the general formula (1): (1) [wherein R1, R2, and R3 are each as defined above; and
R4 is C1-2 alkyl substituted with at least one member selected from among substituted
aryl groups and unsubstituted aryl groups] with a hydrogen donor in the presence of a
catalyst selected from the group consisting of ruthenium catalysts, cobalt catalysts,
rhodium catalysts, nickel catalysts, palladium catalysts, and platinum catalysts.
__________________
[11][21]
167060
לטיפול אוg–csfr אוg–csf גורם מעכב פעילות
למניעת דלקת פרקים
[54]
AGENT WHICH INHIBITS THE
ACTIVITY OF G-CSF OR G-CSFR
FOR TREATMENT OR
PROPHYLAXIS OF ARTHRITIS
[22]
[31]
22.08.2003
2002950957
[32] 23.08.2002
[33] AU
2002951071
29.08.2002
AU
Int. Cl.(2010.01) A01K 67//00, A61K 38//17, 38//18, 39//395, G01N 33//563, 33//68
WALTER AND ELIZA HALL
INSTITUTE OF MEDICAL
RESEARCH, AUSTRALIA
WO/2004/017727
[51]
[71]
[87]
112
August 31,2011 -א' באלול התשע"א
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
[74]
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57]
The present invention relates generally to a method for treating or preventing or
otherwise ameliorating the effects of inflammatory conditions such as but not limited
to chronic immune-mediated inflammatory diseases. The present invention further
provides pharmaceutical compositions comprising agents which inhibit one or more
inflammatory cytokines and/or which down-regulate expression of genes which
encode inflammatory cytokines. Such compositions are useful in the treatment and
prophylaxis of inflammatory conditions such as inflammatory arthritis amongst other
chronic immune-mediated inflammatory diseases. The present invention further
provides an animal model for studying the kinetics of and/or screening for agents
useful in the treatment or prophylaxis of inflammatory conditions.
__________________
[11][21]
167145
ראש קרבי בצורת מוט המופעל ע"י אנרגיה
קינטית עם הפעלה איזוטרופית של הקליעים
[54]
KINETIC ENERGY ROD
WARHEAD WITH ISOTROPIC
DEPLOYMENT OF THE
PROJECTILES
[22]
[31]
15.07.2003
60/406828
[32] 29.08.2002
[33] US
10/301420
21.11.2002
US
Int. Cl.(2010.01) F42B 12//60
RAYTHEON COMPANY, U.S.A.
RICHARD M. LLOYD
WO/2005/036090
JMB, FACTOR & CO. LTD.,
, פקטור אנד קו בע"מ,ג'יי אמ בי
HAR HOTZVIM HI-TECH PARK,
הר חוצבים,רחוב המרפא
P.O.B. 45087,
ירושלים45087 .ד. ת,
JERUSALEM 91450
A kinetic energy rod warhead including a plurality of sections each enclosing a
plurality of projectile and an explosive charge partially surrounding the projectiles
defiriing a primary projectile firing direction. The firing direction of each section is
différent for isotropically deploying the projectiles.
[51]
[71]
[72]
[87]
[74]
[57]
113
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
167173
דיו ומערכות דיו לסימון ואימות פריט ושיטה
לשימושם
[54]
PRINTING INK AND PRINTING
INK SETS FOR MARKING AND
AUTHENTICATING ARTICLES
AND METHOD FOR THEIR USE
[22]
[31]
[51]
[71]
05.09.2003
02021179.3
[32] 24.09.2002
[33] EP
Int. Cl.(2010.01) B41M 03//14, C09D 11//00, G07D 07//12
SICPA HOLDING S.A.,
SWITZERLAND
WO/2004/029163
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[87]
[74]
[57]
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
The invention discloses a method for marking and authenticating a security article,
such as a banknote, a document, a ticket, a foil, a thread, a label, a card, or a
commercial good, so as to provide for an easy authentication of said article by a
machine, such as a currency acceptor, a ticket validator, or a hand-held authentication
device. According to the disclosed method, the security article carries a marking in the
form of a user-defined design, wherein said marking comprises dyes or pigments
belonging to an extended, or hyperchromic color space which is not reproducible by
commercially available, 4-color desktop reproduction equipment. The authentication
of said marking includes the mathematical transformation of the crude spectral
information to statistically independent hyper-color coordinates, and the comparison of
selected hyper-color coordinates with corresponding reference values.
__________________
114
August 31,2011 -א' באלול התשע"א
[11][21]
167194
שתל ביו–מתכלה המגדיל את מימדיו באופן עצמי
בקיבה ושיטה לריסון התיאבון בשימוש בשתל
[54]
BIODEGRADABLE SELFINFLATING INTRAGASTRIC
IMPLANTS AND METHOD OF
CURBING APPETITE BY THE
SAME
[22]
[51]
[71]
[74]
01.03.2005
Int. Cl.(2010.01) A61F 02//00, 02//02, 02//12
TULIP MEDICAL LTD.
DR. EYAL BRESSLER,
11 TUVAL ST.,
RAMAT GAN 52522
[57]
אביב- תל,טוליפ מדיקל בע"מ
,דר' אייל ברסלר עו"פ
11 תובל
גן- רמת
Biodegradable swallowable self-inflating or self-opening intragastric implant for
curbing appetite, constructed from one or more discrete expandable, stretchable and/or
deformable members.
__________________
[11][21]
167209
–'4–'– כלורו3) –4 תהליך להכנת
–3)–6––מתוקסי7–(פלואורואנילינו
מורפולינופרופוקסי( קווינאזולין וחומרי ביניים
שלו כתרכובות חדשות
[54]
PROCESS FOR THE
PREPARATION OF 4-(3'-CHLORO4'-FLUOROANILINO)-7METHOXY-6-(3MORPHOLINOPROPOXY)
QUINAZOLINE AND
INTERMEDIATES THEREOF AS
NOVEL COMPOUNDS
[22]
[31]
[51]
[71]
[72]
09.09.2003
0221245.4
[32] 13.09.2002
[33] GB
Int. Cl.(2010.01) C07C 25/5/54, C07D 23/9/90, 41/3/00
ASTRAZENECA AB, SWEDEN
JOHN PETER GILDAY, DAVID
MOODY
WO/2004/024703
S. HOROWITZ & CO.,
31 AHAD HAAM ST.
P.O.B. 2499
TEL AVIV 65202
[87]
[74]
115
,' הורוביץ ושות.ש
31 רחוב אחד העם
תל אביב2499 .ד. ת,
August 31,2011 -א' באלול התשע"א
[57]
The invention relates to chemical processes and intermediates useful in the
manufacture of the quinazoline derivative 4- (3'-chloro-4'-fluoroanilino)-7-methoxy-6(3-morpholinopropoxy)quinazoline. In particular, the invention relates to processes for
the manufacture of 7-methoxy-6-(3-morpholinopropoxy)-3,4-dihydroquinazolin-4-one
of Formula (II) and 4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile of
Formula (III) and their use in the manufacture of said quinazoline derivative.
__________________
[11][21]
167218
חוט ניאוביום עמיד בטמפרטורות גבוהות
[54]
HIGH TEMPERATURE RESISTANT
NIOBIUM WIRE
[22]
[31]
[51]
[71]
[74]
03.03.2005
102004011214.2 [32] 04.03.2004
[33]
Int. Cl.(2010.01) C22C 01//02, 01//04, 27//00
W.C. HERAEUS GMBH, GERMANY
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57]
High temperature-resistant niobium wire, characterized by the fact that it is enriched
with phosphorus; wherein the phosphorus content is approximately 50 to
approximately 2000 µg/g; and wherein the material shows no massive coarse grain
formation and does not become brittle up to 1,600º C.
DE
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
__________________
[11][21]
[54]
COMMON MESSAGE USER
INTERFACE REGARDLESS OF
THE TYPE OF MESSAGE
[22]
[31]
[51]
[71]
30.07.2004
10/835829
[32] 30.04.2004
Int. Cl.(2010.01) H04M 01//64, 07//00
MICROSOFT CORPORATION,
U.S.A.
116
167273
ממשק משתמש אחיד להודעות ללא תלות בסוג
ההודעה
[33]
US
August 31,2011 -א' באלול התשע"א
[87]
[74]
WO/2005/112409
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57]
Mechanisms for organizing messages across different message types. This may be
accomplished by using a single integrated user interface (201) in which messages
across a variety of different message types (211, 212, 213) are represented in a
common way. For example, the user experience of placing a telephone call is
standardized, regardless of the actual telephone technology (Cell Phone (212), VoIP?
(213), or POTS (211)) used to conduct the telephone conversation. Also, in addition to
a general log that includes the overall list of messages, each message also has a
separate, message-based log, thereby allowing for more flexible querying and
organization of the messages regardless of the message type.
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
__________________
[11][21]
167436
IFN–gamma נוגדים אנושיים מנטרלים אנטי
IFN–כמעכבים סלקטיבים של מסלול ה
gamma
[54]
HUMAN ANTI- IFN-GAMMA
NEUTRALIZING ANTIBODIES AS
SELECTIVE IFN-GAMMA
PATHWAY INHIBITORS
[22]
[31]
16.10.2003
60/419057
[32] 16.10.2002
[33] US
60/479241
17.06.2003
US
Int. Cl.(2010.01) A61K 39//395, C07K 16//18, 16//24
AMGEN INC., U.S.A.
MEDAREX, INC., U.S.A.
WO/2004/035747
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[51]
[71]
[87]
[74]
[57]
117
,' קולב ושות.סנפורד ט
מרמורק,4 שער הגיא
רחובות2273 .ד. ת,
This invention provides antibodies that interact with or bind to human interferongamma (IFN-gamma) and methods for treating IFN-gamma mediated diseases by
August 31,2011 -א' באלול התשע"א
administering a pharmaceutically effective amount of antibodies to IFN gamma.
Methods of detecting the amount of IFN-gamma in a sample using antibodies to IFNgamma are also provided.
__________________
[11][21]
167567
כוונת לרובה המשולבת עם רשתית מוחזרת
[54]
RIFLE SIGHT COMBINED WITH
A REFLECTED RETICLE
[22]
[51]
[71]
[74]
21.03.2005
Int. Cl.(2010.01) F41G 01//30
ITL OPTRONICS LTD.
ראש לציון,אל אופטרוניקס בע"מ.טי.איי
G.E. EHRLICH (1995) LTD.,
,( בע"מ1995) ארליך.אי.ג'י
AYALON TOWER, 15TH FLOOR,
11 רחוב מנחם בגין, 15 קומה,מגדל איילון
11 MENACHEM BEGIN ST.,
רמת גן
RAMAT GAN 52521
A reflex sight, comprising: a beam combiner (10) having high light-transmissivity
with respect to one part of the visible spectrum to permit viewing a target field (16)
along a first optical axis (OA1) of the beam combiner, and high light-reflectivity with
respect to another part of the visible spectrum to permit viewing an aiming-mark (21)
superimposed on the target field when projected through the beam combiner along a
second optical axis (OA2); and an aiming-mark projector (20) for projecting the
aiming-mark along said second optical axis of the beam combiner for viewing as a
superimposition on the target field when viewed along said first optical axis;
characterized in that said aiming-mark projector includes: an aiming-mark device
effective, when illuminated, to project the aiming-mark along said second optical axis
of the beam combiner; and a powered light source including a power supply for
energizing the light source (22); said aiming-mark device being exposed to a passive
light source (26) and said powered light source to enable utilizing said passive light
source and/or said powered light source for illuminating said aiming-mark device.
[57]
118
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
167623
תכשירים,מטריצות פולימריות מצולבות
המכילים אותן ושיטות להכנתן
[54]
CROSS-LINKED POLYMER
MATRICES, COMPOSITIONS
CONTAINING THE SAME AND
METHODS FOR MAKING THE
SAME
[22]
[31]
[51]
[71]
25.09.2003
60/413152
[32] 25.09.2002
[33] US
Int. Cl.(2010.01) A61K 31//715, C08J 03//00
THE JOHNS HOPKINS
UNIVERSITY, U.S.A.
WO/2004/029137
WOLFF, BREGMAN AND GOLLER,
, ברגמן וגולר,וולף
P.O.B. 1352,
ירושלים1352 .ד. ת,
JERUSALEM 91013
Functionalized chrondroitin sulfate, cross-linked polymer matrices comprising
functionalized chrondroitin sulfate, and methods of making and using the same are
provided. Such polymer matrices may be used for tissue engineering, reconstructing
cartilage, and the like. Kits are also provided for detection of cartilage degrading
enzymes.
[87]
[74]
[57]
__________________
[11][21]
[54]
METHOD FOR INSTALLING A
MODULAR COMMUNICATION
CABINET
[22]
[51]
[71]
[74]
05.04.2005
Int. Cl.(2010.01) A47B 47//00
TELEDATA NETWORKS LTD.
GOLD-PATENTS & FINANCIAL
SERVICES LTD.,
P.O.B. 25267, HAIFA
[57]
119
167862
שיטה להתקנת ארון תקשורת מודולרי
הרצליה,טלדטה נטוורקס בע"מ
,( בע"מ1992) פטנטים וייעוץ כלכלי-גולד
15 יוחנן הסנדלר
חיפה25267 .ד. ת,
A method for installing a modular communication cabinet, the method comprising:
determining at least one installation condition; defining a configuration of modular
communication cabinet in response to the at least one installation parameter; installing
August 31,2011 -א' באלול התשע"א
new underground infrastructure to be connected to the modular communication
cabinet, without substantially interrupting an operation of a previously installed
communication cabinet; and replacing connectors of a previously installed
communication cabinet without substantially interrupting an operation of the
previously installed communication cabinet.
__________________
[11][21]
167937
חפצים מרוכבים העמידים לקליעים ואש
[54]
BALLISTIC RESISTANT AND
FIRE RESISTANT COMPOSITE
ARTICLES
[22]
[31]
09.10.2003
60/417596
[32] 10.10.2002
[33] US
10/287929
05.11.2002
US
Int. Cl.(2010.01) B32B 15//14, C09K 21//00, F41H 05//04
HONEYWELL INTERNATIONAL
INC., U.S.A.
COMPOSIX COMPANY, U.S.A.
WO/2004/033196
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[51]
[71]
[87]
[74]
[57]
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
Ballistically resistant and fire resistant composite articles for aircraft interiors and
other applications. Composite articles are provided having a flexural modulus of at
least about 80,000 lbs/sq. in (552 MPa), a flexural strength at yield of at least about
800 lbs/sq. in. (5.52 MPa), an areal density of about 0.9 lb/ft2 (4.40 kg/m2) to about 1.5
lb/ft2 (5.86 kg/m2), a fire resistance meeting the requirements of §25.853 Title 14 of
the United States Code, Jan. 1, 2002, and a V0 velocity of at least about 1430 ft/sec
(427 m/s) when tested by United States Federal Aviation Administration Advisory
Circular 25.795.2, 10 Jan. 2002, using .44 Magnum Jacketed Hollow Point (JHP)
bullets of 240 grains (15.6 g ) mass and using 9 mm Full Metal Jacketed, Round Nose
(FMJ RN) bullets of 124 grains (8.0 g) mass.
__________________
120
August 31,2011 -א' באלול התשע"א
[11][21]
168359
התקן עורקי המתפרק באופן טבעי והמכיל גורם
ממתן
[54]
BIODEGRADABLE VASCULAR
DEVICE WITH BUFFERING
AGENT
[22]
[31]
[51]
[71]
[74]
03.05.2005
856459
[32] 28.05.2004
[33]
Int. Cl.(2010.01) A61F 02//06, A61L 27//44
CORDIS CORPORATION, U.S.A.
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57]
A vascular or cardiovascular medical device (50) for placement at a site in a patient's
body and for controlling pH levels at the site in the patient's body, the device
comprising: one or more structural components (70) made of a first biodegradable
and/or bioabsorbable material (80); and a particle made of a second biodegradable
and/or bioabsorbable material (90) encapsulating a buffering agent, the buffering agent
being dispersed from the second biodegradable and/or bioabsorbable material as the
second biodegradable and/or bioabsorbable material degrades, in response to a
reduction in the pH level at the site in the patient's body resulting from the hydrolysis
of the first biodegradable and/or bioabsorbable material .
US
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
__________________
[11][21]
168371
רכב בדיקה נייד עם סורק על בסיס פיזור קרני
רנטגן
[54]
X-RAY BACKSCATTER MOBILE
INSPECTION VAN
[22]
[31]
03.11.2003
60/424357
[32] 06.11.2002
[33]
10/330000
26.12.2002
10/442687
21.05.2003
Int. Cl.(2010.01) B60P 09//00, G01N 23//04
AMERICAN SCIENCE AND
ENGINEERING, INC., U.S.A.
WO/2004/043740
DR. SHLOMO COHEN & CO.,
[51]
[71]
[87]
[74]
121
US
US
US
,'ד"ר שלמה כהן ושות
August 31,2011 -א' באלול התשע"א
[57]
124 IBN GABIROL ST.,
124 אבן גבירול
P.O.B. 11490,
תל אביב11490 .ד. ת,
TEL AVIV 62038
An inspection system based upon an enclosed conveyance such as a van (10), capable
of road travel, for inspecting objects of inspection that may include persons. The
conveyance is characterized by an enclosing body, or skin. A source of penetrating
radiation (30) and a spatial modulator for forming the penetrating radiation into a
beam, both contained entirely within the body of the enclosed conveyance, irradiate an
object (12) with a time-variable scanning profile. A detector module (100) generates a
scatter signal based on penetrating radiation scattered by contents of the object, while a
relative motion sensor (18) generates a relative motion signal based on a relative
disposition of the conveyance and the inspected object. An image is formed of the
contents of the object based in part on the scatter signal and the relative motion signal.
A detector, which may be separate or part of the scatter detector module, may exhibit
sensitivity to decay products of radioactive material.
,213892
The applications for division
from this application have
not yet been published
בקשות חלוקה מבקשה זו
.שטרם פורסמו
__________________
[11][21]
[54]
MODERN THERMAL SENSOR
UPGRADE FOR EXISTING
MISSILE SYSTEM
[22]
[31]
[51]
[71]
[87]
[74]
06.04.2004
10/413786
[32] 15.04.2003
Int. Cl.(2010.01) F41G 07//20
RAYTHEON COMPANY, U.S.A.
WO/2004/092674
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[57]
122
168405
שדרוג של חיישנים תרמיים מודרניים עבור
מערכת טילים קיימת
[33]
US
,' קולב ושות.סנפורד ט
מרמורק,4 שער הגיא
רחובות2273 .ד. ת,
A method of mapping a first array 20, 60 to a second array 22, 62 is useful where (1)
each of the arrays has pixels in sequential columns and rows and the first array has
sequential integers identifying each row of pixels, (2) sequential integers identify each
column of pixels, and a numerical value is associated with each pixel, (3) the first and
second arrays have (or can be made to have) a one to one pairing between columns of
the first and second arrays, and (4) groups of four unique pixels in the same column of
the first array are paired one to one with a pixel in the paired column of the second
array. The method includes the steps of, for each column in the first array, selecting the
August 31,2011 -א' באלול התשע"א
values associated with the pixels in four sequential odd numbered rows to form an odd
group of four unique pixels, combining the values associated with the pixels in the first
three odd numbered rows of the odd group to form an odd combined value, and
mapping the odd combined value to the pixel in the column and row of the second
array with which the odd group is paired, and thereafter selecting the values associated
with the pixels in four even numbered rows to form an even group of four unique
pixels, combining the values associated with pixels in the last three rows of the even
group to form an even combined value, and mapping the even combined value to the
pixel in column and row of the second array with which the even group is paired.
__________________
[11][21]
169008
תכשיר המכיל מיקרופלסמין לשימוש כתרופה
לעיניים
[54]
COMPOSITION COMPRISING
MICROPLASMIN FOR USE AS A
MEDICAMENT FOR THE EYE
[22]
[31]
[51]
[71]
[87]
[74]
05.12.2003
0228409.9
[32] 06.12.2002
[33] GB
Int. Cl.(2010.01) A61K 38//43, 38//48, A61M 35//00
THROMB-X NV, BELGIUM
WO/2004/052228
PEARL COHEN ZEDEK LATZER,
,פרל כהן צדק לצר
5 SHENKAR ST.,
5 רח' שנקר,1 ים-מרכז גב
P.O.B. 12704,
הרצליה12704 .ד. ת,
HERZLIYA 46733
A method of treating or preventing a disorder, or a complication of a disorder, of an
eye of a subject comprising contacting a vitreous and/or aqueous humor with a
composition comprising a truncated form of plasmin comprising a catalytic domain of
plasmin (TPCD). TPCDs include, but are not limited to, miniplasmin, microplasmin
and derivatives and variants thereof. The methods of the invention can be used to
reduce the viscosity of the vitreous, liquefy the vitreous, induce posterior vitreous
detachment, reduce hemorrhagic blood from the eye, clear or reduce materials toxic to
the eye, clear or reduce intraocular foreign substances from the eye, increase diffusion
of a composition administered to an eye, reduce extraretinal neovascularization and
any combinations thereof. The method can be used in the absence of, or as an adjunct
to, vitrectomy.
[57]
123
August 31,2011 -א' באלול התשע"א
The applications for division
from this application have
not yet been published
,213838,202851
בקשות חלוקה מבקשה זו
.שטרם פורסמו
__________________
[11][21]
169123
מערכות נשק ותקשורת מותאמות בייחוד לתנאי
שדה קרב
[54]
COMMUNICATION AND
WEAPON SYSTEMS
PARTICULARLY USEFUL FOR
BATTLEFIELD CONDITIONS
[22]
[51]
[71]
[72]
09.06.2005
Int. Cl.(2010.01) G08C 17//02, H04B 01//034, 07//26
ITL OPTRONICS LTD.
ראש לציון,אל אופטרוניקס בע"מ.טי.איי
YISHAI HATIR, RAN KAHN,
ישראל רום, רן כהן,ישי חציר
ISRAEL ROM
G.E. EHRLICH (1995) LTD.,
,( בע"מ1995) ארליך.אי.ג'י
AYALON TOWER, 15TH FLOOR,
11 רחוב מנחם בגין, 15 קומה,מגדל איילון
11 MENACHEM BEGIN ST.,
רמת גן
RAMAT GAN 52521
A communication system particularly useful for battlefield conditions, comprising: a
plurality of portable data input units sized so as to be carried by individuals during use
at various locations in the field, each of said portable data units including a data input
device for inputting data into said communication system; a plurality of portable relay
units also sized so as to be carried by individuals during use at various locations in the
field, each of said portable units providing short-range two-way communication with
one or more portable data units at the respective location in the field, and long-range
two-way communication with a plurality of portable data units at other locations In the
field; and a portable display unit for, and communicating with, each of said portable
relay units for displaying information from the portable data input unit received from
the respective portable relay unit via its short-range communication with a portable
data input unit at the respective location, or via its long-range communication with
other portable data input units at other locations; wherein at least one of said portable
[74]
[57]
124
August 31,2011 -א' באלול התשע"א
data input units, at least one of said portable relay units, and at least one of said
portable display units are designed for use by a commander to provide two-way
communication with a plurality of said portable data input units, portable relay units
and portable display units used by individuals in the field under the commander.
__________________
[11][21]
169409
עמדת עזרה ראשונה ניידת
[54]
MOBILE FIRST AID POST
[22]
[31]
24.12.2003
SG
[32] 27.12.2002
[33] SG
200207824-4
Int. Cl.(2010.01) A61G 03//00
TING CHOON MENG, SINGAPORE
MAK KOON HOU, SINGAPORE
WO/2004/058128
JMB, FACTOR & CO. LTD.,
, פקטור אנד קו בע"מ,ג'יי אמ בי
HAR HOTZVIM HI-TECH PARK,
הר חוצבים,רחוב המרפא
P.O.B. 45087,
ירושלים45087 .ד. ת,
JERUSALEM 91450
A mobile first aid post comprising a road vehicle having a compartment of an openable
enclosure for housing medical supplies and equipment, the compartment including a
fixed structure and at least one rigid panel pivotally movable relative to the fixed
structure between a closing condition where the panel defines at least part of a side
wall of the enclosure and an erected condition where the panel is in a substantially or
near horizontal condition creating an opening and providing a region covered overhead
for a person positioned adjacent the side of the vehicle, and wherein medical utilities
selected from one or more of compressed air, suction, water, and oxygen are provided
accessible by a user from the downwardly facing major surface of the panel aiding in
the treatment of patients positioned below the panel. The panel may also be of an
extendable type. Sideboards may also be included acting as a seat to personnel inside
the compartment in a first condition and as a step up for people entering and leaving
the compartment in a second condition.
[51]
[71]
[87]
[74]
[57]
125
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
169519
מיכל פנימי
[54]
INTERNAL CONTAINER
[22]
[51]
[71]
04.07.2005
Int. Cl.(2010.01) B29C 63//34, B65D 08//04, 81//00
TERRASAFE-ENVIRONMENTAL
PROTECTION LTD.
YORAM TSIVION,
,יורם צביון
2 HATOCHEN ST.
פארק התעשיה,2 רח' הטוחן
P.O.B. 3148,
קיסריה3148 .ד. ת,
CAESAREA 38900
A method for applying a replaceable tank within a metallic storage container for
holding a fluid, the container having at least one accessory orifice, the method
comprising: forming said replaceable tank from a plurality of sheets of material
impermeable to said fluid, whereby the replaceable tank is foldable; attaching magnets
to the replaceable tank; folding the replaceable tank, twisting the replaceable tank
about longitudinal axis of the replaceable tank; inserting the replaceable tank within
the metallic storage container through an existing orifice of the storage container
wherein said existing orifice is any one of the small pre-existing orifices of the ground
comprising orifices for filling the container with fuel; dispersing fuel from the
container; measuring the level of the fuel in the container; and venting the container;
and inflating the replaceable tank.
[74]
[57]
__________________
126
August 31,2011 -א' באלול התשע"א
[11][21]
169720
תולדות בנזאימידאזול ותכשירי רוקחות
המכילים אותן
[54]
BENZIMIDAZOLE DERIVATIVES
AND PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME
[22]
[31]
[51]
[71]
29.01.2004
60/443917
[32] 31.01.2003
[33] US
Int. Cl.(2010.01) A61K 31//4184, A61P 31//04, C07D 40/3/14
VERTEX PHARMACEUTICALS
INCORPORATED, U.S.A.
WO/2005/012292
WOLFF, BREGMAN AND GOLLER,
, ברגמן וגולר,וולף
P.O.B. 1352,
ירושלים1352 .ד. ת,
JERUSALEM 91013
The present invention relates to compounds which inhibit bacterial gyrase and/or Topo
IV and pharmaceutically acceptable compositions comprising said compounds. These
compounds, and compositions thereof, are useful in treating bacterial infection.
Accordingly, the present invention also relates to methods for treating bacterial
infections in mammals. Formula (I).
[87]
[74]
[57]
__________________
[11][21]
170108
העברה רכה מעבר לרשתות שונות הנעזרים על
ידי קצה–עד–קצה פרוטוקול יישום
[54]
SOFT HANDOFF ACROSS
DIFFERENT NETWORKS
ASSISTED BY AN END-TO-END
APPLICATION PROTOCOL
[22]
[31]
[51]
[71]
12.02.2004
10/366454
[32] 12.02.2003
[33]
Int. Cl.(2010.01) H04L 12//28, 12//56, 12//66
QUALCOMM INCORPORATED,
U.S.A.
WO/2004/073282
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[87]
[74]
127
US
,' קולב ושות.סנפורד ט
מרמורק,4 שער הגיא
רחובות2273 .ד. ת,
August 31,2011 -א' באלול התשע"א
[57]
A method for soft handoff across different networks is disclosed. A first
communication link (106, 1106) through a first network (104a, 1104a) is used for
communicating between a first user agent (102a, 1102a) and a second user agent
(102b, 1102b). The user agents negotiate to use a second communication link (108,
1108) for the same call. The second communication link is established through a
second network (104b, 1104b) between the first user agent and the second user agent
while maintaining the first communication link. Related data is sent through the first
communication link and the second communication link such that the related data is
for the same call. The first communication link is dropped and communication is
continued using the second communication link. Alternatively, the second
communication link is established between a third user agent (1102c) and the second
user agent, for forwarding to another device.
,214230
The applications for division
from this application have
not yet been published
בקשות חלוקה מבקשה זו
.שטרם פורסמו
__________________
[11][21]
[54]
THROUGH-WALL IMAGING
DEVICE
[22]
[51]
[71]
[72]
06.09.2005
Int. Cl.(2010.01) G01S 13//89
CAMERO-TECH LTD.
AMIR BEERI, DAVID GAZELLE,
MORDECHAY DIVALD
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
[57]
128
170689
מכשיר הדמיה דרך קיר
נתניה,טק בע"מ-קמרו
מרדכי דיוולד, דוד גזלה,אמיר בארי
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
A through-wall imaging device having antenna elements for transmitting and
receiving signals adapted to pass through a wall for imaging objects behind the wall,
the device comprising a base comprising a carrier portion and a plurality of spacedapart extensions connected to the carrier portion, at least a portion of said antenna
August 31,2011 -א' באלול התשע"א
elements being mounted on said extensions, the area between adjacent extensions,
which is different from said carrier portion, being free of any material of the base at
least when said device is in open position; characterized in that said extensions are
connected to the carrier portion in a manner permitting folding of the extensions onto
the carrier portion between a first open position corresponding to an operative state
and a second closed position corresponding to an operative state.
__________________
[11][21]
[54]
METHOD OF MANUFACTURING
AN ORIENTED FILM FROM
ALLOYED THERMOPLASTIC
POLYMERS, APPARATUS FOR
SUCH MANUFACTURE AND
RESULTING PRODUCTS
[22]
[31]
[51]
[71]
26.04.2004
0309315.0
[32] 24.04.2003
Int. Cl.(2010.01) B29C 55//06
OLE-BENDT RASMUSSEN,
SWITZERLAND
WO/2004/094129
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[87]
[74]
[57]
129
171119
שיטה ליצור קרום מכוון העשוי סגסוגת
התקן ליצור זה,מפולימרים תרמופלסטיים
ותוצריו
[33]
GB
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
A blend of two partly incompatible polymers is extruded to form a film under
conditions such that the alloy in the blend comprises fibrils extending mainly in one
direction, the width and thickness of each fibril having a mean lower than 5 µm, the
August 31,2011 -א' באלול התשע"א
fibrils being formed of the polymer component having a higher melting point, and the
fibrils being surrounded by a matrix of the second polymer, which has a lower
coefficient of elasticity. The special morphology is achieved by providing grids (301,
302) in a grid chamber upstream of the exit orifice of the extrusion die, and by
sequential hot stretching at a temperature at which the higher melting polymer is at
least partly crystalline, and cold stretching, at which both polymers are substantially
solid. The second, cold stretching step, is carried out under conditions to give an
elongation at break at 20°C of at least 25%. The films are of particular value for
forming crosslaminates having high shock resistance. Preferably the polymer forming
fibrils is polypropylene and the polymer forming the matrix is an ethylene polymer,
preferably LLDPE.
The applications for division
from this application have
not yet been published
,213966
בקשות חלוקה מבקשה זו
.שטרם פורסמו
__________________
[11][21]
171643
–שימוש באימונוטוקסין המכיל נוגדן הנקשר ל
להכנתA ופסאודומונס אקסוטוקסיןEp–CAM
תרופה לטיפול בסרטן
[54]
USE OF IMMUNOTOXIN
COMPRISING AN ANTIBODY
THAT BINDS EP-CAM AND
PSEUDOMONAS EXOTOXIN A
FOR THE MANUFACTURE OF A
MEDICAMENT FOR TREATING
CANCER
[22]
[31]
[51]
[71]
30.04.2004
60/466608
[32] 30.04.2003
[33] US
Int. Cl.(2010.01) A61K 39//395, 47//48, A61P 35//00, C07K 16//30
UNIVERSITY OF ZURICH,
SWITZERLAND
UWE ZANGEMEISTER-WITTKE,
CLAUDIO DI PAOLO, DOMINIQUE
CHRISTINE TSCHUDI, NICHOLAS
RONALD GLOVER, DIMITRI PETER
FITSIALOS
WO/2004/096271
DR. MARK FRIEDMAN LTD.,
,ד"ר מרק פרידמן בע"מ
MOSHE AVIV TOWER, 54TH
7 רח ז'בוטינסקי, 54. ק,מגדל משה אביב
FLOOR,
גן-רמת
7 JABOTINSKY ST.,
[72]
[87]
[74]
130
August 31,2011 -א' באלול התשע"א
[57]
RAMAT GAN 52520
The present invention relates to methods for preventing or treating head and neck
squamous cell cancer and bladder cancer using an immunotoxin comprising (a) a
ligand that binds to a protein on the cancer cell attached to; (b) a toxin that is cytotoxic
to the cancer cell. In a specific embodiment, the invention is directed to the prevention
or treatment of head and neck squamous cell cancer or bladder cancer using VB4-845,
which is a recombinant immunotoxin comprising a humanized, MOC31-derived,
single-chain antibody fragment that is fused to a truncated form of Pseudomonas
exotoxin A. Also encompassed by the invention are combination therapy methods,
including the use of reduced dosages of chemotherapeutic agents, for the prevention or
treatment of cancer. Also encompassed by the invention are formulations and methods
for direct administration of the recombinant immunotoxin to the carcinoma, for the
prevention or treatment of cancer.
The applications for division
from this application have
not yet been published
,213621
בקשות חלוקה מבקשה זו
.שטרם פורסמו
__________________
[11][21]
171798
הכוללOVR115 נוגדן הקושר מקטע של חלבון
הרכבים הכוללים אתLEU435 עדVAL203
הנוגדן ושיטות שימוש
[54]
ANTIBODY WHICH BINDS TO AN
OVR115 PROTEIN FRAGMENT
COMPRISING VAL203 TO LEU435,
COMPOSITIONS CONTAINING
THE ANTIBODY AND METHODS
OF USE
[22]
[31]
17.05.2004
60/471068
[32] 16.05.2003
[33] US
60/559730
05.04.2004
US
Int. Cl.(2010.01) A61K 39//395, C07K 16//18, 16//30, G01N 33//574
DIADEXUS, INC, U.S.A.
WO/2004/104173
SANFORD T.COLB & CO.,
,' קולב ושות.סנפורד ט
[51]
[71]
[87]
[74]
131
August 31,2011 -א' באלול התשע"א
[57]
P.O.B. 2273,
מרמורק,4 שער הגיא
REHOVOT 76122
רחובות2273 .ד. ת,
The invention provides isolated anti-ovarian, pancreatic, lung or breast cancer antigen
(Ovr115) antibodies that bind to Ovr115 on a mammalian cell in vivo. The invention
also encompasses compositions comprising an anti-Ovr115 antibody and a carrier.
These compositions can be provided in an article of manufacture or a kit. Another
aspect of the invention is an isolated nucleic acid encoding an anti-Ovr115 antibody, as
well as an expression vector comprising the isolated nucleic acid. Also provided are
cells that produce the anti-Ovr115 antibodies. The invention encompasses a method of
producing the anti-Ovr115 antibodies. Other aspects of the invention are a method of
killing an Ovrl 15-expressing cancer cell, comprising contacting the cancer cell with
an anti-Ovr115 antibody and a method of alleviating or treating an Ovrl 15-expressing
cancer in a mammal, comprising administering a therapeutically effective amount of
the anti-Ovr115 antibody to the mammal.
__________________
[11][21]
171851
–חומצת קרבוקסילית2–תולדות פירולופירידין
אמיד ותכשירי רוקחות המכילים אותן
[54]
PYRROLOPYRIDINE-2CARBOXYLIC ACID AMIDE
DERIVATIVES AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME
[22]
[31]
20.05.2004
60/472375
[32] 21.05.2003
[33] US
60/551256
08.03.2004
US
Int. Cl.(2010.01) A61K 31//437, A61P 09//10, C07D 47/1/00, 47/1/04, 51/9/00
PROSIDION LIMITED, UNITED
KINGDOM
WO/2004/104001
WOLFF, BREGMAN AND GOLLER,
, ברגמן וגולר,וולף
P.O.B. 1352,
ירושלים1352 .ד. ת,
JERUSALEM 91013
[51]
[71]
[87]
[74]
132
August 31,2011 -א' באלול התשע"א
[57]
Compounds represented by Formula (I): or pharmaceutically acceptable salts thereof,
are inhibitors of glycogen phosphorylase and are useful in the prophylactic or
therapeutic treatment of diabetes, hyperglycemia, hypercholesterolemia,
hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis or tissue ischemia e.g.
myocardial ischemia, and as cardioprotectants.
__________________
[11][21]
171870
טבליה לשחרור מבוקר של בופרופיון הדרוכלוריד
[54]
MODIFIED-RELEASE TABLET
OF BUPROPION
HYDROCHLORIDE
[22]
[51]
[71]
08.08.2003
Int. Cl.(2010.01) A61K 09//22, 09//24, 09//28, 31//137
BIOVAIL LABORATORIES
INTERNATIONAL S.R.L.,
BARBADOS
WO/2005/016318
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[87]
[74]
[57]
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
A modified-release tablet of bupropion hydrochloride comprising (i) a core
comprising an effective amount of bupropion hydrochloride, a binder, a lubricant; and
(ii) a control releasing coat surrounding said core; and (iii) a moisture barrier
surrounding said control releasing coat, wherein the modified-release tablet is
bioequivalent to Wellbutrin© or Zyban®/Wellbutrin®SR tablets.
__________________
[11][21]
[54]
133
USE OF GLATIRAMER ACETATE
171956
שימוש בגלטירמר אצטאט ומיטוקסנטרון לייצור
August 31,2011 -א' באלול התשע"א
תרופות לטיפול בטרשת נפוצה
AND MITOXANTRONE IN THE
MANUFACTURE OF
MEDICAMENTS FOR THE
TREATMENT OF MULTIPLE
SCLEROSIS
[22]
[31]
[51]
[71]
[72]
[87]
[74]
[57]
14.05.2004
60/470640
[32] 14.05.2003
[33] US
Int. Cl.(2010.01) A61K 31//137, 38//16
TEVA PHARMACEUTICAL
פתח,טבע תעשיות פרמצבטיות בע"מ
INDUSTRIES LTD.
תקוה
TIMOTHY VOLLMER
WO/2004/103297
TEVA PHARMACEUTICAL
,טבע תעשיות פרמצבטיות בע"מ
INDUSTRIES LTD.,
מחלקת פטנטים5 בזל
5 BASEL ST.,
פתח תקוה3190 .ד. ת,
P.O.B. 3190,
PETAH TIQVA 49131
The subject invention provides a method of treating a subject afflicted with a form of
multiple sclerosis comprising periodically administering to the subject an amount of
glatiramer acetate and an amount of mitoxantrone, wherein the amounts when taken
together are effective to alleviate a symptom of the form of multiple sclerosis in the
subject so as to thereby treat the subject. The subject invention also provides a package
comprising glatiramer acetate, mitoxantrone and instructions for use of the together to
alleviate a symptom of a form of multiple sclerosis in a subject. Additionally, the
subject invention provides a pharmaceutical composition comprising an amount of
glatiramer acetate and an amount of mitoxantrone, wherein the amounts when taken
together are effective to alleviate a symptom of a form of multiple sclerosis in a
subject. The subject invention further provides a pharmaceutical combination
comprising separate dosage forms of an amount of glatiramer acetate and an amount of
mitoxantrone, which combination is useful to alleviate a symptom of a form of
multiple sclerosis in a subject.
__________________
[11][21]
[54]
134
USE OF INDAZOLE
DERIVATIVES IN THE
MANUFACTURE OF
MEDICAMENTS FOR THE
TREATMENT OF NEUROPATHIC
PAIN
172101
שימוש בתולדות אינדאזוליות להכנת תרופות
לטיפול בכאב נוירופתי
August 31,2011 -א' באלול התשע"א
[22]
[31]
[51]
[71]
[87]
[74]
[57]
08.07.2004
MI2003A
[32] 18.07.2003
[33] IT
001468
Int. Cl.(2010.01) A61K 31//4439, 31//444, A61P 25//02, 25//04, 29//00, C07D
40/1/12, 40/1/14
AZIENDE CHIMICHE RIUNITE
ANGELINI FRANCESCO A.C.R.A.F.
S.P.A., ITALY
WO/2005/013989
REINHOLD COHN AND PARTNERS,
,ריינהולד כהן ושותפיו
26A HABARZEL ST.,
'א26 רחוב הברזל
RAMAT HACHAYAL 69710
רמת החייל
Use of a compound of formula (I), wherein X is CH or N, and when X is CH, R is H,
OH, a linear or branched alkyl chain having from 1 to 3 carbon atoms, a linear or
branched alkoxy chain having from 1 to 3 carbon atoms, or a halogen atom, and when
X is N, R is H, or an acid addition salt thereof with a pharmaceutically acceptable
organic or inorganic acid, to prepare a pharmaceutical composition active in the
treatment of neuropathic pain.
__________________
[11][21]
172384
מערכת ניידת קומפקטית לתצפית בשטח אויב
[54]
COMPACT MOBILE
RECONNAISSANCE SYSTEM
[22]
[31]
[51]
[71]
[87]
[74]
16.06.2004
156478
[32] 17.06.2003
[33] IL
Int. Cl.(2010.01) F41G 07//22
O.D.F. OPTRONICS LTD.
תל אביב, אופטרניקס בע"מ. אפ. די.או
WO/2004/111673
LUZZATTO & LUZZATTO,
,לוצאטו את לוצאטו
INDUSTRIAL PARK, OMER,
עומר,גן תעשייה
P.O.B. 5352,
באר שבע5352 .ד. ת,
BEER-SHEVA 84152
The present invention provides a compact mobile reconnaissance device (1) that is
[57]
135
August 31,2011 -א' באלול התשע"א
designed to be deployed in hostile, dangerous, or difficult to access environments, to
absorb shocks, to be resistant to adverse environmental conditions, and to transmit
video and audio streams related to events at which it has been deployed to a remote
receiver and display unit.
__________________
[11][21]
172410
מערכת אפקטים רב ממדית הכוללת ממשק
דינאמי לגיטרה חשמלית
[54]
MULTI-SOUND EFFECT SYSTEM
INCLUDING DYNAMIC
CONTROLLER FOR AN
AMPLIFIED GUITAR
[22]
[31]
[51]
[71]
[72]
[87]
[74]
03.06.2004
60/476190
[32] 06.06.2003
[33] US
Int. Cl.(2010.01) G10D 01//08, 03//00, G10H 01//00, 03//18
GUITOUCHI LTD.
גיטאצ'י בע"מ
DANIEL SHAVIT
דניאל שביט
WO/2004/109244
FISHER WEILER JONES,
,פישר וילר ג'ונס
26 HABARZEL STREET
26 הברזל רמת החיל
RAMAT HACHAYAL,
תל אביב
TEL-AVIV 69710
The proposed invention is a portable multi-sound effect system providing a novel and
unique solution for processing the electrical audio signals created by a guitar. The
innovation according to the present invention is by attaching a signal processing unit
along with a touch-sensitive dynamic control unit upon the front panel of the guitar's
body for controlling and processing electrical signals produced by an amplified guitar,
e.g. electric, bass, acoustic or classic guitar.
[57]
__________________
136
August 31,2011 -א' באלול התשע"א
[11][21]
172469
שיטוה לביטוי אינסולין בזרעי צמחים וזרעים
כנ"ל
[54]
METHODS FOR EXPRESSION OF
INSULIN IN PLANT SEEDS AND
SUCH SEEDS
[22]
[31]
17.06.2004
60/478818
[32] 17.06.2003
[33] US
60/549539
04.03.2004
US
Int. Cl.(2010.01) A01H 05//00, 05//10, C12N 15//62, 15//82
SEMBIOSYS GENETICS INC.,
CANADA
WO/2004/111244
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[51]
[71]
[87]
[74]
[57]
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
Methods for the production of insulin in plants are described. In one embodiment, the
present invention provides a method for the expression of insulin in plants comprising:
(a) providing a chimeric nucleic acid construct comprising in the 5’ supl; to 3’
direction of transcription as operably linked components: (i) a nucleic acid sequence
capable of controlling expression in plant seed cells; and (ii) a nucleic acid sequence
encoding an insulin polypeptide; (b) introducing the chimeric nucleic acid construct
into a plant cell; and (c) growing the plant cell into a mature plant capable of setting
seed wherein the seed expresses insulin.
__________________
[11][21]
[54]
137
ELECTRICAL DEVICE TO
LOWER, RAISE AND MOVE
SHUTTERS ON THE SABBATH
172484
מתקן אלקטרוני להנעת תריסים חשמליים בשבת
בכל עת
August 31,2011 -א' באלול התשע"א
AT WILL
[22]
[51]
[71]
[74]
[57]
11.12.2005
Int. Cl.(2010.01) E06B 09//11
AVRAHAM HALEVI
AVRAHAM HALEVI,
2 HARAMBAM ST.,
HASHMONAIM, MOBILE POST
MODI'IN
נ מודיעין ישוב חשמונאים. ד,אברהם הלוי
,אברהם הלוי
2 הרמבם
נ מודיעין ישוב חשמונאים.ד
מתקן המאפשר עבור הציבור הדתי המאפשר הנעת תריסים חשמליים בשבת בכל עת
בשיטה ייחודית המותרת והמאושרת ע"י סמכות הלכתית כל שהיא הכולל מעגל
(אופטיים המחוברים למסגרת הדלתRF) אלקטרוני שאיליו מחוברים סנסורים
המופעלים ע"י רפלקטורים או חוסמי קרן המודבקים לדלת מול החיישנים המאפשר
הנעת התריסים מופעל ע"י פתיחת הדלת והרחקת הרפלקטורים או חוסמי הקרן אשר
.פועלת בצורה מחזורית ע"י פולס
__________________
[11][21]
[54]
METHOD AND SYSTEM FOR
TREATING WASTEWATER
[22]
[31]
[51]
[71]
[87]
[74]
22.06.2004
10/602985
[32] 24.06.2003
Int. Cl.(2010.01) C02F 01//44, 03//28
CAROLLO ENGINEERS, P.C., U.S.A.
WO/2005/003044
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
[57]
138
172590
שיטה ומערכת לטיפול במי–שפכים
[33]
US
עורכי דין ועורכי,קבוצת איתן מהולל
,פטנטים
10 שדרות אבא אבן
הרצליה2081 .ד. ת,
A method and system is disclosed for treating wastewater (100) that utilizes membrane
processes,(30, 50) preferably in combination with anaerobic biological treatment (60),
to provide for economical and environmentally superior treatment without high
production of biological solids. The process eliminates the need for conventional
secondary treatment processes.
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
צורות שוות של פפטיד המעיד על נתרן בשתן
[54]
ISOFORMS OF BRAIN
NATRIURETIC PEPTIDE
[22]
[31]
[51]
[71]
02.06.2004
60/480460
[32] 20.06.2003
Int. Cl.(2010.01) C07K 14//00
MAYO FOUNDATION FOR
MEDICAL EDUCATION AND
RESEARCH, U.S.A.
WO/2005/000095
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[87]
[74]
[57]
172674
[33]
US
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
Methods and materials for diagnosing and treating heart conditions (e.g., heart failure)
and kidney conditions (e.g., kidney failure) are described.
__________________
[11][21]
[54]
ENHANCED UPLINK OPERATION
IN SOFT HANDOVER
[22]
[31]
25.08.2004
60/497747
60/507554
60/508797
139
[32]
25.08.2003
01.10.2003
03.10.2003
172702
פעילות אפ–לינק מוגברת בהעברת מסר
[33]
US
US
US
August 31,2011 -א' באלול התשע"א
[51]
[71]
[87]
[74]
[57]
60/520207
14.11.2003
60/585174
02.07.2004
Int. Cl.(2010.01) H04J 03//24
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2005/022798
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
US
US
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
A method and system for an enhanced uplink (EU) operation in a wireless
communication system during soft handover. The system comprises a wireless
transmit/receive unit (WTRU), at least two Node-Bs, and a radio network controller
(RNC). One Node-B may be designated as a primary Node-B, and the primary Node-B
may control EU operation during soft handover including uplink scheduling and
hybrid automatic repeat request (H-ARQ). Soft buffer corruption is avoided during soft
handover by controlling H-ARQ by the primary Node-B. Alternatively, an RNC may
control EU operation during soft handover including H-ARQ. In this case, an RNC
generates final acknowledge/non-acknowledge (ACK/NACK) decision based on the
error check results of the Node-Bs.
__________________
[11][21]
[54]
PROCESS FOR PREPARING
RALOXIFENE HYDROCHLORIDE
[22]
[31]
[51]
[71]
[87]
[74]
28.06.2004
MI2003A001333 [32] 30.06.2003
Int. Cl.(2010.01) C07D 40/9/12
ERREGIERRE S.P.A., ITALY
WO/2005/003116
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
140
172801
תהליך להכנת רלוקסיפן הידרוכלוריד
[33]
IT
,פרל כהן צדק לצר
5 רח' שנקר,1 ים-מרכז גב
הרצליה12704 .ד. ת,
August 31,2011 -א' באלול התשע"א
[57]
Process for preparing raloxifene hydrochloride with a purity greater than 98% and low
aluminium content comprising the following stages a) demethylation of 6-methoxy-2(4-methoxyphenyl)benzo[b]thiophene in pyridine and hydrochloric acid to obtain 6hydroxy2-(4-hydroxyphenyl)benzo[b]thiophene in pyridine hydrochloride, b)
acetylation of 6-hydroxy-2-(4hydroxyphonyl)benzo[b]thiophene with an acetylating
agent to obtain the corresponding 6-acetoxy-2-(4 acetoxyphenyl)benzo[b]thiophene, c)
acylation of 6-acetoxy-2-(4-acetoxyphonyl)benzo[b]thiophene with 4-(2
piperidinoethoxy)benzoylchloride hydrochloride with aluminium trichloride in
halogenated solvent to obtain 6-acetoxy-2-(4acetoxyphenyl)-3-[4-(2
piperidinoethoxy)benzoyl]-benzo[b]thiophene, d) hydrolysis of 6-acetoxy-2-(4acetoxyphenyl)-3-[4-(2-piperidinoethoxy)benzoyll benzo[b]thiophene according to the
following operating conditions: dl) treatment of 6-acetoxy-2-(4-acetoxyphonyl)-3-[4-(2
piperidinoethoxy)benzoyl]benzo[b]thiophene with alkaline hydroxide in alcohol
solvent, d2) acidification of the product obtained in the preceding stage (dl) with a
strong acid, to obtain the corresponding raloxifene salt with the strong acid,
characterised in that the strong acid used in stage (d2) is concentrated hydrochloric
acid.
__________________
[11][21]
172815
זרבובית בקרה ושפופרת ונטורי לזרימת נוזל
[54]
NOZZLE AND VENTURI FOR
FLUID FLOW CONTROL
[22]
[31]
[51]
[71]
[87]
[74]
29.06.2004
2003903386
[32] 02.07.2003
[33] AU
Int. Cl.(2010.01) E03F 03//00, F15C 01//16, F15D 01//00, F16L 55//00, G05D 07//00
PAX SCIENTIFIC, INC., U.S.A.
WO/2005/003616
SANFORD T.COLB & CO.,
,' קולב ושות.סנפורד ט
P.O.B. 2273,
מרמורק,4 שער הגיא
REHOVOT 76122
רחובות2273 .ד. ת,
A flow controller (11) adapted to control a flow of fluid within the flow controller, the
flow controller having a flow path adapted to convey said fluid, wherein the crosssectional area of the flow path varies along the flow path and wherein in at least a
portion of its length the flow controller comprises an active surface (25) capable of
influencing the fluid flow through the flow path to cause vortical motion of the fluid
within the fluid pathway.
[57]
141
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
172901
מערכת טלפונית פיר לפיר
[54]
PEER-TO-PEER TELEPHONE
SYSTEM
[22]
[31]
[51]
14.07.2004
60/487242
[32] 16.07.2003
[33] US
Int. Cl.(2010.01) H04L 09//00, 12//14, 12//50, 29//06, 29//08, H04M 03//38, 07//00,
15//00, H04Q 11//00
SKYPE LIMITED, IRELAND
WO/2005/009019
REINHOLD COHN AND PARTNERS,
,ריינהולד כהן ושותפיו
26A HABARZEL ST.,
'א26 רחוב הברזל
RAMAT HACHAYAL 69710
רמת החייל
[71]
[87]
[74]
[57]
142
There is provided a peer-to-peer telephone system (10) comprising a plurality of endusers (20, 30) and a communication structure (80) through which one or more endusers (20, 30) are couplable for communication purposes. The system (10) is
distinguished in that: (a) the communication structure (80) is substantially decentralized with regard to communication route switching therein for connecting said
one or more end-users (20, 30); (b) said one or more end-users (20, 30) are operable to
establish their own communication routes through the structure (80) based on
exchange of one or more authorisation certificates, namely User Identity Certificates
(UIC), to acquire access to the structure (80); and (c) said structure (80) includes an
administration arrangement (100) for issuing said one or more certificates to said one
or more end-users (20, 30).
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
172922
מערכת הוצאה לאור אוטומטית הנסמכת על
ארכיטקטורה של שיתוף פעולה ואחריות דיווח
של מסמכים וירטואלים
[54]
AUTOMATED PUBLISHING
SYSTEM THAT FACILITATES
COLLABORATIVE EDITING AND
ACCOUNTABILITY THROUGH
VIRTUAL DOCUMENT
ARCHITECTURE
[22]
[31]
[51]
[71]
[87]
[74]
08.07.2004
60/485472
[32] 08.07.2003
[33] US
Int. Cl.(2010.01) G06F 15//00
US LYNX LLC, U.S.A.
WO/2005/008415
LUZZATTO & LUZZATTO,
,לוצאטו את לוצאטו
INDUSTRIAL PARK, OMER,
עומר,גן תעשייה
P.O.B. 5352,
באר שבע5352 .ד. ת,
BEER-SHEVA 84152
The present invention automates the publishing of financial, legal, and governmental
documents and any other publications that are structured and require compliance with
corporate or external standards and may share content elements. It gives users control
in an always-on, familiar environment: the Internet. Due to its virtual document
architecture and ability to operate over the Internet and intranets, the system facilitates
collaborative work and traces accountability. The key concept behind automating
publishing is to control scheduling and costs by better content management. The
present invention handles document content as small, reusable components, down to
the paragraph and table cell level. The interface helps users assemble documents from
these version-controlled components with automated support. The system applies
context and filtering criteria stored with each component to locate and apply content
fragments to a current document. The system of the present invention can apply
structural rules and content requirements to ensure compliance with regulatory
requirements and company business rules. A working virtual document within the
[57]
143
August 31,2011 -א' באלול התשע"א
system always incorporates the current version of all constituent elements.
__________________
[11][21]
173031
משאף רב–מינוני
[54]
MULTI-DOSE INHALER
[22]
[31]
[51]
[71]
[87]
[74]
09.07.2004
700/MUM/2003 [32] 09.07.2003
Int. Cl.(2010.01) A61M 15//00
CIPLA LIMITED, INDIA
WO/2005/004962
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57]
The present invention relates to an inhaler device and provides such a device
comprising first and second compartments (4, 6) movable relative to one another such
that, upon movement of said components (4, 6), operating means (16, 28, 40, 42, 44,
46) advances a cartridge compartment (140) into a predetermined position relative to
medicament extraction facilitating means (14) and extends the medicament extraction
facilitating means (14) into a position adjacent said advanced compartment (140) for
allowing medicament extraction upon inhalation by a user.
144
[33]
IN
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
[54]
TRANSMISSION OF EMBEDDED
INFORMATION RELATING TO A
QUALITY OF SERVICE
[22]
[31]
01.09.2004
60/499638
[32] 02.09.2003
60/513460
21.10.2003
Int. Cl.(2010.01) H04L 12//56, 29//06
NOKIA 2011 PATENT TRUST, U.S.A.
WO/2005/022865
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[51]
[71]
[87]
[74]
[57]
173303
שידור של מידע משולב המתייחס לאיכות
השירות
[33]
US
US
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
The invention relates to methods of transmitting information relating to a quality of
service, which information is to be transmitted in at least one direction between a first
device (30) and a second device (20). A first method comprises at least at one of the
devices(20, 30) assembling a protocol message containing information other than the
information relating to a quality of service and attaching the quality of service related
information to the protocol message. A second method comprises forming the
information relating to a quality of service inside at least one of a header field and an
attribute of a protocol message. The invention relates equally to corresponding
software codes, devices (20, 30), network elements and systems.
__________________
[11][21]
[54]
145
METHOD FOR PRODUCING
ALPHA-FLUOROMALONIC ACID
DIALKYL ESTERS
173773
–α שיטה ליצור דיאלקיל אסטרים של חומצה
פלואורומלונית
August 31,2011 -א' באלול התשע"א
[22]
[31]
[51]
[71]
[87]
[74]
[57]
13.08.2004
10337885.5
[32] 18.08.2003
Int. Cl.(2010.01) C07C 67//307, 69//34
BAYER CROPSCIENCE AG,
GERMANY
WO/2005/019154
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[33]
DE
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
The invention relates to a novel advantageous method for producing alphafluoromalonic acid dialkyl esters.
__________________
[11][21]
173802
,אזאביציקלו–אוקטן ונונן, נגזרות אדמנתן
תהליך להכנתן ושימוש שלהן להכנת תכשירים
IV– DPP רפואיים מעכבי
[54]
ADAMANTANE, AZABICYCLOOCTANE AND NONANE
DERIVATIVES, PROCESS FOR
THEIR PREPARATION AND
THEIR USE FOR THE
PREPARATION OF
PHARMACEUTICAL
COMPOSITIONS SUITABLE FOR
INHIBITING DPP-IV
[22]
[31]
[51]
[71]
[87]
[74]
27.08.2004
P0302788
[32] 29.08.2003
[33] HU
Int. Cl.(2010.01) C07D 40/1/12, 40/3/12, 40/9/12, 41/7/12
SANOFI AVENTIS, FRANCE
WO/2005/021536
PEARL COHEN ZEDEK LATZER,
,פרל כהן צדק לצר
5 SHENKAR ST.,
5 רח' שנקר,1 ים-מרכז גב
P.O.B. 12704,
הרצליה12704 .ד. ת,
HERZLIYA 46733
The invention relates to new compounds of the general formula (I), which are strong
DPP-IV enzyme inhibitors.
[57]
146
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
174065
מערכת ושיטה לאישור והפצת נתוני כרטיסי
ערך באופן מאובטח
[54]
SYSTEM AND METHOD FOR
SECURELY AUTHORIZING AND
DISTRIBUTING STORED-VALUE
CARD DATA
[22]
[31]
[51]
[71]
03.09.2004
10/655828
[32] 05.09.2003
[33] US
Int. Cl.(2010.01) G06Q 20//00, G07F 07//10
E2INTERACTIVE, INC. D/B/A
E2INTERACTIVE, INC., U.S.A.
WO/2005/024591
DR. SHLOMO COHEN & CO.,
,'ד"ר שלמה כהן ושות
124 IBN GABIROL ST.,
124 אבן גבירול
P.O.B. 11490,
תל אביב11490 .ד. ת,
TEL AVIV 62038
A computerized system and method for securely authorizing and distributing storedvalue card data over a communications network is provided. The method allows for
storing in the database a plurality of records comprising stored-value card data for each
stored-value card as well as information identifying a plurality of trusted sources of
stored-value card activation requests and/or a plurality of trusted communications
networks for transmitting stored-value card activation requests. A transmitting step
allows for a requesting terminal to transmit over a communications network a request
to change the status of a stored-value card. The central processor then determines
whether the requesting terminal and/or the communications network is a trusted
source. Based on whether the requesting terminal or communications network is a
trusted source or trusted communications network, the request can be processed and
the card can be activated. A method for establishing a list of trusted sources and trusted
communications networks is also provided.
[87]
[74]
[57]
__________________
147
August 31,2011 -א' באלול התשע"א
[11][21]
[54]
METHOD FOR IDENTIFYING
IRREGULARITIES IN A
SMOOTH CURVE IN AN IMAGE
[22]
[51]
[62]
[71]
[74]
25.07.1999
Int. Cl.(2010.01) G01N 21//88
DIVISION FROM 131092
ORBOTECH LTD.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[57]
174705
שיטה לזיהוי פגמים בעקומה חלקה בתמונה
יבנה,אורבוטק בע"מ
,' קולב ושות.סנפורד ט
מרמורק,4 שער הגיא
רחובות2273 .ד. ת,
A method for identifying irregularities in a smooth curve in an image, the method
comprising identifying an ordered plurality of points along the smooth curve, each of
the ordered plurality of points having at least one neighboring point in the ordered
plurality of points, determining a normal direction to the smooth curve at each of said
ordered plurality of points, and identifying a point of said ordered plurality of points as
being part of an irregularity based, at least in part, on a local normal difference
comprising a difference between the normal direction to the smooth curve at the point
and a normal direction to the smooth curve at said at least one neighboring point of
said point.
__________________
[11][21]
174716
[54]
METHOD FOR CUTTING AND
FOLDING CONTINUOUSLY FED
PRINTING MEDIUM
[22]
[51]
[71]
[72]
[74]
02.04.2006
Int. Cl.(2010.01) B42D 15//08, B65H 45//30
BE'ERI PRINTERS
GIORA OZ
DEKEL PATENT LTD.,
18 MENUHA VENAHALA ST.,
REHOVOT 76209
[57]
148
שיטה לחיתוך וקיפול אמצעי דפוס מוזן רציף
קיבוץ בארי,דפוס בארי
גיורא עוז
,דקל פטנט בע"מ
27 חדר, 18 מנוחה ונחלה
רחובות
A method comprising: cutting a continuously fed printing medium into different size
sheets in accordance with how much data is printed on the sheets, recognizing which
of the different size sheets require folding and folding those sheets that require folding
August 31,2011 -א' באלול התשע"א
and not folding those sheets that do not require folding.
__________________
[11][21]
175433
[ פירימידיניםD4,3–] –דיאמינופיראזולו7 ,5
PDE–5 בעלי פעילות המעכבת
[54]
5,7-DIAMINOPYRAZOLO [4,3-D]
PYRIMIDINES WITH PDE-5
INHIBITING ACTIVITY
[22]
[31]
[51]
[71]
[87]
[74]
12.11.2004
0327319.0
[32] 24.11.2003
[33] GB
Int. Cl.(2010.01) A61K 31//519, A61P 09//08, 09//12, 15//10, 25//00, C07D 48/7/04
PFIZER INC., U.S.A.
WO/2005/049616
LUZZATTO & LUZZATTO,
,לוצאטו את לוצאטו
INDUSTRIAL PARK, OMER,
עומר,גן תעשייה
P.O.B. 5352,
באר שבע5352 .ד. ת,
BEER-SHEVA 84152
This invention relates to compounds of formula (I).
[57]
__________________
[11][21]
[54]
149
WORKING METHOD FOR
TREATMENT OF ABSTRACT
OBJECTS (THE THOUGHT
SUBSTANCES) OF THE
COMPUTER SYSTEM OF
ARTIFICIAL INTELLIGENCE OF
A CYBORG OR AN ANDROID
175533
שיטה עבודה לטיפול של אוביקט מופשט )חומר
של מחשבה( של מערכת מחשב בעלת בינה
מלאכותית של סייבורג או אנדרואיד
August 31,2011 -א' באלול התשע"א
[22]
[31]
[51]
[71]
[74]
[57]
08.05.2006
102005054901 [32] 17.11.2005
[33] DE
11/368422
03.07.2006
US
Int. Cl.(2010.01) A63H 11//00, B25J 09//00, G06F 17//20
BORIS KAPLAN
ירושלים,בוריס קפלן
BORIS KAPLAN,
,בוריס קפלן
3A RABBI AMIEL ST., JERUSALEM
' א3 רח' הרב עמיאל,מרים גרשנזון
ירושלים
A working method for treatment of abstract objects (the thought substances) of a
computer system (as the computer system of Artificial Intelligence of a cyborg or an
android) based on one natural language; with which the received signal-reaction of the
computer system of Artificial Intelligence of a cyborg or an android, the corresponding
association of the computer system of Artificial Intelligence of a cyborg or an android
and the corresponding thought of the computer system of Artificial Intelligence of a
cyborg or an android which are physically substantiated in the computer system are the
corresponding objects of the same class; with which the abstract object (the thought to
the association) knows only the corresponding associative object (the association to the
received signal, or rather the association to the received signal-reactions) but does not
know the corresponding subject object (the received signal, or rather the received
signal - reactions) and neither, certainly, the surroundings; with which the abstract
object (the thought to the association) is unique according to the complete wordscombination of the vocabulary of both the associative words and the abstract words to
the associative words, or rather to the corresponding association; with which the
computer system treats the abstract object (the thought to the association) relative to
time but not uniquely; with which a reference in another natural language to the
abstract object (to the thought substance) is used for working method in the other
natural language, characterized in that the computer system classifies by itself an
abstract object (which is the thought substance to the corresponding association
substance (to the corresponding associative object) which consist of not less than two
words as well as the class of the abstract object in a way of the thinking paradigm of
the class-based model of OOP only if the class of the objects is a verb in the one
natural language.
__________________
[11][21]
175534
[54]
TRANSGENIC DISEASE
RESISTANT BANANA
[22]
[31]
11.11.2004
60/519654
[32] 14.11.2003
[33] US
60/574235
26.05.2004
US
Int. Cl.(2010.01) A01H 05//00, C12N 05//10, 15//82
[51]
150
בננה טרנסגנית עמידה למחלות
August 31,2011 -א' באלול התשע"א
[71]
[72]
[87]
[74]
[57]
THE STATE OF ISRAEL- MINISTRY
משרד החקלאות ופיתוח- מדינת ישראל
OF AGRICULTURE & RURAL
מרכז, מינהל המחקר החקלאי,הכפר
DEVELOPMENT, AGRICULTURAL
בית דגן,וולקני
RESEARCH ORGANIZATION
VOLCANI CENTER
YIGAL ELAD, JANE
משה, ג'ניה וישנבצקי,יגאל אלעד
VISHNEVETSKY, MOSHE
, מרגריטה וולצבה, יובל כהן,פליישמן
FLAISHMAN, YUVAL COHEN,
אבי פרל,אורי חנניה
MARGARITA VELCHEVA, URI
HANANIA, AVI PERL
WO/2005/047515
G.E. EHRLICH (1995) LTD.,
,( בע"מ1995) ארליך.אי.ג'י
AYALON TOWER, 15TH FLOOR,
11 רחוב מנחם בגין, 15 קומה,מגדל איילון
11 MENACHEM BEGIN ST.,
רמת גן
RAMAT GAN 52521
A nucleic acid construct or construct system which includes (i) a first polynucleotide
encoding endochitinase, (ii) a second polynucleotide encoding stilbene synthase and
(iii) a third polynucleotide encoding superoxide dismutase. In addition, banana cells
transformed with the nucleic acid construct or construct system, banana plants
generated therefrom and methods of producing same.
__________________
[11][21]
[54]
APPARATUS AND METHOD FOR
REDUCING AND REMOVING
AIRBORNE OXIDIZED
PARTICULATES
[22]
[31]
12.11.2004
2003/1474.1
2003/1475.0
2003/1635.1
2003/1686.1
151
[32]
17.11.2003
17.11.2003
01.12.2003
10.12.2003
175597
מתקן ושיטה להפחתת והסרת חלקיקים
מחומצנים מאוויר
[33]
KZ
KZ
KZ
KZ
August 31,2011 -א' באלול התשע"א
[51]
[71]
[87]
[74]
[57]
2004/0911.1
28.06.2004
2004/0924.1
30.06.2004
Int. Cl.(2010.01) B03C 03//00
ABSALUT ECOLOGY
ESTABLISHMENT,
LIECHTENSTEIN
WO/2005/046877
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
KZ
KZ
עורכי דין ועורכי,קבוצת איתן מהולל
,פטנטים
10 שדרות אבא אבן
הרצליה2081 .ד. ת,
An apparatus (10) and method for recovering elemental carbon, elemental sulfur,
elemental iron, elemental gold and other elemental materials from an air flow
including a funnel-shaped receptor (14) and an inverted cone-shape electrode node
body (12) spaced from the funnel receptor, a funnel-shaped reaction zone (45) between
the outer surface of the electrode node body and the inner surface (60) of the receptor
for receiving the air flow, and a plurality of point source electrodes (36) mounted to
the electrode node body (12) and projecting into the reaction zone (45). The electrode
node body (12) and the receptor (14) are electrically isolated from each other, the
receptor (14) is connected to ground, and a voltage source is electrically connected to
the electrode node body (12). The apparatus and method may be used for treating an
air flow containing pollutants generated from the burning of fossil fuels, trash and
other materials to reduce the oxides to elemental matter and water and to remove the
elemental matter from the air flow, for treating emissions of coal-operated power
plants to improve their efficiency by recovering carbon from the plant emissions and
reusing the recovered carbon as fuel, to reduce landfill requirements by burning trash
in incinerators and treating the incinerator emissions to recover elemental material
which is then landfilled in far less space than the original unburned trash, and to
produce valuable elemental material such as fullerenes.
__________________
[11][21]
[54]
152
METHOD, SYSTEM AND
175632
מערכת ומוצר מחשב לחישוב שוטף של,שיטה
August 31,2011 -א' באלול התשע"א
COMPUTER PRODUCT FOR
DERIVING THREE
DIMENSIONAL INFORMATION
PROGRESSIVELY FROM A
STREAMING VIDEO SEQUENCE
[22]
[51]
[71]
[72]
[74]
[57]
נתונים תלת–ממדיים מתוך זרימת ערוץ וידאו
15.05.2006
Int. Cl.(2010.01) G06T 07//00
RAFAEL ADVANCED DEFENSE
,רפא"ל מערכות לחימה מתקדמות בע"מ
SYSTEMS LTD.
חיפה
GILAD ADIV, NITZAN
אמנון קרופניק, ניצן גולדברג,גלעד אדיב
GOLDBERG, AMNON KROPNIK
DR. MARK FRIEDMAN LTD.,
,ד"ר מרק פרידמן בע"מ
MOSHE AVIV TOWER, 54TH
7 רח ז'בוטינסקי, 54. ק,מגדל משה אביב
FLOOR,
גן-רמת
7 JABOTINSKY ST.,
RAMAT GAN 52520
A method for deriving three-dimensional information progressively from a streaming
video sequence, without requiring a priori information, the method comprising: (a) for
each successive frame, identifying a plurality of trackable features having
corresponding features in a previous frame of the sequence; (b) intermittently
designating a current frame as a keyframe; and (c) performing a bundle adjustment
calculation on a group of keyframes including the currently designated keyframe, said
bundle adjustment calculation employing an initial approximation derived from a
result of a previously performed bundle adjustment calculation characterized in that
said bundle adjustment is performed repeatedly for each newly designated keyframe
together with said group of keyframes employed for a previous bundle adjustment
calculation as data accumulates from the streaming video sequence, at least until said
group of keyframes includes at least 10 previously designated keyframes.
__________________
[11][21]
176342
קדם–תרופה של פלורפניקול עם מסיסות
משופרת במים
[54]
FLORFENICOL PRODRUG
HAVING IMPROVED WATER
SOLUBILITY
[22]
[31]
[51]
[71]
20.12.2004
60/532227
[32] 23.12.2003
[33] US
Int. Cl.(2010.01) A61K 31//66, C07F 09//09, 09//141
SCHERING-PLOUGH LTD.,
SWITZERLAND
WO/2005/063257
[87]
153
August 31,2011 -א' באלול התשע"א
[74]
[57]
DR. SHLOMO COHEN & CO.,
,'ד"ר שלמה כהן ושות
124 IBN GABIROL ST.,
124 אבן גבירול
P.O.B. 11490,
תל אביב11490 .ד. ת,
TEL AVIV 62038
The present invention discloses phosphate esters of florfenicol (prodrugs) and
florfenicol analogs having superior water solubility that are hydrolyzed to florfenicol
or the respective florfenicol analog in vivo, upon administration to an animal.
The applications for division
from this application have
not yet been published
,200041
בקשות חלוקה מבקשה זו
.שטרם פורסמו
__________________
[11][21]
176357
חומרי,תולדות פירידו ופירימידופירימידין
תכשירי רוקחות המכילים אותן,ביניים שלהן
ושימוש בהן כנוגדי שגשוג יתר של תאים
[54]
PYRIDO- AND
PYRIMIDOPYRIMIDINE
DERIVATIVES, INTERMEDIATES
THEREOF, PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND THEIR USE AS ANTICELL PROLIFERATION AGENTS
[22]
[31]
15.12.2004
PCT/EP03/51062 [32] 18.12.2003
[33] WO
PCT/EP03/51058
18.12.2003
WO
Int. Cl.(2010.01) A61K 31//519, A61P 35//00, C07D 47/1/04, 47/1/18, 48/7/04,
49/8/18
JANSSEN PHARMACEUTICA, N.V.,
BELGIUM
WO/2005/058913
REINHOLD COHN AND PARTNERS,
,ריינהולד כהן ושותפיו
26A HABARZEL ST.,
'א26 רחוב הברזל
RAMAT HACHAYAL 69710
רמת החייל
[51]
[71]
[87]
[74]
154
August 31,2011 -א' באלול התשע"א
[57]
The present invention concerns the compounds of formula (I) the N-oxide forms, the
pharmaceutically acceptable addition salts and the stereochemically isomeric forms
thereof, wherein a1-a2=a3-a4 represents a divalent radical selected from N-CH=CH-CH,
N-CH N-CH or CH-CH=N-CH; Z represents NH; Y represents -C3-9alkyl-, -Cl-5alkylNR13-Cl-5alkyl-,-C1-6alkyl-NH-CO- or -CO-NH -C1-6alkyl- ; X1 represents -O- or NR11-; X2 represents -C1-2alkyl-, -O-C1-2alkyl, -O- or -O-CH2-;R1 represents hydrogen
or halo; R2 represents hydrogen, cyano, halo, hydroxycarbonyl-Cl-4 alkyloxycarbonyl-,
Het16-carbonyl- or Ar5; R3 represents hydrogen; R4 represents hydroxy, C1-4alkyloxy-,
Ar4-C1-4alkyloxy or R4 represents Cl-4alkyloxy substituted with one or where possible
two or more substituents selected from C1-4alkyloxy- or Het2-; R11 represents hydrogen;
R12 represents hydrogen, Cl-4alkyl- or Cl-4alkyl-oxy-carbonyl-; R13 represents Het14-Cl2
4alkyl, in particular morpholinyl-Cl-4alkyl; Het represents a heterocycle selected from
morpholinyl or piperidinyl optionally substituted with C1-4alkyl-, preferably methyl;
Het14 represents morpholinyl; Het16 represents a heterocycle selected from morpholinyl
or pyrrolidinyl; Ar4 represents phenyl; Ar5 represents phenyl optionally substituted
with cyano.
__________________
[11][21]
[54]
METHOD AND SYSTEM FOR
CONTROLLING ENCODED
IMAGE PRODUCTION USING
IMAGE SIGNATURES
[22]
[31]
22.12.2004
60/531810
[32] 22.12.2003
11/018347
21.12.2004
Int. Cl.(2010.01) H04L 09//00
GRAPHIC SECURITY SYSTEMS
CORPORATION, U.S.A.
WO/2005/062910
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
[51]
[71]
[87]
[74]
155
176380
שיטה ומערכת לשליטה ביצור תמונה מקודדת
ע"י שימוש בחתימות של תמונה
[33]
US
US
,'ד"ר שלמה כהן ושות
124 אבן גבירול
August 31,2011 -א' באלול התשע"א
[57]
P.O.B. 11490,
תל אביב11490 .ד. ת,
TEL AVIV 62038
An automated method for authorizing and controlling the production of optically
encoded images is provided. The method comprises receiving from a user data
processor a request for authorization to produce an encoded image (s110). The
authorization request includes user-supplied data comprising at least one
authentication image file. The method further comprises determining whether the user
is authorized to produce an encoded image using the user-supplied data (s140).
Responsive to a determination that the user is authorized to produce an encoded image
using the user-supplied data, an authentication image signature is generated from the at
least one authentication image file using an image signature algorithm and a positive
authorization response is returned to the user data processor. The positive authorization
response includes the authentication image signature (s170).
__________________
[11][21]
[54]
PROCESS FOR THE
PREPARATION OF 2-AMINO
[1,2,4]TRIAZOLO[1,5A]PYRIMIDINE DERIVATIVES
[22]
[31]
22.12.2004
03029728.7
[32] 23.12.2003
60/531613
23.12.2003
Int. Cl.(2010.01) C07D 48/7/04
DOW AGROSCIENCES LLC, U.S.A.
JOACHIM GEBHARDT
WO/2005/063753
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
[51]
[71]
[72]
[87]
[74]
156
176471
–אמינו2 תהליך להכנת נגזרות
[[ פירימידיןa–5,1[טריאזול1,2,4]
[33]
EP
US
עורכי דין ועורכי,קבוצת איתן מהולל
,פטנטים
10 שדרות אבא אבן
הרצליה2081 .ד. ת,
August 31,2011 -א' באלול התשע"א
[57]
Process for the preparation of unsubstituted or substituted 2-amino[1,2,4]triazolopyrimidines which comprises combining A) 2-amino-pyrimidine or its
derivatives with alkyloxycarbonyl isothiocyanate or aryloxycarbonyl isothiocyanate
with B) hydroxyl ammonium salt and a base wherein the reaction is carried out in a
polar aprotic organic solvent in the temperature range of from 40 to 150 °C.
__________________
[11][21]
176556
של מוקסונידין,III,II I מבנים גבישיים
ותהליכים לקבלתם
[54]
CRYSTALLINE SOLID
MOXONIDINE FORMS I ,II AND
III AND PROCESSES FOR THEIR
PREPARATION
[22]
[51]
[71]
26.06.2006
Int. Cl.(2010.01) A61K 31//506, C07D 23/9/00, 40/3/12
CHEMAGIS LTD.
- בני,כימאגיס בע"מ מחלקת קניין רוחני
ברק
JOSEPH KASPI, VLADIMIR
איתי, עודד ערד, ולדימיר נדקה,יוסף כספי
NADDAKA, ODED ARAD, ITAI
אייל קלופפר, כרמן יושטיין,עדין
ADIN, CARMEN IUSTAIN, EYAL
KLOPFER
CHEMAGIS LTD.,
,כימאגיס בע"מ מחלקת קניין רוחני
29 LEHI ST.,
29 לח"י
P.O.B. 1073,
ברק-בני1073 .ד. ת,
BNEI BRAK 51200
A crystalline solid comprising moxonidine form II, characterized by having an X-ray
powder diffraction pattern wherein the strong diffraction peaks are at 7.5, 12.8, 13.0,
18.0, 22.7, 24.0 and 25.8 ±0.2 degrees 2 theta.
[72]
[74]
[57]
__________________
[11][21]
[54]
[22]
[31]
157
176765
מעכבים של גלוטמיניל ציקלאז
INHIBITORS OF GLUTAMINYL
CYCLASE
04.02.2005
60/542133
[32]
05.02.2004
[33]
US
August 31,2011 -א' באלול התשע"א
[51]
[71]
[87]
[74]
[57]
10/838993
05.05.2004
60/634364
08.12.2004
Int. Cl.(2010.01) C07D 23/3/61
PROBIODRUG AG, GERMANY
WO/2005/075436
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
US
US
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
The present invention relates to novel inhibitors of glutaminyl cyclase and
combinations thereof for the treatment of neuronal disorders, especially Alzheimer’s
disease, Down Syndrome, Parkinson disease, Chorea Huntington, pathogenic
psychotic conditions, schizophrenia, impaired food intake, sleep-wakefulness,
impaired homeostatic regulation of energy metabolism, impaired autonomic function,
impaired hormonal balance, impaired regulation, body fluids, hypertension, fever,
sleep dysregulation, anorexia, anxiety related disorders including depression, seizures
including epilepsy, drug withdrawal and alcoholism, neurodegenerative disorders
including cognitive dysfunction and dementia.
__________________
[11][21]
177148
הרכב אנדוסקופי
[54]
ENDOSCOPE ASSEMBLY
[22]
[31]
07.02.2005
60/542680
[32] 09.02.2004
[33] US
60/559461
06.04.2004
US
Int. Cl.(2010.01) A61B 01//00, A61M 25//01
SMART MEDICAL SYSTEMS LTD.
רעננה,סמארט מערכות רפואיות בע"מ
WO/2005/074377
SANFORD T.COLB & CO.,
,' קולב ושות.סנפורד ט
P.O.B. 2273,
מרמורק,4 שער הגיא
REHOVOT 76122
רחובות2273 .ד. ת,
A locomotive endoscope assembly including a locomotive endoscope head (102)
including a main portion extending along a longitudinal axis and having a first
selectively inflatable balloon (500) associated therewith and a selectably positionable
portion, selectably axially positionable along the main portion and having a second
selectably inflatable balloon (502) associated therewith and a locomotive endoscope
head controller (100) controlling the operation of the locomotive endoscope head (102)
and being operative for controlling positioning of the selectably positionable portion
relative to the main portion and selectable inflation of the first and second selectably
inflatable balloons (500, 502).
[51]
[71]
[87]
[74]
[57]
158
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
[54]
SYSTEM AND METHOD FOR
CONTROLLING CURRENT
PROVIDED TO A STEPPING
MOTOR
[22]
[31]
[51]
[71]
28.02.2005
10/802180
[32] 17.03.2004
Int. Cl.(2010.01) G05B 19//40
BAXTER INTERNATIONAL INC.,
U.S.A.
WO/2005/093533
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[87]
[74]
[57]
159
177191
שיטה ומערכת לבקרת זרם המסופק למנוע צעד
[33]
US
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
A system and method is disclosed for controlling the input electrical current to an
infusion pump stepper motor based on predetermined torque requirements. The system
can include a motor controller and a non-volatile memory containing expected load
torque values throughout a pump cycle. Responsive to the expected load torque values,
the motor controller provides the stepper motor with a varying electrical current for
overcoming load torque at each point in the pumping cycle. Additional factors can also
be considered for varying the electrical current. These factors include, but are not
limited to, temperature, pressure, and elapsed operating time.
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
177335
טיפול מגנטי בדגימות ביולוגיות
[54]
MAGNETIC MANIPULATION OF
BIOLOGICAL SAMPLES
[22]
[31]
[51]
[71]
25.02.2005
102004009985.5 [32] 01.03.2004
[33] DE
Int. Cl.(2010.01) C12M 03//00
FRAUNHOFER-GESELLSCHAFT ZUR
FORDERUNG DER ANGEWANDTEN
FORSCHUNG E.V., GERMANY
WO/2005/083057
PEARL COHEN ZEDEK LATZER,
,פרל כהן צדק לצר
5 SHENKAR ST.,
5 רח' שנקר,1 ים-מרכז גב
P.O.B. 12704,
הרצליה12704 .ד. ת,
HERZLIYA 46733
The invention relates to a cell carrier (10) for receiving a biological sample. Said
carrier comprises a magnetic element (20) and a floor element (30) that forms a stable
support (31) that can be displaced on a solid base surface in at least one direction. The
invention also relates to a manipulation device for biological samples and to a method
for manipulating biological samples.
[87]
[74]
[57]
__________________
[11][21]
[54]
DETECTION OF SKIN
IMPEDANCE
[22]
[31]
[51]
[71]
[74]
10.08.2006
11/213040
[32] 26.08.2005
Int. Cl.(2010.01) G01N 27//00
BIOSENSE WEBSTER, INC., U.S.A.
D. KLIGLER I.P. SERVICES LTD.,
P.O.B. 33111
160
177453
איתור עכבת העור
[33]
US
, קליגלר שירותי קניין רוחני בע"מ.ד
תל אביב33111 .ד. ת,
August 31,2011 -א' באלול התשע"א
TEL AVIV 61330
[57]
An apparatus for position sensing, comprising: a probe, comprising at least one probe
electrode, which is adapted to be inserted into a body of a living subject, said body
having a body surface; a plurality of electroconductive body surface patches, which are
adapted to be fixed to said body surface at respective surface locations, wherein said
body surface patches each comprise a first electrode and a second electrode, said
second electrode being electrically isolated from said first electrode; electrical circuitry
having at least one switch for arranging said first electrode in a series circuit with said
second electrode in a calibration mode of operation and for arranging said first
electrode in a parallel circuit with said second electrode in a sensing mode of
operation; and a controller, operative to control said electrical circuitry, wherein said
controller is adapted to be coupled to said probe and to said body surface patches so as
to pass first electrical signals through said first electrode and said second electrode
thereof in said calibration mode of operation, and to pass respective second electrical
signals through the body between said probe electrode and said body surface patches,
wherein said controller is operative in said calibration mode of operation to determine
a local electrical impedance of said body surface and of an interface thereof with a
respective one of said body surface patches, and to determine position coordinates of
said probe in said sensing mode of operation by measuring respective impedance
characteristics of said second electrical signals, and wherein said impedance
characteristics of said second electrical signals are adjusted by said controller
according to respective instances of said local electrical impedance of said body
surface.
__________________
[11][21]
177728
תכשירי ניקוי של מצעים ננו אלקטרוניים
ומיקרואלקטרוניים
[54]
NANOELECTRONIC AND
MICROELECTRONIC
SUBSTRATE CLEANING
COMPOSITIONS
[22]
[31]
[51]
[71]
11.02.2005
60/548977
[32] 01.03.2004
[33] US
Int. Cl.(2010.01) C11D 11//00, G03F 07//42
AVANTOR PERFORMANCE
MATERIALS, INC., U.S.A.
WO/2005/093032
EITAN MEHULAL LAW GROUP,
עורכי דין ועורכי,קבוצת איתן מהולל
10 ABBA EBEN BLVD.,
,פטנטים
P.O. B. 2081,
10 שדרות אבא אבן
HERZLIYA 46120
הרצליה2081 .ד. ת,
August 31,2011 -א' באלול התשע"א
[87]
[74]
161
[57]
Nanoelectronic and microelectronic cleaning compositions for cleaning nanoelectronic
and microelectronic substrates under supercritical fluid state conditions, and
particularly cleaning compositions useful with and having improved compatibility with
nanoelectronic and microelectronic substrates characterized by silicon dioxide,
sensitive low-κ or high-κ dielectrics and copper, tungsten, tantalum, nickel, gold,
cobalt, palladium, platinum, chromium, ruthenium, rhodium, iridium, hafnium,
titanium, molybdenum, tin and other metallization, as well as substrates of Al or
Al(Cu) metallizations and advanced interconnect technologies, are provided by
nanoelectronic and microelectronic cleaning compositions comprising nanoelectronic
and microelectronic cleaning compositions of this invention are provided by
compositions comprising: (1) a supercritical main fluid reaching a supercritical fluid
state at a temperature of 250°C or less and a pressure of 600 bars or less (592.2 atm,
8702.3 psi), and (2) as a secondary fluid, a modifier formulation selected from the
following formulations: a) a formulation comprising: an oxidizing agent; a polar
organic solvent selected from the group consisting of amides, sulfones, sulfolenes,
selenones and saturated alcohols; and optionally other components; b) a silicate free
formulation comprising: a polar organic solvent selected from the group consisting of
amides, sulfones, selenones and saturated alcohols; a strong alkaline base; and
optionally other components; c) a formulation comprising: from about 0.05% to 30%
by weight of one or more non-ammonium producing strong base containing nonnucleophilic, positively charged counter ions; from about 0.5 to about 99.95% by
weight of one or more corrosion inhibiting solvent compounds, said corrosion
inhibiting solvent compound having at least two sites capable of complexing with
metals; and optionally other components; d) a formulation comprising: from about
0.05 to 20% by weight of one or more non-ammonium producing, non-HF producing
fluoride salt; from about 5 to about 99.95% by weight of water, organic solvent or both
water and organic solvent; and optionally other components; and e) a formulation
comprising: from about 0.05% to 30% by weight of one or more non-ammonium
producing strong base containing non-nucleophilic, positively charged counter ions;
from about 5 to about 99.95% by weight of one or more steric hindered amide
solvents; and optionally other components.
__________________
[11][21]
[54]
POLYSULFATED
OLIGOSACCHARIDE
DERIVATIVES,
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM AND USES THEREOF
[22]
04.03.2005
162
177870
,נגזרות פוליסולפט של אוליגוסכרידים
תכשירים המכילים אותן ושימושיהם
August 31,2011 -א' באלול התשע"א
[31]
[51]
[71]
[72]
[87]
[74]
[57]
2004901103
[32] 04.03.2004
[33] AU
Int. Cl.(2010.01) A61K 31//7016, 31//702, A61P 07//00, 07//02, 09//00, 29//00,
31//00, 35//00, 35//04, C07H 03//00, 03//04, 03//06, 05//00, 05//04, 11//00, 15//00,
15//04
PROGEN PHARMACEUTICALS
LIMITED, AUSTRALIA
VITO FERRO, JON KRUEGER
FAIRWEATHER, TOMISLAV
KAROLI, LIGONG LIU
WO/2005/085264
G.E. EHRLICH (1995) LTD.,
,( בע"מ1995) ארליך.אי.ג'י
AYALON TOWER, 15TH FLOOR,
11 רחוב מנחם בגין, 15 קומה,מגדל איילון
11 MENACHEM BEGIN ST.,
רמת גן
RAMAT GAN 52521
The invention relates to compounds which are polysufated oligosaccharide derivatives
having activity as inhibitors of heparan sulfate-binding proteins and inhibitors of the
enzyme heparanase; methods for the preparation of the compounds; compositions
comprising the compounds, and use of the compounds and compositions thereof for
the antiangiogenic, antimetastatic, anti-inflammatory, antimicrobial, anticoagulant
and/or antithrombotic treatment, lowering of blood triglyceride levels and inhibition of
cardiovascular disease of a mammalian subject.
__________________
[11][21]
177939
אריל פיפרידינים או פיפראזינים המותמרים
בטבעות הטרוציקליות מחומשות ותכשיר רוקחי
המכיל אותן
[54]
ARYL PIPERIDINES OR
PIPERAZINES SUBSTITUTED
WITH 5-MEMBERED
HETEROCYCLES AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM
[22]
[31]
[51]
07.03.2005
04075771.8
[32] 10.03.2004
[33] EP
Int. Cl.(2010.01) A61P 19//00, C07D 23/3/54, 24/9/08, 40/1/04, 40/3/10, 41/3/12,
41/7/10
JANSSEN PHARMACEUTICA, N.V.,
BELGIUM
WO/2005/085226
REINHOLD COHN AND PARTNERS,
,ריינהולד כהן ושותפיו
26A HABARZEL ST.,
'א26 רחוב הברזל
RAMAT HACHAYAL 69710
[71]
[87]
[74]
163
August 31,2011 -א' באלול התשע"א
[57]
רמת החייל
The present invention is concerned with novel aryl piperidine or piperazine
compounds substituted with certain 5-membered heterocycles having apoB
secretion/MTP inhibiting activity and concomitant lipid lowering activity. The
invention further relates to methods for preparing such compounds, pharmaceutical
compositions comprising said compounds as well as the use of said compounds as a
medicine for the treatment of hyperlipidemia, obesity and type II diabetes (Formula
(I)). The invention further relates to methods for preparing such compounds,
pharmaceutical compositions comprising said compounds as well as the use of said
compounds as a medicine for the treatment of atherosclerosis, pancreatitis, obesity,
hypertriglyceridemia, hypercholesterolemia, hyperlipidemia, diabetes and type II
diabetes.
__________________
[11][21]
178006
שיטה להכנת תכשירים קרדיומיוציטיים בעלי
טוהר גבוה המתאימים לרפואה רגנרטיבית
[54]
METHOD FOR MAKING HIGH
PURITY CARDIOMYOCYTE
PREPARATIONS SUITABLE FOR
REGENERATIVE MEDICINE
[22]
[31]
18.03.2005
10/805099
[32] 19.03.2004
[33] US
60/556722
26.03.2004
US
60/650194
03.02.2005
US
Int. Cl.(2010.01) A61K 35//12, 35//34, C12N 05//0775
GERON CORPORATION, U.S.A.
WO/2005/090558
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[51]
[71]
[87]
[74]
[57]
164
,' קולב ושות.סנפורד ט
מרמורק,4 שער הגיא
רחובות2273 .ד. ת,
This invention provides a new procedure for generating cardiomyocyte lineage cells
from embryonic stem cells for use in regenerative medicine. Differentiating by way of
embryoid body formation or in serum is no longer required. Instead, the stem cells are
plated onto a solid substrate, and differentiated in the presence of select factors and
morphogens. After enrichment for cells with the appropriate phenotype, the cells are
allowed to cluster into cardiac bodiesTM, which are remarkably homogeneous and
suitable for the treatment of heart disease.
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
178102
תכשירים רפואיים המכילים,נגזרות פורמאמיד
אותן ושימוש בהכנת תרופות לתרפיה
[54]
FORMAMIDE DERIVATIVES,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USE THEREOF IN
THE PREPARATION OF
MEDICAMENTS FOR THERAPY
[22]
[31]
10.03.2005
04290767.5
[32] 23.03.2004
[33] EP
0425054.4
12.11.2004
GB
Int. Cl.(2010.01) A61K 31//135, 31//165, 31//4035, 31//4353, 31//445, A61P 11//00,
C07C 23/3/43, 23/7/20, 23/7/32, 25/5/60, 31/1/37, 31/1/46, 31/7/32, 32/3/32, C07D
20/9/48, 21/1/32, 21/3/40, 21/7/06, 21/7/16, 22/1/22, 29/5/192, 33/5/02
PFIZER INC., U.S.A.
WO/2005/092840
LUZZATTO & LUZZATTO,
,לוצאטו את לוצאטו
INDUSTRIAL PARK, OMER,
עומר,גן תעשייה
P.O.B. 5352,
באר שבע5352 .ד. ת,
BEER-SHEVA 84152
The invention relates to compounds of formula (1) and to processes for the preparation
of, intermediates used in the preparation of, compositions containing and the uses of,
such derivatives. The compounds according to the present invention are useful in
numerous diseases, disorders and conditions, in particular inflammatory, allergic and
respiratory diseases, disorders and conditions.
[51]
[71]
[87]
[74]
[57]
__________________
[11][21]
[54]
165
CONTROL MECHANISM FOR A
VENETIAN BLIND
178192
מנגנון שליטה לוילון ונציאני
August 31,2011 -א' באלול התשע"א
[22]
[51]
[71]
[72]
[74]
19.09.2006
Int. Cl.(2010.01) E06B 09//307
HOLIS METAL INDUSTRIES LTD.
YACOV GANZI
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57]
A control mechanism for a Venetian blind comprising a plurality of slats suspended
from a headrail by lift cords, said control mechanism comprising a hollow rod
articulated to the headrail and accommodating said lift cords extending to a lead bar
coaxially displaceable within the rod and an elevation assembly manipulable by an
actuator slidingly received over the rod and engaged with the lead bar such that
upward displacing of the actuator entails lowering of the slats and downwards
displacing of the actuator entails raising of the slats, said elevation assembly further
comprising a friction mechanism for arresting the slats at any respective elevation,
wherein the friction mechanism comprises a friction member axially displaceable over
a tapering position of the lead bar, between an unlocked position in which the friction
member is shrunken and is free to slide within the rod, and a locked position in which
the friction member is expanded and frictionally arrested within the rod.
עפולה עלית,הוליס מטל אינדוסטריז בע"מ
יעקב גנזי
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
__________________
[11][21]
[54]
[22]
[31]
166
178353
שימוש בו,פראדופלוקסאצין טריהידראט
להכנת תרופות ותרופה המכילה אותו
PRADOFLOXACIN TRIHYDRATE,
ITS USE IN THE MANUFACTURE
OF MEDICAMENTS AND A
MEDICAMENT CONTAINING IT
19.03.2005
102004015981.5
[32]
01.04.2004
[33]
DE
August 31,2011 -א' באלול התשע"א
[51]
[71]
[87]
[74]
[57]
Int. Cl.(2010.01) A61K 31//4709, A61P 31//04, C07D 47/1/04
BAYER ANIMAL HEALTH GMBH,
GERMANY
WO/2005/097789
REINHOLD COHN AND PARTNERS,
,ריינהולד כהן ושותפיו
26A HABARZEL ST.,
'א26 רחוב הברזל
RAMAT HACHAYAL 69710
רמת החייל
The invention relates to the trihydrate of pradofloxacin, to a method for its production
and to anti-bacterial agents containing said substance.
__________________
[11][21]
178452
חומר ריתוך עבור ריתוך קשתי מוסתר
[54]
SINTERED FLUX FOR
SUBMERGED ARC WELDING
[22]
[31]
04.10.2006
10-2005[32] 17.11.2005
[33] KR
0109937
Int. Cl.(2010.01) B23K 35//00
KISWEL LTD., REPUBLIC OF
KOREA
NOH TAE HOON
DR. MARK FRIEDMAN LTD.,
,ד"ר מרק פרידמן בע"מ
MOSHE AVIV TOWER, 54TH
7 רח ז'בוטינסקי, 54. ק,מגדל משה אביב
FLOOR,
גן-רמת
7 JABOTINSKY ST.,
RAMAT GAN 52520
Sintered flux for submerged arc welding consisting of: 12.0-24.0wt% SiO2, 24.038.0wt% Al2O3, 6.0-13.0wt% TiO2, 2.0-9.0wt% CaO, 7.0-14.0wt% CaF2, 12.023.0wt% MnO, 2.0-17.0wt% MgO, and 1.0-5.0wt% Na2O, K2O, Li2O or a mixture
thereof and wherein basicity (B) of the sintered flux satisfies Formula 1 as given in the
specification.
[51]
[71]
[72]
[74]
[57]
167
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
178518
שטח מרוצף
[54]
TILED SURFACE
[22]
[51]
[71]
[74]
15.10.2006
Int. Cl.(2010.01) E04F 11//16, 15//02, 19//02, E04G 23//00
YOSEF YOSEFI
ציונה- נס,יוסף יוספי
YOSEF YOSEFI,
,יוסף יוספי
P.O.B. 40,
ציונה-נס40 .ד. ת,
NES ZIONA 74100
In one aspect, the present invention is directed to a method for tiling a surface, the
method comprising the steps of: (a) providing at least one profile comprising: one or
more pairs of perpendicular zones wherein each pair comprises: a first zone, for
supporting the bottom of a tile when tiling; and a second zone, for supporting an edge
of the tile; (b) placing the at least one profile on the surface; and (c) placing at least
one tile on the at least one profile such that the bottom of the tile is placed on the first
zone of the profile, an edge of the tile is placed on the second zone of the profile,
while the third zone remains uncovered.
[57]
__________________
[11][21]
178672
נגזרות אימידזול המשמשות כמעכבות
TAFIA
[54]
IMIDAZOLE DERIVATIVES USED
AS TAFIA INHIBITORS
[22]
[31]
[51]
07.04.2005
102004020186.2 [32] 22.04.2004
[33] DE
Int. Cl.(2010.01) A61K 31//41, 31//435, A61P 07//00, C07D 21/1/18, 40/1/06,
40/1/14, 40/9/14, 41/7/06
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2005/105781
PEARL COHEN ZEDEK LATZER,
,פרל כהן צדק לצר
5 SHENKAR ST.,
5 רח' שנקר,1 ים-מרכז גב
P.O.B. 12704,
הרצליה12704 .ד. ת,
HERZLIYA 46733
The invention relates to compounds of formula (I), which are inhibitors of the activated
thrombin-activatable fibrinolysis inhibitor. The compounds of formula (I) are suited
for producing medicaments for the prevention and treatment of diseases accompanied
August 31,2011 -א' באלול התשע"א
[71]
[87]
[74]
[57]
168
by thromboses, embolisms, hypercoagulability or fibrotic changes.
__________________
[11][21]
178705
אריגים לא סרוגים ופריטים המכילים,סיבים
סיבים זעירים המיוצרים מפולימרים בעלי
טמפרטורת מעבר זכוכית גבוה
[54]
FIBERS, NONWOVENS AND
ARTICLES CONTAINING
NANOFIBERS PRODUCED FROM
HIGH GLASS TRANSITION
TEMPERATURE POLYMERS
[22]
[31]
[51]
[71]
19.04.2005
60/563355
[32] 19.04.2004
[33] US
Int. Cl.(2010.01) B32B 05//26, D01D 05//42, D04H 01//42, 13//02
THE PROCTER & GAMBLE
COMPANY, U.S.A.
WO/2005/103357
REINHOLD COHN AND PARTNERS,
,ריינהולד כהן ושותפיו
26A HABARZEL ST.,
'א26 רחוב הברזל
RAMAT HACHAYAL 69710
רמת החייל
[87]
[74]
[57]
The present invention is directed to nonwoven webs and articles comprising
nanofibers. The nanofibers are made from a polymer having a glass transition
temperature above about 25 C. The nanofibers, having a diameter of less than 1
micron, may comprise a significant number of the fibers in one layer of the web
contained by the article. Preferably, the nanofibers are produced in a melt film
fibrillation process. Articles include diapers, training pants, adult incontinence pads,
catamenials products such as feminine care pads and pantiliners, tampons, personal
cleansing articles, personal care articles, and personal care wipes including baby
wipes, facial wipes and feminine wipes.
__________________
[11][21]
169
178757
August 31,2011 -א' באלול התשע"א
–פירידיל כמעכבי2 אימידאזולים מותמרים ב
ALK4 או/ וALK5
[54]
2-PYRIDYL SUBSTITUTED
IMIDAZOLES AS ALK5 AND/OR
ALK4 INHIBITORS
[22]
[31]
09.11.2004
10-2004[32] 21.04.2004
[33] KR
0027591
Int. Cl.(2010.01) A61K 31//4178, 31//4427, 31//4439, 31//498, A61P 07//02, 25//28,
35//00, C07D 24/1/40, 40/1/04, 40/1/12, 40/5/14
SK CHEMICALS CO., LTD.,
REPUBLIC OF KOREA
EWHA UNIVERSITY
COLLABORATION FOUNDATION,
REPUBLIC OF KOREA
WO/2005/103028
EITAN MEHULAL LAW GROUP,
עורכי דין ועורכי,קבוצת איתן מהולל
10 ABBA EBEN BLVD.,
,פטנטים
P.O. B. 2081,
10 שדרות אבא אבן
HERZLIYA 46120
הרצליה2081 .ד. ת,
This invention relates to 2-pyridyl substituted imidazoles which are inhibitors of the
transforming growth factor-beta) TGF-beta) type I receptor (ALK5) and/or the activin
type I receptor (ALK4), methods for their preparation, and their use in medicine,
specifically in the treatment and prevention of a disease state mediated by these
receptors.
[51]
[71]
[87]
[74]
[57]
__________________
[11][21]
[54]
[22]
[31]
[51]
170
STABLE NON-AQUEOUS POLAR
APROTIC PEPTIDE
FORMULATION
178824
תכשיר אפרוטי פולרי בלתי מימי יציב של
פפטיד
01.07.1997
60/022699
[32] 03.07.1996
[33] US
Int. Cl.(2010.01) A61K 09//52, 38//04, 38//08, 38//09, 38//23, 38//24, 38//26, 47//08,
August 31,2011 -א' באלול התשע"א
[62]
[71]
[87]
[74]
[57]
47//16, 47//20, A61P 35//00, C07K 07//23, 14//605
DIVISION FROM 170958
ALZA CORPORATION, U.S.A.
WO/1998/000158
LUZZATTO & LUZZATTO,
,לוצאטו את לוצאטו
INDUSTRIAL PARK, OMER,
עומר,גן תעשייה
P.O.B. 5352,
באר שבע5352 .ד. ת,
BEER-SHEVA 84152
A stable non-aqueous formulation of a peptide compound comprising:
(a) at least one peptide compound; and
(b) at least one polar aptotic solvent,
wherein said peptide compound is selected from the group consisting of glucagon,
glucagon like peptide-1 and glucagon like peptide-2.
__________________
[11][21]
[54]
MORTAR DEPLOYMENT AND
STORAGE SYSTEM
[22]
[31]
[51]
[71]
29.04.2005
60/566587
[32] 29.04.2004
Int. Cl.(2010.01) F41A 23//26
BAE SYSTEMS LAND &
ARMAMENTS L.P., U.S.A.
WO/2006/043981
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[87]
[74]
[57]
171
178830
מערכת לפריסה ואיחסונה של מרגמה
[33]
US
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
A system for stowing and deploying a mortar from a transport vehicle employs a hoist
mechanism, a support frame, a pair of guide arms and a barrel-support strut attached to
a transport vehicle. The support frame is adapted to be temporarily engaged with the
mortar barrel, the base plate and the pair of stabilizer arms of the mortar to prevent
August 31,2011 -א' באלול התשע"א
relative motion between them during stowing and deployment. The hoist mechanism
has a lift arm that pivots between a retracted and a deployed position. One end of the
lift arm is hook shaped for detachable engagement with the support frame. A pair of
guide arms extend in spaced parallel relation from the rear of the vehicle and serve to
guide a trajectory of the mortar as it is being stowed or lowered to the ground.
__________________
[11][21]
179028
–1––)פירידין(–פיפראזין4]–4} – 3 תולדות
– 2 –– אינדולH2––דיהידרו1,3–{–איל[–בוטיל
תהליך להכנתן ותכשירי רוקחות המכילים,און
אותן לטיפול ומניעה של אי סדרים במערכת
העצבים המרכזית ואי סדרים פסיכוסומטיים
[54]
3-{4-[4-(PYRIDINE)-PIPERAZINE1-YL]-BUTYL}-1,3-DIHYDRO-2HINDOLE- 2 -ONE DERIVATIVES,
PROCESS FOR THEIR
PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM FOR THE TREATMENT
AND PROPHYLAXIS OF
DISORDERS OF THE CENTRAL
NERVOUS SYSTEM AND
PSYCHOSOMATIC DISORDERS
[22]
[31]
[51]
11.05.2005
P0400953
[32] 11.05.2004
[33] HU
Int. Cl.(2010.01) A61K 31//496, A61P 25//18, 25//22, 25//28, C07D 20/9/34, 40/1/14,
40/5/14
EGIS GYOGYSZERGYAR NYRT,
HUNGARY
WO/2005/108364
REINHOLD COHN AND PARTNERS,
,ריינהולד כהן ושותפיו
26A HABARZEL ST.,
'א26 רחוב הברזל
RAMAT HACHAYAL 69710
רמת החייל
[71]
[87]
[74]
[57]
172
The present invention is concerned with new indol-2-one derivatives of Formula (I),
which have favourable activity profile for the prophylaxis and treatment of disorders in
the central nervous or in the cardiovascular system.
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
179127
העצמה של היבקעות באמצעות אולטראסאונד
[54]
ENHANCEMENT OF
ULTRASONIC CAVITATION
[22]
[31]
[51]
[71]
[72]
[87]
[74]
05.05.2005
60/569255
[32] 10.05.2004
[33] US
Int. Cl.(2010.01) A61B 08//14
SONNETICA
עומר,סונטיקה בע"מ
DAN ADAM
דן אדם
WO/2005/107600
PASTEL LTD.,
,זימרן פסטל בע"מ-עו"ד רות חרלף
WORLDWIDE IP SERVICES AND
84 יובלים
COUNSEL,
משגב
YUVALIM 84,
MISGAV 20142
The present invention is a two step method of enhancing the cavitational effect
produced by ultrasound signals focused at a specific location in a medium. The first
step is to use one or more transducers to apply the ultrasound signals to create a
waveform that causes formation of bubbles at the location and the second step is to
modulate the amplitude of the ultrasound signals at a frequency of several Hz to
several tens of kilohertz immediately following or coincident with the formation of the
bubbles. The method of the invention can be effectively used for therapeutic purposes.
[57]
173
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
[54]
METHODS FOR THE
PREPARATION OF
CONCENTRATED AQUEOUS
BROMINE SOLUTIONS AND
HIGH ACTIVITY BROMINECONTAINING SOLIDS
[22]
[51]
[71]
10.05.2004
Int. Cl.(2010.01) C01B 07//09
ENVIRO TECH CHEMICAL
SERVICES, INC., U.S.A.
WO/2005/112649
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[87]
[74]
[57]
179239
שיטות להכנת תמיסות מימיות מרוכזות של ברום
ומוצקים המכילים ברום בעל פעילות גבוהה
,' קולב ושות.סנפורד ט
מרמורק,4 שער הגיא
רחובות2273 .ד. ת,
The invention includes convenient methods of preparing: (1) highly concentrated
liquid bromine-containing biocidal solutions, (2) highly concentrated mixed halogen
liquid bromine and chlorine-containing biocidal solutions, and (3) high-activity
bromine containing biocidal solids, all having excellent physical and chemical
stability. One method yields solutions that have concentrations of bromine in excess of
18% as Br2 (8% as C12) in which the mole ratio of hydroxide ion to hydrogen ion
source is at least 1.9: 1. Another method employs elemental bromine in conjunction
with a solid organic or inorganic halogenating agent to yield halogen solutions at
concentrations greater than 22.9% as Br2 (10.2% as C12). This method can be
performed under conditions that exceed the solubility of the active ingredient such that
it crystallizes and is recovered as a hydrated or anhydrous salt in good yield.
__________________
[11][21]
[54]
RUPTURABLE OPENING FOR
SEALED CONTAINER
[22]
[31]
17.05.2005
10/848207
174
[32]
18.05.2004
179281
פתח נקרע למיכל אטום
[33]
US
August 31,2011 -א' באלול התשע"א
[51]
[71]
[87]
[74]
[57]
10/892961
16.07.2004
US
Int. Cl.(2010.01) B65D 77//24, 77//28
EVERGREEN PACKAGING
INTERNATIONAL B.V., THE
NETHERLANDS
WO/2005/113373
DR. SHLOMO COHEN & CO.,
,'ד"ר שלמה כהן ושות
124 IBN GABIROL ST.,
124 אבן גבירול
P.O.B. 11490,
תל אביב11490 .ד. ת,
TEL AVIV 62038
A container formed from a paperboard laminate (10) and including a rupturable
opening for gaining access to the contents of the container, the opening being defined
by an embossment pattern (28) in a wall of the container. The embossment defines a
weakened area which includes the layers of the laminate, but without destruction or
deterioration of selected ones of the barrier/sealing layers (18, 19) of the laminate. A
method is disclosed.
__________________
[11][21]
[54]
SPLICING SYSTEM
[22]
[31]
08.06.2005
0413723.8
[32] 18.06.2004
60/581583
21.06.2004
Int. Cl.(2010.01) H04N 07//16
NDS LIMITED, UNITED KINGDOM
MOSHE SHLISSEL, REUVEN
WACHTFOGEL, EZRA DARSHAN,
ZEEV GEYZEL, DAVID FINK
WO/2005/122688
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[51]
[71]
[72]
[87]
[74]
175
179412
מערכת שזירה
[33]
GB
US
, עזרא דרשן, ראובן וכטפוגל,משה שליסל
דוד פינק,זאב גייזל
,' קולב ושות.סנפורד ט
מרמורק,4 שער הגיא
רחובות2273 .ד. ת,
August 31,2011 -א' באלול התשע"א
[57]
A method for switching from playing a first compressed data segment to playing a
second compressed recorded data segment, the method including playing an
uncompressed copy of a start of the second compressed recorded data segment upon
switching from playing the first compressed data segment, decoding the second
compressed recorded data segment from a preceding random access point, the
preceding random access point preceding, in the second compressed recorded data
segment, a point at which playing is to be switched to the second compressed recorded
data segment, stopping the decoding of the second compressed recorded data segment
when reaching a point beyond a point currently being played in the uncompressed
copy, and switching to playing the second compressed recorded data segment when
playing the uncompressed copy of a start of the second compressed recorded data
segment reaches the point at which the decoding of the second compressed recorded
data segment was stopped. Related apparatus and methods are also provided.
__________________
[11][21]
[54]
ULTRASOUND CONTRAST
AGENT DOSAGE
FORMULATION
[22]
[51]
[71]
[87]
[74]
04.06.2004
Int. Cl.(2010.01) A61K 49//22
ACUSPHERE, INC., U.S.A.
WO/2005/120587
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[57]
176
179594
חומר ניגוד על קולי לפורמולציות מינון
,' קולב ושות.סנפורד ט
מרמורק,4 שער הגיא
רחובות2273 .ד. ת,
Clinical studies have been conducted and specific dosage formulations developed
using polymeric microparticles having incorporated therein perfluorocarbon gases that
provide significantly enhanced images of long duration. The dosage formulation
includes microparticles formed of a biocompatible polymer, preferably including a
lipid incorporated therein, and containing a perfluorocarbon that is a gas at body
temperature. The microparticles are provided to a patient in an amount effective to
August 31,2011 -א' באלול התשע"א
enhance ultrasound imaging in the ventricular chambers for more than 5 minutes or in
the mycocardium for more than a minute, in a dose ranging from 0.025 to 8.0 mg
microparticles/kg body weight. Preferably the dose ranges from 0.05 to 4.0 mg
microparticles/kg body weight. The dosage formulation typically is provided in a vial.
A typical formulation is in the form of a dry powder that is reconstituted with sterile
water prior to use by adding the water to the vial or syringe of the dry powder and
shaking to yield an isosmotic or isotonic suspension of microparticles.
The applications for
division from this
application have not yet
been published
,213897
בקשות חלוקה מבקשה זו
.שטרם פורסמו
__________________
[11][21]
179606
נגזרות פירולפירימידין ופירולפירידין מותמרות
בקבוצת אמינו טבעתית כאנטגוניסטים של
CRF
[54]
PYRROLOPYRIMIDINE AND
PYRROLOPYRIDINE
DERIVATIVES SUBSTITUTED
WITH A CYCLIC AMINO GROUP
AS CRF ANTAGONISTS
[22]
[31]
[51]
[71]
24.06.2005
2004-188128 [32] 25.06.2004
[33] JP
Int. Cl.(2010.01) A61K 31//519, A61P 25//00, C07D 47/1/04, 48/7/04
TAISHO PHARMACEUTICAL CO.,
LTD., JAPAN
WO/2006/001511
LUZZATTO & LUZZATTO,
,לוצאטו את לוצאטו
INDUSTRIAL PARK, OMER,
עומר,גן תעשייה
P.O.B. 5352,
באר שבע5352 .ד. ת,
BEER-SHEVA 84152
An object of the present invention is to provide an antagonist against CRF receptors
and/or an agonist for receptors which is effective as a therapeutic or prophylactic agent
for diseases in which CRF is considered to be involved, such as depression, anxiety,
Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder,
hypertension, gastrointestinal diseases, drug dependence, cerebral infarction, cerebral
ischemia, cerebral edema, cephalic external wound, inflammation, immunity-related
diseases, alopecia, irritable bowel syndrome, sleep disorders, epilepsy, dermatitides,
schizophrenia, pain, etc. A pyrrolopyrimidine or pyrrolopyridine derivative substituted
with a cyclic amino group represented by the following formula [I] has a high affinity
for CRF receptors and/or delta- receptors, and is effective against diseases in which
CRF is considered to be involved.
[87]
[74]
[57]
177
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
179658
D נוגדן רב–שבטי רקומביננטי נוגד רהזוס
ושיטות ליצורו
[54]
ANTI-RHESUS D RECOMBINANT
POLYCLONAL ANTIBODY AND
METHODS OF MANUFACTURE
[22]
[31]
18.07.2005
PA200401133 [32] 20.07.2004
[33] DK
PA200401992
22.12.2004
DK
Int. Cl.(2010.01) A61K 39//395, C07K 16//34, C40B 50//00
SYMPHOGEN A/S, DENMARK
WO/2006/007850
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[51]
[71]
[87]
[74]
[57]
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
The invention relates to a method for manufacturing an anti-RhD recombinant
polyclonal antibody composition (anti-RhD rpAb). The method comprises obtaining a
collection of cells transfected with a library of anti-RhD antibody expression vectors,
wherein each cell in the collection is capable of expressing from a VH and VL
comprising nucleic acid segment, one member of the library, which encodes a distinct
member of anti-RhD recombinant polyclonal antibody composition and which is
located at the same site in the genome of individual cells in said collection. The cells
are cultured under suitable conditions for expression of the recombinant polyclonal
antibody, which is obtained from the cells or culture supernatant. The nucleic acid
segments encoding the anti-RhD rpAb is introduced into the cells by transfection with
a library of vectors for site-specific integration. The present method is suitable for
manufacturing anti-RhD rpAb, thereby making available a superior replacement of
plasma-derived prophylactic and therapeutic immonoglobulin products.
__________________
178
August 31,2011 -א' באלול התשע"א
[11][21]
179695
הליך לקילוף בפלזמה באמצעות מודולציה
מחזורית של כימיה של גזים והוספת פחמימן
[54]
METHOD FOR PLASMA
STRIPPING USING PERIODIC
MODULATION OF GAS
CHEMISTRY AND
HYDROCARBON ADDITION
[22]
[31]
[51]
[71]
27.05.2005
10/860833
[32] 03.06.2004
[33] US
Int. Cl.(2010.01) H01L 21//311
LAM RESEARCH CORPORATION,
U.S.A.
MARK HENRY WILCOXSON, REZA
SADJADI, ERIC A. HUDSON, JAMES
V. TIETZ, SEOKMIN YUN, JI ZHU,
PETER CIRIGLIANO, SANGHEON
LEE, THOMAS S. CHOI, PETER
LOEWENHARDT
WO/2005/122226
JMB, FACTOR & CO. LTD.,
, פקטור אנד קו בע"מ,ג'יי אמ בי
HAR HOTZVIM HI-TECH PARK,
הר חוצבים,רחוב המרפא
P.O.B. 45087,
ירושלים45087 .ד. ת,
JERUSALEM 91450
A method for etching a feature in a low-k dielectric layer through a photoresist etch
mask over a substrate. A gas-modulated cyclic stripping process is performed for more
than three cycles for stripping a single photoresist mask. Each cycle of the gasmodulated cyclic stripping process comprises performing a protective layer formation
phase and a stripping phase. The protective layer forming phase uses first gas
chemistry with a deposition gas chemistry, wherein the protective layer forming phase
is performed in about 0.005 to 10 seconds for each cycle. The stripping phase for
stripping the photoresist mask uses a second gas chemistry using a stripping gas
chemistry, where the first gas chemistry is different than the second gas chemistry,
wherein the etching phase is performed in about 0.005 to 10 seconds for each cycle.
[72]
[87]
[74]
[57]
__________________
179
August 31,2011 -א' באלול התשע"א
[11][21]
179792
–או קדוחי/שיטה וציוד לביצוע חורים עמוקים ו
בקבוק
[54]
METHOD AND APPARATUS FOR
CARRYING OUT DEEP HOLES
AND/OR BOTTLE-BORING
[22]
[31]
[51]
[71]
03.12.2006
05425869.4
[32] 06.12.2006
[33] EP
Int. Cl.(2010.01) B23B 41//02
MAGNAGHI AERONAUTICA S.P.A.,
ITALY
BOROCHOV, KORAKH & CO.,
,'בורוכוב קורח ושות
15TH FLOOR, ATIDIM TOWER,
מגדל כלל עתידים
KIRYAT ATIDIM,
אביב-תל58100 .ד. ת,
P.O.B. 58100,
TEL AVIV 61580
A method for carrying out deep holes and/or bottle boring, in particular borings, with
a high ratio between final linear depth and diameter of the hole carried out by a tool
covering a longitudinal distance with respect to the workpiece supported by a tool
shaft of appropriate length, comprising the steps of:
carrying out a first reference hole, having an axis linked to the deep hole to be carried
out by a predetermined spatial relationship; making a deep hole of a diameter smaller
then the hole to be carried out, so that said reference hole and said first deep hole be in
spatial communication and prearranging a guiding and supporting element internal to
said first reference hole and connecting thereto a tool shaft and a related tool to obtain
a counter internal to the deep hole an/or a deep hole of diameter and axis according to
said predetermined spatial relationship, wherein said first reference hole is carried out
at the opposite end with respect to the access end of the deep hole to be carried out,
said guiding and supporting element forming the coaxial extension of said tool shaft.
[74]
[57]
__________________
[11][21]
179885
תכשיר נגד גדולים ממאירים המכיל גורם
המחזק את ההשפעה נגד גדולים ממאירים
[54]
ANTITUMOR PREPARATION
CONTAINING AN ANTITUMOR
EFFECT FORTIFIER
[22]
[31]
[51]
02.06.2005
2004-171520 [32] 09.06.2004
[33] JP
Int. Cl.(2010.01) A61K 31//132, 31//44, 31//506, 31//53, 33//24, 45//06, A61P 35//00,
C07F 15//00
TAIHO PHARMACEUTICAL CO.,
[71]
180
August 31,2011 -א' באלול התשע"א
[87]
[74]
[57]
LTD., JAPAN
WO/2005/120480
WOLFF, BREGMAN AND GOLLER,
, ברגמן וגולר,וולף
P.O.B. 1352,
ירושלים1352 .ד. ת,
JERUSALEM 91013
An antitumor effect fortifier comprising as an active ingredient an effective amount of
platinum (II) cis-oxalato(1R,2R-diaminocyclohexane) so as to enhance the antitumor
activity of antitumor agent containing a therapeutically effective amount of tegafur, an
amount, effective for the enhancement of antitumor effect, of gimeracil and an amount,
effective for the suppression of side effects, of oteracil potassium; and a relevant
antitumor agent. Further, there is provided a method of therapy for cancer,
characterized in that an amount, effective for the enhancement of antitumor effect, of
platinum (II) cis-oxalato(1R,2R-diaminocyclohexane) is concomitantly administered
to a mammal. Still further, there is provided an antitumor agent consisting of a
pharmaceutical preparation form composed of at least two separate preparations
containing efficacious ingredients consisting of tegafur, gimeracil, oteracil potassium
and platinum (II) cis-oxalato(1R,2R-diaminocyclohexane) each alone or in an arbitrary
combination, or a pharmaceutical preparation form constituted of a single preparation
containing all the efficacious ingredients. Still further, there is provided a relevant kit.
__________________
[11][21]
180047
איזון כח של מחוללים מסונכרים מרובים
[54]
POWER BALANCING OF
MULTIPLE SYNCHRONIZED
GENERATORS
[22]
[31]
[51]
[71]
13.12.2006
11/303726
[32] 16.12.2005
[33] US
Int. Cl.(2010.01) H02P 11//00
GENERAL ELECTRIC COMPANY,
U.S.A.
SELIGSOHN GABRIELI & CO.,
,'זליגסון גבריאלי ושות
31 YAVNE ST.,
31 רח' יבנה
P.O.B. 1426,
תל אביב1426 .ד. ת,
TEL AVIV 61013
A method to balance power in a synchronous generator system, the method
comprising: determining an output power of each synchronous generator of a plurality
of synchronous generators driven by a prime mover; comparing each output power of
the respective synchronous generators to the average output power of the plurality of
synchronous generators to determine a difference between each output power and the
average output power; providing a correction signal to each synchronous generator to
adjust the output power thereof, wherein the correction signal for each synchronous
[74]
[57]
181
August 31,2011 -א' באלול התשע"א
generator depends upon the respective difference between the output power of the
synchronous generator and the average output power of the plurality of synchronous
generators.
__________________
[11][21]
180060
תותבת קארביד מודבק מצופה למכשיר חיתוך
וכרסום
[54]
COATED CEMENTED CARBIDE
CUTTING TOOL MILLING
INSERT
[22]
[31]
[51]
[71]
14.12.2006
0502777-6
[32] 16.12.2005
[33] SE
Int. Cl.(2010.01) B23C 05//16
SANDVIK INTELLECTUAL
PROPERTY AB, SWEDEN
WOLFF, BREGMAN AND GOLLER,
, ברגמן וגולר,וולף
P.O.B. 1352,
ירושלים1352 .ד. ת,
JERUSALEM 91013
A cutting tool milling insert for machining of low and medium alloyed steels, stainless
steels, with or without raw surfaces during wet or dry conditions comprising a
cemented carbide body and a coating characterized in said cemented carbide body
having a composition of 12.0-15.0 wt% Co, preferably 12.5-14.5 wt% Co, most
preferably 13-14 wt% Co, 0.52-0.64 wt% Cr, preferably 0.54-0.62 wt% Cr, most
preferably 0.55-0.61 wt% Cr and balance WC and with a CW-ratio in the range of
0.76-0.84, preferably within 0.78-0.82, and most preferably within 0.79-0.81 and
having a HcJ value in the range of 12.5-14.5 kA/m, preferably 12.7- 14.0 kA/m and
that said insert being at least partly coated with a 4.1-6.9 µm thick coating including at
least three layers of TiCxNyOz with a total thickness of 1.9-3.6 µm, of which one is
adjacent to the cemented carbide and a blasted α-Al2O3-layer being the outer layer at
least on the rake face, the TiCxNyOz layers having a total thickness of 1.9-3.6 µm
comprise:
a first TiCxNyOz layer adjacent to the cemented carbide having a composition of
x+y=1, x>= 0, preferably x < 0.2 and z=0,
a second TiCxNyOz layer having a composition of x>0.4, y>0.4 and 0=< z < 0.1,
preferably Z=0,
a third TiCxNyOz layer adjacent to the α -Al2O3-layer having a composition of x + y +
z >= 1 and z > 0, preferably z > 0.2, most preferably z> 0.2, x+y+z=1 och y<0.2 and
the α -Al2O3-layer having a thickness of 1.8-3.6 µm with flattened grains on the
[74]
[57]
182
August 31,2011 -א' באלול התשע"א
surfaces that have been subjected to the blasting treatment.
__________________
[11][21]
180135
מערכת ושיטה לחיווי תנאי טיסה מסוכנים
[54]
METHOD AND DEVICE FOR
INDICATING DANGEROUS
FLIGHT CONDITIONS
[22]
[51]
[71]
17.12.2006
Int. Cl.(2010.01) B64D 45//00, G01S 13//95, 17//95, G08B 23//00
H.M. DA CONSULTING AND
חיפה,דע יעוץ ופיתוח בע"מ.מ.ה
DEVELOPMENT LTD.
YARON SEGAL
ירון סגל
PEARL COHEN ZEDEK LATZER,
,פרל כהן צדק לצר
5 SHENKAR ST.,
5 רח' שנקר,1 ים-מרכז גב
P.O.B. 12704,
הרצליה12704 .ד. ת,
HERZLIYA 46733
A method for determining existence of dangerous flight conditions in a cloud present
in a flight path of a flying aircraft, the method comprising: acquiring an image of a
surface boundary of cloud using an imaging device; assessing the image to find
temperature changes on the surface boundary of the cloud associated with arrival of
warm air from within the cloud to the surface boundary; and determining the existence
of dangerous flight condition in the cloud based on the temperature changes.
[72]
[74]
[57]
__________________
[11][21]
180172
ג'ל רוקחי נרתיקי המכיל טנופוויר
[54]
PHARMACEUTICAL VAGINAL
GEL COMPRISING TENOFOVIR
[22]
[31]
[51]
[71]
[87]
[74]
01.07.2005
60/586839
[32] 09.07.2004
[33] US
Int. Cl.(2010.01) A61K 09//06, 09//12, 09//16, 09//48, 31//505
GILEAD SCIENCES, INC., U.S.A.
WO/2006/017044
REINHOLD COHN AND PARTNERS,
,ריינהולד כהן ושותפיו
26A HABARZEL ST.,
'א26 רחוב הברזל
RAMAT HACHAYAL 69710
August 31,2011 -א' באלול התשע"א
183
[57]
רמת החייל
The present invention relates to formulations of nucleotide reverse transcriptase
inhibitors (NRTIs), preferably [2-(6-Amino-purin-9-yl)-1-methyl-ethoxymethyl]phosphonic acid (tenofovir, PMPA), or a physiologically functional derivative thereof,
suitable for topical application and their use in the prevention of HIV infections.
,206031
The applications for division
from this application have
not yet been published
בקשות חלוקה מבקשה זו
.שטרם פורסמו
__________________
[11][21]
180236
[54]
PRINTING MATERIAL
CONTAINER AND BOARD
MOUNTED ON PRINTING
MATERIAL CONTAINER
[22]
[31]
21.12.2006
2005-372028 [32] 26.12.2005
[33]
2006-220751
11.08.2006
Int. Cl.(2010.01) B41J 02//175, 03//00, 29//00
SEIKO EPSON CORPORATION,
JAPAN
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[51]
[71]
[74]
[57]
184
מיכל לחומרי הדפסה ומכסה תואם
JP
JP
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
A printing material container detachably attachable to a printing apparatus having a
plurality of apparatus-side terminals, the printing material container comprising: a first
device; a second device; and a terminal group that includes a plurality of first
terminals, at least one second terminal and at least one third terminal, wherein: the
plurality of first terminals are connected to the first device and respectively include a
first contact portion for contacting a corresponding terminal among the plurality of
apparatus-side terminals, the at least one second terminal is connected to the second
device and includes a second contact portion for contacting a corresponding terminal
among the plurality of apparatus-side terminals, the at least one third terminal is for the
detection of shorting between the at least one second terminal and the at least one third
terminal and includes a third contact portion for contacting a corresponding terminal
among the plurality of apparatus-side terminals, the at least one second contact
portion, the plurality of the first contact portions, and the at least one third contact
portion are arranged so as to form one or multiple rows, and the at least one second
contact portion is arranged at an end of one row among the one or multiple rows.
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
180277
,מעכבי חלבון העברת כולסטרול אסטר
תכשירים רפואיים המכילים אותם ושימושם
בהכנת תרופות
[54]
CHOLESTEROL ESTER
TRANSFER PROTEIN
INHIBITORS,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USE THEREOF IN
THE PREPARATION OF
MEDICAMENTS
[22]
[31]
23.06.2005
60/582708
[32] 24.06.2004
[33] US
60/627241
12.11.2004
US
60/664862
24.03.2005
US
Int. Cl.(2010.01) A61K 31//55, A61P 03//06, 09//10, C07D 40/1/14, 40/3/12, 40/3/14,
40/5/14, 40/9/14, 41/3/12, 41/7/12, 41/7/14, 49/1/04
ELI LILLY AND COMPANY, U.S.A.
WO/2006/002342
LUZZATTO & LUZZATTO,
,לוצאטו את לוצאטו
INDUSTRIAL PARK, OMER,
עומר,גן תעשייה
P.O.B. 5352,
באר שבע5352 .ד. ת,
BEER-SHEVA 84152
Compounds of Formula (I): wherein n, m, p, q, Y, R1 R2, R3a, R3b, R4, R5, and R6
are as defined herein and their pharmaceutical compositions and methods of use are
disclosed.
[51]
[71]
[87]
[74]
[57]
185
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
180933
–6,5––הידרוקסי4––ציקלופנטיל6 נגזרות
תכשירים רוקחיים,–און2––פיראןH2–דיהידרו
המכילים אותן ושימוש בהן להכנת תרופות
C לטיפול בזיהום בוירוס דלקת הכבד
[54]
6-CYCLOPENTYL-4-HYDROXY5,6-DIHYDRO-2H-PYRAN-2-ONE
DERIVATIVES,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THE SAME AND USE THEREOF
IN THE PREPARATION OF
MEDICAMENTS FOR TREATING
INFECTION WITH HEPATITIS C
VIRUS
[22]
[31]
[51]
[71]
[87]
[74]
05.08.2005
60/602618
[32] 18.08.2004
[33] US
Int. Cl.(2010.01) A61K 31//4196, A61P 01//16, C07D 48/7/04
PFIZER INC., U.S.A.
WO/2006/018725
SANFORD T.COLB & CO.,
,' קולב ושות.סנפורד ט
P.O.B. 2273,
מרמורק,4 שער הגיא
REHOVOT 76122
רחובות2273 .ד. ת,
The present invention provides compounds of formula (4), and their pharmaceutically
acceptable salts and solvates, which are useful as inhibitors of the Hepatitis C virus
(HCV) polymerase enzyme and are also useful for the treatment of HCV infections in
HCV-infected mammals. The present invention also provides pharmaceutical
compositions comprising compounds of formula (4), their pharmaceutically acceptable
salts and solvates. Furthermore, the present invention provides intermediate
compounds and methods useful in the preparation of compounds of formula (4).
[57]
186
August 31,2011 -א' באלול התשע"א
The applications for division
from this application have
not yet been published
,192919
בקשות חלוקה מבקשה זו
.שטרם פורסמו
__________________
[11][21]
180986
מכונת קפה בלחץ קיטור בעלת אמצעי מעצור
ושיטה עבור ייצור קפה על בסיס משקה ע"י
מכונת קפה בלחץ קיטור בעלת אמצעי מעצור
[54]
STEAM-PRESSURE COFFEE
MACHINE PROVIDED WITH
INHIBITION MEANS AND METHOD
FOR PRODUCING A COFFEE-BASED
BEVERAGE BY USING A STEAMPRESSURE COFFEE MACHINE
PROVIDED WITH INHIBITION
MEANS
[22]
[31]
[51]
[71]
[87]
[74]
06.06.2005
MO2004A000202 [32] 30.07.2004
[33] IT
Int. Cl.(2010.01) A47J 31//30
ILLYCAFFE' S.P.A.
WO/2006/010404
DR. YITZHAK HESS & PARTNERS,
,ד"ר יצחק הס ושותפיו
279 HAYARKON ST.,
279 רחוב הירקון
P.O.B. 6451,
תל אביב6451 .ד. ת,
TEL AVIV 61063
An apparatus for preparing a coffee beverage inducing the passage of an extraction
fluid through a dose (W) of coffee by heating said fluid, comprises separating means
(10, 15) arranged to separate a fraction of said beverage obtained with a prevalently
liquid phase of said fluid from a further fraction of said beverage obtained with a
prevalently steam phase of said fluid; an apparatus for preparing a coffee beverage by
imbibing a dose (W) of coffee with an extraction fluid driven by heating through said
dose (W), comprises inhibition means arranged to inhibit said imbibing when said fluid
contains a substantial steam phase; a method for obtaining a coffee beverage comprises
heating an extraction fluid so as to induce the passage of said extraction fluid through a
[57]
187
August 31,2011 -א' באלול התשע"א
dose (W) of coffee to obtain said beverage and separating a fraction of said beverage
obtained with a prevalently liquid phase of said extraction fluid from a further fraction
of said beverage obtained with a prevalently steam phase of said extraction fluid is
provided for.
__________________
[11][21]
181058
סוליה עמידה למים ונושמת עבור נעליים
[54]
WATERPROOF AND BREATHABLE
SOLE FOR SHOES
[22]
[31]
[51]
[71]
[87]
[74]
25.07.2005
PD2004A000208 [32] 30.07.2004
Int. Cl.(2010.01) A43B 07//12
GEOX S.P.A., ITALY
WO/2006/010578
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57]
A waterproof and breathable sole (10, 100, 200, 300) for shoes, which has a structure
that comprises a lower layer (12, 112, 212, 312), which has at least one large through
hole (13, 113, 313). Above the lower layer (12, 112, 212, 312), there is a mesh (15,
115, 315), arranged substantially so as to overlap at least the large through hole (13,
113, 313). A membrane (18,118, 318) made of a material that is impermeable to water
and permeable to water vapor is associated in an upward region with respect to the
mesh (15, 115, 315) at least at the large hole (13, 113, 313). The membrane (18, 118,
318) is joined hermetically at least perimetrically to at least one component of the sole
(10, 100, 200, 300) in such a manner as to avoid the rise of liquids through the
perimeter of the large hole (13, 113, 313). A perforated upper layer (20, 120, 320) is
arranged above the membrane (18, 118, 318). The lower layer (12, 112, 212, 312) is
overmolded on the mesh (15, 115, 315) and partially incorporates it.
188
[33]
IT
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
181179
טיווח תקופתי במערכת גישה אלחוטית עבור
תחנה ניידת במצב רדום
[54]
PERIODIC RANGING IN A
WIRELESS ACCESS SYSTEM FOR
MOBILE STATION IN SLEEP
MODE
[22]
[31]
09.08.2005
10-2004[32] 09.08.2004
[33] KR
0062623
Int. Cl.(2010.01) H04B 01//16, 07//005, H04W 52//02
LG ELECTRONICS INC., REPUBLIC
OF KOREA
WO/2006/016765
WOLFF, BREGMAN AND GOLLER,
, ברגמן וגולר,וולף
P.O.B. 1352,
ירושלים1352 .ד. ת,
JERUSALEM 91013
A method of performing a ranging process between a base station and a mobile station
in sleep mode in a wireless access system, wherein the base station provides the
mobile station with an initial notification of a periodic ranging time that occurs during
a sleep time interval and during which the mobile station is to perform the ranging
process, the initial notification included in a first message, the first message indicating
whether the mobile station should terminate sleep mode to receive downlink data, and
wherein the base station provides the mobile station with subsequent notifications of
periodic ranging times that occur during the sleep time interval, the subsequent
notifications indicated in a second message, the second message transmitted to the
mobile station as part of the ranging process such that the mobile station performs a
plurality of ranging processes within the sleep time interval.
[51]
[71]
[87]
[74]
[57]
__________________
189
August 31,2011 -א' באלול התשע"א
[11][21]
181195
מחליף לחץ
[54]
PRESSURE EXCHANGER
[22]
[31]
[51]
[71]
[87]
[74]
10.08.2005
60/599760
[32] 10.08.2004
[33]
Int. Cl.(2010.01) B01D 61//06, F04F 13//00
LEIF HAUGE, U.S.A.
WO/2006/020679
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57]
A pressure exchanger for transferring pressure energy from a relatively high-pressure
fluid stream to another relatively low-pressure fluid stream is provided. A ducted rotor
is positioned on a central axle between two end covers inside a pressure vessel with a
coaxial inlet and outlet pair that is in communication with a pair of low pressure ports
having inclination forming an inlet tangential velocity vector in the direction of rotor
rotation and an outlet tangential velocity vector in opposite direction imparting a
rotational momentum on rotor. A pair of high-pressure ports is adapted for flow
without inclination and imparts no momentum to rotor and flow can be varied without
impacting the rotor's RPM.; The end covers have a sloped surface following a flat
sealing area that increases the clearance in the direction of rotation causing increased
outflow during depressurization and lower duct pressure before duct is exposed to low
pressure port and furthermore causing increased inflow during the pressurization phase
before duct is exposed to the high pressure port, which will dissipate pressure energy
as opposed to producing cavitation or pressure waves with result wear and noise.
US
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
__________________
[11][21]
181464
[54]
METHOD FOR PREPARING
IRBESARTAN AND
INTERMEDIATES THEREOF
[22]
[31]
[51]
[71]
23.08.2005
60/603606
[32] 23.08.2004
[33]
Int. Cl.(2010.01) C07D 25/7/04, 48/7/10
BRISTOL-MYERS SQUIBB
COMPANY, U.S.A.
WO/2006/023889
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
[87]
[74]
190
שיטה להכנת אירבסרטן וחומרי ביניים
US
,'ד"ר שלמה כהן ושות
124 אבן גבירול
August 31,2011 -א' באלול התשע"א
[57]
P.O.B. 11490,
תל אביב11490 .ד. ת,
TEL AVIV 62038
A method for preparing irbesartan and intermediates thereof. Irbesartan has the
structure of Formula (I).
__________________
[11][21]
שיטה לייצור מלחי תיאוטרופיום
[54]
METHOD FOR PRODUCING
TIOTROPIUM SALTS
[22]
[31]
[51]
[71]
23.08.2005
102004041253.7 [32] 26.08.2004
Int. Cl.(2010.01) C07D 45/1/00
BOEHRINGER INGELHEIM PHARMA
GMBH & CO. KG, GERMANY
WO/2006/021559
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[87]
[74]
[57]
181522
[33]
DE
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
The invention relates to a novel method for producing tiotropium salts of general
formula (1) via the corresponding silyl compound, wherein X- can have the meanings
cited in the claims and in the description.
The applications for division
from this application have not
yet been published
,213720,213717
בקשות חלוקה מבקשה זו
.שטרם פורסמו
__________________
191
August 31,2011 -א' באלול התשע"א
[11][21]
181569
,הקסאדקאסכרידים מותמרים עם ביוטין
הכנתם והשימוש בהם
[54]
BIOTINYLATED
HEXADECASACCHARIDES,
THEIR PREPARATION AND USE
THEREOF
[22]
[31]
[51]
[71]
[87]
[74]
07.09.2005
0409557
[32] 09.09.2004
[33]
Int. Cl.(2010.01) A61K 31//715, C08B 37//00
SANOFI-AVENTIS, FRANCE
WO/2006/030104
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[57]
FR
,' קולב ושות.סנפורד ט
מרמורק,4 שער הגיא
רחובות2273 .ד. ת,
The invention concerns novel biotinylated hexadecasaccharides of general formula (I)
wherein: Biot is a biotin derivative; R, R1 and R2, represent independently of one
another a C1-C6 alkoxy or and -OSO3; R3 represents a C1-C6 alkoxy or an -OSO3, or R3
constitutes a -O-CH2- bridge; Pe represents a saccharide concatenation; as well as their
pharmaceutically acceptable salts, and their use as medicines.
__________________
[11][21]
181821
מתקן לערבוב והעברה של חומר הניתן לגפר
[54]
CURABLE MATERIAL MIXING
AND DELIVERY DEVICE
[22]
[31]
[51]
[71]
[74]
08.03.2007
11/372642
[32] 10.03.2006
[33]
Int. Cl.(2010.01) A61F 02//46, B01F 13//00
CAREFUSION 2200, INC., U.S.A.
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57]
An apparatus and method for mixing two components and delivering the mixture to a
patient. The apparatus contains a mixing chamber for mixing a liquid component and a
powder component. The liquid component and powder component are mixed within
the mixing chamber by rotation of a collapsible mixing element. A plunger is then
August 31,2011 -א' באלול התשע"א
192
US
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
advanced through the mixing chamber to force the mixture out of the mixing chamber
and deliver the mixture to the patient.
__________________
[11][21]
181836
מיבני זכוכית התנגדותיים בשימוש לעיצוב שדות
חשמליים במכשירים אנליטיים
[54]
RESISTIVE GLASS STRUCTURES
USED TO SHAPE ELECTRIC
FIELDS IN ANALYTICAL
INSTRUMENTS
[22]
[31]
[51]
[71]
11.03.2007
60/781088
[32] 10.03.2006
[33] US
Int. Cl.(2010.01) G01J 03//02, H01J 43//00
BURLE TECHNOLOGIES, INC.,
U.S.A.
WOLFF, BREGMAN AND GOLLER,
, ברגמן וגולר,וולף
P.O.B. 1352,
ירושלים1352 .ד. ת,
JERUSALEM 91013
A reflectron lens comprising a lead silicate glass tube having a lead oxide
semiconductive surface layer formed along the length of said glass tube, said lead
oxide semiconductive surface layer having an electrical resistance gradient along said
length, whereby said tube provides an electric field interior to the tube that varies in
strength along the length of the tube when an electric potential is applied to opposing
ends of the tube.
[74]
[57]
__________________
[11][21]
[54]
193
STABLE FORMULATION
182161
פורמולציה יציבה הכוללת פולימורף גבישי של
August 31,2011 -א' באלול התשע"א
– אריתרו–טטראהידרוביופטריןR)–L6)
דיהידרוכלוריד
COMPRISING A CRYSTALLINE
POLYMORPH OF (6R)-LERYTHROTETRAHYDROBIOPTERIN
DIHYDROCHLORIDE
[22]
[31]
[51]
[71]
[87]
[74]
[57]
16.11.2005
60/629189
[32] 17.11.2004
Int. Cl.(2010.01) A61K 09//20, 31//505
BIOMARIN PHARMACEUTICAL
INC., U.S.A.
WO/2006/055511
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[33]
US
,' קולב ושות.סנפורד ט
מרמורק,4 שער הגיא
רחובות2273 .ד. ת,
The present invention is directed to a stable solid formulations of tetrahydrobiopterin,
processes for producing them and treatment methods using such formulations.
__________________
[11][21]
[54]
INDIVIDUAL CHANNEL SHAPING
FOR BCC SCHEMES AND THE
LIKE
[22]
[31]
07.09.2005
60/620480
[32] 20.10.2004
11/006482
07.12.2004
Int. Cl.(2010.01) G10L 19//00, 19//02
FRAUNHOFER-GESELLSCHAFT
ZUR FORDERUNG DER
ANGEWANDTEN FORSCHUNG
E.V., GERMANY
AGERE SYSTEMS INC., U.S.A.
ERIC ALLAMANCHE, SASCHA
DISCH, CHRISTOF FALLER,
JUERGEN HERRE
WO/2006/045371
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
[51]
[71]
[72]
[87]
[74]
194
182236
BCC עיצוב ערוץ אינדיבידואלי עבור סכמות
וכדומה
[33]
US
US
,'זליגסון גבריאלי ושות
31 רח' יבנה
תל אביב1426 .ד. ת,
August 31,2011 -א' באלול התשע"א
[57]
At an audio encoder, cue codes are generated for one or more audio channels, wherein
an envelope cue code is generated by characterizing a temporal envelope in an audio
channel. At an audio decoder, E transmitted audio channel(s) are decoded to generate
C playback audio channels, where C>=Eo1. Received cue codes include an envelope
cue code corresponding to a characterized temporal envelope of an audio channel
corresponding to the transmitted channel(s). One or more transmitted channel(s) are
upmixed to generate one or more upmixed channels. One or more playback channels
are synthesized by applying the cue codes to the one or more upmixed channels,
wherein the envelope cue code is applied to an upmixed channel or a synthesized
signal to adjust a temporal envelope of the synthesized signal based on the
characterized temporal envelope such that the adjusted temporal envelope substantially
matches the characterized temporal envelope.
__________________
[11][21]
182306
מערכת ושיטה להכנה ומסירה של משקה על ידי
שימוש בחומר גלם הנמצא בתוך מחסנית
[54]
APPARATUS AND METHOD FOR
PREPARING AND DELIVERING
A BEVERAGE WITH THE USE
OF RAW MATTER CONTAINED
IN A CARTRIDGE
[22]
[51]
[71]
01.10.2004
Int. Cl.(2010.01) A47J 31//40
HAUSBRANDT TRIESTE 1892 SPA,
ITALY
WO/2006/038227
LUZZATTO & LUZZATTO,
,לוצאטו את לוצאטו
INDUSTRIAL PARK, OMER,
עומר,גן תעשייה
P.O.B. 5352,
באר שבע5352 .ד. ת,
BEER-SHEVA 84152
The present invention provides for at least a dispensing spout (220) to be directly
formed in the sealing membrane (210) that closes the bottom of a capsule (200)
containing an edible raw material for preparing a beverage, e.g. coffee. In this manner,
[87]
[74]
[57]
195
August 31,2011 -א' באלול התשע"א
the beverage is able to directly fall from the capsule into a drinking vessel arranged
therebelow. What is claimed are both a machine, characterized by the means (109) that
form the spout and the open bottom (156) of the container (151) in which the capsule
is loaded, and a method for preparing and dispensing the beverage.
__________________
[11][21]
182350
שידור מסר במערכת גישה אלחוטית
[54]
MESSAGE TRANSMISSION IN
WIRELESS ACCESS SYSTEM
[22]
[31]
04.10.2005
10-2004[32] 04.10.2004
[33] KR
0078858
10-200517.01.2005
KR
0004248
Int. Cl.(2010.01) H04B 07//185, H04L 12//24, H04W 52//00, 52//02, 60//00, 60//06,
68//00
LG ELECTRONICS INC., REPUBLIC
OF KOREA
WO/2006/038781
WOLFF, BREGMAN AND GOLLER,
, ברגמן וגולר,וולף
P.O.B. 1352,
ירושלים1352 .ד. ת,
JERUSALEM 91013
A method for transmitting messages to alter the operating status between a mobile
station and a base station in a wireless access system comprises, at the mobile station,
transmitting a first message to the base station, setting a first count to a first
predetermined value and enabling a first, the first message requesting a alteration in
operating status between the mobile station and the base station, whereupon expiration
of the first timer before receiving a second message from the base station, the count is
decremented and, if the count is above a second predetermined value, the first timer is
reset and the first message is retransmitted to the base station. The method also
comprises, at a base station, receiving the first message, transmitting a second message
to the mobile station and enabling a second timer, whereupon expiration of the second
[51]
[71]
[87]
[74]
[57]
196
August 31,2011 -א' באלול התשע"א
timer, the alteration in operating status is effected.
__________________
[11][21]
182513
תהליך להכנתו,תכשיר דביק להושטה פומית
ושימושו בהכנת תרופה
[54]
ADHESIVE PREPARATION FOR
APPLICATION IN THE ORAL
REGION, PROCESS FOR
PREPARING THE SAME AND ITS
USE IN THE PREPARATION OF A
MEDICAMENT
[22]
[31]
[51]
[71]
06.10.2005
102004049740.0 [32] 13.10.2004
[33] DE
Int. Cl.(2010.01) A61K 08//02, 08//72, 08//73, 08//81, 09//00, A61Q 11//00
LTS LOHMANN THERAPIE-SYSTEME
AG, GERMANY
WO/2006/040059
LUZZATTO & LUZZATTO,
,לוצאטו את לוצאטו
INDUSTRIAL PARK, OMER,
עומר,גן תעשייה
P.O.B. 5352,
באר שבע5352 .ד. ת,
BEER-SHEVA 84152
The invention relates to a one or multiple layered, film-like, adhesive preparation for
the use in the oral cavity. Said preparation contains at least one polymethylvinylethermaleic acid-anhydride-copolymer, polyvinylacetate and/or at least one copolymer of
the polyvinylacetate with fatty acid vinyl alcohol esters, in addition to at least one
cosmetic and/or pharmaceutical active substance. The invention also relates to a
method for the production of said type of preparations.
[87]
[74]
[57]
__________________
197
August 31,2011 -א' באלול התשע"א
[11][21]
182669
מערכת הפעלה הידרולית העומדת בפני עצמה
[54]
SELF-CONTAINED HYDRAULIC
ACTUATOR SYSTEM
[22]
[31]
[51]
[71]
[72]
20.07.2006
11/186946
[32] 22.07.2005
[33] US
Int. Cl.(2010.01) F16D 31//02
A.A. TECHNOLOGIES & I.P LTD.
ALEXANDER COHEN, AVIRAM
הרצל פרי, אבירם ארבל,אלכסנדר כהן
ARBEL, HERTZEL PERRY
WO/2007/010540
DR. MARK FRIEDMAN LTD.,
,ד"ר מרק פרידמן בע"מ
MOSHE AVIV TOWER, 54TH
7 רח ז'בוטינסקי, 54. ק,מגדל משה אביב
FLOOR,
גן-רמת
7 JABOTINSKY ST.,
RAMAT GAN 52520
The hydraulic linear actuator system of the present invention includes a pump that is
configured to rotate in a single direction at a substantially constant velocity. Both the
direction and flow rate of fluid through the system is controlled by adjusting the
positional relationship between the stator and the rotor of the pump. This positional
relationship is adjustable between a forward flow state, a non-flow state and a reverse
flow state. The hydraulic linear actuator is responsive to the flow of fluid through the
system so as to be displaced in a first direction by the forward flow state of the pump
and in a second direction by the reverse flow state of the pump.
[87]
[74]
[57]
__________________
[11][21]
[54]
198
POLISHING COMPOSITION AND
METHOD FOR HIGH SILICON
NITRIDE TO SILICON OXIDE
REMOVAL RATE RATIOS
182797
הרכב ליטוש ושיטה ליחסי קצב הסרה גבוהים
של צורן ניטריד לעומת תחמוצת צורן
August 31,2011 -א' באלול התשע"א
[22]
[31]
[51]
[71]
[87]
[74]
[57]
21.10.2005
10/982486
[32] 05.11.2004
[33] US
Int. Cl.(2010.01) B24C 01//08
CABOT MICROELECTRONICS
CORPORATION, U.S.A.
WO/2006/052433
SELIGSOHN GABRIELI & CO.,
,'זליגסון גבריאלי ושות
31 YAVNE ST.,
31 רח' יבנה
P.O.B. 1426,
תל אביב1426 .ד. ת,
TEL AVIV 61013
The invention provides a chemical-mechanical polishing composition comprising a
cationic abrasive, a cationic polymer, a carboxylic acid, and water. The invention
further provides a method of chemically-mechanically polishing a substrate with the
aforementioned polishing composition. The polishing composition exhibits selectivity
for removal of silicon nitride over removal of silicon oxide.
__________________
[11][21]
[54]
TECHNIQUE FOR
COMPENSATING UNDESIRED
EFFECTS IN OPTICAL LINKS OF
AN OPTICAL COMMUNICATION
NETWORK
[22]
[51]
[71]
[74]
02.05.2007
Int. Cl.(2010.01) H04B 10//18
ECI TELECOM LTD.
ECI TELECOM LTD.,
30 HASIVIM ST.,
PETACH TIKVA 49517
[57]
199
182937
טכנולוגית קיזוז של תופעות לא רצויות בקווי
רשת תקשורת אופטית
פתח תקוה, טלקום בע"מ. איי. סי.אי
, טלקום בע"מ. איי. סי.אי
30 רחוב הסיבים
פתח תקוה
An adjustment module to be insterted in an optical link of an optical network section
for compensationg two or more different physical effects accumulated in said optical
link when transmitting an optical signal therealong, the adjustment module comprising
at least two controllable blocks respectively comprising: a variable gain optical
amplifier VGA for selectively compensating power loss, and a tunable dispersion
compensation module TDCM for selectively compensating chromatic dispersion; the
adjustment module being provided with a control unit in the form of an internal
controller capable of obtaining information and for controlling the VGA and the
TDCM based on said information.
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
[54]
ACTIVE SUBJECT IMAGING
WITH BODY IDENTIFICATION
[22]
[31]
[51]
[71]
[87]
[74]
10.11.2005
10/987409
[32] 12.11.2004
Int. Cl.(2010.01) G06K 09//00
SAFEVIEW, INC., U.S.A.
WO/2007/050093
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[57]
183046
הדמייה אקטיבית של נבדק עם זיהוי הגוף
[33]
US
,' קולב ושות.סנפורד ט
מרמורק,4 שער הגיא
רחובות2273 .ד. ת,
A method of surveilling a subject (28) including a person's body (66) may include or
an imaging system (20) may provide interrogating the subject (28) with
electromagnetic radiation (30, 32), and generating, from the interrogating, image data
(80) representative of at least a first image (270) of at least a portion of the person's
body (66). In some examples, a first portion of the body (66) may be identified, and a
first feature (232) of the image (270) may be determined based at least partially on the
identified portion of the body (66). In some examples, the orientation of the person’s
body (66) may be determined from one or more features (294) of one or more image
portions (344). In some examples, a portion (362) of the image (270) of the person’s
body (66) may be relaced with a substitute image portion (376).
__________________
[11][21]
[54]
200
METHOD OF UPDATING
CHANNEL INFORMATION BY A
MOBILE STATION THAT IS IN
183099
שיטה לעידכון מידע בערוץ באמצעות תחנה
ניידת הנמצאת במצב חיסכון הספק
August 31,2011 -א' באלול התשע"א
POWER SAVING MODE
[22]
[31]
[51]
[71]
[87]
[74]
[57]
30.12.2005
10-2004[32] 30.12.2004
[33] KR
0117275
10-200509.03.2005
KR
0019841
10-200527.12.2005
KR
0131043
Int. Cl.(2010.01) H04L 12//56, H04W 52//02
LG ELECTRONICS INC., REPUBLIC
OF KOREA
WO/2006/071096
WOLFF, BREGMAN AND GOLLER,
, ברגמן וגולר,וולף
P.O.B. 1352,
ירושלים1352 .ד. ת,
JERUSALEM 91013
A method of updating channel information by a mobile station (MS) that is in power
saving mode is disclosed. More specifically, the method includes the MS which
receives status information of a first channel descriptor and transmission frame
information which includes when the first channel descriptor is to be transmitted.
Furthermore, the MS compares status information of the first channel descriptor with
status information of a second channel descriptor. Here, the second channel descriptor
is stored in the MS. Lastly, if the compared status information are different, the MS
receives the first channel descriptor according to the transmission frame information.
__________________
[11][21]
[54]
IMAGING METHODS, IMAGING
MEMBER, CHARGING METHODS
AND IMAGING ENGINES
[22]
[31]
[51]
[71]
23.11.2005
10/997033
[32] 24.11.2004
Int. Cl.(2010.01) G03G 15//02
HEWLETT-PACKARD
DEVELOPMENT COMPANY, L.P.,
U.S.A.
WO/2006/058238
[87]
201
183220
שיטות הטענה, איבר הדמייה,שיטות הדמייה
ומנועי הדמייה
[33]
US
August 31,2011 -א' באלול התשע"א
[74]
[57]
DR. YITZHAK HESS & PARTNERS,
,ד"ר יצחק הס ושותפיו
279 HAYARKON ST.,
279 רחוב הירקון
P.O.B. 6451,
תל אביב6451 .ד. ת,
TEL AVIV 61063
An imaging Imaging methods, imaging member charging methods, and image engines
are described. According to one embodiment, an imaging method includes providing
an imaging member (20) having an outer surface comprising a plurality of portions
having a plurality of different radii, rotating the portions of the outer surface of the
imaging member (20) adjacent to a charge device (22) configured to provide an
electrical charge to the imaging member (20) which is usable for imaging, first
controlling a position of the charge device (22) with respect to one of the portions of
the outer surface of the imaging member (20) using the one of the portions of the outer
surface at one moment in time, second controlling a position of the charge device (22)
with respect to another of the portions of the outer surface of the imaging member (20)
using a positioning control system (32) at an other moment in time, and using the
charge device (22), providing the electrical charge to the one of the portions of the
imaging member (20) at the one moment in time.
__________________
[11][21]
[54]
FROZEN AERATED
CONFECTIONS
[22]
[31]
[51]
[71]
19.12.2005
04258092.8
[32] 23.12.2004
Int. Cl.(2010.01) A23G 09//32, 09//46
UNILEVER PLC, UNITED
KINGDOM
WO/2006/066979
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[87]
[74]
[57]
202
183257
מרקחות קפואות מאווררות
[33]
EP
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
A frozen aerated confection having an overrun of at least 40% and a fat component in
an amount of 2 to 20% (by weight of the frozen aerated confection), said fat
component comprising triglycerides of fatty acids wherein no more than 55% (by
weight of the fatty acids) of the fatty acids in the triglycerides are saturated, less than
8% (by weight of the triglycerides) of the triglycerides are long chain SSS
August 31,2011 -א' באלול התשע"א
triglycerides; characterized in that the ratio of the percentage of fat that is solid at 5°C
to the percentage of the fatty acids in the triglycerides that are saturated (by weight of
the fatty acids) is greater than 1 and in that the fat component comprises at most 60%
(by weight) cocoa butter or shea nut oil.
__________________
[11][21]
183286
שיטה ומערכת להחלפת משימות ערוץ ואנטנה
ברשתות אלחוטיות בעלות טווח תדרים רחב
[54]
METHOD AND SYSTEM FOR
SWITCHING ANTENNA AND
CHANNEL ASSIGNMENTS IN
BROADBAND WIRELESS
NETWORKS
[22]
[31]
[51]
[71]
[87]
[74]
07.12.2005
11/007064
[32] 07.12.2004
[33] US
Int. Cl.(2010.01) H04B 07//06, 07//204, H04W 72//08
ADAPTIX, INC., U.S.A.
WO/2006/062994
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57]
A method and apparatus for antenna switching, grouping, and channel assignments in
wireless communication systems. The invention allows multiuser diversity to be
exploited with simple antenna operations, therefore increasing the capacity and
performance of wireless communications systems. Channel characteristics indicative
of signal reception quality for downlink or bi-directional traffic for each
channel/antenna resource combination are measured or estimated at a subscriber.
Corresponding channel characteristic information is returned to the base station.
Channel characteristics information may also be measured or estimated for uplink or
bidirectional signals received at each of multiple receive antenna resources. The base
station employs channel allocation logic to assign uplink, downlink and/or bidirectional channels for multiple subscribers based on channel characteristics
measured and/or estimated for the uplink, downlink and/or bi-directional channels.
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
__________________
[11][21]
203
183348
August 31,2011 -א' באלול התשע"א
מערכת נעילה אנכית לדלת עם סגר המשוחרר
באמצעות סלונואיד
[54]
VERTICAL DOOR LOCKING
SYSTEM WITH SOLENOID
RELEASED LATCH
[22]
[31]
[51]
[71]
19.10.2005
11/003296
[32] 03.12.2004
[33]
Int. Cl.(2010.01) E05B 47//00, E06B 09//17
SARGENT MANUFACTURING
COMPANY, U.S.A.
WO/2006/062584
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[87]
[74]
[57]
US
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
A vertical door locking system includes a sliding latch mounted to a door that opens
vertically, such as a garage door or corrugated self-storage door, and an electrically
operated solenoid mounted at a fixed location on a guide rail for the door or the door
frame. The latch includes a latchbolt that extends outward from the door to prevent the
door from being raised vertically and the latchbolt has an opening at one end. The
solenoid includes a spring operated solenoid rod that extends into the opening in the
latchbolt to prevent the latchbolt from being retracted thereby preventing the door from
being opened unless the solenoid is electrically operated to disengage the solenoid rod
and release the latchbolt.
__________________
[11][21]
[54]
MODEL-BASED CORRECTION OF
POSITION MEASUREMENTS
[22]
[31]
[51]
[71]
29.05.2007
11/421519
[32] 01.06.2006
Int. Cl.(2010.01) A61B 01//00
BIOSENSE WEBSTER, INC., U.S.A.
204
183539
תיקונים מבוססי–מדגם של מדידות מיקום
[33]
US
August 31,2011 -א' באלול התשע"א
[74]
[57]
D. KLIGLER I.P. SERVICES LTD.,
, קליגלר שירותי קניין רוחני בע"מ.ד
P.O.B. 33111
תל אביב33111 .ד. ת,
TEL AVIV 61330
An apparatus for position sensing, comprising: a probe, comprising at least one probe
electrode, which is adapted to be inserted into a body of a subject; a plurality of body
surface electrodes, which are adapted to be fixed to a surface of said body at respective
locations; a display; and a controller, which is adapted to be coupled to said probe and
to said body surface electrodes so as to pass electrical currents through said body
between said probe electrode and said body surface electrodes, and to determine
position coordinates of said probe by measuring respective characteristics of said
currents passing through said body surface electrodes, said controller being operative
for: determining an apparent position of said probe in said body; establishing that a
first displacement between said apparent position and a prior position of said probe at a
known time corresponds to a first rate of motion that exceeds a predetermined limit;
adjusting said apparent position to a new position such that a second displacement
between said new position and said prior position corresponds to a second rate of
motion that is less than said predetermined limit; and displaying said new position on
said display.
__________________
[11][21]
[54]
[22]
[31]
[51]
205
183804
–3––אלקוקסיקרבוניל2 תהליך להכנת
אמינותיאופינים מותמרים
PROCESS FOR PREPARING
SUBSTITUTED 2ALKOXYCARBONYL-3AMINOTHIOPHENES
14.12.2005
102004063191.3 [32] 29.12.2004
Int. Cl.(2010.01) C07D 33/3/00, 33/3/38
[33]
DE
August 31,2011 -א' באלול התשע"א
[71]
[87]
[74]
[57]
BAYER CROPSCIENCE AG,
GERMANY
WO/2006/072375
PEARL COHEN ZEDEK LATZER,
,פרל כהן צדק לצר
5 SHENKAR ST.,
5 רח' שנקר,1 ים-מרכז גב
P.O.B. 12704,
הרצליה12704 .ד. ת,
HERZLIYA 46733
The invention relates to a method for producing 4-alkoxycarbonyl-3-aminothiophenes
of general formula (I) and/or the hydrochlorides thereof of formula (I)', wherein R1 and
R2 have the meaning indicated in the description, and the monoacetylated or
diacetylated or the monoformylated or diformylated form thereof by reacting enamines
of formula (Il), wherein R1 and R2 have the meaning indicated in the description,
and/or the monoacetylated or diacetylated or the monoformylated or diformylated form
thereof with a chlorinating agent in the presence of one or several thinners. Also
disclosed is a method for producing the compounds of formula (II).
__________________
[11][21]
183868
[54]
MULTI-ANGLE JOINT
[22]
[51]
[71]
12.06.2007
Int. Cl.(2010.01) F16L 27//00, 27//02, 27//08
KRAUSZ INDUSTRIES
DEVELOPMENT LTD.
ELIEZER KRAUSZ, AVI
CHIPROOT
REUVEN BOROKOVSKY & CO.,
P.O.B. 585, YAVNE
[72]
[74]
[57]
206
מחבר רב זוויתי
ת"א,קראוס תעשיות פיתוח בע"מ
אבי צ'יפרוט,אליעזר קראוס
,'ראובן בורוקובסקי ושות
קרית רב בריח שדרות העצמאות
יבנה585 .ד. ת,
A multi-angle adjustable pipe coupling for two round-section pipes, tubes or roundsection ducts, comprising: a first sleeve provided with a first round inner flange
disposed at an angle A relative to a longitudinal axis of said first sleeve; a second
sleeve provided with a second round inner flange disposed at an angle B relative to a
longitudinal axis of said second sleeve, and when said inner flanges are oriented faceto-face at a central split portion, said flanges can be rotated relative to each other to a
position wherein the total angle C between the longitudinal axes of the two sleeves
ranges from 0o to at least 30o and is the sum of the angles A+B; and an elastomer seal
August 31,2011 -א' באלול התשע"א
element extending along the outer edges of both flanges, disposed inside a tightenable
clamp member enveloping the major portion of said seal element; wherein said
coupling substantially comprises a hollow cylindrical shape and said coupling can be
adjusted within a range of bending and wherein said central split portion is noncylindrical in shape.
__________________
[11][21]
183901
[54]
MEANS AND METHOD OF
PRINTING UPON A SOAP BAR
[22]
[31]
12.12.2005
60/635444
[32] 14.12.2004
[33]
60/668096
05.04.2005
Int. Cl.(2010.01) B41F 33//00, B44C 01//16
PHOTO PRINT SOAP LTD.
SAMUEL ICHT, SHARON MAAYAN
WO/2006/064496
DR. EYAL BRESSLER,
11 TUVAL ST.,
RAMAT GAN 52522
[51]
[71]
[72]
[87]
[74]
[57]
207
אמצעים ושיטה להדפסה על סבון
US
US
רמת השרון,פוטו פרינט סופ בע"מ
שרון מעיין,שמואל איכט
,דר' אייל ברסלר עו"פ
11 תובל
גן- רמת
The inventors disclose a novel method of imprinting on a soap bar or soap sheet. This
method comprises steps of providing printed matter on the surface of said soap and
isolating said surface from water contact, such that said printed matter is partially or
substantially water-insoluble. Moreover, the invention presents a cost effective soap
bar or soap sheet having printed matter on a surface thereon; said surface is protected
by at least one protective layer which is partially or substantially water-insoluble. The
protective layer can be a varnish layer printed on transfer paper and then glued or
August 31,2011 -א' באלול התשע"א
otherwise affixed to the soap as a label. It can also be a wax layer, wherein the printed
matter is either printed on the soap before coating thereof, or be part of a varnish label
to be glued to the soap, which is then coated by a wax layer. The printing color is
durable in water or other predetermined diluents and in water-soap solution.
__________________
[11][21]
183916
תמיכה בבקשה לשידור נישנה אוטומטי
כילאיים במערכת גישת רדיו לגישת ריבוב
חלוקת תדר אורתוגונלית
[54]
SUPPORTING HYBRID
AUTOMATIC RETRANSMISSION
REQUEST IN ORTHOGONAL
FREQUENCY DIVISION
MULTIPLEXING ACCESS RADIO
ACCESS SYSTEM
[22]
[31]
27.12.2005
10-2004[32] 27.12.2004
[33] KR
0112930
10-200510.01.2005
KR
0002246
10-200520.01.2005
KR
0005337
Int. Cl.(2010.01) H04B 07//204, H04J 11//00, H04L 29//04
LG ELECTRONICS INC., REPUBLIC
OF KOREA
WO/2006/071049
WOLFF, BREGMAN AND GOLLER,
, ברגמן וגולר,וולף
P.O.B. 1352,
ירושלים1352 .ד. ת,
JERUSALEM 91013
A method of supporting a hybrid automatic retransmission request (HARQ) in an
orthogonal frequency division multiplexing access (OFDMA) radio access system is
disclosed. Preferably, the method comprises receiving a downlink data frame
comprising a data map information element and a data burst comprising a plurality of
layers, wherein each layer is encoded with a corresponding channel encoder, and
wherein the data map information element is configured to support multiple antennas
to achieve space time transmit diversity by providing control information associated
with each one of the plurality of layers, wherein the control information comprises
allocation of acknowledgement status channels corresponding to the plurality of layers,
and transmitting in an uplink data frame a plurality of acknowledgement status, each
acknowledgement status being associated with whether a corresponding layer of the
plurality of layers is properly decoded.
[51]
[71]
[87]
[74]
[57]
208
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
תולדות סטילבן והשימוש בהן לקשור ולהדמיית
רבדי אמילואיד
[54]
STILBENE DERIVATIVES AND
THEIR USE FOR BINDING AND
IMAGING AMYLOID PLAQUES
[22]
[31]
19.12.2005
60/636696
[32] 17.12.2004
60/686395
02.06.2005
Int. Cl.(2010.01) A61K 49//00, 51//04
THE TRUSTEES OF THE
UNIVERSITY OF PENNSYLVANIA,
U.S.A.
WO/2006/066104
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[51]
[71]
[87]
[74]
[57]
[33]
US
US
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
This invention relates to a method of imaging amyloid deposits and to labeled
compounds, and methods of making labeled compounds useful in imaging amyloid
deposits. This invention also relates to compounds, and methods of making
compounds for inhibiting the aggregation of amyloid proteins to form amyloid
deposits, and a method of delivering a therapeutic agent to amyloid deposits.
The applications for division
209
183946
,206091
בקשות חלוקה מבקשה זו
August 31,2011 -א' באלול התשע"א
.שטרם פורסמו
from this application have
not yet been published
__________________
[11][21]
184107
מערכת לכסוי רדיו סלולרי ומשושה למערכת כזו
[54]
SYSTEM FOR CELLULAR
RADIO COVERAGE AND
ANTENNA FOR SUCH A SYSTEM
[22]
[51]
[71]
30.12.2004
Int. Cl.(2010.01) H04W 16//30
TELEFONAKTIEBOLAGET L M
ERICSSON (PUBL), SWEDEN
WO/2006/071154
WOLFF, BREGMAN AND GOLLER,
, ברגמן וגולר,וולף
P.O.B. 1352,
ירושלים1352 .ד. ת,
JERUSALEM 91013
The invention discloses a system (200) for cellular mobile telephony, comprising a
base station antenna (500, 600, 700) and a plurality of cells (203, 310, 320, 330). Each
cell has an area defined by an azimuth (&agr;1, a2) and a range (R0 R'), and the first
(310) and second (320) cell cover respective areas, said areas being defined by first
(&agr;1,) and second (&agr;2) azimuths and first and second ranges (R0) respectively.
The first and second cells are essentially adjacent to each other in azimuth, and the
system also comprises a third cell (203, 330) with an area coverage defined by a third
azimuth and a third range (R'). The third azimuth is essentially the same as, and
coinciding with, the total azimuths of the first and the second cell, but the third cell
has a range coverage which is much smaller than the first or second range coverages.
[87]
[74]
[57]
__________________
[11][21]
210
184263
August 31,2011 -א' באלול התשע"א
מערכות ושיטות למעקב לילה
[54]
SYSTEMS AND METHODS FOR
NIGHT TIME SURVEILLANCE
[22]
[31]
[51]
[71]
[87]
[74]
03.01.2006
60/640244
[32] 03.01.2005
[33] US
Int. Cl.(2010.01) G08B 13//196
VUMII, INC, U.S.A.
WO/2006/074161
FISHER WEILER JONES,
,פישר וילר ג'ונס
26 HABARZEL STREET
26 הברזל רמת החיל
RAMAT HACHAYAL,
תל אביב
TEL-AVIV 69710
Methods and systems for surveillance are described. One described method for use in a
surveillance system having a camera, comprises generating a background image of the
camera's field of regard, receiving a live video image of the camera's current field of
view, wherein the field of view is within the field of regard, and correlating a position
of the live video image within the background image.
[57]
The applications for division
from this application have
not yet been published
,208110
בקשות חלוקה מבקשה זו
.שטרם פורסמו
__________________
[11][21]
184462
נשא חישה מתמיד לגישות מרובות עבור מערכות
תקשורת קוליות דיגיטליות אלחוטיות שאינן
מנתיות
[54]
P-PERSISTENT CARRIER SENSE
MULTIPLE ACCESS (CSMA) FOR
NON-PACKETIZED WIRELESS
DIGITAL VOICE NETWORKS
[22]
[31]
[51]
[71]
[74]
05.07.2007
11/457191
[32] 13.07.2006
[33] US
Int. Cl.(2010.01) H04L 12//43, H04W 74//00, 74//08
HARRIS CORPORATION, U.S.A.
REINHOLD COHN AND PARTNERS,
211
,ריינהולד כהן ושותפיו
August 31,2011 -א' באלול התשע"א
'א26 רחוב הברזל
רמת החייל
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57]
A communication system, comprising a plurality of radios that form a CSMA wireless
communications network and communicate non-packetized digital voice with each
other; each radio being operative for dividing the period following the end of a
received transmission into a sequence of time slots and in each time slot, deciding
randomly or pseudo-randomly with probability p whether to start transmitting on the
channel in that slot, provided that a new transmission has not been detected on the
channel prior to the start of the slot.
__________________
[11][21]
[54]
ANTIGEN BINDING MOLECULE
THAT BINDS HUMAN EGFR, A
POLYNUCLEOTIDE ENCODING
THE SAME, A VECTOR
COMPRISING A
POLYNUCLEOTIDE ENCODING
THE SAME, A CELL EXPRESSING
A POLYNUCLEOTIDE ENCODING
THE SAME, A METHOD OF
PRODUCING THE SAME, A
PHARMACEUTICAL
COMPOSITION COMPRISING
THE SAME AND USES OF THE
SAME IN THE PREPARATION OF
MEDICAMENTS
[22]
[31]
[51]
[71]
07.02.2006
60/650115
[32] 07.02.2005
Int. Cl.(2010.01) C07K 16//28
GLYCART BIOTECHNOLOGY AG,
212
184498
EGFR מולקולה קושרת אנטיגן אשר קושר
ווקטור, חומצת גרעין המקודדת אותה,אנושי
, תא המבטא אותה,הכולל את חומצת הגרעין
תכשיר הכולל אותה,שיטה להכנת המולקולה
ושימושה בהכנת תכשירים רפואיים
[33]
US
August 31,2011 -א' באלול התשע"א
[87]
[74]
[57]
SWITZERLAND
WO/2006/082515
LUZZATTO & LUZZATTO,
,לוצאטו את לוצאטו
INDUSTRIAL PARK, OMER,
עומר,גן תעשייה
P.O.B. 5352,
באר שבע5352 .ד. ת,
BEER-SHEVA 84152
The present invention relates to antigen binding molecules (ABMs). In particular
embodiments, the present invention relates to recombinant monoclonal antibodies,
including chimeric, primatized or humanized antibodies specific for human EGFR. In
addition, the present invention relates to nucleic acid molecules encoding such ABMs,
and vectors and host cells comprising such nucleic acid molecules. The invention
further relates to methods for producing the ABMs of the invention, and to methods of
using these ABMs in treatment of disease. In addition, the present invention relates to
ABMs with modified glycosylation having improved therapeutic properties, including
antibodies with increased Fc receptor binding and increased effector function.
__________________
[11][21]
184599
עיצובים ותכשירי רוקחות המכילים פוליפפטיד
Aß המלכד
[54]
FORMULATIONS AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
AN Aß BINDING POLYPEPTIDE
[22]
[31]
[51]
[71]
27.01.2006
60/648631
[32] 28.01.2005
[33] US
Int. Cl.(2010.01) A61K 09//00, 09//19, 39//395, 47//02, 47//18, 47//26, C07K 16//18
WYETH LLC, U.S.A.
ELAN PHARMA INTERNATIONAL
LTD., IRELAND
WO/2006/083689
WOLFF, BREGMAN AND GOLLER,
, ברגמן וגולר,וולף
P.O.B. 1352,
ירושלים1352 .ד. ת,
JERUSALEM 91013
The present invention provides formulations for maintaining the stability of A-beta
binding polypeptides, for example, A-beta antibodies. Exemplary formulations include
a tonicity agent such as mannitol and a buffering agent or amino acid such as histidine.
Other exemplary formulations include an antioxidant in a sufficient amount as to
inhibit by-product formation, for example, the formation of high molecular weight
polypeptide aggregates, low molecular weight polypeptide degradation fragments, and
mixtures thereof. The formulations of the invention optionally comprise a tonicity
agent, such as mannitol, and a buffering agent or amino acid such as histidine. The
formulations are suitable for several different routes of administration.
[87]
[74]
[57]
213
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
[54]
SYSTEM FOR SAVING ENERGY
AND WATER AND FOR
INCREASING SYSTEM
LIFETIME IN HARD DRINKING
WATER SUPPLY SYSTEMS
[22]
[51]
[71]
15.07.2007
Int. Cl.(2010.01) F24D 03//00, 03//08
TAMHIL-THE ISRAELI CENTER
FOR WATER IMPROVEMENT
LTD.
SHIMON REDLICH
SHIMON REDLICH
DR. EYAL BRESSLER,
11 TUVAL ST.,
RAMAT GAN 52522
[72]
[74]
[57]
184623
מערכת לחיסכון באנרגיה ומים במערכות מי
שתייה
המרכז הישראלי להשבחת מים-תמהיל
פתח תיקוה,בע"מ
פתח תקווה,שמעון רדליך
שמעון רדליך
,דר' אייל ברסלר עו"פ
11 תובל
גן- רמת
A system for saving energy, water, and increasing system lifetime in hard drinking
water supply systems, comprising one or more modules listed in the specification and
providing increased water efficiency due to instant availability of hot water at all hot
water taps as well as due to smaller pipe volume between hot water reservoir and taps,
and furthermore providing increased energy efficiency due to smaller volumes of hot
water that must be heated or kept hot at any given time as well as due to increased heat
transfer between heating elements and reduced-scale pipes, and due to use of solar
energy instead of electrical or chemical energy for part of the heating load, and
furthermore providing corrosion protection of the pipe interiors due to formation of a
thin zinc oxide layer on the pipe interiors.
The applications for
division from this
application have not yet
been published
,209609,209608,209607
בקשות חלוקה מבקשה זו
.שטרם פורסמו
__________________
[11][21]
[54]
214
SURGICAL PLATE SYSTEM AND
184819
מערכת משטח ניתוחי ומערכת השתלה לשימשו
בתיקון של עצם קטנה
August 31,2011 -א' באלול התשע"א
IMPLANT SYSTEM FOR USE IN
SMALL BONE REPAIR
[22]
[31]
[51]
[71]
[87]
[74]
[57]
27.01.2006
60/648364
[32] 28.01.2005
11/340028
26.01.2006
Int. Cl.(2010.01) A61B 17//58
ORTHOHELIX SURGICAL
DESIGNS, INC., U.S.A.
WO/2006/081422
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[33]
US
US
,' קולב ושות.סנפורד ט
מרמורק,4 שער הגיא
רחובות2273 .ד. ת,
The present invention relates to an orthopedic plate and screw system and instruments
for surgical fixation of a small bone or bones. The plate facilitates three dimensional
contouring to provide for a variety of applications and to accommodate individual
variation in bone shape. The plate has a modified x shape including a central trunk
portion including one or more screw holes along a longitudinal axis and a set of
divergent upper and an oppositely extending set of divergent lower arms, each arm
including screw holes which are placed at a radially equal distance but which
diverging asymmetrically from the longitudinal axis relative to its paired upper or
lower mate. The screws of the system are self-starting, self-tapping screws including
the option of partial or full cannulation.
The applications for division
from this application have
not yet been published
,209247
בקשות חלוקה מבקשה זו
.שטרם פורסמו
__________________
[11][21]
[54]
[22]
215
ANTIBODY WHICH INHIBITS
HER DIMERIZATION FOR USE
AS A MEDICAMENT IN A
METHOD FOR EXTENDING TIME
TO DISEASE PROGRESSION
184884
דימריזציה לשימושHER נוגדן אשר מעכב
כתרופה בשיטה להארכת זמן התקדמות המחלה
21.02.2006
August 31,2011 -א' באלול התשע"א
[31]
[51]
[71]
[87]
[74]
60/655277
[32] 23.02.2005
[33]
Int. Cl.(2010.01) A61K 39//395, A61P 35//00
GENENTECH, INC., U.S.A.
WO/2006/091693
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57]
The present application describes extending time to disease progression or survival in a
cancer patient, where the patient's cancer displays HER activation, by treating the
patient with a HER dimerization inhibitor, such as pertuzumab.
The applications for division
from this application have
not yet been published
US
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
,214332
בקשות חלוקה מבקשה זו
.שטרם פורסמו
__________________
[11][21]
[54]
SEPARATION/PURIFICATION OF
DESFLURANE FROM HYDROGEN
FLUORIDE
[22]
[31]
[51]
[71]
09.02.2006
60/653146
[32] 15.02.2005
Int. Cl.(2010.01) C07C 41//22, 43//12
HALOCARBON PRODUCTS
CORPORATION, U.S.A.
WO/2006/121479
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[87]
[74]
[57]
184922
טיהור של דספלוראן ממימן פלוריד/הפרדה
[33]
US
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
An azeotrope comprising desflurane (CF3CFHOCF2H) and hydrogen fluoride (HF).
The azeotrope can be prepared by fractionally distilling a crude mixture of desflurane
and HF. Purer desflurane can be readily and easily separated from the azeotrope.
The applications for division
from this application have
not yet been published
,210346
בקשות חלוקה מבקשה זו
.שטרם פורסמו
__________________
216
August 31,2011 -א' באלול התשע"א
[11][21]
184931
תכשיר פרמצבטי לדיכוי או טיפול
בהיפרגליצמיה
[54]
PHARMACEUTICAL
COMPOSITION FOR
SUPPRESSION OR TREATMENT
OF HYPERGLYCEMIA
[22]
[31]
23.02.2006
2005-046562 [32] 23.02.2005
[33] JP
2006-003219
11.01.2006
JP
Int. Cl.(2010.01) A61K 38//22, A61P 03//10, 43//00, C07K 14//435, 14//575, 14//60
DAIICHI SANKYO COMPANY,
LIMITED, JAPAN
KYOTO UNIVERSITY, JAPAN
WO/2006/090767
DANIEL FREIMANN & CO.,
,'דניאל פריימן ושות
5 DROYANOV ST., 10TH FLOOR ,
10 בית כלל קומה5 דרויאנוב
TEL AVIV 63143
תל אביב
A pharmaceutical preparation comprising ghrelin or a derivative thereof as the active
ingredient, which can promote the generation or regeneration of pancreatic beta cells
which produce and secrete insulin and can promote the production of insulin in the
beta cells.
[51]
[71]
[87]
[74]
[57]
__________________
[11][21]
184952
מסוע קרמי מסולסל עם כיסוי מתכת בצדדיו
ושיטה להרכבתו
[54]
CERAMIC CONVEYOR ROLL
WITH METAL END CAPS AND ITS
ASSEMBLY
[22]
[31]
[51]
[71]
21.02.2006
05447040.6
[32] 22.02.2005
[33] EP
Int. Cl.(2010.01) B65G 39//02, F16D 01//08, F27D 03//02
VESUVIUS CRUCIBLE COMPANY,
U.S.A.
WO/2006/089716
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[87]
[74]
217
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
August 31,2011 -א' באלול התשע"א
[57]
The present invention relates to conveyor rolls used in high temperature applications,
and more particularly concerns an improved end cap assembly for such rolls.
According to the invention, the conveyor roll (1) comprises a) a ceramic spool (2), b)
at each end (21 ,22) of the ceramic spool (2), an end cap (4) comprising a metal ferrule
(41) and having a certain internal circumference adapted to fit over an end (21) of the
ceramic spool; and c) interposed between each end (21 ,22) of the ceramic spool (2)
and the end cap (4) a tolerance ring (3) of resilient metal having a plurality of
circumferentially arranged corrugations. This conveyor roll can resist temporary
overheat or blockage without damages
__________________
[11][21]
184992
תומך אינטגרלי למראה
[54]
INTEGRALLY FORMED
SUPPORT FOR A MIRROR
[22]
[31]
01.08.2007
0615727.5
[32] 08.08.2006
[33] GB
06254142.0
08.08.2006
EP
Int. Cl.(2010.01) G02B 07//00, 07//182
SELEX GALILEO LTD, UNITED
KINGDOM
PEARL COHEN ZEDEK LATZER,
,פרל כהן צדק לצר
5 SHENKAR ST.,
5 רח' שנקר,1 ים-מרכז גב
P.O.B. 12704,
הרצליה12704 .ד. ת,
HERZLIYA 46733
An integrally formed support for a mirror comprising; a rigid portion; a plurality of
base portions suitable for mounting the mirror thereto; and a plurality of substantially
linear flexure elements provided substantially perpendicular to one another and
disposed between the mount portion and the base portion to connect the mount portion
and the base portion together; wherein the flexure elements each define an axis of
rotation and are operable to allow the mount portion to rotate relative to the base
portion along either said axis of rotation.
[51]
[71]
[74]
[57]
218
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
185375
שיטות ומיכשור לעיצוב כלי מצרר על בסיס
פלאזמה
[54]
METHODS AND APPARATUS FOR
CONFIGURING PLASMA
CLUSTER TOOLS
[22]
[31]
16.02.2006
60/656862
[32] 25.02.2005
[33] US
11/098037
31.03.2005
US
Int. Cl.(2010.01) G06F 19//00
LAM RESEARCH CORPORATION,
U.S.A.
CHUNG-HO HUANG, SHIH-JEUN
FAN, CHIN-CHUAN CHANG
WO/2006/093695
JMB, FACTOR & CO. LTD.,
, פקטור אנד קו בע"מ,ג'יי אמ בי
HAR HOTZVIM HI-TECH PARK,
הר חוצבים,רחוב המרפא
P.O.B. 45087,
ירושלים45087 .ד. ת,
JERUSALEM 91450
A method for configuring a specific plasma cluster tool having a plurality of modules.
The method includes providing a set of module option definition files, the set of
module option definition files containing generic configuration definitions for generic
plasma cluster tools. The method further includes providing a set of tool-specific
protection information, the set of tool-specific protection information including data
that specifically identifies the particular plasma cluster tool for which the configuring
is intended. The method further includes providing a set of tool-specific options
specifications, the set of tool-specific options specifications specifying options that are
specified for the specific plasma cluster tool. The method additionally includes
generating a key file, the key file encapsulating configuration restrictions imposed on
[51]
[71]
[72]
[87]
[74]
[57]
219
August 31,2011 -א' באלול התשע"א
the specific plasma cluster tool, the key file being configured to be a required file in
the configuring the specific plasma tool.
__________________
[11][21]
[54]
PROCESSES FOR OXIDATION OF
BROMIDES TO PRODUCE
BROMINE AND CATALYSTS
USEFUL THEREIN
[22]
[31]
[51]
[71]
22.08.2007
60/840196
[32] 25.08.2006
Int. Cl.(2010.01) C01B 07//09
ALBEMARLE CORPORATION,
U.S.A.
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
[74]
[57]
185455
תהליכים לחימצון ברומידים לייצור ברום וזרזים
שימושיים לכך
[33]
US
עורכי דין ועורכי,קבוצת איתן מהולל
,פטנטים
10 שדרות אבא אבן
הרצליה2081 .ד. ת,
A method comprising: (i) passing an aqueous solution and steam through a packed
column in a continuous process and wherein the aqueous solution (a) has been formed
from at least a bromide source, hydrogen peroxide (H2O2), a mineral acid, and a
catalyst comprising a Group I cation and an oxide of a transition metal, (b) has a pKa
of less than about -1.74, and (c) is at 15 to 20º C; and (iii) producing bromine in at
least a 90 wt % hydrogen peroxide-based yield.
__________________
[11][21]
[54]
220
OPTICAL TRACKING SYSTEM
FOR REFUELING
185475
מערכת מעקב אופטית לתדלוק
August 31,2011 -א' באלול התשע"א
[22]
[31]
[51]
[71]
[87]
[74]
[57]
24.02.2006
60/656084
[32] 25.02.2005
[33] US
11/249262
14.10.2005
US
Int. Cl.(2010.01) B64D 39//00, G01S 17//74
GE AVIATION SYSTEMS, LLC,
U.S.A.
WO/2006/091779
SELIGSOHN GABRIELI & CO.,
,'זליגסון גבריאלי ושות
31 YAVNE ST.,
31 רח' יבנה
P.O.B. 1426,
תל אביב1426 .ד. ת,
TEL AVIV 61013
An aerial refueling system including a refueling drogue assembly (100) including a
refueling drogue and a refueling hose (110) in captive relation with the refueling
drogue and a drogue positioning system. The drogue positioning system including a
radiation emitter (200), a radiation receiver (300) and a signal processor. Then the
radiation emitter (200) is adapted to direct radiation to a positioning area (400) a
defined distance from the radiation emitter, the radiation carrying a modulated location
signal containing information corresponding to positions within the positioning area
(400). The radiation receiver (300) is adapted to receive at least a portion of the
emitted radiation carrying the modulated signal and output a signal to the signal
processor indicative of the modulation of the location signal of the received radiation.
And the signal processor is adapted to process the outputted signal and identify a
position within the positioning area (400) indicative of the location in the positioning
area of the received radiation.
The applications for division
from this application have
not yet been published
,210302,210301
בקשות חלוקה מבקשה זו
.שטרם פורסמו
__________________
[11][21]
[54]
221
7-(2-(4-(3-TRIFLUOROMETHYLPHENYL)-1,2,3,6-TETRAHYDROPYRID-1-YL) ETHYL)
ISOQUINOLINE BESYLATE SALT,
ITS PREPARATION AND
185537
– 3)– 4)– 2)– 7 מלח בסילט של
–1 ,2 3 ,6 – (טריפלואורומתיל– פניל
, –איל( אתיל איזוקווינולין1–טטראהידרופיריד
הכנתו ושימוש רפואי בו
August 31,2011 -א' באלול התשע"א
THERAPEUTIC USE THEREOF
[22]
[31]
[51]
[71]
[87]
[74]
[57]
15.03.2006
0502611
[32] 17.03.2005
[33] FR
Int. Cl.(2010.01) A61K 31//4709, A61P 19//02, 29//00, 37//00, C07D 40/1/10
SANOFI-AVENTIS, FRANCE
WO/2006/097624
SANFORD T.COLB & CO.,
,' קולב ושות.סנפורד ט
P.O.B. 2273,
מרמורק,4 שער הגיא
REHOVOT 76122
רחובות2273 .ד. ת,
The invention concerns 7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydro-pyrid-1yl)ethyl) isoquinoline besylate salt. The invention also concerns a method for
preparing 7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydro-pyrid-1-yl)ethyl)
isoquinoline besylate salt, as well as the therapeutic use thereof.
__________________
[11][21]
185692
תולדות של אצטילניל–פירזולו–פירימידין
MGLUR2 כאנטגוניסטים של
[54]
ACETYLENYL-PYRAZOLOPYRIMIDINE DERIVATIVES AS
MGLUR2 ANTAGONISTS
[22]
[31]
[51]
14.03.2006
05102332.3
[32] 23.03.2005
[33] EP
Int. Cl.(2010.01) A61K 31//4745, 31//5025, 31//519, A61P 25//00, C07D 47/1/04,
48/7/04
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2006/099972
LUZZATTO & LUZZATTO,
,לוצאטו את לוצאטו
INDUSTRIAL PARK, OMER,
עומר,גן תעשייה
P.O.B. 5352,
באר שבע5352 .ד. ת,
BEER-SHEVA 84152
The present invention relates to compounds of formula (I): a process for the
manufacture thereof, their use for the preparation of medicaments for treating CNS
disorders and pharmaceutical compositions containing them, wherein R1 to R3, A, M,
L, E, G, and J are as defined in the description and claims.
[71]
[87]
[74]
[57]
222
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
185765
קרומים מורכבים ננו המכילים חלקקי ננו
ושיטות להכנתם
[54]
NANOCOMPOSITE MEMBRANES
CONTAINING NANO PARTICLES
AND METHODS FOR MAKING
THE SAME
[22]
[31]
[51]
[71]
27.02.2006
60/660428
[32] 09.03.2005
[33] US
Int. Cl.(2010.01) B01D 63//00
THE REGENTS OF THE
UNIVERSITY OF CALIFORNIA,
U.S.A.
WO/2006/098872
WOLFF, BREGMAN AND GOLLER,
, ברגמן וגולר,וולף
P.O.B. 1352,
ירושלים1352 .ד. ת,
JERUSALEM 91013
Disclosed are nanocomposite membranes and methods for making and using same. In
one aspect, the nanocomposite membrane comprises a film comprising a polymer
matrix and nanoparticles disposed within the polymer matrix, wherein the film is
substantially permeable to water and substantially impermeable to impurities. In a
further aspect, the membrane can further comprise a hydrophilic layer. In a further
aspect, the nanocomposite membrane comprises a film having a face, the film
comprising a polymer matrix, a hydrophilic layer proximate to the face, and
nanoparticles disposed within the hydrophilic layer, wherein the film is substantially
permeable to water and substantially impermeable to impurities.
[87]
[74]
[57]
__________________
223
August 31,2011 -א' באלול התשע"א
[11][21]
185880
שיטה לניהול תחנה ניידת במערכת גישה ברשת
אלחוטית רחבת–רצועה
[54]
METHOD OF MANAGING
MOBILE STATION IN
BROADBAND WIRELESS ACCESS
SYSTEM
[22]
[31]
24.03.2006
10-2005[32] 24.03.2005
[33] KR
0024703
Int. Cl.(2010.01) H04B 07//26, H04W 08//24, 36//08, 60//06, 76//04
LG ELECTRONICS INC., REPUBLIC
OF KOREA
WO/2006/101370
PEARL COHEN ZEDEK LATZER,
,פרל כהן צדק לצר
5 SHENKAR ST.,
5 רח' שנקר,1 ים-מרכז גב
P.O.B. 12704,
הרצליה12704 .ד. ת,
HERZLIYA 46733
The primitives between an upper management layer and the MAC layer within a
mobile station and a base station are defined in order to specify and clarify the
operations within the protocol stack layers in a broadband wireless access system to
allow management of a mobile station. Media Independent Handover (MIH)
procedures can be achieved because the NCMS and MIH layer can communicate
through use of these primitives.
[51]
[71]
[87]
[74]
[57]
__________________
[11][21]
[54]
RF MEMS SWITCH WITH A
FLEXIBLE AND FREE SWITCH
MEMBRANE
[22]
[31]
07.03.2006
05370005.0
224
[32]
21.03.2005
185992
–מפסק תדירי רדיו למערכות מיקרו
אלקטרומכניות עם מפסק ממברנה גמיש חופשי
[33]
EP
August 31,2011 -א' באלול התשע"א
[51]
[71]
[87]
[74]
[57]
Int. Cl.(2010.01) H01H 01//00
DELFMEMS, FRANCE
WO/2006/099945
PEARL COHEN ZEDEK LATZER,
,פרל כהן צדק לצר
5 SHENKAR ST.,
5 רח' שנקר,1 ים-מרכז גב
P.O.B. 12704,
הרצליה12704 .ד. ת,
HERZLIYA 46733
The RF MEMS switch comprising micromechanical switching means that are carried
by a substrate (1) and that can be actuated between two positions: a first position (offstate/ figure 1) and a second position (on- state), and actuation means for actuating the
position of the switching means. The micromechanical switching means comprise a
flexible membrane (6) which is freely supported by support means (3), which is
bendable under the action of the actuation means (7), and which can freely slide
relatively to the support means (3) during its bending movement.
__________________
[11][21]
186160
התקן לקירור מהיר
[54]
QUICK REFRIGERATION
APPARATUS
[22]
[51]
[71]
[87]
[74]
31.03.2005
Int. Cl.(2010.01) A23L 03//36, F25D 23//00
NORIO OWADA, JAPAN
WO/2006/114813
WOLFF, BREGMAN AND GOLLER,
, ברגמן וגולר,וולף
P.O.B. 1352,
ירושלים1352 .ד. ת,
JERUSALEM 91013
To provide a quick refrigeration apparatus and a quick refrigerating method for
refrigerating an object to be preserved while maintaining the freshness and high
quality of the object over a long term by suppressing subtle reactions of the object and
the gas in the storage thereby preventing deformation/degeneration of the object, and
applicable to long term preservation of a tissue of an organism. [MEANS FOR
SOLVING PROBLEMS] The quick refrigeration apparatus comprises a refrigerated
storage (11) provided with a door for placing and taking out an object (3) to be
preserved, a refrigerating machine (17) capable of lowering the temperature in the
[57]
225
August 31,2011 -א' באלול התשע"א
storage below about -30°C, a pressure regulator (60) for regulating the gas pressure in
the storage, and a means (31) for supplying cooling air to the object contained in the
storage at a wind velocity of 1-5 m/sec. The pressure regulator (60) comprises an
operation control means (68) which detects the temperature in the storage and operates
a pressure reducing means (62) to reduce the pressure in the storage to the atmospheric
pressure or below when the temperature in the storage exceeds a predetermined level,
stops the operation of the pressure reducing means (62) when the temperature in the
storage exceeds the predetermined level, and operates a pressurizing means (61) to
increase the pressure in the storage above the atmospheric pressure.
__________________
[11][21]
186163
תהליך להכנת תולדות צקלופרופילפניל
[54]
PROCESS FOR PRODUCING
CYCLOPROPYLPHENYL
DERIVATIVES
[22]
[31]
[51]
[71]
31.03.2006
2005-102820 [32] 31.03.2005
[33] JP
Int. Cl.(2010.01) C07C 37//00, 37//01, 37//20, 39//17
SANKYO AGRO COMPANY,
LIMITED, JAPAN
WO/2006/106906
WOLFF, BREGMAN AND GOLLER,
, ברגמן וגולר,וולף
P.O.B. 1352,
ירושלים1352 .ד. ת,
JERUSALEM 91013
A method of easily synthesizing a cyclopropylphenol derivative. The method, which is
a process for producing a cyclopropylphenol derivative represented by the general
formula (10): [wherein R1, R2, R3, and R4 each independently is hydrogen, etc.; Z is
hydrogen, etc.; and Y1, Y2, and Y3 each independently is hydrogen, etc.], comprises
reacting a compound represented by the general formula (7): [wherein the symbols
have the same meanings as defined above; X is halogeno; and V is hydrogen, etc.]
with a metal, metal salt, or organometallic compound represented by the general
formula M2 (8) to obtain a compound represented by the general formula (9): [wherein
[87]
[74]
[57]
226
August 31,2011 -א' באלול התשע"א
the symbols have the same meanings as defined above]. When V is a -W-R5 group,
hydrolysis is further conducted. Thus, a compound of the general formula (10) is
obtained.
__________________
[11][21]
186213
[54]
TREATMENT OF GAS FROM AN
IN SITU CONVERSION PROCESS
[22]
[31]
[51]
[71]
24.04.2006
60/674081
[32] 22.04.2005
[33]
Int. Cl.(2010.01) C10L 03//08, E21B 36//04
SHELL INTERNATIONALE
RESEARCH MAATSCHAPPIJ B.V.,
THE NETHERLANDS
WO/2006/116207
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[87]
[74]
[57]
227
טיפול בגז מתהליך המרה פנימי
US
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
The invention provides methods of producing methane that include: producing
formation fluid from a subsurface in situ conversion process and separating the
formation fluid to produce a liquid stream and a first gas stream. The first gas stream
includes olefins. The first gas stream is contacted with a hydrogen source in the
presence of one or more catalysts to produce a second gas stream. Steam, carbon
monoxide, and/or hydrogen may be present or added to in the first stream during
contacting. The second gas stream is contacted with a hydrogen source in the presence
of one or more additional catalysts to produce a third gas stream that includes methane.
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
186327
שיטה ומערכת ליישום מדיניות הרשאה לשרותי
רשת
[54]
METHOD AND SYSTEM FOR
IMPLEMENTING
AUTHORIZATION POLICIES FOR
WEB SERVICES
[22]
[31]
[51]
[71]
[87]
[74]
20.02.2006
10/907577
[32] 06.04.2005
[33] US
Int. Cl.(2010.01) H04L 09//00, 29//06
IBM CORPORATION, U.S.A.
WO/2006/106010
SUZANNE EREZ, IBM R&D
,R&D מעבדות יבמ,סוזן ארז
LABORATORIES,
הר הכרמל,אוניברסיטת חיפה
HAIFA UNIVERSITY,
חיפה
HAIFA 31905
A method, system and computer program product for implementing authorization
policies for web services may include defining an authorization policy for access to a
web service. The method, system and computer program product may also include
attaching the authorization policy to a service definition for the web service.
[57]
__________________
228
August 31,2011 -א' באלול התשע"א
[11][21]
186449
דיסק לקריעה הפועל במהופך בעל קו חולשה
אלקטרו–מלוטש מוגדר–לייזר ושיטה ליצור קו
החולשה
[54]
REVERSE ACTING RUPTURE
DISC WITH LASER-DEFINED
ELECTROPOLISHED LINE OF
WEAKNESS AND METHOD OF
FORMING THE LINE OF
WEAKNESS
[22]
[31]
[51]
[71]
[87]
[74]
23.03.2006
11/096466
[32] 01.04.2005
[33] US
Int. Cl.(2010.01) B23K 26//02, B65D 90//36
FIKE CORPORATION, U.S.A.
WO/2006/107629
EITAN MEHULAL LAW GROUP,
עורכי דין ועורכי,קבוצת איתן מהולל
10 ABBA EBEN BLVD.,
,פטנטים
P.O. B. 2081,
10 שדרות אבא אבן
HERZLIYA 46120
הרצליה2081 .ד. ת,
A reverse acting rupture disc is provided having a laser defined electropolished line-ofweakness recess, and an improved method of forming an electropolished line-ofweakness recess in a reverse acting rupture disc that assures full opening of the disc
upon reversal. A rupture disc blank is pre-bulged, final bulged, and then provided with
a layer of resist material. A laser is used to remove at least a portion of the layer of
resist material corresponding to a desired line-of-weakness recess in the concave face
of the bulged rupture disc. The disc is then subjected to an electropolishing operation
to remove metal from the lased area of the rupture disc, thereby forming a lustrous
polished line-of-weakness recess in the disc of desired configuration and of a
predetermined depth that is related to material thickness.; The electropolished line of
weakness is defined by spaced opposed channel portions separated by a central raised
crown portion wherein the channel portions are of greater depth than the crown
portion. The burst/reversal pressure of the disc having an electropolished line-ofweakness recess may be selectively controlled by varying the pre-bulging pressure on
the disc.
[57]
__________________
[11][21]
[54]
229
4-PHENYL-5-OXO-1,4,5,6,7,8HEXAHYDROQUINOLINE
DERIVATIVES AS
186676
–8,7,6,5,4,1––אוקסו5––פניל4 תולדות
הקסאהידרוקווינולין כתרופות לטיפול בעקרות
August 31,2011 -א' באלול התשע"א
MEDICAMENTS FOR THE
TREATMENT OF INFERTILITY
[22]
[31]
[51]
[71]
[87]
[74]
[57]
02.05.2006
05103738.0
[32] 04.05.2005
[33] EP
Int. Cl.(2010.01) A61K 31//47, 31//4709, A61P 05//24, C07D 21/5/20, 40/1/12,
40/5/12, 41/7/12
N.V. ORGANON, THE
NETHERLANDS
WO/2006/117370
REINHOLD COHN AND PARTNERS,
,ריינהולד כהן ושותפיו
26A HABARZEL ST.,
'א26 רחוב הברזל
RAMAT HACHAYAL 69710
רמת החייל
The invention relates to a 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydroquinoline derivative
according to Formula (I), wherein the substituents are defined as in the description, or
a pharmaceutically salt thereof. The compounds of this invention are potent FSH
receptor activators and may be used for treating fertility disorders in e.g. controlled
ovarian hyperstimulation and IVF procedures.
__________________
[11][21]
[54]
BREATH ACTUATED INHALER
[22]
[31]
[51]
[71]
[87]
[74]
07.04.2006
10/908133
[32] 28.04.2005
Int. Cl.(2010.01) A61M 16//04
KOS LIFE SCIENCES, INC., U.S.A.
WO/2006/115732
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
230
186698
משאף המופעל בנשימה
[33]
US
,'ד"ר שלמה כהן ושות
124 אבן גבירול
תל אביב11490 .ד. ת,
August 31,2011 -א' באלול התשע"א
[57]
A breath actuated metered dose inhaler including a housing, a mouthpiece positioned
at one end of the housing, and a mechanical release mechanism positioned at another
end of the housing. The release mechanism is triggered by a diaphragm and the inhaler
is configured such that the air inhalation pathway is unimpeded by the release
mechanism.
__________________
[11][21]
186725
שיטה ומתקן לגלגול בצק ובצק בצורת דיסק
המיוצר לפי השיטה
[54]
METHOD AND APPARATUS FOR
ROLLING FOOD DOUGH AND
DISK-SHAPED FOOD DOUGH
MANUFACTURED BY THE
METHOD
[22]
[31]
01.06.2006
2005-163837 [32] 03.06.2005
[33] JP
2005-210490
20.07.2005
JP
2005-211278
21.07.2005
JP
2005-376011
27.12.2005
JP
Int. Cl.(2010.01) A21C 03//02, 11//00
RHEON AUTOMATIC MACHINERY
CO., LTD., JAPAN
MICHIO MORIKAWA, TORAHIKO
HAYASHI, TAKAMASA
TSUCHIDA, HIROSHI EBATA,
NORIO KOBAYASHI
WO/2006/129759
DR. MARK FRIEDMAN LTD.,
,ד"ר מרק פרידמן בע"מ
MOSHE AVIV TOWER, 54TH
7 רח ז'בוטינסקי, 54. ק,מגדל משה אביב
FLOOR,
גן-רמת
7 JABOTINSKY ST.,
RAMAT GAN 52520
A method and a device for uniformly spreading a lump of food dough without
[51]
[71]
[72]
[87]
[74]
[57]
231
August 31,2011 -א' באלול התשע"א
occurrence of slippage between the food dough and a spreading roller and without
occurrence of shrinkage of the food dough when the food dough is spread in a flat
shape, and a disk-like food dough obtained by the method. In the method of spreading
the lump of the food dough (3) placed on a loading table (7) in the flat shape, the
conical spreading roller revolvable and rotatable relative to the loading table is
installed on a lifting frame vertically movable relative to the loading table, and when
the food dough is spread by pressing the spreading roller against the food dough, the
spreading roller is drivingly rotated at a speed higher than that when the spreading
roller is revolved and rotated in a driven manner to spread the food dough. The
pressing speed of the spreading roller relative to the food dough is lowered at the end
time more than that at the beginning time.
__________________
[11][21]
186748
– 8 ,7 ,6 ,5 ,4 ,1– –אוקסו5 –– פניל4 נגזרות של
הקסאהידרוקווינולין לטיפול בעקרות
[54]
4-PHENYL-5-OXO-1, 4, 5, 6, 7, 8HEXAHYDROQUINOLINE
DERIVATIVES FOR THE
TREATMENT OF INFERTILITY
[22]
[31]
[51]
02.05.2006
05103735.6
[32] 04.05.2005
[33] EP
Int. Cl.(2010.01) A61K 31//47, 31//4709, A61P 05//24, C07D 21/5/20, 40/1/12,
40/5/12, 40/9/12, 41/7/12
N.V. ORGANON, THE
NETHERLANDS
WO/2006/117368
REINHOLD COHN AND PARTNERS,
,ריינהולד כהן ושותפיו
26A HABARZEL ST.,
'א26 רחוב הברזל
RAMAT HACHAYAL 69710
רמת החייל
[71]
[87]
[74]
[57]
232
The present invention relates to 4-phenyl-5-oxo-l,4)5,6,7,8-hexahydroquinoline
derivatives according to Formula I, Formula I or a pharmaceutically acceptable salt
thereof, wherein R1 is (l-6C)alkyl, (2-6C)alkenyl or (2-6C)aDcynyl; R2, R3 are
August 31,2011 -א' באלול התשע"א
independently halogen, (l-4C)allcyl, (2-4C)alkenyl, (2-4C)- alkynyl, (1 -4C)aBcoxy,
(3-4C)alkenyloxy or (3-4C)alkynyloxy; R4 is phenyl or (2-5C)- heteroaryl, both
substituted with R7 and optionally substituted on the (hetero)aromatic ring with one or
more substituents selected from hydroxy, amino, halogen, nitro, trifluoromethyl,
cyano, (l-4C)alkyl, (l-4C)alkoxy , (l-4C)alkylthio and (di)(l-4C)- alkylamino. The
invention also relates to pharmaceutical compositions comprising said derivatives, as
well as to the use of these 4-phenyl-5-oxo-l, 4,5,6, 7,8-hexahydro- quinoline
derivatives in therapy, more specifically for the treatment of infertility
__________________
[11][21]
186769
פריט לבוש דתי עם אמצעי המתנגד לתנועה
סיבובית של הפתילים שלו
[54]
RELIGIOUS GARMENT WITH
MEANS FOR RESISTING THE
ANGULAR DISPLACEMENT OF
THE STRANDS THEREOF
[22]
[51]
[71]
18.10.2007
Int. Cl.(2010.01) A41B 09//02, A41D 01//00
MATITYAHU TENENBAUM,
U.S.A.
LUZZATTO & LUZZATTO,
,לוצאטו את לוצאטו
INDUSTRIAL PARK, OMER,
עומר,גן תעשייה
P.O.B. 5352,
באר שבע5352 .ד. ת,
BEER-SHEVA 84152
A four cornered religious garment having four sets of braided strands, each of said sets
of braided strands comprising a knotted portion, a plurality of strands extending from
the knotted portion wherein each of said strands has an unattached end, and a loop of
strands connected to the knotted portion and displacingly attached to a corresponding
aperture formed in the vicinity of each of the corners by a loop of strands and passing
through said aperture, said religious garment comprising a plurality of rigidizing
elements for resisting the angular displacement of a corresponding set of braided
strands, each of said rigidizing elements being attached to fabric of the religious
[74]
[57]
233
August 31,2011 -א' באלול התשע"א
garment in the vicinity of the corresponding aperture and thereby being capable of
resisting a vertical downwardly directed bending including weight of at least 200 g
applied to a knotted portion when the religious garment is placed on a raised
horizontal surface and immobilized.
__________________
[11][21]
186831
– 8,7,6,5,4,1 – – אוקסו5 – – פניל4 תולדות
הקסאהידרוקווינולין כתרופות לטיפול בעקרות
[54]
4-PHENYL-5-OXO-1,4,5,6,7,8HEXAHYDROQUINOLINE
DERIVATIVES AS
MEDICAMENTS FOR THE
TREATMENT OF INFERTILITY
[22]
[31]
[51]
[71]
02.05.2006
05103741.4
[32] 04.05.2005
[33] EP
Int. Cl.(2010.01) A61K 31//47, 31//4709, A61P 05//24, C07D 21/5/20, 40/1/12
N.V. ORGANON, THE
NETHERLANDS
WO/2006/117371
REINHOLD COHN AND PARTNERS,
,ריינהולד כהן ושותפיו
26A HABARZEL ST.,
'א26 רחוב הברזל
RAMAT HACHAYAL 69710
רמת החייל
[87]
[74]
[57]
234
The present invention- relates to 2-methyl-4-phenyl-5-oxo-1 ,4,5,6,7,8hexahydroquinoline derivatives having the general Formula (I) wherein the
substituents are defined as in the description, or a pharmaceutically acceptable salt
thereof. The invention also relates to pharmaceutical compositions comprising said
derivatives, as well as to the use of these 2-methyl-4-phenyl-5-oxo-1 ,4,5,6,7,8hexahydroquinoline derivatives in therapy, more specifically for the treatment of
fertility disorders.
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
[54]
LARGE MESH DEFORMATION
USING THE VOLUMETRIC
GRAPH LAPLACIAN
[22]
[31]
[51]
[71]
22.06.2006
11/158428
[32] 22.06.2005
Int. Cl.(2010.01) G06G 05//00
MICROSOFT CORPORATION,
U.S.A.
WO/2007/002453
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[87]
[74]
[57]
186858
דפורמצית רשת גדולה המשתמשת בגרף
ולומטרי לאפלסיאני
[33]
US
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
Large mesh deformation using the volumetric graph Laplacian is described. In one
aspect, information is received from a user, wherein the information indicates how an
original mesh is to be deformed. The original mesh is then deformed based on the
information and application of a volumetric differential operator to a volumetric graph
generated from the original mesh.
__________________
[11][21]
[54]
LOCK DEVICE AND METHOD OF
ASSEMBLY THEREOF
[22]
[31]
27.04.2006
0500977-4
235
[32]
29.04.2005
186922
התקן נעילה ושיטה להרכבתו
[33]
SE
August 31,2011 -א' באלול התשע"א
[51]
[71]
[87]
[74]
[57]
Int. Cl.(2010.01) E05B 27//00, 47//02, 47//06
ASSA AB, SWEDEN
WO/2006/118521
EITAN MEHULAL LAW GROUP,
עורכי דין ועורכי,קבוצת איתן מהולל
10 ABBA EBEN BLVD.,
,פטנטים
P.O. B. 2081,
10 שדרות אבא אבן
HERZLIYA 46120
הרצליה2081 .ד. ת,
A lock device comprises a housing (2) which includes an opening (4) and a core (10)
which is rotatably mounted in the opening (4) about a longitudinal axis of the core and
which includes a key way (12) for reception of a key. A latching element (20) co-acts
between the housing (2) and the core (10). An electronically controllable actuator (30)
is mounted in the core (10) and which is movable by means of a motor (40) between
an opening-registering position in which movement of the latching element (20) to the
release position is permitted, and a latching position in which movement of the
latching element (20) to the release position is blocked. The motor (40) is provided in
a recess (10a) in the barrel surface (10b) of the core at a distance from the end surfaces
of the core. Because the recess turns into a bore (10c) having a cross-section that
essentially correspond to the cross-section of the actuator and which extends parallel to
the longitudinal axis of the core and in which the actuator (30) is provided; and that the
latching element (20) is provided in a slit (10d) provided between the bore and the
barrel surface of the core, the advantage is achieved that forces on the latching element
are taken up by the core itself, which improves the security. The provision of the
recess at a distance from the end surfaces of the core gives at the same time a flexible
solution as regards assembly. A method of assembling the lock device is also
described.
__________________
[11][21]
[54]
PEST DETERRENT SYSTEM
[22]
[51]
28.10.2007
Int. Cl.(2010.01) A01M 01//22, 29//00
236
186962
מערכת להרתעת מזיקים
August 31,2011 -א' באלול התשע"א
[71]
[74]
[57]
DAN MILNER
יהודה- אבן,דן מילנר
ZEEV EFRAT
רמת השרון,זאב אפרת
NAOMI ASSIA & CO. LAW
,נעמי אסיא ושות' משרד עורכי דין
OFFICES,
רמת החייל32 רח' הברזל
32 HABARZEL ST.
אביב-תל
RAMAT HACHAYAL
TEL AVIV 69710
A system for deterring pests from an area of crop growth, comprising: (a) irrigation
means; (b) at least one power generating module adapted to convert fluid flow within
said irrigation means into electrical power, (c) pest deterring modules capable of
emitting pest deterring effects; (d) control means for programming and controlling
said system; wherein said control means are in electrical communication with said at
least one power generating module and with said pest deterring modules.
__________________
[11][21]
187125
תכשירים, תהליך לייצורן,נגזרות פתלוציאנין
רוקחיים המכילים אותן ושימוש בהם
[54]
PHTHALOCYANINE
DERIVATIVES, PROCESS FOR
THEIR PREPARATION,
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM AND THEIR USE
[22]
[31]
[51]
[71]
04.05.2006
FI2005A00092 [32] 05.05.2005
[33] IT
Int. Cl.(2010.01) A61K 33//30, A61P 31//04, C07D 48/7/22
L. MOLTENI & C. DEI FRATELLI
ALITTI SOCIETA' DI ESERCIZIO
S.P.A., ITALY
GABRIO RONCUCCI, GIACOMO
CHITI, ANNALISA COCCHI, LIA
FANTETTI, STEFANO
MASCHERONI, DONATA DEI
WO/2006/117399
PEARL COHEN ZEDEK LATZER,
,פרל כהן צדק לצר
5 SHENKAR ST.,
5 רח' שנקר,1 ים-מרכז גב
P.O.B. 12704,
הרצליה12704 .ד. ת,
HERZLIYA 46733
Phthalocyanine derivatives are described having photosensitising characteristics and
high solubility in water, useful for photodynamic treatment of bacterial infections, in
particular infections generated by Gram-negative bacteria.
[72]
[87]
[74]
[57]
237
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
187182
–מחסנית לאחסון ואספקה של תרכובת דו
פאזית
[54]
CARTRIDGE FOR STORAGE AND
DELIVERY OF A TWO-PHASE
COMPOUND
[22]
[31]
[51]
[71]
[72]
27.01.2006
VI2005A000152 [32] 20.05.2005
[33] IT
Int. Cl.(2010.01) A61F 02//46, A61J 01//06, A61M 05//315, B01F 13//00
TECRES S.P.A., ITALY
GIOVANNI FACCIOLI, RENZO
SOFFIATTI
WO/2006/123205
JMB, FACTOR & CO. LTD.,
, פקטור אנד קו בע"מ,ג'יי אמ בי
HAR HOTZVIM HI-TECH PARK,
הר חוצבים,רחוב המרפא
P.O.B. 45087,
ירושלים45087 .ד. ת,
JERUSALEM 91450
This invention finds application in the field of the devices and methods for physical or
chemical mixing of products and particularly relates to a cartridge for storage and
sterile delivery of a two-phase compound. The cartridge comprises a first tubular
member (2) which defines a first chamber (3) for storage of a solid phase, having a
bottom wall (6) with an opening (7) for the passage of the compound, a second tubular
member (9) which defines a second hermetically sealed chamber (12) for storage of a
liquid phase, and a piston which sealably slides within the first tubular member (2),
means (8) for occluding said opening (7) which comprise at least one rupturable
membrane (15) associated to the bottom wall (6).
[87]
[74]
[57]
238
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
187266
מודול ניהול עם מיתוג חכם ושיטה
[54]
SMART-SWITCH MANAGEMENT
MODULE SYSTEM AND METHOD
[22]
[31]
[51]
[71]
[72]
12.05.2006
11/127850
[32] 12.05.2005
[33] US
Int. Cl.(2010.01) G06F 15//173
AVOCENT FREMONT CORP., U.S.A.
GRAHAM HOLT, HENRIQUE
GOBBI DE OLIVIERA, IVAN
PASSOS, DAVID IAN WHITE
WO/2006/124612
JMB, FACTOR & CO. LTD.,
, פקטור אנד קו בע"מ,ג'יי אמ בי
HAR HOTZVIM HI-TECH PARK,
הר חוצבים,רחוב המרפא
P.O.B. 45087,
ירושלים45087 .ד. ת,
JERUSALEM 91450
A system for transparent switching of management sessions utilizing in-band and outof- band technologies is provided. The system provides continuous access to the
managed system(s) by combining in-band tools, which generally require lower
network bandwidth and provide better response time with less latency when the system
under management is in-service, with out-of- band tools that provide continued access
to the system under management when the network interface or operating system
become unstable or the system in placed by an operator or falls unexpectedly to an outof-service condition.
[87]
[74]
[57]
__________________
239
August 31,2011 -א' באלול התשע"א
[11][21]
187313
מערכת ושיטה לגילוי פאסיבי של חוטים
[54]
SYSTEM AND METHOD FOR
PASSIVE WIRE DETECTION
[22]
[31]
[51]
[71]
[87]
[74]
22.05.2006
11/184472
[32] 19.07.2005
Int. Cl.(2010.01) G06T 05//00
THE BOEING COMPANY, U.S.A.
WO/2007/011450
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57]
Method and system for passively detecting wires from a mobile transport system is
provided. The method includes, pre-processing a digital image taken from a digital
camera of the transport system, wherein the pre-processing is performed by a preprocessing module to reduce non-wire like clutter from the digital image,- identifying
pixels that can be classified as wire like by using a segment finder module on the
digital image that has been pre- processed by the pre-processing module; and linking
the identified pixels to determine if a wire like structure is present, wherein a linker
module links the pixels that can be classified as wire like, to generate a wire overlay.
[33]
US
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
__________________
[11][21]
[54]
ESTABLISHMENT OF A HUMAN
EMBRYONIC STEM CELL LINE
USING MAMMALIAN CELLS
[22]
[31]
17.05.2006
595/MUM/2005 [32] 17.05.2005
11/436193
17.05.2006
Int. Cl.(2010.01) C12N 05//07, 05//071
RELIANCE LIFE SCIENCES PVT.
LTD., INDIA
MANDAL ARUNDHATI, SHABARI
TIPNIS, RAVINDRAN GEETA,
[51]
[71]
[72]
240
187352
ייסוד של קו תאי גזע עובריים אנושיים על ידי
שימוש בתאי יונק
[33]
IN
US
August 31,2011 -א' באלול התשע"א
[87]
[74]
[57]
KULKAMI JAYANT, PATKI ARNEET,
PAL RAJARSHI, BOSE BIPASHA,
KHAN ALAM, KHANNA APARNA
WO/2007/020655
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
עורכי דין ועורכי,קבוצת איתן מהולל
,פטנטים
10 שדרות אבא אבן
הרצליה2081 .ד. ת,
Purified preparations of human embryonic stem cells with certain population-specific
characteristics are disclosed. This preparation is characterized by the positive
expression of the following pluripotent cell surface markers: SSEA-1 (-); SSEA-4 (+);
TRA-1-60 (+); TRA-1-81 (+); alkaline phosphatase (+), as well as a set of ES cell
markers including Oct-4, Nanog, Rexl, Sox2, Thyl, FGF4, ABCG2, Dppa5, UTFl,
Criptol, hTERT, Connexin-43 and Connexin-45. The cells of the preparation are
negative for lineage specific markers like Keratin 8, Sox-1, NFH (ectoderm), MyoD,
brachyury, cardiac-actin (mesoderm), HNF-3 beta, albumin, and PDXl (endoderm).
The cells of the preparation are human embryonic stem cells, have normal karyotypes,
exhibit high telomerase activity and continue to proliferate in an undifferentiated state
after continuous culture for over 40 passages. The embryonic stem cell line RelicellTM
Hes1 also retains the ability, throughout the culture, to differentiate into cell and tissue
types derived from all three embryonic germ layers (endoderm, mesoderm and
ectoderm). Methods for isolating a human embryonic stem cell line are also disclosed.
__________________
[11][21]
187542
ראש מקלחת עם מנגנון מדגש טורבו
[54]
SHOWERHEAD WITH
TURBOCHARGER MECHANISM
[22]
[31]
[51]
[71]
[74]
21.11.2007
200720120924.0 [32] 19.06.2007
[33] CN
Int. Cl.(2010.01) B05B 01//18
WEI HU, CHINA
FISHER WEILER JONES,
,פישר וילר ג'ונס
26 HABARZEL STREET
26 הברזל רמת החיל
RAMAT HACHAYAL,
תל אביב
TEL-AVIV 69710
A showerhead with a turbocharger mechanism including a showerhead housing and a
turbo-compressor unit is provided. The showerhead housing (10) has a water inlet port
(100) for introducing a water flow, a case wall (101) that gradually expands, and a
water drainage panel (11). The turbo-compressor unit (3) is accommodated in a
housing chamber (102) and includes a compressor compartment (300) where the water
[57]
241
August 31,2011 -א' באלול התשע"א
flow is converted into a vortex flow, a turbo-pump impeller (32) accommodated in the
compressor compartment, and a turbo-generator capable of generating electric energy.
The turbo-generator (4) is electrically connected to an illumination means, so as to
emit light beams. The present invention is provided with the turbocharger mechanism,
so as to make use of the water flow flowing through the showerhead effectively to
generate electricity for illumination.
__________________
[11][21]
187548
שיטה לסיכול פיראטיות של סרט
[54]
METHOD FOR FRUSTRATING
PIRACY OF A MOVIE
[22]
[31]
12.07.2006
60/710054
[32] 22.08.2005
[33] US
60/710264
22.08.2005
US
60/710048
22.08.2005
US
Int. Cl.(2010.01) G03B 21//32, 21//56, 41//04
NDS LIMITED, UNITED KINGDOM
SHLOMO KIPNIS, PERRY SMITH,
, כפיר משה, פרי סמיט,שלמה קיפניס
KFIR MOSHE, GAVRIEL BENAILY,
אור טייב,אלי-גבריאל בן
OR TAIEB
WO/2007/023482
SANFORD T.COLB & CO.,
,' קולב ושות.סנפורד ט
P.O.B. 2273,
מרמורק,4 שער הגיא
REHOVOT 76122
רחובות2273 .ד. ת,
[51]
[71]
[72]
[87]
[74]
[57]
242
A method for frustrating piracy of a movie, the movie including a plurality of filmed
frames, each of the filmed frames including an image, the method including editing the
movie prior to projection such that different regions of the image of one of the filmed
frames are in different frames so that the different regions will be projected at different
times, and repeating the editing for other ones of the filmed frames. Related apparatus
and methods are also described.
August 31,2011 -א' באלול התשע"א
,213788
The applications for division
from this application have
not yet been published
בקשות חלוקה מבקשה זו
.שטרם פורסמו
__________________
[11][21]
187853
יריעת אסוף מים ושיטה,עזר לצמח
[54]
PLANT AID, WATER
COLLECTION SHEET AND
METHOD
[22]
[31]
08.06.2006
1029216
[32] 08.06.2005
[33] NL
1029307
21.06.2005
NL
Int. Cl.(2010.01) E03B 03//28
P.M.M. HOFF HOLDING B.V., THE
NETHERLANDS
WO/2006/132526
PEARL COHEN ZEDEK LATZER,
,פרל כהן צדק לצר
5 SHENKAR ST.,
5 רח' שנקר,1 ים-מרכז גב
P.O.B. 12704,
הרצליה12704 .ד. ת,
HERZLIYA 46733
The invention relates to a plant aid for surrounding a young plant. The plant aid (1)
comprises a tube (2) at least partly sideways surrounding a young plant (3) placeable in
the plant aid (1). The plant aid (1) further comprises a water collection sheet (8) for
collecting moisture present in the atmosphere. The water collection sheet (8) comprises
a water collection surface (9) comprising a receiving surface (10), which receiving
surface (10) operatively makes a first angle with respect to the orientation of gravity.
The water collection sheet (8) further comprises a collecting surface (11) adjoining a
lower edge of the receiving surface (10), which collecting surface (11) operatively
makes a second angle with respect to the orientation of gravity. The first angle is
smaller than the second angle.
[51]
[71]
[87]
[74]
[57]
243
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
187965
צמר חוטים וסיבים של פוליאמיד בעלי תכונות
משופרות
[54]
POLYAMIDE YARNS,
FILAMENTS AND FIBERS WITH
ENHANCED PROPERTIES
[22]
[31]
[51]
[71]
[87]
[74]
09.06.2006
0505915
[32] 10.06.2005
Int. Cl.(2010.01) D01F 01//10, 06//60
RHODIA CHIMIE, FRANCE
WO/2006/131658
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57]
The invention concerns polyamide yarns, fibers and filaments wherein are dispersed
nanometric particles, the method for preparing said yarns, fibers and filaments and
uses thereof.
[33]
FR
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
__________________
[11][21]
[54]
HIGH VELOCITY LOW
PRESSURE EMITTER
[22]
[31]
13.06.2006
60/689864
[32] 13.06.2005
60/776407
24.02.2006
Int. Cl.(2010.01) A62C 05//02
[51]
244
188017
חומר הפולט קרינה במהירות תחת לחץ נמוך
[33]
US
US
August 31,2011 -א' באלול התשע"א
[71]
[87]
[74]
VICTAULIC COMPANY, U.S.A.
WO/2006/135890
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57]
An emitter for atomizing and discharging a liquid entrained in a gas stream is
disclosed. The emitter has a nozzle with an outlet facing a deflector surface. The
nozzle discharges a gas jet against the deflector surface. The emitter has a duct with an
exit orifice adjacent to the nozzle outlet. Liquid is discharged from the orifice and is
entrained in the gas jet where it is atomized. A method of operating the emitter is also
disclosed. The method includes establishing a first shock front between the outlet and
the deflector surface, a second shock front proximate to the deflector surface, and a
plurality of shock diamonds in a liquid-gas stream discharged from the emitter.
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
__________________
[11][21]
188130
גשר קוטבי עבור סוללה
[54]
POLE BRIDGE FOR A BATTERY
[22]
[31]
[51]
[71]
08.06.2006
102005028066.8 [32] 16.06.2005
[33] DE
Int. Cl.(2010.01) H01M 02//04, 02//06, 02//26, 02//30
DEUTSCHE EXIDE GMBH,
GERMANY
WO/2006/133674
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[87]
[74]
[57]
245
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
The invention relates to a cell connector (6) for a battery, especially for absorbing, in
conjunction with at least one damping element (9), the vertical forces that are caused
by the impact of shocks. The cell connector (6), at one end, is connected to the positive
or negative electrodes (4, 5) which are received in a housing (2) having a housing
August 31,2011 -א' באלול התשע"א
cover (3), and, at the other end, comprises at least one terminal (7, 8) projecting from
the housing cover (3). The aim of the invention is to elastically dampen the electrode
plates (4, 5) of an accumulator (1) which are disposed inside a housing (2). For this
purpose, a terminal (6) having a supporting shoulder (11), integrally molded thereto, is
used in the housing (2), a damping element (9), disposed between the housing cover
(3) of an accumulator (1) and the cell connector (6), coming to rest thereon. The forces
caused by the impact of shocks are passed from the cell connector (6) into the damping
element (9) and from the at least one damping element (6) into the housing cover (3)
via large-area plane faces (30, 31), said cover being fixed to the housing (2). This
measure allows to elastically cushion the electrode plates (4, 5) inside the housing (2).
For this purpose, the at least one damping element (9) has corresponding large
dimensions and is adapted to receive higher vertical forces. The invention also allows
the terminals (7, 8) to move in relation to the housing cover (3) if there is a movement
of the electrode plates (4, 5) in relation to the housing (2).
__________________
[11][21]
[54]
SOIL CONDITIONING DEVICE
[22]
[31]
[51]
[71]
26.06.2006
11/176569
[32] 07.07.2005
Int. Cl.(2010.01) A01B 29//04, 39//08
TERRACON TECHNOLOGIES LLC.,
U.S.A.
WO/2007/008393
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[87]
[74]
[57]
246
188527
התקן לריכוך אדמה
[33]
US
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
A soil conditioning device (100) having a series of peripheral ridge members (104)
having a leading (106) and trailing (108) prow shaped surface circumscribing a disc,
wheel or drum (102) and a method of use. Optionally the prow shaped peripheral ridge
members are joined by sub-ridge members (110) forming a single ridge of varying
August 31,2011 -א' באלול התשע"א
heights circumscribing the disc, wheel or drum.
__________________
[11][21]
[54]
METHOD AND DEVICE FOR
SUPPLY TO A MAGNETIC
COUPLER
[22]
[31]
[51]
[71]
04.07.2006
0507136
[32] 05.07.2005
Int. Cl.(2010.01) H02M 07//48
CENTRE NATIONAL DE LA
RECHERCHE SCIENTIFIQUE,
FRANCE
INSTITUT NATIONAL
POLYTECHNIQUE DE TOULOUSE,
FRANCE
UNIVERSITE MONTPELLIER II,
FRANCE
WO/2007/006902
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[87]
[74]
[57]
247
188543
שיטה ומתקן לאספקת מצמד מגנטי
[33]
FR
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
The invention relates to a method for supply to a magnetic coupler comprising several
pairs of windings, each pair being formed from a first and a second adjacent paired
winding, magnetically coupled to each other by means of a core of magnetic material.
The method further consists of supplying (in 34) the first winding of each pair with a
supply voltage or current out of phase by an angle a with relation to the supply voltage
or current for the second winding of the same pair. The absolute value of the angle a is
greater than or equal to 4p/N for at least one pair of windings.
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
188545
,תרכובת אגוניסטית של קולטן מלאנוקורטין
תכשיר רוקחות המכיל תרכובת זו ושימוש בה
לייצור תרופות לטיפול באי סדרים
[54]
MELANOCORTIN RECEPTOR
AGONIST COMPOUND,
PHARMACEUTICAL
COMPOSITION COMPRISING
SUCH A COMPOUND AND USE
THEREOF IN THE
MANUFACTURE OF
MEDICAMENTS FOR TREATING
DISORDERS
[22]
[31]
10.07.2006
60/697779
[32] 08.07.2005
[33] US
60/748850
09.12.2005
US
Int. Cl.(2010.01) A61K 38//04, C07K 09//00, 14//435, 14//68
IPSEN PHARMA S.A.S., FRANCE
WO/2007/008704
REINHOLD COHN AND PARTNERS,
,ריינהולד כהן ושותפיו
26A HABARZEL ST.,
'א26 רחוב הברזל
RAMAT HACHAYAL 69710
רמת החייל
[51]
[71]
[87]
[74]
[57]
The present invention is directed to compounds according to formula, (R2R3)-A1-c(A2A3-A4-A5-A6-A7-A8-A9)-A10-R1, and pharmaceutically-acceptable salts thereof that act
as ligands for one or more of the melanocortin receptors, to methods of using such
compounds to treat mammals and to pharmaceutical compositions comprising said
compounds.
The applications for division
from this application have
not yet been published
248
,201732
בקשות חלוקה מבקשה זו
.שטרם פורסמו
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
188568
קוצץ שיער עם מוביל חיתוך ממונע
[54]
HAIR CLIPPER WITH
MOTORISED CUTTING GUIDE
[22]
[31]
[51]
[71]
[87]
[74]
20.06.2006
05447164.4
[32] 07.07.2005
[33] EP
Int. Cl.(2010.01) B26B 19//06
BABYLISS FACO S.A., BELGIUM
WO/2007/006106
PEARL COHEN ZEDEK LATZER,
,פרל כהן צדק לצר
5 SHENKAR ST.,
5 רח' שנקר,1 ים-מרכז גב
P.O.B. 12704,
הרצליה12704 .ד. ת,
HERZLIYA 46733
The invention concerns a hair clipper comprising a device for adjusting the position of
a powered cutting guide slaved to an electronic device, automatically adapting the
position of said cutting guide based on the option selected by the user.
[57]
__________________
[11][21]
188875
MAGE שיטה להכנה או ניקוי של חלבון
והשימוש בחלבון להכנת חיסון
[54]
PROCESS FOR THE
PURIFICATION OR
PRODUCTION OF A MAGE
PROTEIN AND THE USE OF THE
PROTEIN FOR THE
PRODUCTION OF A VACCINE
[22]
[31]
02.02.1999
9802543.0
[32] 05.02.1998
[33] GB
9802650.3
06.02.1998
GB
Int. Cl.(2010.01) A61K 39//39, 48//00, C07K 01//00, 14//47, 19//00, C12N 01//21,
[51]
249
August 31,2011 -א' באלול התשע"א
[62]
[71]
[87]
[74]
[57]
15//12, 15//62, 15//70
DIVISION FROM 137442
SMITHKLINE BEECHAM
BIOLOGICALS S.A., BELGIUM
WO/1999/040188
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
The present invention relates to novel proteins and to their production, from the
MAGE family. In particular, to a MAGE protein fused to an immunological fusion
partner, such as Lipoprotein D. Such antigens may be formulated to provide vaccines
for the treatment of a range of tumours. Novel methods for purifying MAGE proteins
are also provided.
__________________
[11][21]
189086
עגלת תינוקות מתקפלת עבור תינוקות וילדים
קטנים
[54]
FOLDABLE PUSHCHAIR FOR
BABIES AND SMALL CHILDREN
[22]
[31]
[51]
[71]
[74]
28.01.2008
200700618U
[32] 21.03.2007
[33] ES
Int. Cl.(2010.01) B62B 07//08
JANE, S.A., SPAIN
DR. YITZHAK HESS & PARTNERS,
,ד"ר יצחק הס ושותפיו
279 HAYARKON ST.,
279 רחוב הירקון
P.O.B. 6451,
תל אביב6451 .ד. ת,
TEL AVIV 61063
A pushchair when folded has its sides brought closer together and the rear wheels
spaced away with respect to the front wheels. The support of the rear wheels has a pinjointed connection allowing folding with respect to the corresponding leg. Each of the
supports of the rear wheels has a second pin-jointed connection below its pin-jointed
connection linking it to the corresponding leg, allowing increasing the degree of
folding of the support when folding the pushchair. The supports of the rear wheels
form two lengths linked to each other in a pin-jointed connection and are articulately
linked to component members of the chassis of the pushchair that when folding, pull
the two lengths of said supports to bring about the folding of the rear wheels.
[57]
__________________
250
August 31,2011 -א' באלול התשע"א
[11][21]
189200
רובוט לניקוי בריכות מים
[54]
POOL CLEANING ROBOT
[22]
[31]
[51]
[71]
[87]
[74]
03.08.2006
11/196737
[32] 04.08.2005
Int. Cl.(2010.01) E04H 04//00, 04//16
MAYTRONICS LTD.
WO/2007/015251
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57]
A pool cleaning robot comprising a frame, at least one inlet, at least one outlet, and a
motor carrying module. The robot further comprises a filter unit mountable to the
frame. The filter unit has a filter bag with an inlet facing surface and an outlet facing
surface. The robot further comprises a filter cavity formed between the outlet facing
surface of the filter bag and the frame. The frame has an open area above the cavity.
The open area faces the outlet and is designed for the insertion therethrough of the
module into the filter cavity when the filter unit is mounted to the frame.
The applications for division
from this application have
not yet been published
[33]
US
עמק יזרעאל,מיטרוניקס בע"מ
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
,214205,214204,203412
בקשות חלוקה מבקשה זו
.שטרם פורסמו
__________________
[11][21]
[54]
ULTRASONIC FLOW METER
[22]
[31]
[51]
[71]
28.07.2006
0516754.9
[32] 13.08.2005
Int. Cl.(2010.01) G01F 01//66
FLOWNETIX LIMITED, UNITED
KINGDOM
SIMON JOHN RHODES
WO/2007/020375
DR. EYAL BRESSLER,
11 TUVAL ST.,
RAMAT GAN 52522
[72]
[87]
[74]
[57]
251
189350
מונה זרימה על–קולי
[33]
GB
,דר' אייל ברסלר עו"פ
11 תובל
גן- רמת
There is described an ultrasonic flow meter comprising a pipe having two ends,
August 31,2011 -א' באלול התשע"א
electronic circuitry, a first enclosure housing the electronic circuitry, a second
enclosure housing the pipe, and a plurality of ultrasonic transducers attached to an
external surface of the pipe in the second enclosure. The first enclosure is watertight,
whereas the second enclosure is not watertight. The two ends of the pipe protrude from
the second enclosure. Each transducer is covered by a respective cap and sealed from
water ingress. Each transducer is connected to the electronic circuitry by a respective
pair of wires.
__________________
[11][21]
190414
שיטה והתקן להכנת משקאות
[54]
METHOD AND APPARATUS FOR
PREPARING BEVERAGES
[22]
[31]
[51]
[71]
[87]
[74]
03.10.2006
MI2005A001986 [32] 19.10.2005
[33] IT
Int. Cl.(2010.01) A47J 31//40
RHEA VENDORS S.P.A., ITALY
WO/2007/045949
WOLFF, BREGMAN AND GOLLER,
, ברגמן וגולר,וולף
P.O.B. 1352,
ירושלים1352 .ד. ת,
JERUSALEM 91013
A method for the preparation of a beverage by mixing water and at least one powdered
product in a mixing chamber (1) and dispensing the mixture to a final container (5)
provides for the preparation and delivery of at least a first portion of beverage by
mixing a first soluble product with water, in the absence of mechanical stirring and for
the preparation and delivery of at least a second portion of beverage by mixing a
second soluble product with water in the presence of mechanical stirring and for the
possible delivery of further portions of beverage to the final container (5).
[57]
252
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
[54]
PROTECTION APPARATUS FOR
AN ELECTRICAL LOAD
[22]
[31]
[51]
[71]
27.09.2006
11/241095
[32] 30.09.2005
Int. Cl.(2010.01) H01H 73//00
EATON CORPORATION, U.S.A.
ROCKWELL AUTOMATION
TECHNOLOGIES, INC., U.S.A.
WO/2007/041162
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[87]
[74]
[57]
190494
מנגנון הגנה עבור עומס חשמלי
[33]
US
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
The invention provides methods to control scale formation that utilize microbes and
exopolymers and other chemical compounds that they produce. The microbes produce
polymers and similarly that control scale formation. The polymers work via a variety
of mechanisms depending on their chemical structures. The polymers work by
sequestering scale-forming ions, promoting dissolution of existing scale, increasing the
solubility of newly formed scale, and inhibiting scale formation on pipes.
__________________
253
August 31,2011 -א' באלול התשע"א
[11][21]
190546
שיטה לתרביות תאים והתקן ליישומה
[54]
METHOD OF CELL CULTURE
AND DEVICE FOR
IMPLEMENTING IT
[22]
[31]
[51]
[71]
[87]
[74]
03.10.2006
2005/0483
[32] 04.10.2005
Int. Cl.(2010.01) C12M 03//00
ARTELIS S.A., BELGIUM
WO/2007/039600
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[57]
Cell culture device (1) comprising a culture vessel (2) provided with a cover (19) in
which there is a first zone (3) for transferring culture medium essentially free from
cells internal to a second cell culture zone (5), a third (4) and a fourth zone (6) for
transferring culture medium essentially free from cells. The third zone (4) is internal to
the second zone (5) and external to the first zone (4) and the fourth zone (6) being a
zone external to said second zone (5). All the zones are in medium communication.
The device also comprises culture medium circulation means, allowing a circulation of
the culture medium through the culture zone (5) from bottom to top.
[33]
BE
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
__________________
[11][21]
[54]
PROJECTILE WITH A
PENETRATION CAPABILITY
[22]
[31]
01.04.2008
102007016488.4
254
[32]
05.04.2007
190560
קליע עם יכולת חדירה
[33]
DE
August 31,2011 -א' באלול התשע"א
[51]
[71]
[74]
[57]
202008002145.6
15.02.2008
DE
Int. Cl.(2010.01) F42B 12//02
DIEHL BGT DEFENCE GMBH & CO.
KG, GERMANY
JUNGHANS MICROTEC GMBH,
GERMANY
PEARL COHEN ZEDEK LATZER,
,פרל כהן צדק לצר
5 SHENKAR ST.,
5 רח' שנקר,1 ים-מרכז גב
P.O.B. 12704,
הרצליה12704 .ד. ת,
HERZLIYA 46733
A penetration-capable projectile has a casing and a fuse with a fuse housing lower part.
An interface area between the casing of the projectile and the fuse housing lower part
is formed with a shape and/or strength modification which prevents the fuse housing
lower part from being pushed into the casing on impact with a target that is to be
penetrated.
__________________
[11][21]
[54]
UNSATURATED FATTY
HYDROXY ACID DERIVATIVES
AND THE
DERMOCOSMETOLOGIC USE
THEREOF
[22]
[31]
[51]
[71]
20.10.2006
0510792
[32] 21.10.2005
Int. Cl.(2010.01) C07C 59//42, 59//56
PIERRE FABRE DERMOCOSMETIQUE, FRANCE
WO/2007/045693
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[87]
[74]
[57]
255
190597
–תולדות של חומצות הידרוקסי שומניות לא
רוויות ושימוש דרמטוקסמטי שלהן
[33]
FR
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
The invention relates to unsaturated fatty hydroxy acid derivatives of formula (I),
wherein Rn is independent from each other H or linear or branched alkyl group which
contain from 1 to 6 carbon atoms and which are possibly substituted by a halogen
atom, in particular a fluorine atom, R1 is H, F, Cl, Br or CF3, R is H or linear or
branched alkyl group which contain from 1 to 6 carbon atoms and which are possibly
substituted by a halogen atom, in particular a fluorine atom and 3 = n = 14. Said
derivatives is suitable for producing an anti-radical, anti-inflammatory and antipruritic
dermocosmetologic composition and/or for treating keratinisation and pigmentation
August 31,2011 -א' באלול התשע"א
troubles and/or for improving healing.
__________________
[11][21]
190685
[54]
SINGLE USE PULSE OXIMETER
[22]
[31]
[51]
[71]
10.10.2006
11/259092
[32] 27.10.2005
[33]
Int. Cl.(2010.01) A61B 05//00, 05//1455
SMITHS MEDICAL ASD, INC.,
U.S.A.
WO/2007/050269
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[87]
[74]
[57]
256
שימוש יחידי במכשיר פולסי למדידת אחוז
ההמוגלובין המחומצן בדם
US
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
A single use, self-contained, self-powered disposable oximeter, in the form of a patch
or a bandage strip, has mounted thereto a light emitter and a light sensor that together
measure at least the SpO2 of the patient. Mounted to an electronics layer of the patch
is an application specific integrated circuit (ASIC) that has electronics integrated
thereto that controls the operation of the light emitter and light sensor, and the
algorithm for calculating from the data collected by the sensor at least the SpO2 of the
patient. Optionally, a display and an alarm may also be mounted or embedded onto the
patch for respectively displaying at least the SpO2, and for informing the
caregiver/patient that at least the SpO2 is not within an acceptable range, if such is the
case.
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
190805
–272 אוCCI–779 –שימוש בשילוב הרצפטין ו
להכנת תרופה לטיפול בסרטןHKI
[54]
USE OF A COMBINATION OF
HERCEPTIN AND CCI-779 OR
HKI-272 IN THE PREPARATION
OF A MEDICAMENT FOR
TREATING A NEOPLASM
[22]
[31]
02.11.2006
60/733562
[32] 04.11.2005
[33] US
60/837509
14.08.2006
US
Int. Cl.(2010.01) A61K 31//436, 39//395, 45//06
WYETH LLC, U.S.A.
WO/2007/056118
LUZZATTO & LUZZATTO,
,לוצאטו את לוצאטו
INDUSTRIAL PARK, OMER,
עומר,גן תעשייה
P.O.B. 5352,
באר שבע5352 .ד. ת,
BEER-SHEVA 84152
A combination of temsirolimus and herceptin in the treatment of cancer is provided. A
combination of temsirolimus and HKI-272 is provided. A combination of herceptin
and HKI-272 is also provided. Regimens and kits for treatment of metastatic breast
cancer, containing herceptin, temsirolimus and/or HKI-272, optionally in combination
with other anti-neoplastic agents, or immune modulators are described.
[51]
[71]
[87]
[74]
[57]
__________________
[11][21]
190896
מנורת פלורואסנט קומפקטית
[54]
COMPACT FLUORESCENT
LAMP
[22]
[51]
[71]
26.10.2005
Int. Cl.(2010.01) H01J 05//48
SKIRTLIGHT S.A.,
LIECHTENSTEIN
WO/2007/049083
PEARL COHEN ZEDEK LATZER,
,פרל כהן צדק לצר
5 SHENKAR ST.,
5 רח' שנקר,1 ים-מרכז גב
P.O.B. 12704,
הרצליה12704 .ד. ת,
HERZLIYA 46733
Compact fluorescent lamp having a known base (1), a central hollow column (2),
August 31,2011 -א' באלול התשע"א
[87]
[74]
[57]
257
attached to the base (1), and the outer surface of which has a heat- and light-reflecting
coating; a cap (3) closing the hollow column (2); and one or more light-radiating
members (4) secured to the cap (3) and/or to the hollow column (2). The lightradiating members (4) start from the hollow column (2) and connect to electronic and
electric elements and pass through the holes (3b) of the hollow column and/or the cap
(3). The lamp further comprises a guide-ring (11) to support the light-radiating
members (4) extending until or beyond the meeting boundary edge of the base (1) and
the hollow column (2). The hollow column (2), the base (1), the cap (3) and the guide
ring (11) are encompassed with the light-radiating members (4) extending in at least a
direction parallel with the longitudinal axis of the lamp towards the base (1) and back
and the light-radiating members (4) have curved sections (4a). The lamp is retrofit
with conventional bulb sockets.
__________________
[11][21]
191048
איתור קצוות בדימות אולטראסאונד
[54]
EDGE DETECTION IN
ULTRASOUND IMAGES
[22]
[31]
27.04.2008
60/915152
[32] 01.05.2007
[33] US
12/028210
08.02.2008
US
Int. Cl.(2010.01) A61B 01//00, G06T 07//00
BIOSENSE WEBSTER, INC., U.S.A.
D. KLIGLER I.P. SERVICES LTD.,
, קליגלר שירותי קניין רוחני בע"מ.ד
P.O.B. 33111
תל אביב33111 .ד. ת,
TEL AVIV 61330
A computer-assisted method for defining structures on images, comprising the steps
of: acquiring an image of a target structure for edge detection thereof; establishing a
seed point within said structure on said image; detecting an edge in said image so as to
generate a partially processed image of said structure having a computed edge
indicated thereon; extending a plurality of rays radially from said seed point to
intersect said computed edge at respective intersection points; connecting said
intersection points to form an initial closed contour having respective segments
connecting neighboring ones of said intersection points; computing deforming force
gradients in an area of interest of said image; deforming said closed contour
responsively to said deforming force gradients to define a deformed closed contour;
and deleting ones of said segments from said deformed closed contour that meet a
predefined undesirability criterion.
[51]
[71]
[74]
[57]
258
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
191580
חומרי ביניים שהם נגזרות אינדול ותהליכים
להכנתם
[54]
INTERMEDIATES WHICH ARE
INDOLE DERIVATIVES AND
PROCESSES FOR THEIR
PREPARATION
[22]
[31]
[51]
[62]
[71]
[87]
[74]
08.02.2000
99400305.1
[32] 10.02.1999
[33] EP
Int. Cl.(2010.01) C07D 40/1/14
DIVISION FROM 144745
ASTRAZENECA AB, SWEDEN
WO/2000/047212
S. HOROWITZ & CO.,
,' הורוביץ ושות.ש
31 AHAD HAAM ST.
31 רחוב אחד העם
P.O.B. 2499
תל אביב2499 .ד. ת,
TEL AVIV 65202
The invention relates to the use of compounds of formula (I), wherein ring C is an 8, 9,
10, 12 or 13-membered bicyclic or tricyclic moiety which optionally may contain 1-3
heteroatoms selected independently from O, N and S; Z is -O-, -NH-, -S-, -CH2- or a
direct bond; n is 0-5; m is 0-3; R2 represents hydrogen, hydroxy, halogeno, cyano,
nitro, trifluoromethyl, C1-3alkyl, C1-3alkoxy, C1-3alkylsulphanyl, -NR3R4 (wherein
R3 and R4, which may be the same or different, each represents hydrogen or C13alkyl), or R5X1- (wherein X1 and R5 are as defined herein; R1 represents hydrogen,
oxo, halogeno, hydroxy, C1-4alkoxy, C1-4alkyl, C1-4alkoxymethyl, C1-4alkanoyl,
C1-4haloalkyl, cyano, amino, C2-5alkenyl, C2-5alkynyl, C1-3alkanoyloxy, nitro, C14alkanoylamino, C1-4alkoxycarbonyl, C1-4alkylsulphanyl, C1-4alkylsulphinyl, C14alkylsulphonyl, carbamoyl, N-C1-4alkylcarbamoyl, N,N-di(C1-4alkyl)carbamoyl,
aminosulphonyl, N-C1-4alkylaminosulphonyl, N,N-di(C1-4alkyl)aminosulphonyl, N(C1-4alkylsulphonyl)amino, N-(C1-4alkylsulphonyl)-N-(C1-4alkyl)amino, N,Ndi(C1-4alkylsulphonyl)amino, a C3-7alkylene chain joined to two ring C carbon
[57]
259
August 31,2011 -א' באלול התשע"א
atoms, C1-4alkanoylaminoC1-4alkyl, carboxy or a group R56X10 (wherein X10 and
R56 are as defined herein); and salts thereof, in the manufacture of a medicament for
use in the production of an antiangiogenic and/or vascular permeability reducing effect
in warm-blooded animals, processes for the preparation of such compounds,
pharmaceutical compositions containing a compound of formula (I) or a
pharmaceutically acceptable salt thereof as active ingredient and compounds of
formula (I). The compounds of formula (I) and the pharmaceutically acceptable salts
thereof inhibit the effects of VEGF, a property of value in the treatment of a number of
disease states including cancer and rheumatoid arthritis.
__________________
[11][21]
חומר מגן
[54]
FRAG SHIELD
[22]
[31]
[51]
[71]
17.11.2006
11/285817
[32] 23.11.2005
Int. Cl.(2010.01) B32B 27//08
HONEYWELL INTERNATIONAL
INC., U.S.A.
WO/2007/089317
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[87]
[74]
[57]
191662
[33]
US
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
Fabric laminates having superior resistance to penetration of fragments, such as
shrapnel. The fabrics are formed of high-strength fibers consolidated with from about
7% to about 15% by weight of an elastomeric matrix composition, and in combination
with protective layers of a polymer film on each surface of the fabric. The fabrics
achieve a significant improvement in fragment resistance compared to fabrics of the
prior art, while also maintaining excellent ballistic resistant properties.
__________________
[11][21]
[54]
260
MOVABLE SINK PARTS WASHER
191666
מכשיר לשטיפת רכיבים בעל כיור הניתן להזזה
August 31,2011 -א' באלול התשע"א
[22]
[31]
[51]
[71]
[74]
[57]
22.05.2008
11/767299
[32] 22.06.2007
[33] US
Int. Cl.(2010.01) B08B 03//04, 13//00
SAFETY-KLEEN SYSTEMS, INC.,
U.S.A.
BOROCHOV, KORAKH & CO.,
,'בורוכוב קורח ושות
15TH FLOOR, ATIDIM TOWER,
מגדל כלל עתידים
KIRYAT ATIDIM,
אביב-תל58100 .ד. ת,
P.O.B. 58100,
TEL AVIV 61580
An apparatus for washing parts comprising: a support frame; a sink movably
connected to the support frame such that the sink is movable between a service
configuration and a work configuration, the sink including a cleaning portion defined
by a basin having a work area, a drain, and a fluid distribution device; a cleaning
solution reservoir disposed under the basin in registration with the drain when the sink
is disposed in the work configuration to collect and store a cleaning solution; a pump
in fluid communication with the fluid distribution device to circulate the cleaning
solution from the cleaning solution reservoir to the basin through the fluid distribution
device and back to the cleaning solution reservoir through the drain; and a lid movably
connected to the sink such that the lid is movable between a down configuration and
an up configuration.
__________________
[11][21]
191769
–4]–2]–4––בנזואיל1 צורות קריסטליניות של
–1––טריאזולH1–4,2,1––מתיל3)–7–מתוקסי
–H1–[–])פוספונואוקסי(מתיל1–(איל
–2,1–[–איל3–[פירידיןC–3,2]פירולו
דיאוקסואתיל[–פיפרזין
[54]
CRYSTALLINE FORMS OF 1BENZOYL-4-[2-[4-METHOXY-7-(3METHYL-1H-1,2,4-TRIAZOL-1YL)-1[(PHOSPHONOOXY)METHYL]-1HPYRROLO[2,3-C]PYRIDIN-3-YL]1,2-DIOXOETHYL]-PIPERAZINE
[22]
[31]
[51]
[71]
13.12.2006
60/750247
[32] 14.12.2005
[33] US
Int. Cl.(2010.01) A61K 31//437, A61P 31//18, C07D 47/1/04, C07F 09//09
BRISTOL-MYERS SQUIBB
COMPANY, U.S.A.
WO/2007/070589
DR. SHLOMO COHEN & CO.,
,'ד"ר שלמה כהן ושות
124 IBN GABIROL ST.,
124 אבן גבירול
[87]
[74]
261
August 31,2011 -א' באלול התשע"א
[57]
P.O.B. 11490,
תל אביב11490 .ד. ת,
TEL AVIV 62038
The instant disclosure provides crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3methyl-1H-1,2,4-triazol-1-yl)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-c]pyridin-3yl]-1,2-dioxoethyl]-piperazine, salts and solvates thereof. The present disclosure also
generally relates to pharmaceutical compositions comprising the crystalline form(s), as
well of methods of using the crystalline form(s) in the treatment of HIV and/or AIDS,
and methods for obtaining such crystalline form(s).
__________________
[11][21]
191828
חומר מגנזיום תואם ביו
[54]
BIOCOMPATIBLE MAGNESIUM
MATERIAL
[22]
[31]
[51]
[71]
14.12.2006
102005060203.7 [32] 14.12.2005
[33] DE
Int. Cl.(2010.01) A61K 33//00, A61L 24//02, 27//42
GKSS-FORSCHUNGSZENTRUM
GEESTHACHT GMBH, GERMANY
WO/2007/068479
DR. YITZHAK HESS & PARTNERS,
,ד"ר יצחק הס ושותפיו
279 HAYARKON ST.,
279 רחוב הירקון
P.O.B. 6451,
תל אביב6451 .ד. ת,
TEL AVIV 61063
The invention relates to a material for fixing bone fractures and/or damage. Said
material contains a homogeneous mixture of apatite and a magnesium alloy and is
produced by grinding a mixture of apatite and a magnesium alloy in the form of chips
or powder in a ball grinder until a homogeneous mixture is obtained, and consolidating
said homogeneous mixture in a second step.
[87]
[74]
[57]
262
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
192219
תכשיר המכיל אוליגוסכרידים כסיבים
תזונתיים מסיסים לטיפול ומניעה של
התדלדלות שרירים
[54]
COMPOSITION COMPRISING
OLIGOSACCHARIDES AS
SOLUBLE DIETARY FIBRES FOR
USE AGAINST MUSCLE
WASTING
[22]
[31]
[51]
[71]
18.12.2006
05112336.2
[32] 16.12.2005
[33] EP
Int. Cl.(2010.01) A23L 01//29, 01//308, A61K 31//702, 31//715, A61P 21//00
N.V. NUTRICIA, THE
NETHERLANDS
MARCHEL GORSELINK,
ADRIANUS LAMBERTUS
BERTHOLDUS VAN HELVOORT,
ROBERT JOHAN JOSEPH
HAGEMAN
WO/2007/069900
G.E. EHRLICH (1995) LTD.,
,( בע"מ1995) ארליך.אי.ג'י
AYALON TOWER, 15TH FLOOR,
11 רחוב מנחם בגין, 15 קומה,מגדל איילון
11 MENACHEM BEGIN ST.,
רמת גן
RAMAT GAN 52521
A composition nutritional containing dietary fibres is useful for the treatment of
muscle wasting, if the dietary fibre comprise at least 30 wt. % of galactooligosaccharides or other oligosaccharides having mainly anhydropyranose units, and
having a chain length of 3-10 units. The composition may further contain other oligoor polysaccharides, especially polysaccharides having a majority of anhydrofuranose
units.
[72]
[87]
[74]
[57]
263
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
192273
כלי סגירה המייצר צורה ומוצר סגור המיוצר
באמצעותו
[54]
SHAPE-FORMING SHUTTER
APPARATUS AND SHUTTER
PIECE THEREOF
[22]
[31]
19.12.2006
2005-368816 [32] 21.12.2005
[33] JP
2006-274161
05.10.2006
JP
Int. Cl.(2010.01) A21C 11//12, A23G 03//02, A23P 01//08
RHEON AUTOMATIC MACHINERY
CO., LTD., JAPAN
WO/2007/072823
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[51]
[71]
[87]
[74]
[57]
264
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
A shape-forming shutter device includes a plurality of shutter pieces (15) disposed in a
ring-like form and also includes a pressure-contact energizing means (21), wherein
each shutter piece (15) has a shape-forming surface (17) and a sliding surface (19), the
shape-forming surface (17) of each shutter piece (15) is in slidable contact with the
sliding surface of its neighboring shutter piece (15), an opening (9) surrounded by the
shape-forming surfaces (17) of the shutter pieces (15) is expandable, and the pressurecontact energizing means (21) always maintains contact between the shape-forming
surfaces (17) and the sliding surfaces (19) of the neighboring shutter pieces (15) in
such a way that the surfaces (17, 19) are slidably pressed against each other. The
pressure-contact energizing means (21) is an elastic member for uniformly energizing
the shutter pieces (15) in the direction to close the opening (9). The shape-forming
surface (17) and the sliding surface (19) of each shutter piece (15) meet at one end of
the shutter piece (15), and the elastic member is stretched around the other ends that
are each spaced from the one end.
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
192771
מוביל כוס והתקן אחיזה עבור מכונות לחלוקת
משקה
[54]
CUP CONVEYOR AND HOLDER
DEVICE FOR BEVERAGE
DISPENSING MACHINES
[22]
[31]
[51]
[71]
[87]
[74]
16.01.2007
06001415.6
[32] 24.01.2006
[33] EP
Int. Cl.(2010.01) B67D 01//00, G07F 13//06, 13//10
RHEA VENDORS S.P.A., ITALY
WO/2007/085926
WOLFF, BREGMAN AND GOLLER,
, ברגמן וגולר,וולף
P.O.B. 1352,
ירושלים1352 .ד. ת,
JERUSALEM 91013
A cup conveyor and holder device (1) for a beverage dispensing machine comprises a
body (2) into which cups (C1-C3) are vertically dropped for filling with a drink and/or
being delivered to the user; the internal surface of the body (2) is provided with at least
two steps (3, 4, 8) transversal to the cup dropping direction (X), at different heights of
said body (2) with respect to the same direction (X), for vertically supporting said cups
(C1 , C2, C3) at different diameters.
[57]
__________________
[11][21]
[54]
[22]
[31]
[51]
[71]
265
192849
מכשיר לגידול בתרבית ולהעברה של תאים
DEVICE FOR CULTURING AND
TRANSPORTING CELLS
13.11.2006
60/MUM/2006 [32] 16.01.2006
Int. Cl.(2010.01) C12M 01//22
RELIANCE LIFE SCIENCES PVT.
[33]
IN
August 31,2011 -א' באלול התשע"א
[72]
[87]
[74]
[57]
LTD., INDIA
DEEPA GHOSH, SUDHEER SHENOY
WO/2007/080600
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
עורכי דין ועורכי,קבוצת איתן מהולל
,פטנטים
10 שדרות אבא אבן
הרצליה2081 .ד. ת,
A disposable device is provided for culturing and/or packaging and transporting readyto-use viable cells cultured on membranes,, gels or micro porous substrata. The device
includes a housing base (1) defining an interior for culturing cells. The membrane to be
used for culturing the cells is placed inside the housing base and fixed with a ring (2).
The base is closed by a lid (4), which would protect the underlying cells during
transport as well as minimize the -volume of media used during culture as well as
transport. Media leakage is prevented by the silicon gasket (3) as well as the snaps
provided in the device.
__________________
[11][21]
[54]
T2 RNASE COMPOSITIONS FOR
INHIBITING ANGIOGENESIS
AND THE USE THEREOF FOR
PREPARATION OF
MEDICAMENTS FOR TREATING
AND PREVENTING TUMORS
[22]
[31]
[51]
[62]
[71]
29.08.2000
09/385411
[32] 30.08.1999
Int. Cl.(2010.01) C12N 15//55
DIVISION FROM 148345
YISSUM RESEARCH
DEVELOPMENT COMPANY OF
THE HEBREW UNIVERSITY OF
JERUSALEM LTD.
266
193006
למניעת אנג'יוגנזהT2 תרכובות ריבונוקליאז
ושימושיהן למניעת גידולים
[33]
US
יישום חברה לפיתוח המחקר של
,האוניברסיטה העברית בירושלים בע"מ
ירושלים
August 31,2011 -א' באלול התשע"א
[72]
[87]
[57]
ODED SHOSEYOV, LEVAVA ROIZ,
, בטי שוורץ, לבבה רויז,עודד שוסיוב
BETTY SCHWARTZ, PATRICIA
פטרישה סמירנוף
SMIRNOFF
WO/2001/015531
A pharmaceutical composition comprising, as an active ingredient, a therapeutically
effective amount of a ribonuclease of the T2 family wherein the ribonuclease T2 has
the following characteristics:
(i) a molecular weight of between 24-36kda; and,
(ii) binds actin in either active or non-active ribonucleolytic form, and a
pharmaceutically acceptable carrier.
__________________
[11][21]
193262
שיטה ומכשיר למצק נוזל הניתן להתמצק
באמצעות קרינה
[54]
METHOD AND APPARATUS FOR
CURING A RADIATION CURABLE
FLUID
[22]
[31]
22.12.2003
0229825.5
[32] 20.12.2002
[33] GB
PCT/GB03/0028.34
01.07.2003
WO
Int. Cl.(2010.01) B41M 01//00
DIVISION FROM 169212
INCA DIGITAL PRINTERS LIMITED,
UNITED KINGDOM
SERICOL LIMITED, UNITED KINGDOM
WO/2004/056581
PEARL COHEN ZEDEK LATZER,
,פרל כהן צדק לצר
5 SHENKAR ST.,
5 רח' שנקר,1 ים-מרכז גב
P.O.B. 12704,
הרצליה12704 .ד. ת,
HERZLIYA 46733
A method of curing a radiation-curable fluid, the method including: emitting radiation
from a radiation source towards the fluid to be cured, wherein at least 90% of the
radiation has a wavelength in a band having a width of less than 50nm ; and providing
an inerting environment in the region of the radiation source.
[51]
[62]
[71]
[87]
[74]
[57]
__________________
267
August 31,2011 -א' באלול התשע"א
[11][21]
193365
,אוראט אוקסידאזות חופשיות מאגרגאטים
תצמידי פולימר שלהן ותכשירים המוכנים מהם
[54]
AGGREGATE-FREE URATE
OXIDASES, POLYMER
CONJUGATES THEREOF AND
COMPOSITIONS PREPARED
THEREFROM
[22]
[31]
[51]
[62]
[71]
07.02.2001
09/501730
[32] 10.02.2000
[33] US
Int. Cl.(2010.01) A61K 47//48, C12N 09//06, 09//96
DIVISION FROM 151065
DUKE UNIVERSITY, U.S.A.
MOUNTAIN VIEW
PHARMACEUTICALS, INC., U.S.A.
WO/2001/059078
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[87]
[74]
[57]
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
A naturally occurring or recombinant protein, especially a mutein of porcine urate
oxidase (uricase), that is essentially free of large aggregates can be rendered
substantially non-immunogenic by conjugation with a sufficiently small number of
strands of polymer such that the bioactivity of the protein is essentially retained in the
conjugate. Such conjugates are unusually well suited for treatment of chronic
conditions because they are less likely to induce the formation of antibodies and/or
accelerated clearance than are similar conjugates prepared from protein preparations
containing traces of large aggregates.
__________________
[11][21]
268
193534
August 31,2011 -א' באלול התשע"א
מערכת לשיפור בטיחות החגירה של ילד
במכונית
[54]
SYSTEM FOR IMPROVEMENT OF
CHILD SAFETY SEAT SET-UP IN
A VEHICLE
[22]
[31]
[51]
[71]
21.11.2006
11/560864
[32] 17.11.2006
[33] US
Int. Cl.(2010.01) A47D 01//00, 15//00, B60R 22//30
YAIR DAVID
DAVID ARNON
DAVID DORON
[72]
YAIR DAVID, DAVID ARNON,
DAVID DORON
WO/2008/059472
YAIR DAVID,
6 ANKOR ST.
[87]
[74]
[57]
השרון- רמת,יאיר דוד
השרון- רמת,דוד ארנון
חוף אשקלון,דוד דורון
דוד דורון, דוד ארנון,יאיר דוד
,יאיר דוד
רמת השרון6 אנקור
השרון-רמת
A seatbelt adaptor and a method to be used to improve of the setup of a child safety
seat (13) in a vehicle, the seatbelt adaptor (20e) comprising a central lengthening
device and two connectors disposed at both ends of the central lengthening device. The
connectors are suited for the buckles (15, 16) of the vehicle's seatbelts, and wherein the
length of the seatbelt adaptor is suited to improve upon the latching of the buckle of
the seatbelt that secures a child seated in a safety seat within a vehicle.
__________________
[11][21]
193730
זרם סוללה/מניע משאבה למנוע לינארי בעל כח
קבוע
[54]
PUMPING DEVICE FOR LINEAR
MOTOR WITH CONSTANT
BATTERY POWER/CURRENT
[22]
[31]
[51]
27.08.2008
60/968321
[32] 28.08.2007
[33] US
Int. Cl.(2010.01) G02F 01//1333, G09G 03//20, 03//36, 05//00, 05//18
269
August 31,2011 -א' באלול התשע"א
[71]
[72]
[74]
[57]
SOREQ NUCLEAR RESEARCH
CENTER ISRAEL ATOMIC ENERGY
COMMISSION
VLADIMIR MARON
DEKEL PATENT LTD.,
18 MENUHA VENAHALA ST.,
REHOVOT 76209
המרכז למחקר גרעיני נחל שורק הועדה
יבנה,לאנרגיה אטומית
ולדימיר מרון
,דקל פטנט בע"מ
27 חדר, 18 מנוחה ונחלה
רחובות
A pumping driver for a linear motor comprising: a DC/DC converter connected to a
battery, an output of said DC/DC converter being connected to a communicator,
wherein said communicator is connected to a linear motor; and a temperature
controller, wherein temperature feedback from said linear motor is fed to said
temperature controller, and said temperature controller processes the feedback and a
temperature control signal to output a control signal to a battery current controller that
outputs to said DC/DC converter, such that said DC/DC converter performs at least
one of constant power pumping and constant input current pumping of said battery to
said linear motor.
__________________
[11][21]
194074
2 שיטה לזיהוי תרופות אנטי–סוכרת נעורים סוג
[54]
METHOD OF IDENTIFYING
ANTI-TYPE 2 DIABETES
MELLITUS DRUGS
[22]
[31]
[51]
[62]
[71]
20.01.2003
02001401.5
[32] 19.01.2002
[33] EP
Int. Cl.(2010.01) A61K 38//43, C12N 15//54, C12Q 01//68, G01N 33//68
DIVISION FROM 162973
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2003/060130
EITAN, PEARL, LATZER AND
, לצר וכהן צדק, פרל,איתן
COHEN ZEDEK,
7 רחוב שנקר
August 31,2011 -א' באלול התשע"א
[87]
[74]
270
[57]
P.O.B. 12688,
הרצליה12688 .ד. ת,
HERZLIYA 46733
A method of identifying anti-type 2 diabetes mellitus drugs, comprising: (a)
determining expression level of a PIM-3 nucleic acid molecule in a forst adipocyte in
the presence of a candidate compound wherein the PIM-3 nucleic acid molecule is
selected from the group consisting of SEQ ID NO 1, SEQ ID NO 3, SEQ ID NO 5 and
SEQ ID NO 7 (b) determining expression level of the PIM-3 nucleic acid molecule in
a second adipocyte in the absence of a candidate compound, and (c) identifying an
anti-type 2 diabetes mellitus drug by determining whether there is a difference in PIM3 expression in the first adipocyte in the presence of the candidate compound
compared to PIM-3 expression in the second adinocyte in the absence of candidate
compound.
__________________
[11][21]
194361
מכשיר למתן טיפות
[54]
DROPLET DEPOSITION
APPARATUS
[22]
[31]
[51]
[71]
03.04.2007
0606685.6
[32] 03.04.2006
[33] GB
Int. Cl.(2010.01) B41J 02//14
XAAR TECHNOLOGY LIMITED,
UNITED KINGDOM
WO/2007/113554
PEARL COHEN ZEDEK LATZER,
,פרל כהן צדק לצר
5 SHENKAR ST.,
5 רח' שנקר,1 ים-מרכז גב
P.O.B. 12704,
הרצליה12704 .ד. ת,
HERZLIYA 46733
Droplet deposition apparatus comprising an array of fluid chambers defined by a pair
of opposing chamber walls, and in fluid communication with a nozzle for droplet
ejection therefrom; a cover member is joined to the edges of the chamber walls and
thus seals one side of the chambers. The cover member has a ratio of cover thickness
to chamber wall separation less than or equal to 1:1.
[87]
[74]
[57]
__________________
[11][21]
[54]
271
INITIAL CELL SEARCH
ALGORITHM
194548
אלגוריתם עבור תא חיפוש ראשוני
August 31,2011 -א' באלול התשע"א
[22]
[31]
[51]
[62]
[71]
[87]
[74]
04.02.2002
60/271642
[32] 27.02.2001
[33] US
09/918611
31.07.2001
US
Int. Cl.(2010.01) H04B 01//707, H04J 13//00, H04W 56//00
DIVISION FROM 157450
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2002/069551
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
[57]
A user equipment (UE), comprising: a first module configured to process a received
communication signal and generate an index value associated with a primary
synchronization code within the communication signal, the first mudule comprising: a
splitter configured to split a sampled communication signal into even and odd samples;
a Hierarchical Golay Correlator (HGC) configured to correlate the even and odd
samples with primary synchronization code of the communication signal, and to
generate complex values of the even and odd samples; an absolute value modifier
(AVM) configured to approximate signal strength values for each of the even and odd
samples; a decision circuit configured to accumulate the approximate signal strength
values of the sample within a frame of the communication signal, assigning as an
index value a highest accumulated signal strength value , and to determine a chip
offset based on the index value; a normalized cirfuit configured to normalize the
accumulated signal strength value; a look-up table configured to determine a gain
factor; a multiplier configured to generate a noise threshold based on the normalized
signal strength value and on the gain factor; and a computer configured to compare the
noise threshold to the index value in order to make a first decision; a second module
configured to generate a scrambling code group number, a slot offset, and secondary
synchronization code based on output provided by the first module; a third module
configured to retrieve a primary scrambling code based on the scrambling code group
number and slot offset; and a controller coupled to the first module, second module,
and third module, the controller configured to control a search frequency of the UE for
establishing a communication link.
272
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
194579
שיטה ומערכת לקביעת ריכוז של לפחות אנליט
אחד אצל חולה
[54]
METHOD AND SYSTEM FOR
DETERMINING THE
CONCENTRATION OF AT LEAST
ONE ANALYTE IN A PATIENT
[22]
[31]
[51]
[71]
11.04.2007
60/791059
[32] 11.04.2006
[33] US
Int. Cl.(2010.01) A61B 01//227, 05//00
OREGON HEALTH & SCIENCE
UNIVERSITY, U.S.A.
WO/2007/121209
LUZZATTO & LUZZATTO,
,לוצאטו את לוצאטו
INDUSTRIAL PARK, OMER,
עומר,גן תעשייה
P.O.B. 5352,
באר שבע5352 .ד. ת,
BEER-SHEVA 84152
Methods and compositions for the non-invasive determination of the concentration of
an analyte are provided.
[87]
[74]
[57]
__________________
[11][21]
194842
מערכת ושיטה לבקרה אוטומטית בטיסה של כנף
מונע כוח במשטח אוויר
[54]
SYSTEM AND PROCESS FOR
AUTOMATICALLY
CONTROLLING THE FLIGHT OF
POWER WING AIRFOILS
[22]
[51]
[71]
10.05.2006
Int. Cl.(2010.01) F03D 03//00, 05//00, 07//00, 07//06
KITE GEN RESEARCH S.R.L.,
ITALY
WO/2007/129341
DR. YITZHAK HESS & PARTNERS,
,ד"ר יצחק הס ושותפיו
279 HAYARKON ST.,
279 רחוב הירקון
P.O.B. 6451,
תל אביב6451 .ד. ת,
TEL AVIV 61063
A system (1) is described for automatically controlling the flight of at least one power
wing airfoil (2) , comprising first detecting means (3) on board of such power wing
airfoil (2) adapted to detect first pieces of information (3a) dealing with at least one
August 31,2011 -א' באלול התשע"א
[87]
[74]
[57]
273
position and one orientation in space of the power wing airfoil (2) and accelerations to
which the power wing airfoil (2) is subjected; second detecting means (5) on the
ground adapted to detect tension on the driving cables (21) of the power wing airfoil
(2) and a position of a driving unit (9) counterweight; processing and controlling
means (7) adapted to transform the contents of such information (3a, 5a) into a
mechanical drive operating on the winches of the driving unit (9) to drive the power
wing airfoil (2) along a flight trajectory TVl, TV2 , TV3, ..., TVn maximising a 'lift'
effect generated on the power wing airfoil (2) . A process is further described for
automatically controlling the flight of at least one power wing airfoil (2) through the
system (1) .
__________________
[11][21]
195020
[54]
METHOD AND APPARATUS FOR
MEASURING CHANNEL STATE
INFORMATION
[22]
[31]
[51]
[62]
[71]
20.03.2001
09/539224
[32] 30.03.2000
[33]
Int. Cl.(2010.01) H04B 01//707, 07//04, 11//00
DIVISION FROM 169251
QUALCOMM INCORPORATED,
U.S.A.
WO/2001/076110
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[87]
[74]
[57]
274
שיטה והתקן למדידת מידע מצב ערוץ
US
,' קולב ושות.סנפורד ט
מרמורק,4 שער הגיא
רחובות2273 .ד. ת,
An apparatus for measuring and reporting transmission characteristics of a propagation
channel in a multiple input/multiple output communication system comprising: means
for receiving, by at least one receive antenna, at least one pilot symbol on at least some
of sub-channels of a plurality of subsets of subchannels from a plurality of transmit
antennas of a transmitter unit, where in the sub-cannel of each subset are noncontiguous; means for determining a set of transmission characteristics for at least one
August 31,2011 -א' באלול התשע"א
of the plurality of sub-channels, wherein determining the set of transmission
characteristics uses the at least one pilot symbol received at the at least one receive
antenna and means for reporting an information signal to the transmitter unit, wherein
the information signal carries the set of transmission characteristics for at least one of
the plurality of sub-channels.
__________________
[11][21]
195539
גלאי רב משתמשים עבור מספר גורמי
התפשטות
[54]
MULTIUSER DETECTOR FOR
VARIABLE SPREADING
FACTORS
[22]
[31]
[51]
[62]
[71]
02.02.2000
60/154985
[32] 21.09.1999
[33] US
Int. Cl.(2010.01) H04B 01//707, 07//216, H04J 13//02, 13//04
DIVISION FROM 182118
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2001/022610
REINHOLD COHN AND PARTNERS,
,ריינהולד כהן ושותפיו
26A HABARZEL ST.,
'א26 רחוב הברזל
RAMAT HACHAYAL 69710
רמת החייל
[87]
[74]
[57]
275
An apparatus for recovering data from a plurality of data signals comprising: means
for receiving the plurality of data signals, each data signal having an associated
spreading factor; means for determining an individual response matrix the represents a
plurality of filter response characteristics for each received data signal; a processor
configured to assemble a total system response matrix with limited matrix bandwidth
from the plurality of individual response matrices; said processor configured to: group
individual response matrices having equal spreading factors; assemble spreading factor
group matrices from said groups of individual response matrices with equal spreading
factors; use an assemble spreading factor group matrix having the lowest spreading
factor as a base total response matrix; and insert the assemble spreading factor group
matrices having higher spreading factors within said base total response matrix to form
the total system response matrix; and means for determining data of the data signals
August 31,2011 -א' באלול התשע"א
using the total system response matrix.
__________________
[11][21]
195749
מכשיר לניוד גלובלי של חלקי גוף
[54]
APPARATUS FOR GLOBAL
CORPORAL MOBILIZATION
[22]
[31]
[51]
[71]
[87]
[74]
08.06.2007
0605137
[32] 09.06.2006
[33] FR
Int. Cl.(2010.01) A61H 01//00, A63B 22//14, 26//00
GENDA LIMITED, IRELAND
WO/2007/141429
LUZZATTO & LUZZATTO,
,לוצאטו את לוצאטו
INDUSTRIAL PARK, OMER,
עומר,גן תעשייה
P.O.B. 5352,
באר שבע5352 .ד. ת,
BEER-SHEVA 84152
The invention concerns an apparatus (1) comprising a chassis (10) supported on the
ground (S), a mobile platform (44) supporting a subject, and motorized means (30, 32,
38) for driving the platform relative to the chassis. In order to put the subject off
balance while moving its lifting polygon, so as to act on the subject's body according
to advanced kinematics, the driving means are capable of moving the platform offcenter relative to a substantially vertical fixed axis (Z-Z) and of driving the platform in
rotation about said axis when the platform is off-center, whereas the platform is
provided with peripheral mobile supporting means (60, 62) on corresponding bearing
means (64) secured to the chassis (10), said supporting means being capable of resting
the platform on the chassis by adjustably inclining same relative to the horizontal in a
plane passing through the fixed axis and a central region of the platform when the
driving means move the platform off-center relative to said axis. The apparatus thus
generates remarkable neuro-biomechanical actions, while having a reliable lightweight
and compact structure.
[57]
276
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
196060
רקמת החיבור, במיוחד לעיסוי, מכשיר לטיפול
של העור
[54]
DEVICE FOR TREATING, IN
PARTICULAR MASSAGING, THE
CONNECTIVE TISSUE OF THE
SKIN
[22]
[31]
[51]
[71]
21.06.2007
0605596
[32] 22.06.2006
[33] FR
Int. Cl.(2010.01) A61H 09//00
LOUISIN RESEARCH AND
DEVELOPMENT LIMITED,
IRELAND
WO/2007/147977
LUZZATTO & LUZZATTO,
,לוצאטו את לוצאטו
INDUSTRIAL PARK, OMER,
עומר,גן תעשייה
P.O.B. 5352,
באר שבע5352 .ד. ת,
BEER-SHEVA 84152
This device (1) comprises, on the one hand, a casing (10) defining a treatment chamber
(40) which opens onto the skin and is designed to be connected to a vacuum source
and, on the other hand, elements (241 and 242) which work the skin and which are
mounted movably in the casing with sliding contact against associated walls (281, 282)
of the casing. To pinch the skin reliably and effectively, while allowing the device to
be moved easily and with precision along areas of skin that are awkward to treat, such
as highly curved areas, each working element is displaceable relative to the casing both
in rotation (R) on itself about a central axis (Z1-Z1, Z2-Z2) of the element and also in
translation (T) along this axis against the associated wall.
[87]
[74]
[57]
__________________
277
August 31,2011 -א' באלול התשע"א
[11][21]
197546
–מכשיר להקרנת נקודות דיקור באור מולטי
כרומטי
[54]
DEVICE FOR MULTICHROMATIC LIGHT
IRRADIATION OF
ACUPUNCTURE POINTS
[22]
[51]
[71]
12.03.2009
Int. Cl.(2010.01) A61H 39//00, A61N 05//01, 05//06
MICHAEL GRENADER
YOHAI TAHOR
ROSHEL MIRZAKANDOV
[74]
[57]
חיפה,מיכאל גרנדר
חולון,יוחאי טהור
תקוה- פתח,רושל מירזקנדוב
MICHAEL GRENADER,
,מיכאל גרנדר
50/15 HATIVAT CARMELI ST.
15 דירה50 רחוב חטיבת כרמלי
HAIFA 32629
חיפה
A device for multi-chromatic light irradiation of acupuncture points, that include a
group of sources (4,5) of directed light and irradiation program control unit (22) that is
connected to them, where: each source is installed with the ability of orientation at
only one acupuncture point; the group of sources include at least one pair of light
sources of different colors, which are installed with the possibility of orientation at
two adjacent acupuncture points, according to irradiation program; the device
includes a unit for modifying the mutual orientation of the light sources in the
mentioned pairs; the control unit includes a processor (31) with a shaper of the
parameters of the procedure and connected modulators (24) of the intensity and
duration of the pulses (26) of light irradiation; the modulators of the intensity and
duration of the pulses of light irradiation allow varying the intensity and frequency of
mono chromatic irradiation of light sources in such a way that they simultaneously
generate irradiation in two contrasting colors from at least two of the mentioned
adjacent light sources.
278
August 31,2011 -א' באלול התשע"א
לתקנות35 פירוט זה נבחן בהתאם לתקנה
1968 – תשכ"ח,הפטנטים
This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 - 1968
__________________
[11][21]
[54]
REMOTE ADMINISTRATION OF
SMART CARDS FOR SECURE
ACCESS SYSTEMS
[22]
[51]
[62]
[71]
[72]
[74]
13.10.1998
Int. Cl.(2010.01) H04L 09//00, 29//02
DIVISION FROM 179175
NDS LIMITED, UNITED KINGDOM
SHLOMO KIPNIS, RANNEN MEIR
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[57]
279
198096
שימוש אלחוטי של כרטיסים חכמים במערכות
גישה בטוחות
רענן מאיר,שלמה קיפניס
,' קולב ושות.סנפורד ט
מרמורק,4 שער הגיא
רחובות2273 .ד. ת,
A remote administrator for administrating via a communication network, at least one
smart card associated with a remote administrator, the remote administrator
comprising: a processor comprising: a first database module comprising an access
control list and information corresponding to the at least one smart card; an access
August 31,2011 -א' באלול התשע"א
control module operative to control access to a protected information resource; the
access control module controlling access by at least one of authentication, validation
and verification of the at least one smart card, the at least one of authentication,
validation and verification of the of the at least one smart card comprising one of:
comprising information related to one of authentication, validation and verification
information, recieved from the at least one smart card with the information
corrresponding to the at least one smart card ; and execution of a public-key based
software program; the database module operative to map at least one smart card to the
access control list, based on a positive result of the at least one of authentication,
validation and veification of the at least one smart card; and the remote administrator
further comprising communication apparatus for transmitting, via the communication
network, authorization information from the at least one smart card to a second smart
card associated with the remote administrator, wherein the mapping of said at least
one smart card to the access control list entitles said at least one smart card to access a
protected information resource.
__________________
[11][21]
198978
––דיהידרו3,1––אוקסו1––אמינו4)–3
–4 –דיאון או6,2––יל(–פיפרידין2–איזואינדול
–((–פיפרידיל3) דיאוקסו2,6)–2–()אמינו
–דיאון לטיפול בעמילואידוזיס1,3–איזואינדולין
[54]
3-(4-AMINO -1-OXO-1,3DIHYDRO- ISOINDOL-2- YL)PIPERIDINE-2,6 DIONE OR 4(AMINO)-2-(2,6 DIOXO(3PIPERIDYL))-ISOINDOLINE-1,3DIONE FOR TREATING
AMYLOIDOSIS
[22]
[31]
16.05.2003
60/380842
[32] 17.05.2002
[33] US
60/424600
06.11.2002
US
Int. Cl.(2010.01) A61K 31//454, A61P 01//00, 05//00, 07//00, 11//00, 13//12, 25//00,
31//00, 35//00, C07D 40/1/04
DIVISION FROM 178747
CELGENE CORPORATION, U.S.A.
WO/2003/097052
DR. SHLOMO COHEN & CO.,
,'ד"ר שלמה כהן ושות
124 IBN GABIROL ST.,
124 אבן גבירול
P.O.B. 11490,
תל אביב11490 .ד. ת,
TEL AVIV 62038
An immunomodulatory compound for treating amyloidosis, selected from:
I 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
II 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
[51]
[62]
[71]
[87]
[74]
[57]
280
August 31,2011 -א' באלול התשע"א
optionally in combination with additional therapeutically effective agent(s).
The said compounds are for use for the preparation of medicaments. Pharmaceutical
compositions comprising them are also claimed.
178747
The parent application from which
this application has been divided has
not yet been published
בקשת הורה לבקשה זו שטרם פורסמה
__________________
[11][21]
199123
מערכת ושיטה לבכורתיות של שידור מחדש של
פרוטוקול יחידות מידע על מנת לסייע בשידור
מחדש מבוקר רדיו
[54]
SYSTEM AND METHOD FOR
PRIORITIZATION OF
RETRANSMISSION OF
PROTOCOL DATA UNITS TO
ASSIST RADIO-LINK-CONTROL
RETRANSMISSION
[22]
[31]
[51]
[62]
[71]
09.05.2003
60/379829
[32] 10.05.2002
[33] US
Int. Cl.(2010.01) H04B 07//26, H04L 01//18, 29//06, H04W 72//10, 80//02
DIVISION FROM 165127
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2003/096617
REINHOLD COHN AND PARTNERS,
,ריינהולד כהן ושותפיו
26A HABARZEL ST.,
'א26 רחוב הברזל
RAMAT HACHAYAL 69710
רמת החייל
[87]
[74]
[57]
281
A method for wireless communication of data comprising: storing a data block in a
first memory queue for transmission; transmitting the data block in a number of times
until a determination of successful receipt is made; determining, after each
transmission, whether the data block was received successfully or was not received
successfully; and each time the determining reflects that the data block was not
received successfully; marking the data block for retransmission with an indication of
the number of times a determination of non-successful receipt occurred for the data
block; and storing the data block in a second memory queue for retransmission based
on the marking such that the second memory queue has a higher transmission priority
than the first memory queue so that the data block is transmitted in advance of data
blocks stored in the first memory queue.
August 31,2011 -א' באלול התשע"א
__________________
[11][21]
200260
בקרת ויסות הספק עבור בקרת ערוץ רגילה של
אות משודר ללווין עבור אפנון מוסגל ושיטות
הצפנה
[54]
COMMON CONTROL CHANNEL
UPLINK POWER CONTROL FOR
ADAPTIVE MODULATION AND
CODING TECHNIQUES
[22]
[31]
14.05.2002
60/290730
[32] 14.05.2001
[33] US
10/100383
18.03.2002
US
Int. Cl.(2010.01) H04B 01//707, H04W 52//10, 52//22, 52//24
DIVISION FROM 195540
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2002/093952
REINHOLD COHN AND PARTNERS,
,ריינהולד כהן ושותפיו
26A HABARZEL ST.,
'א26 רחוב הברזל
RAMAT HACHAYAL 69710
רמת החייל
[51]
[62]
[71]
[87]
[74]
[57]
A method for determining uplink power level, implemented in a base station,
comprising: receiving a communication signal over an uplink common control
channel; measuring interference on the uplink common control channel in response to
the received communication signal; monitoring a chanel quality of the uplink common
control channel and providing a quality margin for the communication signal; and
transmitting the quality margin over a downlink control channel.
__________________
282
August 31,2011 -א' באלול התשע"א
[11][21]
201428
שיטה ומכשיר עבור השגת מערכת נתוני נפח של
רקמה ניידת או איבר של מטופל
[54]
METHOD AND DEVICE FOR
OBTAINING A VOLUME DATA
SET OF A MOBILE TISSUE OR
ORGAN OF A PATIENT
[22]
[31]
04.04.2008
10 2007 016
[32] 10.04.2007
[33] DE
902.9
Int. Cl.(2010.01) A61B 06//00, G06T 11//00
BIOSENSE WEBSTER, INC., U.S.A.
WO/2008/122599
D. KLIGLER I.P. SERVICES LTD.,
, קליגלר שירותי קניין רוחני בע"מ.ד
P.O.B. 33111
תל אביב33111 .ד. ת,
TEL AVIV 61330
The invention relates to a method and to a device for obtaining a volume data set of a
mobile tissue or organ (H) of a patient (P) by means of a C-arm X-ray device (1) and
an electromagnetic position detection system (10), in which at least one, preferably Xray positive electromagnetic sensor (13) of the position detection system (10) is
arranged at least indirectly on the tissue or organ (H). The C-arm X-ray device (1)
enables a plurality of X-ray projections from the tissue or organ (H) of the patient (P)
from various projection directions to be obtained. A first method consists of
reconstructing a volume data set, based on each X-ray projection, in which the X-ray
positive electromagnetic sensor (13) essentially adopts a position (19) characterising a
determined displacement phase of the tissue or organ (H). A second method consists of
reconstructing a volume data set, based on each X-ray projection, that had been
captured at the time when the electromagnetic sensor (13) was essentially located in a
position characterising a determined displacement phase of the tissue or organ (H). A
third method does not capture an X-ray projection for the reconstruction of the volume
data set if the electromagnetic sensor (13) is essentially located in a position
characterising a determined displacement phase.
[51]
[71]
[87]
[74]
[57]
__________________
283
August 31,2011 -א' באלול התשע"א
[11][21]
202331
MHC תאים מולידיים אנושיים בעלי פנוטיפ
שלילי כפול ושיטות להשיג אותם
[54]
HUMAN PROGENITOR CELLS
HAVING AN MHC DOUBLENEGATIVE PHENOTYPE AND
METHODS OF OBTAINING SAME
[22]
[31]
[51]
[62]
[71]
10.02.2004
60/446275
[32] 11.02.2003
[33] US
Int. Cl.(2010.01) C12N 05//00
DIVISION FROM 170221
JOHN E. DAVIES, CANADA
DOLORES BAKSH, CANADA
RAHUL SARUGASER, CANADA
MORRIS HOSSEINI, GERMANY
ANTONY DAVID SUTTON
LICKORISH, CANADA
WO/2004/072273
JMB, FACTOR & CO. LTD.,
, פקטור אנד קו בע"מ,ג'יי אמ בי
HAR HOTZVIM HI-TECH PARK,
הר חוצבים,רחוב המרפא
P.O.B. 45087,
ירושלים45087 .ד. ת,
JERUSALEM 91450
Human progenitor cells are extracted from Wharton's jelly that lies within a
perivasculature zone of human umbilical cord.
[87]
[74]
[57]
__________________
[11][21]
202468
מערכת לאספקת מים לשירותים ושיטה עבורה
[54]
TOILET WATER SUPPLY
SYSTEM AND METHOD
THEREFOR
[22]
[51]
[71]
02.12.2009
Int. Cl.(2010.01) E03B 01//04, 03//00, 07//04
DALIA KATZIR
SASI KATZIR
DALIA KATZIR
DALIA KATZIR,
18 GILBOA ST.,
REUT 71908
[72]
[74]
284
רעות,דליה קציר
רעות,ששי קציר
דליה קציר
,דליה קציר
18 גלבוע
רעות
August 31,2011 -א' באלול התשע"א
[57]
A toilet water supply system, comprising: a used water reservoir, in addition
to a tank of said toilet, for storing used water for supplying thereof to a toilet
tank from a domestic water source; an adequate water sensor, for sensing
whether said reservoir is full; and a water directing apparatus, for directing
water from said source towards said water reservoir upon said sensing that
said reservoir is not full, and wherein said directing is carried out using a
pump and the operation thereof is regulated, wherein water directing
apparatus, said sensor and said pump being separated from said water
reservoir and the capacity of said apparatus being less than about 3 liters,
thereby allowing placing said water directing apparatus in an easy accessible
location, resulting with convenient maintenance.
לתקנות35 פירוט זה נבחן בהתאם לתקנה
1968 – תשכ"ח,הפטנטים
This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 - 1968
__________________
[11][21]
202827
הכנתן ותכשירים,[[אזפיןd נגזרות של בנזו
רוקחיים הכוללים אותן
[54]
BENZO [D]AZEPINE DERIVATIVES, THEIR
PREPARATION AND PHARMACEUTICAL
COMPOSITIONS COMPRISING THEM
[22]
[31]
18.12.2003
0229820.6
[32]
20.12.2002
[33]
GB
0312607.5
02.06.2003
GB
Int. Cl.(2010.01) A61K 31//55, A61P 25//26, 25//28, C07D 40/1/12, 40/3/12
DIVISION FROM 169091
GLAXO GROUP LIMITED, UNITED KINGDOM
WO/2004/056369
LUZZATTO & LUZZATTO,
,לוצאטו את לוצאטו
INDUSTRIAL PARK, OMER,
עומר,גן תעשייה
P.O.B. 5352,
באר שבע5352 .ד. ת,
BEER-SHEVA 84152
A compound which is 6-(3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yloxy)-N-methylnicotinamide.
[51]
[62]
[71]
[87]
[74]
[57]
285
August 31,2011 -א' באלול התשע"א
or a pharmaceutically acceptable salt thereof.
169091
The parent application from which this application
has been divided has not yet been published
בקשת הורה לבקשה זו שטרם
פורסמה
__________________
[11][21]
205411
שיטה והתקן להתאמת קצב מהירה במעגל סגור
בשידור נתונים בעל קצב גבוה של מארזים
[54]
METHOD AND APPARATUS FOR
FAST CLOSED-LOOP RATE
ADAPTATION IN A HIGH RATE
PACKET DATA TRANSMISSION
[22]
[31]
[51]
[62]
[71]
11.05.2001
09/570210
[32] 12.05.2000
[33] US
Int. Cl.(2010.01) H04B 07//212, H04L 12//50, H04W 28//18
DIVISION FROM 180344
QUALCOMM INCORPORATED,
U.S.A.
WO/2001/089162
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[87]
[74]
[57]
,' קולב ושות.סנפורד ט
מרמורק,4 שער הגיא
רחובות2273 .ד. ת,
A wireless apparatus, the apparatus comprising: means for recieving a first slot n of a
first multi-slot packet, wherein the first multi-slot packet comprises a plurality of data
slots interlaced with one or more gap slots in an alternating pattern, characterized in
that the first multi-slot packet is formatted to further include slots n+2, n+4, n+6 that
each carry a repetition of a codeword carried in the first slot; means for decoding the
first slot n of the first multi-slot packet; and means for transmitting an indicator
message indicating a reception status of the first slot n of the first multi-slot packet.
__________________
286
August 31,2011 -א' באלול התשע"א
[11][21]
205606
תרביות פרפוזיה המכילות מדיום לתרבית תא
ותאי חיה שעוברים אגרגציה
[54]
PERFUSION CULTURES
COMPRISING A CELL CULTURE
MEDIUM AND AGGREGATING
ANIMAL CELLS
[22]
[31]
04.03.2005
04075703.1
[32] 05.03.2004
[33] EP
04075702.3
05.03.2004
EP
04077656.9
27.09.2004
EP
04077657.7
27.09.2004
EP
Int. Cl.(2010.01) C12M 03//06, C12N 05//00
DIVISION FROM 177724
DSM IP ASSETS B.V., THE
NETHERLANDS
WO/2005/095578
LUZZATTO & LUZZATTO,
,לוצאטו את לוצאטו
INDUSTRIAL PARK, OMER,
עומר,גן תעשייה
P.O.B. 5352,
באר שבע5352 .ד. ת,
BEER-SHEVA 84152
A perfusion culture comprising a cell culture medium and aggregating animal cells.
[51]
[62]
[71]
[87]
[74]
[57]
__________________
[11][21]
[54]
APPARATUS FOR PRODUCING
HIGH ASPECT RATIO ETCH
USING MODULATION OF RF
POWERS OF VARIOUS
FREQUENCIES
[22]
[31]
06.08.2004
10/645665
[32] 22.08.2003
10/737022
15.12.2003
Int. Cl.(2010.01) H01L 21//311
DIVISION FROM 173861
LAM RESEARCH CORPORATION,
U.S.A.
LUMIN LI, ERIC A. HUDSON,
CAMELIA RUSU, RAJINDER
DHINDSA, MUKUND SRINIVASAN,
[51]
[62]
[71]
[72]
287
205779
התקן לייצר חריטה בעלת יחס רוחב גובה על ידי
בתדרים שוניםRF מודולציה של כוחות
[33]
US
US
August 31,2011 -א' באלול התשע"א
[87]
[74]
[57]
FELIX KOZAKEVICH
WO/2005/022623
JMB, FACTOR & CO. LTD.,
, פקטור אנד קו בע"מ,ג'יי אמ בי
HAR HOTZVIM HI-TECH PARK,
הר חוצבים,רחוב המרפא
P.O.B. 45087,
ירושלים45087 .ד. ת,
JERUSALEM 91450
A method for etching a high aspect ratio feature through a mask into a layer to be
etched over a substrate is provided. The substrate is placed (404) in a process chamber,
which is able to provide RF power at a first frequency, a second frequency different
than the first frequency, and a third frequency different than the first and second
frequency. An etchant gas is provided (408) to the process chamber. A first etch step is
provided (412) where the first frequency, the second frequency, and the third
frequency are at power settings for the first etch step. A second etch step is provided
(416), where the first frequency, the second frequency and the third frequency are at a
different power setting. Optionally, a third etch step may also be provided.
__________________
[11][21]
207057
הקצאת רוחב פס דינמית עבור תקשורת רבת
כניסות
[54]
DYNAMIC BANDWIDTH
ALLOCATION FOR MULTIPLE
ACCESS COMMUNICATION
USING SESSION QUEUES
[22]
[31]
[51]
[62]
[71]
[87]
[74]
17.01.2002
09/773252
[32] 31.01.2001
[33] US
Int. Cl.(2010.01) H04B 01//707, H04J 13//00, H04W 72//04
DIVISION FROM 195538
IPR LICENSING, INC., U.S.A.
WO/2002/061993
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
288
,ריינהולד כהן ושותפיו
'א26 רחוב הברזל
רמת החייל
August 31,2011 -א' באלול התשע"א
[57]
A technique for providing high speed data service over standard wireless connections
via an unique integration of protocols and existing cellular signaling is disclosed.
Channel resources are allocated according to a buffer monitoring scheme between a
base station (104) and multiple subscriber units (101-1,...,101-n). Each buffer (4401,...,440-N) is monitored over time for threshold levels of data and a probability is
calculated that takes into account the arrival of data into the buffer (440-1,...,440-N).
__________________
[11][21]
207587
שיטה לייצור מודל חולייתן לא הומני בעל רקמת
מטרה נורמאלית בעלת פנוטיפ בוגר או רקמת
מודל רקמה הנוצר בשל כך,מטרה חולה
ומכרסם פגוע אימונית המיוצר בהתאם לשיטה
הנ"ל
[54]
METHOD FOR GENERATING A
NON-HUMAN VERTEBRATE
ANIMAL MODEL HAVING
EITHER TARGET NORMAL
TISSUE OF MATURE
PHENOTYPE OR TARGET
DISEASED TISSUE, A TISSUE
MODEL THEREOF AND AN
IMMUNODEFICIENT RODENT
GENERATED ACCORDING TO
SAID METHOD
[22]
[31]
[51]
30.05.2003
60/384715
[32] 30.05.2002
[33] US
Int. Cl.(2010.01) A01K 33//00, 67//027, A01N 65//00, A61K 35//12, 49//00, G01N
33//15
DIVISION FROM 165128
RAVEN BIOTECHNOLOGIES, U.S.A.
WO/2003/101187
LUZZATTO & LUZZATTO,
,לוצאטו את לוצאטו
INDUSTRIAL PARK, OMER,
עומר,גן תעשייה
P.O.B. 5352,
באר שבע5352 .ד. ת,
BEER-SHEVA 84152
[62]
[71]
[87]
[74]
289
August 31,2011 -א' באלול התשע"א
[57]
The invention relates to the use of fetal tissues to generate a tissue model in a nonhuman animal. The tissue model comprises target tissues allowed to progress through
development in vivo in a non-human host in order to obtain tissues having a mature
phenotype that can be sued to assess toxicity and/or efficacy of an agent.
__________________
[11][21]
[54]
HIGH ENERGY SOLID-STATE
LASER WITH OFFSET PUMP AND
EXTRACTION GEOMETRY
[22]
[31]
[51]
[62]
[71]
[87]
[74]
20.12.2005
11/033585
[32] 12.01.2005
Int. Cl.(2010.01) H01S 03//091
DIVISION FROM 184418
RAYTHEON COMPANY, U.S.A.
WO/2007/084111
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[57]
290
208460
לייזר מצב מוצק בעל אנרגיה גבוהה עם משאבה
מאזנת ויחוס גאומטרי
[33]
US
,' קולב ושות.סנפורד ט
מרמורק,4 שער הגיא
רחובות2273 .ד. ת,
A laser system and method. The inventive laser includes an annular gain medium (37);
a source of pump energy (13, 15, 17), and an arrangement (25, 27, 29, 31) for
concentrating energy from the source on the gain medium. In a more specific
implementation, a mechanism is included for rotating the gain medium (37) to effect
extraction of pump energy and cooling. In the illustrative embodiment, the pump
source is a diode array. Energy from the array is coupled to the medium via an array of
optical fibers (25, 27, 29). The outputs of the fibers are input to a concentrator (31) that
directs the pump energy onto a pump region of the medium (37). In the best mode,
plural disks (30, 32, 34) of gain media are arranged in an offset manner to provide a
single resonator architecture. First (46) and second (48) mirrors are added to complete
the resonator. In accordance with the inventive teachings, a method for pumping and
cooling a laser is taught. In the illustrative embodiment, the inventive method includes
the steps of providing a gain medium; pumping energy into a region of the gain
medium; moving the medium; extracting energy from the region of the medium; and
cooling region of the medium.
August 31,2011 -א' באלול התשע"א
The parent application from which
this application has been divided has
not yet been published
184418
בקשת הורה לבקשה זו שטרם פורסמה
__________________
[11][21]
208799
שיטה להערכת טווח של כלי ירי על ידי גילוי גלי
הלם ורשף אש
[54]
METHOD FOR ESTIMATING A
SHOOTER RANGE BY
DETECTING SHOCK WAVE AND
MUZZLE BLAST
[22]
[31]
24.08.2005
10/925875
[32] 24.08.2004
[33] US
11/210295
23.08.2005
US
Int. Cl.(2010.01) F41J 05//06, G01S 03//80, 03//803
DIVISION FROM 181509
RAYTHEON BBN TECHNOLOGIES
CORP, U.S.A.
WO/2006/096208
LUZZATTO & LUZZATTO,
,לוצאטו את לוצאטו
INDUSTRIAL PARK, OMER,
עומר,גן תעשייה
P.O.B. 5352,
באר שבע5352 .ד. ת,
BEER-SHEVA 84152
A method for estimating a shooter range by detecting shock wave and muzzle blast,
comprising: measuring shockwave-only signals at a plurality of spaced ocoustic
sensors forming an antenna; measuring a muzzle blast signal at the plurality of
acoustic sensors; determining from the measured shock wave and muzzle blast signals
an initial estimate of the shooter range; assuming an initial bullet velocity and a bullet
drag coefficient; and iteratively computing an instantaneous bullet velocity along a
bullet trajectory to obtain an updated shooter range.
[51]
[62]
[71]
[87]
[74]
[57]
291
August 31,2011 -א' באלול התשע"א
The parent application from which
this application has been divided has
not yet been published
181509
בקשת הורה לבקשה זו שטרם פורסמה
__________________
[11][21]
208800
שיטה לקביעה חד משמעית של מסלול קליע
[54]
METHOD FOR DETERMINING AN
UNAMBIGUOUS PROJECTILE
TRAJECTORY
[22]
[31]
24.08.2005
10/925875
[32] 24.08.2004
[33] US
11/210295
23.08.2005
US
Int. Cl.(2010.01) G01S 03//80, 03//803, 03//808, 05//22
DIVISION FROM 181509
RAYTHEON BBN TECHNOLOGIES
CORP, U.S.A.
WO/2006/096208
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[51]
[62]
[71]
[87]
[74]
[57]
292
,לוצאטו את לוצאטו
עומר,גן תעשייה
באר שבע5352 .ד. ת,
A method for determining an unambiguous projectile trajectory using an array of
spaced acoustic sensors when a Shockwave associated with a projectile is detected by
at least five of the sensors but a muzzle blast associated with the projectile is detected
by fewer than four of the sensors, comprising: obtaining four or more Shockwave
TDOA measurements from the sensors detecting the Shockwave, wherein the
Shockwave TDOA measurements are insufficient to compute the unambiguous
projectile trajectory; obtaining fewer than three muzzle blast TDOA measurements
from the sensors detecting the muzzle blast; and iteratively computing solutions to a
ballistic model using the Shockwave TDOA measurements and the muzzle blast
TDOA measurements to obtain the unambiguous projectile trajectory.
August 31,2011 -א' באלול התשע"א
The parent application from which
this application has been divided has
not yet been published
181509
בקשת הורה לבקשה זו שטרם פורסמה
__________________
293
August 31,2011 -א' באלול התשע"א
פטנטים
PATENTS
פטנטים שניתנו
PATENTS GRANTED
156713
177586
178568
179413
180123
180674
181132
181813
181926
182566
183230
183831
162201
164004
184258
184950
187205
188319
189066
191007
165576
167131
168555
169540
170349
192483
196213
148153
171969
172889
174201
175187
175991
176767
203245
156532
177518
178474
179215
180052
180662
181118
181696
181913
182544
183156
183745
160993
163798
184005
184913
186905
188282
189016
190537
154209
166950
168543
169415
170252
171058
196082
147902
171916
172878
174166
175172
175801
176730
203244
156378
177422
178398
179212
179976
180531
180971
181682
181898
182482
183052
183548
160454
163488
184000
184865
186896
188261
188767
190355
153265
166842
168228
169412
170018
170873
195704
147094
171677
172679
173973
174957
175794
176728
203243
א' באלול התשע"אAugust 31,2011 -
156376
177385
178255
179160
179941
180507
180852
181438
181893
182439
182970
183491
160417
163344
183993
184803
186404
188191
188518
189964
152325
166794
167849
169375
169956
170719
195439
147093
171494
172518
173943
174921
175708
176727
202313
208120
156361
159920
178103
179082
179879
180485
180715
181406
181884
182435
182839
183486
160248
163208
183950
184654
186259
188174
188439
189724
151568
166620
167587
169332
169889
170620
195374
146674
171460
172505
173784
174870
175691
176707
200933
205515
155692
158729
177945
179026
179815
180445
180704
181351
181848
182374
182647
183388
145480
162862
183909
184568
186181
188023
188437
189719
151105
166467
167554
168802
169667
170618
195308
200258
171150
172371
173641
174826
175439
176629
177124
204550
155492
158624
177723
178978
179803
180386
180687
181322
181834
182057
182612
183358
142393
162856
165446
184358
185337
187719
188429
189604
150984
166305
167530
168694
169663
170586
194527
196628
150018
172141
173506
174586
175285
176559
176898
204302
141640
157231
177612
178902
179458
180169
180678
181298
181831
182003
182567
183350
125168
162713
164129
184279
185232
187568
188349
189551
137466
165608
167483
168651
169604
170547
193714
196509
148512
172109
173110
174229
175190
176197
176813
203246
294
פטנטים שחודשו
PATENTS RENEWED
106682
106815
106999
121482
121531
121590
121661
124308
128069
128229
128334
128512
128602
128714
129245
136701
144718
144959
145125
145619
149560
152803
153832
154132
154252
154305
154390
154480
154564
154626
154693
154773
155722
158301
159917
161540
163439
164007
167180
168500
169584
170010
170266
106638
106809
106994
121481
121521
121588
121659
124307
127963
128215
128332
128511
128586
128690
129171
136265
144709
144908
145103
145400
149492
152337
153647
154094
154244
154303
154374
154478
154536
154616
154692
154764
155661
157676
159788
160546
163112
163697
167131
168402
169472
169970
170254
106635
106777
106923
121456
121519
121586
121658
124306
127920
128211
128321
128507
128580
128689
129033
134654
144685
144907
145091
145342
149450
151395
153632
154044
154231
154302
154368
154474
154534
154603
154684
154763
155579
157418
159421
160454
162857
163675
167047
167799
169423
169917
170165
א' באלול התשע"אAugust 31,2011 -
106589
106773
106874
121398
121514
121583
121623
124305
127800
128198
128314
128496
128574
128638
128991
134355
144512
144905
145088
145227
149352
151322
153512
154035
154220
154301
154350
154465
154520
154594
154669
154723
154978
156532
159418
160311
162692
163667
166950
167628
169415
169896
170153
106576
106746
106850
121385
121513
121561
121607
121902
127342
128146
128311
128480
128552
128637
128848
134180
144443
144855
145083
145212
149029
150737
153436
154014
154197
154266
154333
154464
154517
154591
154668
154719
154926
156378
158956
160309
162071
163639
166881
167500
169157
169824
170140
106570
106743
106849
121250
121512
121555
121605
121737
127290
128129
128274
128407
128551
128636
128810
130230
144008
144818
145061
145211
148433
150430
153422
153993
154174
154259
154331
154440
154495
154585
154653
154717
154843
156376
158438
160123
161900
163579
166832
167433
169150
169783
170101
106537
106700
106842
120417
121511
121543
121600
121725
127049
128124
128258
128360
128539
128631
128765
130005
140855
144806
145036
145206
146678
150414
153322
153978
154170
154256
154327
154426
154489
154583
154643
154705
154779
156308
158303
160054
161892
163546
166467
167275
168636
169691
170081
106536
106693
106835
107050
121483
121538
121593
121718
125168
128121
128245
128358
128535
128610
128715
129262
137466
144805
145016
145182
146475
149654
153297
153945
154147
154254
154325
154418
154481
154574
154632
154696
154777
155878
158302
159986
161665
163522
165250
167249
168543
169612
170075
295
170320
170732
171337
172064
172546
172962
173543
174826
175190
176031
176634
177198
178043
178913
179571
180635
181059
181432
181859
182206
182810
184136
185535
187467
188767
193845
198933
170458
170755
171390
172069
172583
173101
173561
174870
175192
176087
176685
177371
178103
179022
179800
180705
181112
181449
181937
182321
183138
184358
185578
187568
188821
194037
199910
170502
170873
171539
172164
172611
173110
173909
174936
175235
176299
176794
177590
178481
179082
179941
180715
181131
181587
181942
182341
183470
184359
185680
187700
188954
194063
200258
170573
171058
171650
172186
172692
173119
174163
174973
175495
176344
176957
177599
178646
179099
179976
180765
181205
181588
182003
182403
183573
184454
186031
188245
189128
194382
200933
170618
171091
171677
172201
172766
173256
174416
175059
175510
176415
177039
177672
178662
179304
180012
180776
181208
181591
182023
182435
183574
184561
186758
188392
189719
195308
202880
170620
171214
171706
172280
172770
173405
174477
175146
175821
176481
177072
177881
178863
179379
180248
180892
181298
181620
182072
182440
183784
185140
186759
188518
190930
195439
204660
170651
171324
171874
172370
172878
173506
174680
175161
175847
176629
177118
177945
178904
179385
180269
180991
181393
181627
182073
182541
183823
185365
186791
188573
192255
195622
204661
170667
171332
171878
172371
172895
173542
174688
175187
175991
176632
177160
177948
178912
179550
180531
181055
181429
181723
182074
182559
183969
185508
186824
188721
193367
196482
פטנטים שחודשו לעשרים שנה
PATENTS RENEWED FOR 20 YEARS
148972
156120
176192
189037
צווי הארכה שחודשו
EXTENSION ORDERS RENEWED
97045
296
100756
August 31,2011 -א' באלול התשע"א
פטנטים שלגביהם הוגשו
בקשות להארכת תקופת
ההגנה על פי פרק ד' סימן
לחוק הפטנטים1'ב
Patents for which
applications have been filed
for extension of the patent
term under chapter 4, part
B1 of the Patens Law
No. of basic patent:
142023
:מס' פטנט בסיסי
:שם המבקש
Proprietors:
KIRIN-AMGEN INC.
Date of application:
297
07.07.2011
:תאריך הגשת הבקשה
August 31,2011 -א' באלול התשע"א
הודעה
NOTICE
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:
לחוק60 לפי סעיף
1967- תשכ"ז,הפטנטים
הוגשה בקשה להחזר תוקפו
,של הפטנט המפורט מטה
שתוקפו פקע מחמת אי
תשלום אגרות החידוש
:הקבועות
153184
2/2009
מס' הפטנט
:'קיבול פורסם ביומן מס
:שם בעל הפטנט
SAFASOFT CO., LTD.
:שם האמצאה
מערכת שלמה למניעת זרימת מידע החוצה מבפנים
TOTAL SYSTEM FOR PREVENTING INFORMATION OUTFLOW FROM INSIDE
Any person may oppose the
כל אדם רשאי להתנגד
said application within three
לבקשה האמורה תוך
months from the date of this
שלושה חודשים מתאריך
Patents Journal, as
כפי שנקבע,יומן פטנטים זה
prescribed by section 61 of
92 לחוק ובתקנה61 בסעיף
the law and by regulation 92
תשכ"ח,לתקנות הפטנטים
of the Patent Regulations,
1968
5728-1968
Title of invention:
298
August 31,2011 -א' באלול התשע"א
הודעה
NOTICE
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:
לחוק60 לפי סעיף
1967- תשכ"ז,הפטנטים
הוגשה בקשה להחזר תוקפו
,של הפטנט המפורט מטה
שתוקפו פקע מחמת אי
תשלום אגרות החידוש
:הקבועות
165898
1/2006
מס' הפטנט
:'קיבול פורסם ביומן מס
:שם בעל הפטנט
NORTHROP GRUMMAN CORPORATION
Title of invention:
:שם האמצאה
שיטה לחולל נתוני תנועה ומסלול עבור גוף על במה מסתובבת
A METHOD OF GENERATING MOTION DATA AND TRAJECTORY DATA FOR
AN OBJECT ON A ROTATABLE PLATFORM
Any person may oppose the
כל אדם רשאי להתנגד
said application within three
לבקשה האמורה תוך
months from the date of this
שלושה חודשים מתאריך
Patents Journal, as
כפי שנקבע,יומן פטנטים זה
prescribed by section 61 of
92 לחוק ובתקנה61 בסעיף
the law and by regulation 92
- תשכ"ח,לתקנות הפטנטים
of the Patent Regulations,
1968
5728-1968
299
August 31,2011 -א' באלול התשע"א
הודעה
NOTICE
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:
לחוק60 לפי סעיף
1967- תשכ"ז,הפטנטים
הוגשה בקשה להחזר תוקפו
,של הפטנט המפורט מטה
שתוקפו פקע מחמת אי
תשלום אגרות החידוש
:הקבועות
165899
1/2006
מס' הפטנט
:'קיבול פורסם ביומן מס
:שם בעל הפטנט
NORTHROP GRUMMAN CORPORATION
Title of invention:
:שם האמצאה
שיטה לחולל נתוני תנועה ומסלול עבור גוף המשוגר מבמה מסתובבת
A METHOD FOR GENERATING MOTION DATA AND TRAJECTORY DATA FOR
AN OBJECT LAUNCHED FROM A ROTATABLE PLATFORM
Any person may oppose the
כל אדם רשאי להתנגד
said application within three
לבקשה האמורה תוך
months from the date of this
שלושה חודשים מתאריך
Patents Journal, as
כפי שנקבע,יומן פטנטים זה
prescribed by section 61 of
92 לחוק ובתקנה61 בסעיף
the law and by regulation 92
- תשכ"ח,לתקנות הפטנטים
of the Patent Regulations,
1968
5728-1968
300
August 31,2011 -א' באלול התשע"א
NOTICE
NOTICE under section 64E of the
Patents Law, 5727-1967
It is the intention of the
Commissioner of Patents to grant an
order for the extension of the period
of protection of the following patent
in accordance with Chapter Four,
Article Two bis, of the Patents Law,
5727-1967
No. of basic patent:
The order will be in effect until:
Acceptance published in Journal
הודעה
ה לחוק64 הודעה לפי סעיף
1967-הפטנטים התשכ"ז
בכוונת רשם הפטנטים ליתן צו
להארכת תקופת הגנה ע"פ פרק
, לחוק הפטנטים1 סימן ב,'ד
לגבי הפטנט1967-התשכ"ז
:המפורט מטה
102008
25.4.2010
9/1995
:מס' פטנט בסיסי
:הצו יעמוד בתוקפו עד ליום
:'קיבול פורסם ביומן מס
Title of invention:
:שם האמצאה
תולדות קוינוקלידין תכשירי רוקחות הכוללים אותם ושימושיהם
QUINUCLIDINE DERIVATIVES
PHARMACEUTICAL COMPOSITIONS
CONTAINING THEM AND USES THEREOF
Proprietors:
:בעלי הפטנט
PFIZER INC.
Any person desiring to oppose the
said grant of an order may, within
three months from the date of this
journal, serve to the Commissioner
of Patents a notice of opposition
under Section 64F of the Law, as
prescribed by Rule 3 of the Patent
Regulations (extension of period of
protection – procedure of
application for order, opposition to
order, application to annul) 57581998.
301
כל המעוניין להתנגד למתן צו
הארכה רשאי תוך שלושה
להגיש,חודשים מתאריך יומן זה
לרשם הפטנטים הודעה התנגדות
בדרך,ו לחוק64 לפי סעיף
לתקנות3 הקבועה בתקנה
– הפטנטים )הארכת תקופה הגנה
בהתנגדות,סדרי דין בבקשה לצו
- התשנ"ח,( ובבקשה לביטול,לצו
1998
August 31,2011 -א' באלול התשע"א
ארכת פטנט
PATENT EXTENSION
Patent Extension Order
Granted to Patent No. 100553
Until
302
22.09.2014
צו הארכת פטנט
100553 ניתן לפטנט מספר
עד ליום
August 31,2011 -א' באלול התשע"א
הודעה
NOTICE
Under section 66 of the Patents
Law, 5727-1967
This is to notify that permission
has been granted to the owner of
Patent Application No.
Acceptance published in journal
To amend the specification of the
said Patent Application.
Any person may oppose such
grant of permission within three
months from the date of this
Patents Journal, as prescribed by
section 67 of the Law and by
regulation 99 of the Patent
Regulations, 5728-1968.
303
167740
7/2010
, לחוק הפטנטים66 לפי סעיף
1967-תשכ"ז
מודע בזאת כי ניתנה רשות
'לבעלת בקשת הפטנט מס
דבר הקיבול פורסם ביומן
לתקן את הפירוט של בקשת
הפטנט האמורה
כל אדם רשאי להתנגד למתן
הרשות תוך שלושה חודשים
כפי,מתאריך יומן פטנטים זה
לחוק ובתקנה67 שנקבע בסעיף
- התשכ"ח, לתקנות הפטנטים99
.1968
August 31,2011 -א' באלול התשע"א
הודעה
NOTICE
Under section 66 of the Patents
Law, 5727-1967
This is to notify that permission
has been granted to the owner of
Patent Application No.
Acceptance published in journal
To amend the specification of the
said Patent Application.
Any person may oppose such
grant of permission within three
months from the date of this
Patents Journal, as prescribed by
section 67 of the Law and by
regulation 99 of the Patent
Regulations, 5728-1968.
304
173221
2/2010
, לחוק הפטנטים66 לפי סעיף
1967-תשכ"ז
מודע בזאת כי ניתנה רשות
'לבעלת בקשת הפטנט מס
דבר הקיבול פורסם ביומן
לתקן את הפירוט של בקשת
הפטנט האמורה
כל אדם רשאי להתנגד למתן
הרשות תוך שלושה חודשים
כפי,מתאריך יומן פטנטים זה
לחוק ובתקנה67 שנקבע בסעיף
- התשכ"ח, לתקנות הפטנטים99
.1968
August 31,2011 -א' באלול התשע"א
שינויים בפרטים רשומים בפנקס
CHANGES IN PARTICULARS ENTERED IN REGISTER
305
August 31,2011 -א' באלול התשע"א
תיקונים ביומן
Gournal Corrections
Patent application No
No. of Patent:
CORRECT DATE OF
APPLICATION
12.2.2003
306
163490
72011
'בקשת פטנט מס
:מספר יומן בו נפלה טעות
תקן את תאריך הבקשה
12.2.2003
August 31,2011 -א' באלול התשע"א
מדגמים
DESIGNS
מדגמים שנרשמו
DESIGNS REGISTERED
48853
7(07)
12.01.2010
Class
סוג פרסום
יהודה כהן
ספל לנטילת ידיים
YEHUDA COHEN
Cup for washing hands
49012
9(03)
14.02.2010
Class
סוג פרסום
פרזנט פרפקט בע"מ
אריזה
PRESENT PERFECT LTD.
Package
47107
9(03)
13.01.2009
Class
KAL KAR EIN CARMEL LTD.
Cooling box for storaging fish
Class
ISRAEL MAMAN
REUVEN MAMAN
Advertising bord
307
48507 ,48506 ,48505
20(03)
08.11.2009
סוג פרסום
קל קר עין כרמל בע"מ
ארגז קירור לאיחסון דגים
סוג פרסום
ישראל ממן
ראובן ממן
לוח פרסום
August 31,2011 -א' באלול התשע"א
Class
48543 ,48542 ,48541
48546
6(13)
17.11.2009
סוג פרסום
ציפי דבש בע"מ
שמיכה
TZIPI DEVASH LTD.
Blanket
Class
48799
23(02)
23.12.2009
סוג פרסום
תה ולימון בע"מ
סיר לילה מתקפל
TEA AND LEMON LTD.
Folding potty
Class
48816
12(06)
28.12.2009
סוג פרסום
אריה טרופיאנסקי
סירה
ARIE TROPIANSKY
Boat
Class
48914
9(07)
24.01.2010
סוג פרסום
סנפלסט בע"מ
מכסה מחורר לשתיה
SANPLAST LTD.
Lid with holes for drink
Class
48941
9(07)
25.01.2010
סוג פרסום
COLGATE-PALMOLIVE COMPANY
308
August 31,2011 -א' באלול התשע"א
Cap for a container
Convention date (U.S.A.)
31.07.2009
48948
9(03)
27.01.2010
Class
SHAHAM Y. ARICHA AND SONS
LTD.
מכסה עבור מיכל
(תאריך האמנה )ארצות הברית
סוג פרסום
אריכא ובניו בע"מ.שחם י
אשפתון
Dustbin
48982 ,48980
25(01)
07.02.2010
Class
שוקת אלומיניום בע"מ
פרופיל
SHOKET ALUMINIUM LTD.
Profile
Class
49031 ,49029 ,49028
49032
6(04)
18.02.2010
Chest
TEXTURA FURNITURE LTD.
Baby crib
309
סוג פרסום
טקסטורה רהיטים בע"מ
שידה
TEXTURA FURNITURE LTD.
Class
סוג פרסום
49033 ,49030
6(01)
18.02.2010
סוג פרסום
טקסטורה רהיטים בע"מ
מיטת תינוק
August 31,2011 -א' באלול התשע"א
Class
48553
11(02)
17.11.2009
סוג פרסום
הצורפים בע"מ
צלחת קישוטית
HAZORFIM LTD.
Decorative plate
Class
49086
14(03)
01.03.2010
חברה לשיווק ומסחר בע"מ.ג.ל.גליל ש
GALIL S.L.G. TRADING &
MARKETING COMPANY LTD.
מחשב/פרופיל לזרוע למסך טלוויזיה
Profile for tv/computers screen
Class
49118
25(03)
04.03.2010
KAL BINYAN LTD.
Prefabricated element for double stature grave
Class
49123
21(03)
07.03.2010
סוג פרסום
קל בנין בע"מ
אלמנט טרומי לקבר דו קומתי
סוג פרסום
גנית פארק בע"מ
מתקן למגרש משחקים
GANIT PARK LTD.
Playground equipment
Class
סוג פרסום
49259
15(08)
08.04.2010
סוג פרסום
SANTOS
Appliance for preparing food
310
מכשיר להכנת מזון
August 31,2011 -א' באלול התשע"א
Convention date (OHIM)
Class
09.10.2009
49272 ,49271
24(02)
13.04.2010
(תאריך האמנה )איחוד אירופי
סוג פרסום
.ROCHE DIAGNOSTICS S.L
Portable medical equipment for clinical
מכשיר רפואי נייד לביצוע אבחון קליני
analysis
Convention date (OHIM)
14.10.2009
(תאריך האמנה )איחוד אירופי
Class
49280
9(01)
14.04.2010
סוג פרסום
YEREVAN BRANDY COMPANY CJSC
Bottle
Convention date (OHIM)
Class
23.11.2009
49050
29(02)
21.02.2010
בקבוק
(תאריך האמנה )איחוד אירופי
סוג פרסום
נאור רן
אורטק מערכות מיגון בע"מ
RAN NAOR
ORTECH DEFENCE SYSTEMS
LTD.
עמדת חי"ר ניידת
Mobil infantry fighting position
Class
KAL GAV LTD.
Back bag
311
49373
3(01)
02.05.2010
סוג פרסום
קל גב בע"מ
תיק גב
August 31,2011 -א' באלול התשע"א
Class
49447
15(08)
13.05.2010
סוג פרסום
PLUMATECH SAS
Poultry plucker
Convention date (OHIM)
Class
11.01.2010
49454
23(04)
13.05.2010
49515
24(02)
27.05.2010
סוג פרסום
רפיד מדיקל בע"מ
מכשיר להסרת קרישים בכלי הדם
RAPID MEDICAL LTD.
Embolectomy device
Class
סוג פרסום
טויטופלסט בע"מ
מתאם למערכת מיזוג אוויר
TWITOPLAST LTD.
Conditioning system adapter
Class
מורט נוצות לעופות
(תאריך האמנה )איחוד אירופי
49580
6(13)
14.06.2010
סוג פרסום
רונית קריסטל
ציפה לשמיכה
RONIT KRISTAL
Blanket cover
Class
49589
4(02)
14.06.2010
סוג פרסום
COLGATE-PALMOLIVE COMPANY
Toothbrush
Convention date (U.S.A.)
312
15.12.2009
מברשת שיניים
(תאריך האמנה )ארצות הברית
August 31,2011 -א' באלול התשע"א
Class
49655
9(03)
20.06.2010
סוג פרסום
CURVER LUXEMBOURG SARL
Box with cover
Convention date (OHIM)
Class
21.12.2009
49682
9(01)
24.06.2010
קופסה עם מכסה
(תאריך האמנה )איחוד אירופי
סוג פרסום
V & S LUKSUSOWA ZIELONA GORA S.A.
Bottle
Convention date (OHIM)
Class
22.01.2010
49725
3(02)
01.07.2010
בקבוק
(תאריך האמנה )איחוד אירופי
סוג פרסום
יעקב ג'קי קמחי
נושא משקפיים
JACKOB JACKY KAMHY
Eye Glasses carrier
Class
49743
12(11)
04.07.2010
סוג פרסום
כתר פלסטיק בע"מ
אופניים
KETER PLASTIC LTD.
Bicycle
Class
313
49803 ,49801
9(03)
14.07.2010
סוג פרסום
August 31,2011 -א' באלול התשע"א
CURVER LUXEMBOURG SARL
Trash container
Convention date (OHIM)
15.01.2010
פח אשפה
(תאריך האמנה )איחוד אירופי
49859 ,49857 ,49855
49870 ,49863 ,49862
Class
11(01)
25.07.2010
סוג פרסום
H. STERN COMERCIO E INDUSTRIA S.A.
תכשיט
Jewel
Class
49898
26(03)
29.07.2010
סוג פרסום
.KONINKLIJKE PHILIPS ELECTRONICS N.V
Road lighting fixture
התקן תאורה לדרך
Convention date (OHIM)
18.02.2010
(תאריך האמנה )איחוד אירופי
314
August 31,2011 -א' באלול התשע"א
Class
49905
4(02)
02.08.2010
סוג פרסום
TANGLE TEEZER LTD.
Hairbrush with cover
Convention date (OHIM)
Class
מברשת שיער עם מכסה
(תאריך האמנה )איחוד אירופי
05.02.2010
49079
23(01)
25.02.2010
סוג פרסום
VICTAULIC COMPANY
Pipe coupling segment
Convention date (U.S.A.)
Class
28.08.2009
49083
23(01)
28.02.2010
פלח ממחבר לצינור
(תאריך האמנה )ארצות הברית
סוג פרסום
VICTAULIC COMPANY
Pipe coupling segment
Convention date (U.S.A.)
Class
28.08.2009
49311 ,49309
23(01)
18.04.2010
פלח ממחבר לצינור
(תאריך האמנה )ארצות הברית
סוג פרסום
VICTAULIC COMPANY
Pipe coupling segment
Convention date (U.S.A.)
Class
315
19.10.2009
49998
11(01)
19.08.2010
פלח ממחבר לצינור
(תאריך האמנה )ארצות הברית
סוג פרסום
August 31,2011 -א' באלול התשע"א
H. STERN COMERCIO E INDUSTRIA S.A.
תכשיט
Jewel
Class
50023
4(02)
25.08.2010
סוג פרסום
COLGATE-PALMOLIVE COMPANY
Oral care implement
Convention date (U.S.A.)
Class
26.02.2010
50032
11(01)
30.08.2010
מכשיר לטיפול בפה
(תאריך האמנה )ארצות הברית
סוג פרסום
נטע גבע
אירית אטיאס
מערכת תכשיטים
NETA GEVA
IRIT ATIAS
Jewel set
Class
50046
9(01)
02.09.2010
סוג פרסום
GLAXO GROUP LIMITED
Bottle
Convention date (OHIM)
Class
316
04.03.2010
50071
6(09)
13.09.2010
בקבוק
(תאריך האמנה )איחוד אירופי
סוג פרסום
August 31,2011 -א' באלול התשע"א
לירון קמפליס
יהונתן רוט
כרית נצמדת לחלון רכב
LIRON KEMPLIS
YEHONATAN ROTH
A pillow attachable to a vehicle's window
Class
50113
11(01)
03.10.2010
סוג פרסום
H. STERN COMERCIO E INDUSTRIA S.A.
תכשיט
Jewel
Class
50121
4(02)
03.10.2010
סוג פרסום
COLGATE-PALMOLIVE COMPANY
Oral care implement
Convention date (U.S.A.)
Class
30.03.2010
50168 ,50167
25(01)
17.10.2010
מכשיר לטיפול בפה
(תאריך האמנה )ארצות הברית
סוג פרסום
ארנון ברק
פרופיל
ARNON BARAK
Profile
Class
50350
14(03)
28.11.2010
סוג פרסום
SONY COMPUTER ENTERTAINMENT, INC.
Holder for remote controller
Convention date (JAPAN)
317
14.06.2010
מחזיק לשלט רחוק
(תאריך האמנה )יפן
August 31,2011 -א' באלול התשע"א
50391
9(03)
07.12.2010
Class
סוג פרסום
קיסריה עיצוב בנוף בע"מ
CAESAREA LANDSCAPE DESIGN
LTD.
מתקן לאיסוף קרטונים
Cardboard collection facility
Class
50419 ,50418 ,50417
6(13)
13.12.2010
סוג פרסום
ציפי דבש בע"מ
שמיכה
TZIPI DEVASH LTD.
Blanket
50421
7(05)
14.12.2010
Class
סוג פרסום
רביד טכנולוגיות הנדסת מכונות בע"מ
RAVID TECHNOLOGIES AND
MECHANICAL ENGINEERING
מייבש כלים
Dish dryer
Class
50424
23(01)
14.12.2010
סוג פרסום
נטפים בע"מ
מעמד לממטיר
Netafim ltd.
Sprinkler stand
Class
50436
24(02)
20.12.2010
סוג פרסום
MICHAEL G. ROSS
Handle for medical device
318
ידית למכשיר רפואי
August 31,2011 -א' באלול התשע"א
תאריך האמנה )איחוד אירופי(
סוג פרסום
24.06.2010
50462 ,50460 ,50459
50465 ,50464
)25(01
29.12.2010
)Convention date (OHIM
Class
אלי רום
פרופיל
ELI ROM
Profile
סוג פרסום
50471
)19(02
30.12.2010
Class
יפעה בורשטין
מעמד לפתקי ממו
YFAH BURSTIN
Memo stand
סוג פרסום
50487 ,50486 ,50485
50488
)25(01
04.01.2011
קליל תעשיות בע"מ
פרופיל
Class
KLIL INDUSTRIES LTD.
Profile
סוג פרסום
קליל תעשיות בע"מ
פרופיל
א' באלול התשע"אAugust 31,2011 -
50547 ,50546
)25(01
18.01.2011
Class
KLIL INDUSTRIES LTD.
Profile
319
מדגמים שחודשו
DESIGNS RENEWED
42950
43211
43238
43247
42627
43062
43219
43239
43248
43112
43220
43240
43544
43113
43221
43241
43662
43114
43222
43242
43921
43149
43223
43243
35598
43151
43224
43244
35604
43184
43229
43245
35675
34691
34692
34708
מדגמים שבוטלו
DESIGNS VOID
26568
34709
26602
34710
26605
26628
Asa Kling
Commissioner of Patents,
Designs and Trade Marks
320
34687
34725
34688
אסא קלינג
המדגמים,רשם הפטנטים
וסימני מסחר
August 31,2011 -א' באלול התשע"א
מפתחות לבקשות שקובלו
INDICES OF APPLICATIONS ACCEPTED
מפתח שמי
NAME INDEX
הפאקור בע"מ 157922 -
אברהם הלוי 172484 -
או .די .אפ .אופטרניקס בע"מ 172384 -
אוניברסיטת תל-אביב פיתוח טכנולוגיות
עתידיות )שותפות מוגבלת(אצל טי.אי.יו.
ניהול טכנולוגיות עתידיות בע"מ 163285 -
אורבוטק בע"מ 174705 -
אורידיון מדיקל 1987בע"מ 145821 -
אי .סי .איי .טלקום בע"מ 182937 -
איי.טי.אל אופטרוניקס בע"מ , 167567 -
169123
אינפלואנס מדיקל טכנולוג'יס בע"מ -
113909
אמ.אל.איי.אס .פרוייקטים בע"מ 162854 -
אשרדן אחזקות בע"מ 182669 -
אתוס רשתות בע"מ 166390 -
בוריס קפלן 175533 -
ביוגארד רכיבים וטכנולוגיות בע"מ -
134527
גיטאצ'י בע"מ 172410 -
דוד ארנון 193534 -
דוד דורון 193534 -
דורון מרקו 167194 -
דליה קציר 202468 -
דן מילנר 186962 -
דפוס בארי 174716 -
ה.מ.דע יעוץ ופיתוח בע"מ 180135 -
הוליס מטל אינדוסטריז בע"מ 178192 -
המרכז למחקר גרעיני נחל שורק הועדה
לאנרגיה אטומית 193730 -
א' באלול התשע"אAugust 31,2011 -
וובר פרוייקטים והשקעות בע"מ 169519 -
וונוסוניקס בע"מ 179127 -
ויז'נסנס בע"מ 157374 -
וסקולר ביוג'ניק בע"מ 156770 -
זאב אפרת 186962 -
טבע תעשיות פרמצבטיות בע"מ 171956 -
טוליפ מדיקל בע"מ 167194 -
טלדטה נטוורקס בע"מ 167862 -
יאיר דוד 193534 -
יגאל שרון 162854 -
יהונתן לוין 150148 -
יוחאי טהור 197546 -
יוסף יוספי 178518 -
יישום חברה לפיתוח המחקר של
האוניברסיטה העברית בירושלים בע"מ -
161472
יישום חברה לפיתוח המחקר של
האוניברסיטה העברית בירושלים בע"מ -
193006
כימאגיס בע"מ מחלקת קניין רוחני -
176556
מדינת ישראל -משרד החקלאות ופיתוח
הכפר ,מינהל המחקר החקלאי ,מרכז וולקני
175534מיטרוניקס בע"מ 189200 -
מיכאל גרנדר 197546 -
321
175632
- רפאל מערכות לחימה מתקדמות בע"מ
147881
179127 - סונטיקה בע"מ
134527 - סטארטן בע"מ
177148 - סמארט מערכות רפואיות בע"מ
184623 - שמעון רדליך
202468 - ששי קציר
183901 - פוטו פרינט סופ בע"מ
160843 - קבוץ סאסא- פלסאן
157922 - פרוכון ביוטק בע"מ
166085 - תדיראן טלקום בע"מ
המרכז הישראלי להשבחת מים-תמהיל
184623 - בע"מ
160182 - קליל תעשיות בע"מ
170689 - טק בע"מ-קמרו
183868 - קראוס תעשיות פיתוח בע"מ
197546 - רושל מירזקנדוב
- רפא"ל מערכות לחימה מתקדמות בע"מ
A.A. TECHNOLOGIES & I.P LTD. 182669
ABSALUT ECOLOGY
ESTABLISHMENT - 175597
ACUSPHERE, INC. - 179594
ADAPTIX, INC. - 183286
AGERE SYSTEMS INC. - 182236
ALBEMARLE CORPORATION - 185455
ALEXANDER VASILIEVICH
BORISENKO - 175597
ALLEGIANCE CORPORATION - 181821
ALZA CORPORATION - 178824
AMERICAN SCIENCE AND
ENGINEERING, INC. - 168371
AMGEN INC. - 167436
AMGEN INC. - 167436
AMS RESEARCH CORPORATION 113909
ANTONY DAVID SUTTON LICKORISH
- 202331
ARTELIS S.A. - 190546
ASHRADAN HOLDINGS LTD - 182669
ASK S.A. - 147979
ASSA AB - 186922
ASTRAZENECA AB - 167209 , 191580
AVANTOR PERFORMANCE
MATERIALS, INC. - 177728
AVANTOR PERFORMANCE
MATERIALS, INC. - 177728
AVENTIS HOLDINGS INC. - 154589
322
AVENTIS PHARMA S.A. - 161843
AVENTIS PHARMACEUTICALS INC. 154589
AVENTISUB II INC. - 154589
AVOCENT FREMONT CORP. - 187266
AVRAHAM HALEVI - 172484
AZIENDE CHIMICHE RIUNITE
ANGELINI FRANCESCO A.C.R.A.F.
S.p.A. - 172101
BABYLISS FACO S.A. - 188568
BAE SYSTEMS LAND & ARMAMENTS
L.P. - 178830
BASF AKTIENGESELLSCHAFT - 165248
BAXTER INTERNATIONAL INC. 177191
BAYER ANIMAL HEALTH GMBH 178353
BAYER CROPSCIENCE AG - 173773 ,
183804
BAYER SCHERING PHARMA AG 178353
BE'ERI PRINTERS - 174716
BIOGUARD COMPONENTS AND
TECHNOLOGY LTD. - 134527
BIOMARIN PHARMACEUTICAL INC. 182161
BIOSENSE WEBSTER, INC. - 177453 ,
183539 , 191048 , 201428
BIOVAIL LABORATORIES
August 31,2011 -א' באלול התשע"א
INTERNATIONAL S.R.L. - 171870
BIOVAIL LABORATORIES (2005) INC.
- 171870
BOEHRINGER INGELHEIM PHARMA
GMBH & CO. KG - 181522
BOEHRINGER INGELHEIM
PHARMACEUTICALS, INC. - 143394
BORIS KAPLAN - 175533
BRISTOL-MYERS SQUIBB COMPANY 181464 , 191769
BURLE TECHNOLOGIES, INC. - 181836
CABOT MICROELECTRONICS
CORPORATION - 182797
CAMERO-TECH LTD. - 170689
CAREFUSION 2200, INC. - 181821
CAROLLO ENGINEERS, P.C. - 172590
CELGENE CORPORATION - 198978
CENTRE NATIONAL DE LA
RECHERCHE SCIENTIFIQUE - 188543
CHEMAGIS LTD. - 176556
CHIESI FARMACEUTICI S.P.A. - 163843
CIPLA LIMITED - 173031
CLAUDIO DI PAOLO - 171643
COMPOSIX COMPANY - 167937
CORDIS CORPORATION - 168359
CYDEX PHARMACEUTICALS, INC. 165022
DAIICHI SANKYO COMPANY,
LIMITED - 184931
DALIA KATZIR - 202468
DAN MILNER - 186962
DAVID ARNON - 193534
DAVID DORON - 193534
DELFMEMS - 185992
DEUTSCHE EXIDE GMBH - 188130
DIADEXUS, INC - 171798
DIEHL BGT DEFENCE GMBH & CO. KG
- 190560
DIMITRI PETER FITSIALOS - 171643
DOLORES BAKSH - 202331
DOMINIQUE CHRISTINE TSCHUDI 171643
DOW AGROSCIENCES LLC - 176471
DSM IP ASSETS B.V. - 205606
DUKE UNIVERSITY - 193365
323
e2INTERACTIVE, INC. d/b/a
e2INTERACTIVE, INC. - 174065
EATON CORPORATION - 190494
ECI TELECOM LTD. - 182937
EGIS GYOGYSZERGYAR NYRT 179028
EISAI CO., LTD. - 162214
EISAI RESEARCH AND
DEVELOPMENT MANAGEMENT CO.,
LTD. - 162214
ELAN PHARMA INTERNATIONAL
LTD. - 184599
ELI LILLY AND COMPANY - 164773 ,
180277
ENVIRO TECH CHEMICAL SERVICES,
INC. - 179239
ERREGIERRE S.P.A. - 172801
ETHOS NETWORKS LTD. - 166390
EVERGREEN PACKAGING
INTERNATIONAL B.V. - 179281
EWHA UNIVERSITY
COLLABORATION FOUNDATION 178757
F. HOFFMANN-LA ROCHE AG - 185692
FIKE CORPORATION - 186449
FLOWNETIX LIMITED - 189350
FRAUNHOFER-GESELLSCHAFT ZUR
FORDERUNG DER ANGEWANDTEN
FORSCHUNG E.V. - 177335 , 182236
GE AVIATION SYSTEMS, LLC - 185475
GENDA LIMITED - 195749
GENENTECH, INC. - 136201 , 184884
GENERAL ELECTRIC COMPANY 180047
GEOX S.P.A. - 181058
GERON CORPORATION - 178006
GILEAD PALO ALTO, INC. - 165304
GILEAD SCIENCES, INC. - 180172
GKSS-FORSCHUNGSZENTRUM
GEESTHACHT GMBH - 191828
GLAXO GROUP LIMITED - 202827
GLAXOSMITHKLINE BIOLOGICALS
S.A. - 166433
August 31,2011 -א' באלול התשע"א
GLYCART BIOTECHNOLOGY AG 184498
GRAPHIC SECURITY SYSTEMS
CORPORATION - 176380
GUITOUCHI LTD. - 172410
H.M. DA CONSULTING AND
DEVELOPMENT LTD. - 180135
HALOCARBON PRODUCTS
CORPORATION - 184922
HARRIS CORPORATION - 184462
HAUSBRANDT TRIESTE 1892 SPA 182306
HEPACORE LTD. - 157922
HEWLETT-PACKARD DEVELOPMENT
COMPANY, L.P. - 183220
HMR PHARMA INC. - 154589
HOLIS METAL INDUSTRIES LTD. 178192
HONEYWELL INTERNATIONAL INC. 167937 , 191662
IBM CORPORATION - 186327
IGAL SHARON - 162854
ILLYCAFFE' S.P.A. - 180986
INCA DIGITAL PRINTERS LIMITED 193262
INFLUENCE MEDICAL
TECHNOLOGIES LTD. - 113909
INSTITUT NATIONAL
POLYTECHNIQUE DE TOULOUSE 188543
INSTITUTE OF MATERIA MEDICA,
CHINESE ACADEMY OF MEDICAL
SCIENCES - 164845
INTERDIGITAL TECHNOLOGY
CORPORATION - 172702 , 194548 ,
195539 , 199123 , 200260
INTERNATIONAL PAPER COMPANY 179281
IPR LICENSING, INC. - 207057
IPSEN PHARMA S.A.S. - 188545
ITL OPTRONICS LTD. - 167567 , 169123
JANE, S.A. - 189086
JANSSEN PHARMACEUTICA, N.V. 176357 , 177939
324
JOHN E. DAVIES - 202331
JUNGHANS MICROTEC GMBH - 190560
JUNIPER NETWORKS, INC. - 161735
KISWEL LTD. - 178452
KITE GEN RESEARCH S.R.L. - 194842
KLIL INDUSTRIES LTD. - 160182
KOS LIFE SCIENCES, INC. - 186698
KRAUSZ INDUSTRIES DEVELOPMENT
LTD. - 183868
KYOTO UNIVERSITY - 184931
L. MOLTENI & C. DEI FRATELLI
ALITTI SOCIETA' DI ESERCIZIO S.P.A.
- 187125
LAM RESEARCH CORPORATION 179695 , 185375
LAM RESEARCH CORPORATION 205779
LEIF HAUGE - 181195
LES LABORATOIRES SERVIER 167013
LG ELECTRONICS INC. - 181179 ,
182350 , 183099
LG ELECTRONICS INC. - 183916 ,
185880
LONZA INC. - 166830
LOUISIN RESEARCH AND
DEVELOPMENT LIMITED - 196060
LTS LOHMANN THERAPIE-SYSTEME
AG - 182513
M.L.I.S. PROJECTS LIMITED - 162854
MAGNAGHI AERONAUTICA S.P.A. 179792
MAK KOON HOU - 169409
MARCO DORON - 167194
MATITYAHU TENENBAUM - 186769
MAYO FOUNDATION FOR MEDICAL
EDUCATION AND RESEARCH - 172674
MAYTRONICS LTD. - 189200
MEDAREX, INC. - 167436
MICHAEL GRENADER - 197546
MICROSOFT CORPORATION - 167273 ,
186858
MORRIS HOSSEINI - 202331
MOUNTAIN VIEW
August 31,2011 -א' באלול התשע"א
PHARMACEUTICALS, INC. - 193365
MOUNTAIN VIEW
PHARMACEUTICALS, INC. - 193365
QUALCOMM INCORPORATED - 166501
, 170108 , 195020
QUALCOMM INCORPORATED - 205411
N.V. NUTRICIA - 192219
N.V. ORGANON - 186676 , 186748 ,
186831
NDS LIMITED - 179412
NDS LIMITED - 187548
NDS LIMITED - 198096
NETSCREEN SSL, INC. - 161735
NETSCREEN TECHNOLOGIES, INC. 161735
NICHOLAS RONALD GLOVER - 171643
NOKIA 2011 PATENT TRUST - 173303
NOKIA CORPORATION - 173303
NORIO OWADA - 186160
NOVARTIS AG - 164783
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD. - 175632
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD. - 147881
RAHUL SARUGASER - 202331
RAVEN BIOTECHNOLOGIES - 207587
RAYTHEON BBN TECHNOLOGIES
CORP - 208799 , 208800
RAYTHEON COMPANY - 167145 ,
168405 , 208460
RELIANCE LIFE SCIENCES PVT. LTD. 187352 , 192849
RETRACTABLE TECHNOLOGIES, INC.
- 166755
RHEA VENDORS S.P.A. - 190414 ,
192771
RHEON AUTOMATIC MACHINERY
CO., LTD. - 186725 , 192273
RHODIA CHIMIE - 187965
ROCKWELL AUTOMATION
TECHNOLOGIES, INC. - 190494
ROSHEL MIRZAKANDOV - 197546
O.D.F. OPTRONICS LTD. - 172384
OLE-BENDT RASMUSSEN - 171119
OPTINOSE AS - 144988
ORBOTECH LTD. - 174705
OREGON HEALTH & SCIENCE
UNIVERSITY - 194579
ORIDION MEDICAL 1987 LTD. - 145821
ORTHOHELIX SURGICAL DESIGNS,
INC. - 184819
ORTHO-MCNEIL PHARMACEUTICAL,
INC. - 162405
OTLAV SPA - 160598
P.M.M. HOFF HOLDING B.V. - 187853
PAX SCIENTIFIC, INC. - 172815
PFIZER INC. - 175433
PFIZER INC. - 178102
PFIZER INC. - 180933
PHOTO PRINT SOAP LTD. - 183901
PIERRE FABRE DERMO-COSMETIQUE
- 190597
PLASAN -KIBBUTZ SASA - 160843
PROBIODRUG AG - 176765
PROCHON BIOTECH LTD. - 157922
PROGEN PHARMACEUTICALS
LIMITED - 177870
PROSIDION LIMITED - 171851
325
SAFETY-KLEEN SYSTEMS, INC. 191666
SAFEVIEW, INC. - 183046
SANDVIK INTELLECTUAL PROPERTY
AB - 180060
SANKYO AGRO COMPANY, LIMITED 186163
SANOFI AVENTIS - 173802
SANOFI-AVENTIS - 181569 , 185537
SANOFI-AVENTIS DEUTSCHLAND
GMBH - 178672
SANOFI-AVENTIS DEUTSCHLAND
GMBH - 178672 , 194074
SARGENT MANUFACTURING
COMPANY - 183348
SASI KATZIR - 202468
SCHERING-PLOUGH LTD. - 176342
SEIKO EPSON CORPORATION - 180236
SELEX GALILEO LTD - 184992
SEMBIOSYS GENETICS INC. - 172469
August 31,2011 -א' באלול התשע"א
SERICOL LIMITED - 193262
SHELL INTERNATIONALE RESEARCH
MAATSCHAPPIJ B.V. - 186213
SHIMON REDLICH - 184623
SICPA HOLDING S.A. - 167173
SILVERBROOK RESEARCH PTY. LTD.
- 165002
SK CHEMICALS CO., LTD. - 178757
SKIRTLIGHT S.A. - 190896
SKYPE LIMITED - 172901
SMART MEDICAL SYSTEMS LTD. 177148
SMITHKLINE BEECHAM
BIOLOGICALS S.A. - 188875
SMITHS MEDICAL ASD, INC. - 190685
SONNETICA - 179127
SOREQ NUCLEAR RESEARCH CENTER
ISRAEL ATOMIC ENERGY
COMMISSION - 193730
STARTEN LTD. - 134527
SUMITOMO CHEMICAL COMPANY,
LIMITED. - 167058
SYMPHOGEN A/S - 179658
SYNGENTA PARTICIPATIONS AG 163770 , 165226
THE BOEING COMPANY - 187313
THE JOHNS HOPKINS UNIVERSITY 167623
THE PROCTER & GAMBLE COMPANY
- 178705
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA - 185765
THE STATE OF ISRAEL- MINISTRY OF
AGRICULTURE & RURAL
DEVELOPMENT, AGRICULTURAL
RESEARCH ORGANIZATION VOLCANI
CENTER - 175534
THE TRUSTEES OF THE UNIVERSITY
OF PENNSYLVANIA - 183946
THROMB-X NV - 169008
TING CHOON MENG - 169409
TULIP MEDICAL LTD. - 167194
TADIRAN TELECOM LTD. - 166085
TAIHO PHARMACEUTICAL CO., LTD. 179885
TAISHO PHARMACEUTICAL CO., LTD.
- 179606
TAMHIL-THE ISRAELI CENTER FOR
WATER IMPROVEMENT LTD. - 184623
TECRES S.P.A. - 187182
TEJAS ISRAEL LTD. - 166390
TEL AVIV UNIVERSITY FUTURE
TECHNOLOGY DEVELOPMENT L.P. 163285
TELEDATA NETWORKS LTD. - 167862
TELEFONAKTIEBOLAGET L M
ERICSSON (PUBL) - 184107
TERRACON TECHNOLOGIES LLC. 188527
TERRASAFE-ENVIRONMENTAL
PROTECTION LTD. - 169519
TEVA PHARMACEUTICAL
INDUSTRIES LTD. - 171956
VASCULAR BIOGENICS LTD. - 156770
VENOUSONICS LTD. - 179127
VERISIGN, INC. - 161721
VERTEX PHARMACEUTICALS
INCORPORATED - 169720
VESUVIUS CRUCIBLE COMPANY 184952
VICTAULIC COMPANY - 188017
VISIONSENSE LTD. - 157374
VIVENTIA BIOTECH INC. - 171643
VUMII, INC - 184263
326
UNILEVER PLC - 183257
UNIVERSITE MONTPELLIER II - 188543
UNIVERSITY OF ZURICH - 171643
UNIVERSITY OF ZURICH - 171643
US LYNX LLC - 172922
UWE ZANGEMEISTER-WITTKE 171643
W.C. HERAEUS GMBH - 167218
WALTER AND ELIZA HALL
INSTITUTE OF MEDICAL RESEARCH 167060
WEFFER PROJECTS AND
INVESTMENTS LTD. - 169519
WEI HU - 187542
WYETH LLC - 184599 , 190805
August 31,2011 -א' באלול התשע"א
XAAR TECHNOLOGY LIMITED 194361
YAIR DAVID - 193534
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM LTD. 161472
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM LTD. 193006
327
YOHAI TAHOR - 197546
YONATAN LEVIN - 150148
YOSEF YOSEFI - 178518
ZEEV EFRAT - 186962
ZYMOGENETICS INC. - 163066
August 31,2011 -א' באלול התשע"א
מפתח ענייני
SUBJECT MATTER INDEX
A01B - 188527
A01H - 163770, 175534
A01K - 207587
A01M - 186962
A21C - 186725
A23G - 183257, 192273
A23L - 192219
A41B - 186769
A43B - 181058
A47B - 167862
A47D - 193534
A47J - 180986, 182306, 190414
A61B - 177148, 179127, 183539,
184819, 190685, 191048,
194579, 201428
A61F - 167194, 187182
A61G - 169409
A61H - 195749, 196060
A61K - 136201, 156770, 157922,
161843, 163285, 163843,
164783, 166433, 166830,
167060, 167436, 169008,
171643, 171798, 171870,
171956, 172101, 176556,
179594, 179658, 179885,
180172, 182161, 182513,
183946, 184599, 184884,
184931, 186676, 188545,
190805, 191828, 198978
A61L - 168359
A61M - 113909, 144988, 145821,
162854, 166755, 173031,
186698
A61N - 197546
A62C - 188017
B01D - 181195, 185765
B01F - 181821
B03C - 175597
328
B05B - 187542
B08B - 191666
B23B - 179792
B23C - 180060
B23K - 178452, 186449
B24C - 182797
B25J - 175533
B26B - 188568
B29C - 171119
B32B - 191662
B41J - 180236, 194361
B41M - 193262
B44C - 183901
B60P - 168371
B62B - 189086
B64D - 185475
B65D - 169519, 179281
B65G - 184952
B65H - 174716
B67D - 192771
C01B - 179239,
C02F - 172590
C07C - 162405,
167209,
184922,
C07D - 143394
C07D - 162214,
165248,
169720,
173802,
176471,
178353,
179028,
180933,
183804,
186748,
191580,
C07F - 176342,
185455
164845, 167058,
173773, 178102,
186163, 190597
164773,
165304,
171851,
175433,
176765,
178672,
179606,
181464,
185537,
186831,
202827
191769
165226,
167013,
172801,
176357,
177939,
178757,
180277,
181522,
185692,
187125,
August 31,2011 -א' באלול התשע"א
C07H - 177870
C07K - 163066, 172674,
184498, 188875
C08B - 165022, 181569
C08J - 167623
C09D - 167173
C12M - 177335, 190546,
C12N - 154589, 161472,
178006, 187352,
193365, 202331,
C22C - 167218
178824,
192849
172469,
193006,
205606
D01F - 187965
D04H - 178705
E03B - 187853, 202468
E04G - 178518
E04H - 189200
E05B - 183348, 186922
E05D - 160598
E06B - 160182, 172484, 178192
E21B - 186213
F03D - 194842
F16D - 182669
F16L - 150148
F16L - 183868
F24D - 184623
F25D - 186160
F41A - 178830
F41G - 167567, 168405, 172384
F41H - 147881, 160843, 167937
F42B - 167145, 190560
G01F - 189350
G01J - 181836
G01N - 174705, 177453, 194074
G01S - 170689, 208799, 208800
329
G02B - 184992
G02F - 193730
G03B - 187548
G03F - 177728
G03G - 183220
G05B - 177191
G05D - 172815
G06F - 161721,
172922,
G06G - 186858
G06K - 147979,
G06Q - 174065
G06T - 175632,
G08B - 180135,
G10D - 172410
G10L - 182236
161735, 165002,
185375, 187266
183046
187313
184263
H01H - 185992, 190494
H01J - 190896
H01L - 179695, 205779
H01M - 188130
H01S - 208460
H02M - 188543
H02P - 180047
H04B - 157374, 166501, 169123,
182937, 183286, 183916,
194548, 195020, 195539
H04J - 172702
H04L - 134527, 166085, 166390,
170108, 173303, 176380,
182350, 186327, 198096
H04M - 167273
H04N - 179412
H04Q - 172901
H04W - 181179, 183099, 184107,
184462, 185880, 199123,
200260, 205411, 207057
August 31,2011 -א' באלול התשע"א
קודים למדינת המופיעים ביומן
COUNTRY CODES APPEARING IN THIS JOURNAL
Code
AR
AT
AU
BA
BE
BR
CA
CH
CN
CU
CZ
DE
DK
EC
EP
ES
FI
FR
GB
GE
GR
GT
HR
HU
IE
IL
IN
IT
JP
KR
LK
LU
LV
330
Country or Organization
Argentina
Austria
Australia
Herzegovina
Belgium
Brazil
Canada
Switzerland
China
Cuba
Czech Republic
Germany
Denmark
Ecuador
European Patent Office
Spain
Finland
France
United Kingdom
Georgia
Greece
Guatemala
Croatia
Hungary
Ireland
Israel
India
Italy
Japan
Republic of Korea
Sri Lanka
Luxembourg
Latvia
Code
MX
MY
NL
NO
NZ
PL
PT
RU
SE
SG
SI
SK
TH
TR
TW
UA
US
UY
UZ
WO
ZA
Country or Organization
Mexico
Malaysia
The Netherlands
Norway
New Zealand
Poland
Portugal
Russian Federation
Sweden
Singapore
Slovenia
Slovakia
Thailand
Turkey
Taiwan
Ukraine
United States of America
Uruguay
Uzbekistan
World Intellectual Property
Organization (W.I.P.O.)
South Africa
August 31,2011 -א' באלול התשע"א
ירושלים, משרד המשפטים,נערך ע"י רשות הפטנטים
EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEM
331
August 31,2011 -א' באלול התשע"א
© Copyright 2026 Paperzz